ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000413.1|Pyoverdine_1 # 1 # 717 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.669	BGC0000413.1|Pyoverdine_1 	1	717	-	Loose	900	25.409	MdtK	36.84	3001327	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGCAAGCCCTGCACAACATCAACCTGGACTCGCTGATCGATACCCTGGTCAGCCTCAGCGCCGCCTTTATCCTGGGGGGCCTGATCGGCTTCGAACGCCAGTACCGCCAGCGCACCGCGGGTTTGCGCACCAATGTGCTGGTGGCGGTGGGGGCCGCGATCTTCGTCGACATGGCCAACCGCCTGGGGGGCGCCGAAGGGGCGGTGCGGGTGGTGGCCTACGTGGTCTCCGGCATCGGCTTTCTCGGCGCCGGGGTGATCATGCGCGAGGAGGGTAATGTCCGTGGGCTGAATACCGCCGCCACCCTCTGGGCCTCGGCTGCGGTGGGGGCCTGCGCCGGTGCCGACCTGATCCTCGAGGCACTGCTGGGCACCCTGTTCGTGCTGGCCGCCAATACCCTGCTGCGGCCCATCGTCAACAACATCAACCGCCAGCCCCTGGACGTGGTGTCCGCCGAGGTCACCAATATCGTCTACGTGATCGCCCACCGCTCGAAGCAGAAGGCAGTGTTCGCCCTGCTGGAAGCGGAGCTGGCGCGCTGCAACTACCCCGCCAGCGACGTTGATGTGCACGCCTTCGGTACGGAGGATGTGGAGATCGAGGCGACCCTGGCGACCACCTCGGTGGACGGTGACGAACTGGATGCGCTGGTGGCCCGGCTGTCCACATCGCCCTGGGTGCAGCAGGTGTTCTGGAGCCCGAGCACCACCGAATGA	MQALHNINLDSLIDTLVSLSAAFILGGLIGFERQYRQRTAGLRTNVLVAVGAAIFVDMANRLGGAEGAVRVVAYVVSGIGFLGAGVIMREEGNVRGLNTAATLWASAAVGACAGADLILEALLGTLFVLAANTLLRPIVNNINRQPLDVVSAEVTNIVYVIAHRSKQKAVFALLEAELARCNYPASDVDVHAFGTEDVEIEATLATTSVDGDELDALVARLSTSPWVQQVFWSPSTTE	MNVSTALRQAVVRTPWYAKRKSYKVLFWREITPLAIPIFLENTCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRRRARAAARQSLVIMTLFAVVLAVVIHYFGSEIINIVAGEATPEVKGLALTYLELTVLSYPAAAIALIGSGALRGAGNTKIPLMINGGMNILNIIISSILIYGAFSWQGLGFAGAGLGLTISRYIGAVAIIWVLMIGFNPALRIPLKSYLKPLNFGIIWEVMGIGIPASIESVLFNGSKLLTQMFVAGMGTNVIAGNFIAFSVAALINLPGNALGSASTIITGKRLGTGQIGQAERQLRHVFWMSTIVLTAIAWGTAPFAGLFASFYTQEQDVKEVVKVLLWLNAAFMPIWAAAWVLPSGFKGARDVRFAMWVSMLGMWGCRVVAGYTLGIVLGMGVVGVWLGMFLDWAVRGALFYWRLISGRWLWRYPRVKRE	50.21	gnl|BL_ORD_ID|1650|hsp_num:0	1752			369	483	ciprofloxacin
BGC0000413.1|Pyoverdine_2 # 922 # 3687 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.645	BGC0000413.1|Pyoverdine_2 	922	3687	-	Loose	500	26.5646	OXA-623	43.48	3005844	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGCTCACCCTGTTGAAAGAGTTCTTTGCCGGCTTCCTGCGGACCCGGCATTTCGCCCGGCACTTCCGCCGCCTGGCACTGCTGGAAAGTTTCAGCGATGCCAGCGTCAGCCGCGACGTGCCGCCGACCCTGGCGCAAACCCTGGTGGCCGCGGCCAACAGCGATGCCGCGCAACTGCTGGACCAGCTCGGCAGCCACACCGACGGCCTGAGCACCGAGGAGGCCGATGCCCTGCGTGAGCGTCACGGCCTCAACGAGGTCGAGCACGAGCAGGCGCTGCCCTGGTGGACCCACCTGTGGCACTGCTACAAGAACCCCTTCAACCTGCTGCTGACCCTGCTGGCGGTGATTTCCTGGCTGACCGAAGACATGAAGGCGGCCACGGTGATCTTCTCCATGGTGGTGCTTTCGACCCTGCTGCGCTTCTGGCAGGAGGCCAAGTCGAACAAGGCCGCCGATGCCCTCAAGGCCATGGTCAGCAACACCGCCACGGTCATGCGCCCAGGGTCGGCGCCCCAGGCCGCGCCGATGCTCGGCCGCCTGCTGGGGGCCGCCGCCGAGGTCAAGGGCGCTCAGCGCATCGAGTTGCCGATCAAGCAACTGGTGCCCGGCGACCTGATCGTGCTCTCGGCCGGCGACATGATTCCCGCCGACTGCCGGGTGCTCAGCGCCAAGGACTTGTTCGTCAGCCAGGCGGCCATGACCGGCGAATCCATGCCGGTGGAGAAATTCCCCCGCCAGCAGGACGCCGACACCAGCAACCCCCTGGACCTGGACAACATCCTGTTCATGGGCACCAACGTGGTCTCCGGTTCCGCCACGGCAGTGATCCTGACCACCGGCAACAGCACCTATTTCGGCGCCCTGGCCCAGCGTGTCAGCGCCACCGACCGCGCGCCCACCTCGTTCCAGAGCGGGGTCAACAAGGTCAGCTGGCTGCTGATCCGCTTCATGTTCGTCATGGCGCCCCTGGTGCTGTTCATCAACGGCTTCACCAAGGGCGACTGGATGGAGGCGCTGCTGTTCGCCCTGTCGATTGCCGTGGGCCTGACCCCGGAAATGCTGCCGATGATCGTCACCTCGACCCTGGCCAAGGGCGCGGTGTTCCTGTCGCGCAAGAAGGTCATCGTCAAGCGCCTGGACGCGATCCAGAACTTCGGCGCCATGGACGTGCTGTGCACCGACAAGACCGGCACCCTGACCCAGGACAAGATCTTCCTGGCGCGGCACGTGGACGTCTGGGGCGAGGATTCCGACGACGTGCTGGAAATGGCCTACCTCAACAGCTACTACCAGACCGGGCTGAAGAACCTGCTGGACGTGGCGGTACTGGAGCACGTCGAGGTGCACCGCGAGCTCAAGGTCGGCACGGCATTCCAGAAGGTCGATGAAATCCCCTTCGATTTCACCCGTCGGCGCATGTCGGTAGTGGTGGCGGAACAGGACCGGCCGCACCTGCTGATCTGCAAGGGGGCGGTGGAGGAAGTGCTGGCGGTGTGCCGCAACGTACGCCATGGCGAAGCCGAGGAAGCCCTGACCGAGAGCCTGCTGGCGCGGATCCGCCAGGTGACCGCCGACCTCAACGAAGAGGGGCTGCGGGTGGTGGCGGTGGCCGCGCGGCCGATGATCGACGGGCGCGATACCTACAGCCTGGCGGACGAGTGCGAGCTGACCCTGATCGGCTACGTGGCATTCCTCGACCCGCCCAAGGAAAGTACCGCGCCGGCCCTCAAGGCCCTGGCCGAACATGGCGTTGCGGTGAAAGTGCTGACCGGTGACAACGAACTGGTGACGGCGAAGATCTGCCGCGAAGTGGGCCTGGAGCAGCAGGGCCTGCTGATGGGCAACGACATCGAGCGCATGAGCGACGAGCAACTGGCCCAGGCGGTGGAAACCACCAACGTGTTCGCCAAGCTGACCCCGACCCACAAGGAGCGCATTGTCCGCCTGCTCAAGGCCAACGGCCACGTGGTGGGCTTCATGGGCGACGGCATCAACGATGCCCCGGCGCTGCGCACCGCCGACATCGGCATTTCCGTGGACAGCGCGGTGGACATCGCCAAGGAAGCGGCGGACATCATCCTCCTGGAAAAGAGCCTGATGGTGCTGGAGGAGGGCGTGCTGGAAGGGCGCCGGACCTTCGCCAACATGCTCAAGTACATCAAGATGACCGCCAGCTCGAACTTCGGCAACGTGTTCTCGGTGCTGGTGGCCAGTGCCTTCATTCCGTTCCTGCCGATGCTGCCGATGCACCTGTTGGTGCAGAACCTGCTGTACGACATTTCCCAGATCGCCATTCCCTTCGATAACGTCGATGAGGAAATGCTGAAAAAACCGCAGCGCTGGCAGCCGGCGGATGTGGGGCGGTTCATGCTGTTCTTCGGGCCTATCAGCTCGATCTTCGACATCACCACCTTTGCCCTGATGTGGTACGTGTTCGACGCCAATACCCCGGACCACCAGACGCTGTTCCAGTCCGGCTGGTTCGTGGTGGGGCTCCTGACCCAGACCCTGATCGTGCACATGATCCGCACGCCGAAGATTCCGTTTTTGCAGAGCCGCGCGGCCATGCCGTTGATGGTGATGACCGGCGTCATCATGGCGGTGGGGATCTTCCTGCCGATGGGCCCGCTGGCGCACTACTTCAAGCTGCAGGCGCTGCCGTCGCTGTACTTCGTGTTCCTGCCGCTGATCCTGCTGGCCTACATGGCCCTGACCCAGGCGGTGAAGGGCTTCTACGTGCGGCGCTTCGGCTGGCAGTAA	MKLTLLKEFFAGFLRTRHFARHFRRLALLESFSDASVSRDVPPTLAQTLVAAANSDAAQLLDQLGSHTDGLSTEEADALRERHGLNEVEHEQALPWWTHLWHCYKNPFNLLLTLLAVISWLTEDMKAATVIFSMVVLSTLLRFWQEAKSNKAADALKAMVSNTATVMRPGSAPQAAPMLGRLLGAAAEVKGAQRIELPIKQLVPGDLIVLSAGDMIPADCRVLSAKDLFVSQAAMTGESMPVEKFPRQQDADTSNPLDLDNILFMGTNVVSGSATAVILTTGNSTYFGALAQRVSATDRAPTSFQSGVNKVSWLLIRFMFVMAPLVLFINGFTKGDWMEALLFALSIAVGLTPEMLPMIVTSTLAKGAVFLSRKKVIVKRLDAIQNFGAMDVLCTDKTGTLTQDKIFLARHVDVWGEDSDDVLEMAYLNSYYQTGLKNLLDVAVLEHVEVHRELKVGTAFQKVDEIPFDFTRRRMSVVVAEQDRPHLLICKGAVEEVLAVCRNVRHGEAEEALTESLLARIRQVTADLNEEGLRVVAVAARPMIDGRDTYSLADECELTLIGYVAFLDPPKESTAPALKALAEHGVAVKVLTGDNELVTAKICREVGLEQQGLLMGNDIERMSDEQLAQAVETTNVFAKLTPTHKERIVRLLKANGHVVGFMGDGINDAPALRTADIGISVDSAVDIAKEAADIILLEKSLMVLEEGVLEGRRTFANMLKYIKMTASSNFGNVFSVLVASAFIPFLPMLPMHLLVQNLLYDISQIAIPFDNVDEEMLKKPQRWQPADVGRFMLFFGPISSIFDITTFALMWYVFDANTPDHQTLFQSGWFVVGLLTQTLIVHMIRTPKIPFLQSRAAMPLMVMTGVIMAVGIFLPMGPLAHYFKLQALPSLYFVFLPLILLAYMALTQAVKGFYVRRFGWQ	MKKIILFLWILNFAFGQDKILEDFFKDYNTSGTFIVFDGKNYASNDFQRAKQTFSPASTFKIFNALIALDNGVIKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSNKSQEEVKKLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREKLLEKYIYSLN	371.37	gnl|BL_ORD_ID|3879|hsp_num:0	4949			474	543	cloxacillin; oxacillin; cefalotin
BGC0000413.1|Pyoverdine_3 # 4236 # 5573 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.628	BGC0000413.1|Pyoverdine_3 	4236	5573	-	Loose	500	27.335	OXA-45	33.33	3001794	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACACAGGCAATTGCATCGGCCCACGTTCACGATTTGATCGGTATCGGTTTCGGCCCCTCGAACCTGGCGCTGGCCATTGCGCTGGAGGAGCGCGGGCAGGAGCACGGTCCGCTGGACGCGTTGTTCCTCGACAAGCAGGCTGACTATCGCTGGCACGGCAACACCCTGGTAACCCAGAGCGAACTGCAGATTTCCTTCCTCAAGGACCTGGTGACCCTGCGCAACCCCACCAGCCCCTATTCCTTCGTCAACTACCTCAAGCACCACGGGCGCCTGGTGGACTTCATCAACCTGGGCACCTTCTATCCATGCCGCATGGAGTTCAACGACTACCTGCGCTGGGTGGCCGGGCATTTCCAGGAACACAGCCGCTACGGCGAAGAAGTGCTGGCCATCGAGCCAGTGCTGCACAACCAGCAGGTCGAGGCGTTGCGGGTGATTTCCCGGGATGCCCAGGGCAGCGAACTGGTGCGAACCACCCGTTCGGTGGTGGTCAGTGCCGGCGGCACGGCGCGTGTTCCGGAAACCTTCAAGGGGCTCAAGGGCGATGCGCGGGTGTTCCACCATTCCCAGTACCTGGAACGCATGGCCAGCCAGCCCTGTGTCAGTGGCAAACCGATGAACATCGCCATCATCGGCGGCGGGCAGAGCGCGGCAGAAGCCTTCATCGACCTCAACGACAGTTTCCCTTCGGTGCAGGCCGACATCATCATGCGCGGTTCGGCACTCAAGCCGGCGGATGACAGCCCGTTTGTCAACGAAGTGTTCTCCCCGGCCTTCACCGACCTGGTGTTCCAGCAGACCGGCAGTGAGCGCGAGCGCCTGGTCAGCGAGTACCAGAACACCAACTATTCGGTGGTGGACATCGACCTGATCGAGCGCATCTACGGGATCTTCTACCGGCAGAAGGTTTCCGGCATCGCGCGCCACACCTTCCGCACCATGACCACGGTGGAGAAGGCCACCGCTACCGACCTGGGCATCGAACTGATCCTGCGCAACAGTGCCAGCGGCGAGCGCGAAGTGCGTCACTACGATGCGGTGGTGCTGGCCACCGGCTACGAGCGGCAGATGCATCGTCAACTGCTGGCGCCGCTGCAGGCCTACCTGGGTGACTTCGAGGTGGACCGCAATTACCGCCTGGTGACCGACGAGCGCTGCAAGGCCGGCGTCTACATGCAGGGCTTCAGCCAGGCCAGCCATGGCCTGAGCGACACCTTGCTGTCGGTGCTGCCGATCCGTGCCCAGGAGATTGCCGATTCGCTCTACGAACACGGCAAGAGCCGCGGTCACAGCCGTTCGGTGCGTGACATGCTGCTGGCCACCGCCAGCTGA	MTQAIASAHVHDLIGIGFGPSNLALAIALEERGQEHGPLDALFLDKQADYRWHGNTLVTQSELQISFLKDLVTLRNPTSPYSFVNYLKHHGRLVDFINLGTFYPCRMEFNDYLRWVAGHFQEHSRYGEEVLAIEPVLHNQQVEALRVISRDAQGSELVRTTRSVVVSAGGTARVPETFKGLKGDARVFHHSQYLERMASQPCVSGKPMNIAIIGGGQSAAEAFIDLNDSFPSVQADIIMRGSALKPADDSPFVNEVFSPAFTDLVFQQTGSERERLVSEYQNTNYSVVDIDLIERIYGIFYRQKVSGIARHTFRTMTTVEKATATDLGIELILRNSASGEREVRHYDAVVLATGYERQMHRQLLAPLQAYLGDFEVDRNYRLVTDERCKAGVYMQGFSQASHGLSDTLLSVLPIRAQEIADSLYEHGKSRGHSRSVRDMLLATAS	MRGKHTVILGAALSALFAGAAGAQMLECTLVADAASGQELYRKGACDKAFAPMSTFKVPLAVMGYDAGILVDAHNPRWDYKPEFNGYKFQQKTTDPTIWEKDSIVWYSQQLTRKMGQKRFAAYVAGFGYGNGDISGEPGKSNGLTHSWLGSSLKISPEGQVRFVRDLLSAKLPASKDAQQMTVSILPHFAAGDWAVQGKTGTGSFIDARGAKAPLGWFIGWATHEERRVVFARMTAGGKKGEQPAGPAARDAFLKALPDLAKRF	168.56	gnl|BL_ORD_ID|23|hsp_num:0	28			435	525	cloxacillin; oxacillin; cefalotin
BGC0000413.1|Pyoverdine_4 # 5723 # 6256 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.637	BGC0000413.1|Pyoverdine_4 	5723	6256	-	Loose	450	25.7942	OXA-647	52.0	3005337	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCCGGACTTGCTCAAGGACAGAACCGCCCCAGTGGGCGCTCGGGAGCCCTGTTGGAAAACTACTATCGCGAGCTGATGTGCTTCCTCAACGCCAAGCTGGGCAATCGCCAGGTGGCCGAGGATGTGGTGCATGACGCTTATGTGCGGGTCCTGGAGCGCTCCAGCGATACCCCCATCGAGCAGCCGCGGGCGTTTCTCTATCGCACGGCCCTGAACCTGGTGATCGACGGCCATCGGCGCAATGCCTTGCGCCAGTCCGAGCCCCTGGAGGTGCTGGACAACGAAGAGCGTTACTTCAACCCTTCGCCGCAGACCAGCCTGGATCACGGCCAGCGCCTGGAAATGCTGCAACGGGCCCTGGCCGAGCTGCCCCGGCTGTGTCGCGAGAGCTTCCTGCTGCGCAAGCTCGAAGGCCTGTCCCACCCGCAGATCGCCGAACAGCTGGGGATTTCCCGCAGCCTGGTGGAGAAACACATCGTCAATGCCATGAAGCATTGCCGGTCGCGCCTGCGCCAGTGGGATGCTCAATAA	MAGLAQGQNRPSGRSGALLENYYRELMCFLNAKLGNRQVAEDVVHDAYVRVLERSSDTPIEQPRAFLYRTALNLVIDGHRRNALRQSEPLEVLDNEERYFNPSPQTSLDHGQRLEMLQRALAELPRLCRESFLLRKLEGLSHPQIAEQLGISRSLVEKHIVNAMKHCRSRLRQWDAQ	MKILILLPLLSCLGLTACSLPVSSLPSPSTSTQAIASLFDQAQSSGVLVIQRDQQVQVYGNDLNRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKDEG	64.84	gnl|BL_ORD_ID|4766|hsp_num:0	4069			720	795	cloxacillin; oxacillin; cefalotin
BGC0000413.1|Pyoverdine_5 # 6532 # 7704 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.652	BGC0000413.1|Pyoverdine_5 	6532	7704	+	Loose	760	193.741	macA	36.39	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAACGTCCTCGCCCTACCCGACGCGCCCTGCTTGCCGCACTGTGTGTGATCCCCGTTGTTGCCATCGCTGCCTGGAAGTTCATCCCGGCGGGCCGTGACCAGTTCACCACCGTGCAAGTGAGCCGCGGCGATATAGAAAGCAGCGTCACCGCCCTAGGCACCTTGCAGCCACGACGCTACGTGGATGTGGGCGCCCAGGCGTCCGGGCAGATCCGCAAGATCCACGTCGAATCCGGTGATCAGGTCAAGGAAGGCCAGTTGCTGGTGGAGATCGACCCCTCCACCCAGCAGGCAAAACTCGACGCCAGCCGTTTCTCCATCGAGAACCTGCAGGCCCAGTTGCAGGAGCAGTACGCCCAGAACCAGCTGGCCCGGCAGAAGTACCAGCGCCAGCAGAACCTCAAGGCCGGCGGCGCCACCCGCGAGGAAGACGTACAGACCGCCCAGGCCGAACTCAAGGCCACCCAGGCGCGGATCGACATGTACAAGGCGCAGATCCGCCAGGCCCAGGCCAGCCTGCGCAGCGACCAGGCCGAACTGGGCTACACGCGCATCTATGCGCCCATGTCCGGCACCGTGGTCGCGGTGGACGCCCGCGAAGGCCAGACCCTCAACGCCCAACAGCAGACCCCGTTGATCCTGCGCATCGCCAAGCTCTCGCCCATGACCGTCTGGGCCGAAGTCTCGGAAGCCGATATCGGCCACGTCAAACCCGGCATGCACGCCTACTTCACCACCCTGAGCGGCGGCAACCGACGCTGGACCAGCACTGTGCGGCAGATCCTGCCGATCCCGCCCAAGCCCCTCAACGAATCCAGCCAGGGCAGCGGCAGCCCCAACAGCACCAGCAAGAGCGGCAGCGGCCGGGTGGTGCTCTACACCGTGCTGCTGGACGTGGACAACGCCGACAACGCCCTGATGGCGGAAATGACCACCCAGGTGTTCTTCGTCGCCAATCAGGCAAAAAATGTGCTCACCGCCCCCATCGCCGCCCTGCACGGCAGTACCGAGCCGGACCTGCAGATGGCTCGGGTAGTGGCCAAGAACGGCTCGATCGACGAACGCAAGGTCCGGGTCGGCATCAGCGACCGCCTGCGCATCCAGATCCTCGACGGCTTGAACGAAGGTGATCATCTGCTGATCGGCCCGGCCAACAGCAGCGGGGGTTGA	MKRPRPTRRALLAALCVIPVVAIAAWKFIPAGRDQFTTVQVSRGDIESSVTALGTLQPRRYVDVGAQASGQIRKIHVESGDQVKEGQLLVEIDPSTQQAKLDASRFSIENLQAQLQEQYAQNQLARQKYQRQQNLKAGGATREEDVQTAQAELKATQARIDMYKAQIRQAQASLRSDQAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAEVSEADIGHVKPGMHAYFTTLSGGNRRWTSTVRQILPIPPKPLNESSQGSGSPNSTSKSGSGRVVLYTVLLDVDNADNALMAEMTTQVFFVANQAKNVLTAPIAALHGSTEPDLQMARVVAKNGSIDERKVRVGISDRLRIQILDGLNEGDHLLIGPANSSGG	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	99.49	gnl|BL_ORD_ID|1546|hsp_num:0	1680			57	1110	erythromycin
BGC0000413.1|Pyoverdine_6 # 7705 # 9678 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.666	BGC0000413.1|Pyoverdine_6 	7705	9678	+	Loose	1280	494.197	macB	41.45	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCAGACGCCTCTGATCGACCTCAGGAACATCCGCAAATCCTACGGCGGCGGCGACAGCCCGCAGGTCGATGTCCTGCGGGGCATCGACCTGTCGATCCACGCCGGCGAGTTCGTCGCCATCGTCGGCGCCTCGGGCTCCGGCAAGTCGACGCTGATGAACATCCTCGGCTGCCTGGATCGCCCAACCTCGGGCGAGTACCTGTTCGCCGGGGAGAACGTGGCTCACCTGGACAGCGACGAACTGGCCTGGCTACGCCGCGAAGCCTTCGGCTTCGTGTTCCAGGGCTACCACCTGATCCCCTCGGCTTCGGCCCAGGAAAACGTCGAGATGCCGGCCATCTACGCCGGCACCCCGACCGCCGAACGTCACACCCGCGCCGCCGCCCTGCTGGAGCGCCTGGGCCTGGCCAGCCGCAGCGGCAACCGCCCGCATCAATTGTCCGGTGGCCAGCAGCAGCGAGTGTCCATCGCCCGCGCCCTGATGAACGGCGGCCACATCATCCTCGCCGACGAACCTACCGGCGCCCTGGACAGCCACAGCGGCGCCGAAGTCATGGCCCTGCTGGACGAACTGGCCAGCCAGGGCCACGTGGTGATCCTCATCACCCACGACCGCGAAGTGGCGGCCCGGGCCAAGCGCATCATCGAGATCCGCGACGGCGAGATCATCAGCGACACCGCCACCAGCGATCCCTCGGTACAACTGAGCGCCAACGCCGGCGCCTTGCAAGCCGTGGACCTGCGCCAGCGCCTGGCCGACGGCAGCGAGCCCACCGGTGCCTGGAAAGGCGAACTGCTGGAAGCCATACAGGCCGCCTGGCGGGTGATGTGGATCAACCGCTTCCGCACCGCCCTGACCCTGCTGGGGATCATCATCGGCGTGGCCTCGGTGGTGGTGATGCTGGCGGTGGGCGAAGGCAGCAAGCGCCAGGTGATGGCGCAGATGGGGGCGTTTGGCTCGAACATCATTTACCTGAGCGGCTACTCGCCCAACCCGCGCACCCCGGAAGGCATCGTCACCCTGGATGACGTCGCCGCCCTGGCCAACCTACCCCAGGTGAAACGGATCATGGCGGTCAACGGCGCCAAGGCCGGGGTGCGTTTCGGCAACGCCGACTACATGAGCTACGTGGGCGGCAACGACACCAACTTCCCGGAAATCTTCAACTGGCCCGTGGCCCAGGGCAGCTACTTCAGCGAGGCCGACGAAAGCTCGGCGGCGGCAGTGGCGGTGATTGGCCACAAGGTCCGGGAAAAGCTCCTCAAGGACGTGGCCAACCCCATCGGCCAGTACATCCTCATCGAAAACGTGCCGTTCCAGGTGGTCGGCGTACTCTCGGAAAAAGGCGCCAGCTCCGGCGACAGCGACAGTGACGACCGCATCGCCGTGCCCTACTCCGCCGCCAGCATCCGCCTGTTCGGCGACCACAACCCGCAGTACGTGGCGATCGCCGCCGCCGATGCCAGCCGGGTCAAGCAGACCGAACAGGAGATCGATGAACTGATGCTACGCATGCACGGCGGCAAGCGCGATTTCGAACTGACCAACAACGCCGCGATGATCCAGGCCGAGGCCCGGACCCAGAACACCCTGTCGCTGATGCTCGGCGCCATCGCCGCGATCTCGCTGCTGGTGGGCGGCATCGGGGTGATGAACATCATGCTCATGACCGTGCGCGAACGCACCCGGGAAATCGGTATCCGCATGGCCACCGGTGCCCGCCAGCGCGACATCCTGCGCCAGTTCCTCACTGAAGCAGTGATGCTTTCAGTGGTCGGTGGCCTGGCCGGCATCGGCGTGGCCCTGATCATCGGCGGCATCCTGATTCTCAGCGAAGTGGCGGTGGCCTTCTCCCTGGCCGCAGTGCTCGGTGCCTTCGCCTGCGCCCTGGTCACCGGCGTCATCTTCGGCTTCATGCCGGCCCGCAAAGCTGCCCGGCTCGACCCGGTCACGGCCCTTACCAGTGAATGA	MQTPLIDLRNIRKSYGGGDSPQVDVLRGIDLSIHAGEFVAIVGASGSGKSTLMNILGCLDRPTSGEYLFAGENVAHLDSDELAWLRREAFGFVFQGYHLIPSASAQENVEMPAIYAGTPTAERHTRAAALLERLGLASRSGNRPHQLSGGQQQRVSIARALMNGGHIILADEPTGALDSHSGAEVMALLDELASQGHVVILITHDREVAARAKRIIEIRDGEIISDTATSDPSVQLSANAGALQAVDLRQRLADGSEPTGAWKGELLEAIQAAWRVMWINRFRTALTLLGIIIGVASVVVMLAVGEGSKRQVMAQMGAFGSNIIYLSGYSPNPRTPEGIVTLDDVAALANLPQVKRIMAVNGAKAGVRFGNADYMSYVGGNDTNFPEIFNWPVAQGSYFSEADESSAAAVAVIGHKVREKLLKDVANPIGQYILIENVPFQVVGVLSEKGASSGDSDSDDRIAVPYSAASIRLFGDHNPQYVAIAAADASRVKQTEQEIDELMLRMHGGKRDFELTNNAAMIQAEARTQNTLSLMLGAIAAISLLVGGIGVMNIMLMTVRERTREIGIRMATGARQRDILRQFLTEAVMLSVVGGLAGIGVALIIGGILILSEVAVAFSLAAVLGAFACALVTGVIFGFMPARKAARLDPVTALTSE	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	102.02	gnl|BL_ORD_ID|446|hsp_num:0	487			6	1932	erythromycin
BGC0000413.1|Pyoverdine_7 # 9686 # 11077 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000413.1|Pyoverdine_7 	9686	11077	+	Loose	600	191.43	OprZ	32.4	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTGCACCTGACCCTCCTGGCCGCCAGCGTCTTGCTGGCGGCCTGCAGCAGCCCGGCGCCGCGCCCGGAAAGCGGCCTGCAAGCACCGGCGTCCTGGCACTCTCCCGCCAGCCAGGGCGACCGGCAGCAAGACCTGCGCTGGTGGACCCGTTTCGGCAGCCCGGAGCTGGACCAACTGATCGCCGAAGCCCGGGCCGGCAGCCATGACCTGGCCGCCGCCATGGCCCGGGTCCGCCAGGCCCAGGCCAGTGCCATCGTCGCCGGGGCACCGCTGCTGCCCAGCGTCAATGGCACCTTCAACGCCAGCCGCAGAAAACAGTTGCGCGGCAACAACTCCAGCCAGCTCGATTCCAGCAGCAACAGCACGGTCACGAACTCGTTCGACGCGGGCCTGAGCGCCACCTATGAAGTCGACTTCTGGGGCGGTCGCCGCGCCGCCTACGACAGCGCCCTGCTCGGGGTCCAGGCCAGCGAGTTCGACCAGGCCACCGTTGAGCTGACCCTGCTCAGCGGCGTGGCCAACAGCTATGCCCAGGTCCTGTCCCTGCGCGAACAGAGCCGTATCGCCGAACTCAACCTGGCCAATGCGCAGAACGTGTTGCAACTGGTGCAGACCCGCTATGACTCCGGCTCGGCCACCGCCCTGGAACTGGCCCAGCAGAAAAGCCTGGTGGCCGCCCAGCAACGCCAGGTGCCCCTGGTGCAACAGCAGGCCGAAGAGGCGCAGATCACCCTCGCCACCCTGCTGGGCCGGCCGGTACAGAGCCTGAAACTGAACGACCAGCCCTTTGCCCAATTGAACTGGCCGACCATCGATGCCGGGGTGCCCAGCGAACTGCTGACCCGCCGTCCCGATATCGCCGGTGCCGAGGCCCGGCTGGCGGCGGCCCAGGCCGATGTCAAAGTGGCGCGGGCGGCAATGCTGCCGACCCTGACCCTGACCGCCAACCTGGGTTCGAACGCCGACAAGCTGGGCAATGTCTTGCGCAATCCCTTCTACAACCTCACCTCCGGGCTGGTGGCGCCGATCTTCAACAACGGGCGCCTGAGCGCCGAACGGGACAGGACCACAGCGCGCCAGCAAGAGCTGCTGGAGACTTATCGCGGGGCGATCATCAATGGTTTTGCCGATGTGGAGAAAGCCCTCAATAGCATTCGCGGCCTGGACCAGCAGCGCCAGTGGCAGAGCGAAGAACTGAACCAGGCGCAGCGCGCCTTCGAGATCGCCCAGAGCCGCTATCAGGCCGGCGCCGAAGACCTGCTGACCGTCCTGGAAACCCAGCGCACCCTGTACACCGCCCAGGACCAGAACGTGCAACTGCGGCTGTCGCGCCTGCAGTCGAGCATTGCCCTGTACAAGGCCCTGGGGGGCGGCTGGAGCCACTGA	MKVHLTLLAASVLLAACSSPAPRPESGLQAPASWHSPASQGDRQQDLRWWTRFGSPELDQLIAEARAGSHDLAAAMARVRQAQASAIVAGAPLLPSVNGTFNASRRKQLRGNNSSQLDSSSNSTVTNSFDAGLSATYEVDFWGGRRAAYDSALLGVQASEFDQATVELTLLSGVANSYAQVLSLREQSRIAELNLANAQNVLQLVQTRYDSGSATALELAQQKSLVAAQQRQVPLVQQQAEEAQITLATLLGRPVQSLKLNDQPFAQLNWPTIDAGVPSELLTRRPDIAGAEARLAAAQADVKVARAAMLPTLTLTANLGSNADKLGNVLRNPFYNLTSGLVAPIFNNGRLSAERDRTTARQQELLETYRGAIINGFADVEKALNSIRGLDQQRQWQSEELNQAQRAFEIAQSRYQAGAEDLLTVLETQRTLYTAQDQNVQLRLSRLQSSIALYKALGGGWSH	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	100.00	gnl|BL_ORD_ID|2408|hsp_num:0	2796			0	1362	erythromycin; cefepime
BGC0000413.1|Pyoverdine_8 # 11178 # 11477 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0000413.1|Pyoverdine_8 	11178	11477	+	Loose	1250	24.2534	mecC	44.83	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGTCCCTCGAAAATGTGCCGCACGACCCACTGGCAGACCTGCTGGCCCTGCTGCGCAAGGTCTACCCCAACGGGCTCGACAACCGCGACTACAAGCGCCTTCTGGTGCTGCTGTACCCACACTTGTGCGACCGCAATCTGGCGCAGTTGATGGCGCAGCTCACCCACAGGGACGCGGACCTCATTCTCAACGACCTCTACGCCGCCGTGACCGGCCAGCCGCCGCCCGCCGCAGAGCTGGAAGCGTTGCAGGCGCTACTGGAGCGGCACGGCGCCCGGGCCCTCCTGACGGACGACTGA	MSLENVPHDPLADLLALLRKVYPNGLDNRDYKRLLVLLYPHLCDRNLAQLMAQLTHRDADLILNDLYAAVTGQPPPAAELEALQALLERHGARALLTDD	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	14.89	gnl|BL_ORD_ID|742|hsp_num:0	810			1053	1140	methicillin
BGC0000413.1|Pyoverdine_9 # 11496 # 11933 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.607	BGC0000413.1|Pyoverdine_9 	11496	11933	+	Loose	1750	29.6462	amrB	31.03	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACGTCGAGGACTTCAAGCAACTGCTGGACGAGCGCAAGCGCAGCCATCCGATCTGGTTCGAACTGCCGTCGGACCGCCTTGCCAGCCAAACCCAAATCCTGGAGGCGCAGCAGGCCTTGGGGCTGCAACTGCCAGCCGACTACACCTGGTTCCTCAAGGAGTGCGGCGGCGGCTACTTTGCCCTGGCCATGCTCTACTCACTGGACAGCAGCAGTGATTTCCACCTGGTGCAGATCAACCGGGCGCACCCGGCCATCACCGGCCGTCACCTGCTGTTTTCAGAGAACGGTTGTGGTGACTTCTACGGGTTCAGGATCGAGAACCGGCACTGCCTGGCACCGGTCGAGTTTTTCGACCACAGCTGCGGGCAATGGCAAACCAGCCGATACAACGGGCTCTTGAGCTTCCTCGCCGAAGTGGCCCTGAGCAACTGA	MNVEDFKQLLDERKRSHPIWFELPSDRLASQTQILEAQQALGLQLPADYTWFLKECGGGYFALAMLYSLDSSSDFHLVQINRAHPAITGRHLLFSENGCGDFYGFRIENRHCLAPVEFFDHSCGQWQTSRYNGLLSFLAEVALSN	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	13.90	gnl|BL_ORD_ID|428|hsp_num:0	476			2229	2478	
BGC0000413.1|Pyoverdine_10 # 11944 # 13512 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.665	BGC0000413.1|Pyoverdine_10 	11944	13512	-	Loose	1050	26.1794	carA	47.62	3002817	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGGCGTACTACACCCAGAAGGAGTTGCTGCGTCAGGATGTTCGCCGCAAGGAAGAGCAGGAGATCACCCCCGGGGAAGCCAAGCTGGAGGTGGCCCTGGACCCTGGTGTGCGCCTTGCCGATCACCTGCGGGGCATCTGGGATATCGAGTTTCTCGACGCCAACGGACCGCAATCCCTGCCTCGTAAAGGTTGTGAGTTGTTACTGGATGCCGGCCCCACCGGGCGCGGCTTGCGTGGCCTCCTGGGGCGTGCGCAGAGCCTGCGAGGCGACGGCCCGGTGGAGTTCATGGTGCAGGGCGACCTGGCGTCGGTGGACGCCGCCAGGTTGCGCTGGCGCTTGTTTGCCGGTGGCCGCATCGCCGGTGCCCCCAGCTATGAATGCCAGGTGGTGCTCGATGAGGTCTGGGCCAGTTGGGGCAATGCCGGCAGCGGCACCCTCAGTGGCAGCCTGCAGTCGCTGCAGGCGTCGCCACTGGCGCCGGTATCCGCGGCGCGTTTTGTGGCGCGCAAGCGAGTCTTTCCTGCCGCCCGGGACCAGAGCGGGCTGAGCCCCGCCTTGCTGGCGTGGCTGGTATCGCCGCAGCACCGCCTGTTCCATCAGCTCTGGCACGCTTCGCGGGACCGTTGGCACACCCTGCCCAAGGACAAGCGCAACAGCCTGCGGGGGCTCGGCTGGCAGCCGGGCCCGGTCAAGCATGAACGTGACGCCCGTGGGCGGCGCAAGCACCGCAATGCCTCGGGCATCGATTTTCTGTTCATGCACCGGCACATGCTCCTGCACGCCCGCTCGTTGCAGCCGGACCTGGTGTCCTGGCAGCAGTTGCCGCAGCCCTGTGCCCGTCTTGAGCAGGACCGGCAGGCCTTTATCCGCTATTACGAAAACCACGACGGCTGTTCGGTGCCACCGGCCTGGGTGGCCGACGATGATGAAGAGTTCACCCAATGGCTGCACGGGCTGAAAAGTGATGCGGCGTTCTATGGCAACTTCCAGGTCTGGGAGTCGCAGTACCAGGACCCCGAGTACCTCAGCCGCCTGACCCTGGGCCAGTTCGGGTCCGAGGTCGAGCTGGGCCTGCACGACTGGCTGCACATGCGCTGGGCGGATGTCGCCCGCGATCCTTCCAACGGCATGCCGGTGATGGAAGCGCGCCTGTCCTCGGACTTCGCCGGGCGCTGGTACCAGCCGCAGAATGACTTTCTCGGCGATCCCTTCTCGTCCCACGTGCACCCCATGTTCTGGAAATTCCATGGCTGGATCGATGACCGGATCGACGACTGGTTCCGGGCCCACGAGCGCTACCACCCCGGCGAAGTGTTGCGCCGTGAGGTCAATGGCGTGCCCTGGTTCGCCCCCGGGCGTTGGGTCGAGATCGACGACCCGTGGCTGGGGGCCTCGACCCATGGCTGCGGCCCCCTGGGCAATGCCCCGGGAGAAATGTCCCTGGAGATGGATCAGGAGGTCATGAAGCTGGCCTTGCGCATCGCCCTGAGCCGCGACGAAGAGGTGCCGGACCTGCTCAAGCGGGCACCGCGCCGGCCCTGGTATGCCCAGCACTTGAAGCTCTGA	MAYYTQKELLRQDVRRKEEQEITPGEAKLEVALDPGVRLADHLRGIWDIEFLDANGPQSLPRKGCELLLDAGPTGRGLRGLLGRAQSLRGDGPVEFMVQGDLASVDAARLRWRLFAGGRIAGAPSYECQVVLDEVWASWGNAGSGTLSGSLQSLQASPLAPVSAARFVARKRVFPAARDQSGLSPALLAWLVSPQHRLFHQLWHASRDRWHTLPKDKRNSLRGLGWQPGPVKHERDARGRRKHRNASGIDFLFMHRHMLLHARSLQPDLVSWQQLPQPCARLEQDRQAFIRYYENHDGCSVPPAWVADDDEEFTQWLHGLKSDAAFYGNFQVWESQYQDPEYLSRLTLGQFGSEVELGLHDWLHMRWADVARDPSNGMPVMEARLSSDFAGRWYQPQNDFLGDPFSSHVHPMFWKFHGWIDDRIDDWFRAHERYHPGEVLRREVNGVPWFAPGRWVEIDDPWLGASTHGCGPLGNAPGEMSLEMDQEVMKLALRIALSRDEEVPDLLKRAPRRPWYAQHLKL	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	94.74	gnl|BL_ORD_ID|853|hsp_num:0	928			597	660	carbomycin
BGC0000413.1|Pyoverdine_11 # 13780 # 15153 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.643	BGC0000413.1|Pyoverdine_11 	13780	15153	+	Loose	700	30.0314	AQU-3	30.0	3004648	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	AQU beta-lactamase	ATGATCAAAATATCTGGTAAGAAAACCCTCTATCTGAGCCTGCTGATACTTATCATCGCCGCCCTCGGCGTCGGTGCCGGCGCGGCCTGGCACTACTACTGGAAGGATCGGGTGTCCTACCCCAACGAAATCGTCAAGCACGCCAACGACCTGCAGGAGCGCATCATTTCCTTCGACAGCCACATTACCGTGCCCCTGGATTTCGGCACCGAAGGCAGCGAAGCGGACAAGGACACCTCTCGCCAGTTCGACCTGGTCAAGGCCGGTCGCGGCCGCATGTCCGGCGCCGCCCTGAGCATCCTGGCCTGGCCGGAGATGTGGAACGGCGCCAACGCACCGCACCGTCCCACCGCCGGCTTCGTCGAGGAAGCCCGCCACCAGCGCGAGACCCGCTACCGGATCATCCAGGGCATGGTGCGTGACTTCCCCAACCAGGCCGCCATCGCCTACACCCCCGCCGACCTGCGCCGCATTGCCTCCGAAGGCAAGGTGGCGGTGGTGATCAGCCTGCTCAATGCCTACGCCATGGGCGACGACCTGGACCAGCTGGACCAGTGGGCCGCACGGGGCATGCGCCTGTTCGGCTTCAGCTATGTGGGTAACAACGACTGGGCCGACTCGTCGCGCCCGCTGCCCTTCTTCAATGACACCCGGGACGCCCTCGGCGGCCTCTCGCCCATCGGCAAGCAGGCGGTGCAGCGGCTCAATGACCTGGGGGTGGTGATCGACGTCTCGCAGATGTCGAGCAAGGCCCTGGACGACGTTGCGAGCCTGACCCGGGCACCGGTGGTGGCTTCCCACTCCGCCCCCAGGGCGCTGGTGGATATCCCGCGCAACCTCAGCGACCAGGAAATGCAACAGATCAAGGCCACCGGCGGGGTGATCCAGGTCGTGGGCTTCTCCACCTACCTGCGCCCCCTCAGCCAGCCGACCCTGGACAAGCTCAATGCCTTGCGCAAGCGCTTCGACCTCGGGCCGCTGCAAGGCCTGGAGAACGCACTGATGCCCGGCGACGCCGTGATCACCATCTGGCCGGAACAGCGCTTTGGCGAATACGCCAGCTCCCTGTACGGCATCCTCGATGAGGAACCCAAGGCCAGCCTCAAGGACTATGTCGACGCCATCGATTACACGGTGAAGAAAGTCGGCATCGACCACGTCGGCATCAGCTCGGACTTCAACGAGGGCGGTGGCGTCAATGGCTGGATGAGCGTGGCGGACAACCGCAACGTCACCGCCGAGCTGATCCAGCGTGGCTACAGCGATATCGAGATCGCCAAGCTCTGGGGCGAGAACTATCTGCGCGTCTGGGAACAGGTGCAGAAACTGGCCAAGCCTGCAAAACCCGCCCCTCAACCCGCCATCGCCGGCTAA	MIKISGKKTLYLSLLILIIAALGVGAGAAWHYYWKDRVSYPNEIVKHANDLQERIISFDSHITVPLDFGTEGSEADKDTSRQFDLVKAGRGRMSGAALSILAWPEMWNGANAPHRPTAGFVEEARHQRETRYRIIQGMVRDFPNQAAIAYTPADLRRIASEGKVAVVISLLNAYAMGDDLDQLDQWAARGMRLFGFSYVGNNDWADSSRPLPFFNDTRDALGGLSPIGKQAVQRLNDLGVVIDVSQMSSKALDDVASLTRAPVVASHSAPRALVDIPRNLSDQEMQQIKATGGVIQVVGFSTYLRPLSQPTLDKLNALRKRFDLGPLQGLENALMPGDAVITIWPEQRFGEYASSLYGILDEEPKASLKDYVDAIDYTVKKVGIDHVGISSDFNEGGGVNGWMSVADNRNVTAELIQRGYSDIEIAKLWGENYLRVWEQVQKLAKPAKPAPQPAIAG	MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVLKGGQAHYFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSEQTLQVGNSREVSFKGNPVKGFKAPVTFGEARLYNKTGSTNGFGAYVAFVXAKGVGIVMLANRNYPIQERVKAAHAILSKLAP	119.63	gnl|BL_ORD_ID|2148|hsp_num:0	3347			840	990	
BGC0000413.1|Pyoverdine_12 # 15157 # 16470 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000413.1|Pyoverdine_12 	15157	16470	+	Loose	600	27.335	OprZ	50.0	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACGAGCCTTCCTGTGACCAACCGTCGGACATTCCTCAAACAAGCAGGCCTGTTGGCCGCCGCCCTGCCCCTGGGCAACCTCGCCATCAGCCAGGCCCGGGCCGACAGTGCCACCGCCAGTGCTTCGCAGTGGACCCAATTGCGCCAGTTGTTCGACCTCGACCCGGACTACGTGCACCTGGCCAATTTCCTCATCACCTCGCACCCGAGGCCGGTGCGCGAGGCCATCGAAAAATACCGCGCAGTGCTCGACCGCAACCCGGCCATGGCCATGGACTACGACACCCAGTACACCTGGAAGCGCGAGGCCCAGGTGCGCGAAAGTGTCGGCCGCTACCTGCAGATCAAGCCCGGCCAGGTGGCCCTGACCGGCAGCACCACCGAAGGCCTGGCCCTGATGTATGGCGGCATCCACGTGCGCCCCGGACAGGAGATCCTGACCACGGTTCACGAGCACTACTCGACCCGCAACGCTCTGAAGTACCGCACCCAGCGCGACGGCACCCAGGTGCGCACCATCGAACTGTTCAAGTCGCCCCACCGGATGTCCACCGACGAAGTGCTGGGCAACATCGACCGCAACATCCGCGCCAACACCCGCGTACTGGGCATGACCTGGGTGCAGTCGGGCAGCGGCGTGAAACTGCCGATCGGCGAGATCGGCAAGCTGGTGGACCAGCACAACCGCAATCGCGATGAGCACGAGCGGATTCTCTACTGCGTCGATGGTGTGCACGGGCTGGGGGTGGAGGACATCACCTTTGCCGACCTGAACTGCGACTTCTTCGTCGCCGGCACCCACAAATGGATGTTCGGCCCGCGGGGCACCGGGATCTTCTGCTCACGTTCGGAACAACTCGAACACCTGACGCCGATGGTGGCGACCTTCTCCGAAAACCAGAACTTCGCCACCACCATGACCCCCGGCGGCTACCACAGCTTCGAGCACCGCTGGGCCGTGGACCAGGCTTTCGACCTGCACATGCAGCTGGGCAAGGCCAACATCCAGTCGCGCATCCATGAACTCAACAGCTACCTCAAGCAGCGCCTGCAGGAGCACCCGGGCATCGAACTGGTCACGCCCCTGAGCCCGGAGCACTCCGCCGGCTTCACCTTCTTCCGCGGCCAGAACCTGGACACCGACGCCACCGCCGCCTGGCTGATCGAGAACCGCATCCTGGTGGACGCGGTGGACCGCGATGCCGGGCCGGTAGTGCGCATGGCCCCCGGCCTGCTCAACAGCGAGGCGGATATCGACCGGACCATGGACCTGCTAGGCAAGCGCCTGCGCAGCAGCAAGACCGCCTGA	MTTSLPVTNRRTFLKQAGLLAAALPLGNLAISQARADSATASASQWTQLRQLFDLDPDYVHLANFLITSHPRPVREAIEKYRAVLDRNPAMAMDYDTQYTWKREAQVRESVGRYLQIKPGQVALTGSTTEGLALMYGGIHVRPGQEILTTVHEHYSTRNALKYRTQRDGTQVRTIELFKSPHRMSTDEVLGNIDRNIRANTRVLGMTWVQSGSGVKLPIGEIGKLVDQHNRNRDEHERILYCVDGVHGLGVEDITFADLNCDFFVAGTHKWMFGPRGTGIFCSRSEQLEHLTPMVATFSENQNFATTMTPGGYHSFEHRWAVDQAFDLHMQLGKANIQSRIHELNSYLKQRLQEHPGIELVTPLSPEHSAGFTFFRGQNLDTDATAAWLIENRILVDAVDRDAGPVVRMAPGLLNSEADIDRTMDLLGKRLRSSKTA	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	94.38	gnl|BL_ORD_ID|2408|hsp_num:0	2796			939	1011	erythromycin; cefepime
BGC0000413.1|Pyoverdine_13 # 16518 # 17411 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.651	BGC0000413.1|Pyoverdine_13 	16518	17411	+	Loose	550	30.0314	vgbC	23.81	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGAAACCCATCGCCTGTTCCTCCCTGGCCGCCCTGGCCGGTTGCCTGATCAGCCTCAACGCACACGCGGTAGAACCGCCCAAGCCCGGCAGCGTGTTCAAGGACTGCAAGAACTGCCCGGAAATGGTGGTCCTGCCGGCCGGCAGCTTTGTCATGGGTACCCCGGAAGACGAAGTGGGCCGCGAGCCCGATGAAGGCCCGCAGCACACCGTGACCTTCAAGAACGCCTTCGCCATGAGCCGCTTCCATGTCACTGCCGCCGAGCTTGATGCCTACATCCGCGAAACCGGTACCGTGATCAAGGACGGCGACGACCGCCCCGGCCGCCTGTGCCAGGCCAGCAAACCACGCTATGAACAGGGGCCGCGCCAGCCGGCGGTCTGCGTCGACTACGCCGACGTGCAGGCCTATACCCAGTGGCTGTCGAAGAAAACCGGCAAGCACTATCGGATGGTCAGCGAGGCGGAACGCGAATACGCCGCACGCGCCGGCAGCACCGGTTCCTTCCCCTTCCCTTTCGACGAGGAAGGCCAGTACCAGATCACCAAGCACGCCAACACCTACGGCCCCAAGGACGGCTTCAGTTTCACCGCCCCGGTGGGCAGCTATCCGCCCAATGCCTTCGGCATGTATGACATGCACGGCAACGTCTATGAATGGGTCGCCGACTGCTGGCACCCCGACTACGTGGGCGCACCTGCCGATGGCCGGGCCTGGATGGAAGAGTCGGAAGGGGTGTGCCTGGATGCCCAGATTCGCGGCAACGACTGGGGCGAGGCACCGGTATTCTCGCGTTCGGGCAATCGCAACAGCCGCAAGCGCGAAGTGCGCGGGGACTGGCTGAGCTTCCGCGTCGTGCGCGAGCTGGAGCAGCCCGGCGCCAGCCACAAGTAG	MKPIACSSLAALAGCLISLNAHAVEPPKPGSVFKDCKNCPEMVVLPAGSFVMGTPEDEVGREPDEGPQHTVTFKNAFAMSRFHVTAAELDAYIRETGTVIKDGDDRPGRLCQASKPRYEQGPRQPAVCVDYADVQAYTQWLSKKTGKHYRMVSEAEREYAARAGSTGSFPFPFDEEGQYQITKHANTYGPKDGFSFTAPVGSYPPNAFGMYDMHGNVYEWVADCWHPDYVGAPADGRAWMEESEGVCLDAQIRGNDWGEAPVFSRSGNRNSRKREVRGDWLSFRVVRELEQPGASHK	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	100.34	gnl|BL_ORD_ID|2244|hsp_num:0	2526			105	492	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000413.1|Pyoverdine_14 # 17466 # 18329 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.632	BGC0000413.1|Pyoverdine_14 	17466	18329	-	Loose	125	26.9498	vanXY gene in vanL cluster	31.75	3002968	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGACAAAGAAGAATCTGGTGTATGTCTGGTCCCTGCGAAATGCCGCCGCCGACAAGGCCGGGCAGCCGGTGGCTTACAAGGACCACGAGCGCTACATGAAATCGGTGCTGGAATTTCTGGTCCAGACGCTGAACCAGACGCCCCTGGGCGAGGCCTACGAACTGGTGGGCGTGGTCTACGACGATGACGAGCAGTCGCCACGGGACCAGCAGTTGGTCAGTGACTACGGCTTTGCCTACCAGCCGGGCCGCCAGTGGCTGTACCCGGCGGACCTGGAAGTGCAGGGCAAGCGGGTCAACGACTTGCTGCTGAGCGTGCCGTCCACCTATCGCCGCCATCCCCGCGGCAGTGCCGAACACATCGCCGGCAAGCAGGATTTCGAACGCCGCCTGCACGACACCCTGGTGGAGCTCAAAGCCGATATCGTGGTGCTCGACGGCCTGCTGGTGATCCTCGATGAACTGGTGCGCCCGGGAGCGCCTTTCGCCCGGCGGATCATGAACATCCACCCGGGCATCACCCGCATCGAATCGCCCTATGAGCGTCGCGGGGCCTATGCCACCTGGAATGCCCTGTACGGCGCCCGTGGACAGAAAGTAGTGGATTGGGCGACGAAGGAAACCGAGCCGACCGCGCCGCTATACCTGACCGGTGCCTCGTTCCACTACGTGGACAACGGTATCGACTCCGGCGAGGTGCTGCATGACGTGCTCAACACCGAAATCGGCCCCGAGGACACCATCCTCGAACTGCGCTGGAACAACTTCAACAACAGCCTGTTCCCGGCCTTGCGCCAGGGCCTGTGGCTGATGCTGGAGAACCTTCGCCAGGCTCAGGCCGGCAAGGCCCGGGACGTCGCCTGA	MTKKNLVYVWSLRNAAADKAGQPVAYKDHERYMKSVLEFLVQTLNQTPLGEAYELVGVVYDDDEQSPRDQQLVSDYGFAYQPGRQWLYPADLEVQGKRVNDLLLSVPSTYRRHPRGSAEHIAGKQDFERRLHDTLVELKADIVVLDGLLVILDELVRPGAPFARRIMNIHPGITRIESPYERRGAYATWNALYGARGQKVVDWATKETEPTAPLYLTGASFHYVDNGIDSGEVLHDVLNTEIGPEDTILELRWNNFNNSLFPALRQGLWLMLENLRQAQAGKARDVA	MDNDYKYYLQLVNKQYPWQINNGSKKMVRVPYTDKEIYLDAVVVEHLIQLIETIQLQEKIEIVDGYRTIDEQKELWEFSLKDRGKRYTHDYVAYPGCSEHHTGLALDIGLKKTAHDIIAPKFNGEEAKKFLEHMKDYGFILRYPPNKKKVTGIAYEPWHFRYVGVPHSQIITQQAWTLEEYIAFLHTVGEKVS	148.70	gnl|BL_ORD_ID|4744|hsp_num:0	1872			36	219	vancomycin
BGC0000413.1|Pyoverdine_15 # 18530 # 20182 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.632	BGC0000413.1|Pyoverdine_15 	18530	20182	+	Loose	1050	277.715	YojI	34.32	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCGACCCCAAGCGCGGCGCCTTCAACGGTCTGCTCGCATTGCTCAGGCCCTTTCGCACCATCGTGGTGATCTCCGTTGCCCTGGGCATGGCCGGCGGCCTGGCCATCACCCTGTTGCTGGCCACCATCAACAACGCCCTGCACTCGGCGACTGGTATGACCCAGGGCGTGGTCCTGACCTTCGCCGCCCTGTGCCTGCTGGCCCTGGTCAGTTCCATCGTCTCGGACATCGGCACCAACTATGTGGGACAACGGATCATTGCCGCCCTGCGCAAGGACCTGGGTGAAAAAGTACTCTCGGCGCCCATCACCCAGATCGAACGCTATCGCTCCCACCGCCTGATCCCGGTACTGACCCACGACGTCGACACCATCAGCGACTTCTCTTTCGCCTTCACTCCCCTGGCCATCGCCACCACCGTCACCCTGGGCTGCCTGGGCTACCTGGCGTACCTCTCGGTGCCGATGTTCCTGATGATGGTGGTGGCCATCATCATCGGCACCAGTGTGCAACTGGTGGCCGGCGGCAAGGGCATCAAGGGCTTCGATGAGGCTCGCGACCATGAGGACGAGCTGCAGCGCTACTACAACGCGATTGCCTCCGGTGCCAAGGAACTGCGCATTCACCGGCCCCGGCGCTTTCGCATGAATACCCAGCGCATCCAGAAAACCGCGGATCGCATCAGCGATATCCAGGTGCGCTCGGTAAACATCTACATCCTGGCCAAGAGCTTCGGCTCGATGCTGTTCTTCGTGGTCATCGGCCTGGCCCTGGCCATGCAGGCCTACTACCCGAACCCGGACCCTGCGGTGATCACCGGTTTCGTGCTGGTGCTGCTGTACATGAAGGGCCCGCTGGAACACGTGGTCGGCTACCTGCCCATCGTCGGCAAGGCCAAGATCGCCTTCGCCCGGATCAGCGAACTGTCCGAACGCTTCTCTTCTCCCGAGCCGCACCTGCTGATGGACGACAGCGAAGCGCCGCAAGCGGTAGTGCACAGCCTGGAACTGCGCGAGGTGCGCTACAGCCCGCCGCCGGTGGAAGGCAGCGAACCGTTCCACCTGGGCCCGATCAACCTGAACATCAAGCAGGGCGACATCGTCTTCATCGTCGGCGAGAACGGCTGCGGCAAGACCACCCTGATCAAGCTGTTGCTGGGCCTGTACCAGCCCCAGTCCGGGGAGATCCGTCTCAATGGCGAAGCGGTGACCGACCGGGCCCGGGATGACTACCGGCAGCTGTTCACCACGGTATTTGCCGACTACTACCTGTTCGACGACCTGGTCCAGGGCAATGCCGGCAAGTCGCTGGACGTCGCCACCCAGTACCTGAACCGCCTGGAAATCGCCCACAAGGTCAGCGTCAAGGATGGCGCCTTCACCACCACCGACCTGTCCACCGGCCAGCGCAAGCGCCTGGCCCTGGTCAATGCCTGGCTGGAAGAGCGCCCGGTGCTGGTGTTCGACGAATGGGCCGCCGACCAGGACCCGGCCTTCCGGCGGATTTTCTACACCGAGCTGCTGCCCGATCTCAAGCGCCTGGGCAAGACCATCATCGTGATCAGCCACGACGATCGCTACTTCGACATTGCCGACCAGTTGGTGCGCATGAAGGCCGGACGAGTCCTGACTGAACTGCAACCGGCGTGA	MTDPKRGAFNGLLALLRPFRTIVVISVALGMAGGLAITLLLATINNALHSATGMTQGVVLTFAALCLLALVSSIVSDIGTNYVGQRIIAALRKDLGEKVLSAPITQIERYRSHRLIPVLTHDVDTISDFSFAFTPLAIATTVTLGCLGYLAYLSVPMFLMMVVAIIIGTSVQLVAGGKGIKGFDEARDHEDELQRYYNAIASGAKELRIHRPRRFRMNTQRIQKTADRISDIQVRSVNIYILAKSFGSMLFFVVIGLALAMQAYYPNPDPAVITGFVLVLLYMKGPLEHVVGYLPIVGKAKIAFARISELSERFSSPEPHLLMDDSEAPQAVVHSLELREVRYSPPPVEGSEPFHLGPINLNIKQGDIVFIVGENGCGKTTLIKLLLGLYQPQSGEIRLNGEAVTDRARDDYRQLFTTVFADYYLFDDLVQGNAGKSLDVATQYLNRLEIAHKVSVKDGAFTTTDLSTGQRKRLALVNAWLEERPVLVFDEWAADQDPAFRRIFYTELLPDLKRLGKTIIVISHDDRYFDIADQLVRMKAGRVLTELQPA	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	100.55	gnl|BL_ORD_ID|4707|hsp_num:0	2424			9	1590	microcin J25
BGC0000413.1|Pyoverdine_16 # 20284 # 22752 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.619	BGC0000413.1|Pyoverdine_16 	20284	22752	+	Loose	500	31.187	ANT(6)-Ia	27.12	3002626	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGCCCGCACAACACCGACTGACCCCTTTGACGAAAGCGCTGCTTCGCCAGGCCTTCTCGCCAAAACTGGCTTCCCGCACCCTGGGCCTGGCCCTGACCCTGCCACTGATGGCTCAGGTCCAGGCCCAGGAAATCCATTTCAACATCGTCTCGCAGTCCATGTCTGCGGCCCTGCAGGAGTTCGGGCGCCAGGCCAATATGCAGGTGCTCTACAACCCTGACGATGTGCAAGGCAAGCGCAGCAACGCCCTCAGCGGCAGCTATTCGCCGGAGCGGGCCATCGCGGCCATGCTCAATGGCACGGGGGTGGCCTACACCCTCAAGGACAACTCGGTCACTATCCGCAACCATGGTGGCAACGGCTCGCTGGAACTGGGGACCAGCACCATCAGCGGCCAGGGCCTGGGCACCACCACCGAGGACACAGGTTCCTACACCACCGGGGCCATGCAGACCGCCAGCAAGCTGTCGCTGACGGCCCGGGAAACCCCGCAGTCGGTCACGGTCATCACCCGCCAGCGCATGGATGACCAGAACATGAGGTCCCTGGAGGATGTGCTCAAGGCCACCCCCGGCATTTCCATCACCAAGGACGGTCCGCAGCGGCCGACCTTCTACTCCCGTGGTTTTGCCGTCGAAAACCTGATGACCGACGGCTTGCCCAACGATTTGACCCACTACCTGAGCCGGGACATGAACTCCTCGGCTGACATGGCGATCTTCGACCATGTGGAAGTGGTGCGTGGCGCCACCGGGATGATGCAGGGCGCAGGTAACCCGTCGGCAGCGATCAACATGGTGCGCAAGCGCCCCACCGCCACACCGCGGGTCACCGTCACCGGCAGCGCCGGCAGCTGGGACGACTACCGCACCGAGATCGACGCCTCCAACGCCCTCAACGAAAGCGGCACCCTGCGCGGCCGGGTGGTCGCCGCCTATCAGAGCAAGGGCAGCTTCCAGGACTTCGTCAGCAGTGAACGCAACGTGTTCTACGGCATCACCGAGGCCGACCTGAACGAAGACACCACCTTCACTTTTGGCGCCTCCAACCAGAGCGGCAGAAACAACACTTCCTGGGGTGGCCTGCCGGTTGCAGCCGACGGCAGCGACCTGCACCTCAAGCGCTCGACCTACCTGGGCAGCAAGTGGGAGTACTGGGATCAGAACAACACCACGGCGTTCAGCCGCCTGGAGTATCGCTTCGCCAACAGCTGGAAAATGCTCCTGTCCGCCAGCAAGAGCTGGTCGGACCTGAACATGCTCGGCTCCATTCCGGAACGCATGGGCGCCAACTACGATGAGTTCGGCCAGAATATCGGTCGCTACGACTACGAAGACCAGCAAAACAGCTACGACGGCTACGTCACCGGTCCCTTCTCCCTGTTCGGGCGTACCCATGAACTGGTGGTGGGCGCCAGCCGGCGCGACTTGACGTTCAAGGGCAAGGGCCTGCCCATCGACCTCGAGACCCACACCAACATCTACAAACCCAGCGGCATTCCCAAGCCGGACATGAGTGCCAACCCCTGGACACAACGCCGTACCAGCCAGCTGGAAGGCACCTACGTCACCACTCGGCTGAGCATCACCGATGACCTGAAGCTGATCCTGGGCGGCCGCCTGGACTGGTACGACTATGACGTGACCACCACCTGGAACGGCAAGGCCTCCGCCTCCAGCCTGCCGAACAAAGTGACACGCCACCTGACCCGCTATGCCGGAGCCATCTATGACCTGGACCAGAACCACTCGGTCTATGTCAGCTACACCGATATCTTCAAGCCACAGACCGAACTCGACACCTCCAACGGCGCGCTCAAGCCCATCGAAGGCAAGAACTACGAACTGGGCATCAAGGGCGAGTACTTCGACGGCAAACTCAATGCCAGTGCGGCGATCTTCCGCATCGACCAGGAAAACCGTGCCAAGGTACTCAACCCCAACCAGTGCAACCCGGTGGGAAGCACCTGCTACGAAGCCGCGGGCCAGGTGCGCAGCGAAGGTATCGAGCTGGAAATCAACGGCACCCTGGCCCCGGGCTGGGAACTGGGGGCGGGCTACACCTATGCCTCGGTCAAGTACACCAAGGACTCCAATGAAGCCAACGTCGGCCGCCTGTTCGACACCGACATCCCGCGCAGCGTGTTCAAGGCCTTCACCACCTACCAACTGCCCGGCGACCTTAACCGCTGGACCATCGGCGGCGGGATCTATGGCCAGAACACCATCTACAACAAGGGCACCAACGACTACCTGAGCACCTTCGACTACCGCATCGAACAGAAGTCCTACGCCCTGGTGGACCTGATGACCAGCTACAAGGCCTCGGAGAATGTGAACATTCGCCTCAACGTCAACAACCTCTTCGACAAGCGCTACTACCAGAGCATCGGCACCAACACCGACTACGGCACCAGCCTCTACGGCGACCCGCGCAATGCCATGGTCACGGTCAGCTGGTCTCTGTGA	MPAQHRLTPLTKALLRQAFSPKLASRTLGLALTLPLMAQVQAQEIHFNIVSQSMSAALQEFGRQANMQVLYNPDDVQGKRSNALSGSYSPERAIAAMLNGTGVAYTLKDNSVTIRNHGGNGSLELGTSTISGQGLGTTTEDTGSYTTGAMQTASKLSLTARETPQSVTVITRQRMDDQNMRSLEDVLKATPGISITKDGPQRPTFYSRGFAVENLMTDGLPNDLTHYLSRDMNSSADMAIFDHVEVVRGATGMMQGAGNPSAAINMVRKRPTATPRVTVTGSAGSWDDYRTEIDASNALNESGTLRGRVVAAYQSKGSFQDFVSSERNVFYGITEADLNEDTTFTFGASNQSGRNNTSWGGLPVAADGSDLHLKRSTYLGSKWEYWDQNNTTAFSRLEYRFANSWKMLLSASKSWSDLNMLGSIPERMGANYDEFGQNIGRYDYEDQQNSYDGYVTGPFSLFGRTHELVVGASRRDLTFKGKGLPIDLETHTNIYKPSGIPKPDMSANPWTQRRTSQLEGTYVTTRLSITDDLKLILGGRLDWYDYDVTTTWNGKASASSLPNKVTRHLTRYAGAIYDLDQNHSVYVSYTDIFKPQTELDTSNGALKPIEGKNYELGIKGEYFDGKLNASAAIFRIDQENRAKVLNPNQCNPVGSTCYEAAGQVRSEGIELEINGTLAPGWELGAGYTYASVKYTKDSNEANVGRLFDTDIPRSVFKAFTTYQLPGDLNRWTIGGGIYGQNTIYNKGTNDYLSTFDYRIEQKSYALVDLMTSYKASENVNIRLNVNNLFDKRYYQSIGTNTDYGTSLYGDPRNAMVTVSWSL	MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHLNQILRFELLRMMSWKVGIKTEFSLSVGKNYKYINKYIDEDLWNRLLSTYRMDSYENIWKSLFICHQLFREVSKEVAELLGFDYPEYGKNITRYTEDMYKKYVENDYF	286.41	gnl|BL_ORD_ID|841|hsp_num:0	914			699	858	streptomycin
BGC0000413.1|Pyoverdine_17 # 23151 # 36383 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.650	BGC0000413.1|Pyoverdine_17 	23151	36383	-	Loose	1000	138.658	almE	27.4	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCAAGCTTTAATCGACTCGGTAGGCACGCTTTCTTCCAAGGAAAGAAGAGCCCTGGCGATTTTGCTTAAAGAAAAGGGCATCAACCTCTTTGGTATCGCTCCTATCTGCAGCCGCGGCGCCGACGAGGCGCCGGTTCTCTCCTATACCCAGGAAAGCCAATGGTTCCTTTGGCAACTGGAGCCCGACAGCACCGCGTACCACATCACCACGGCGCTGCGCTTGACCGGAGAACTGGACCTCGACGCGCTGCGCCATGCATTCGATACCCTGATTGCCCGGCATGAAACCCTGCGCACTACCTTTTCCGAAGACGATGGCACGGCGGTACAGGTGGTTCATCCACCGGCACCACTGGACATCGAGGTCATCGAACTGCACGCCGGCGGCCTGTCCTATGAGGCCCAGGTCCATGCCCTGACCGACAGCAAGAGCCAGCCGCCCTTCGATCTGCGCAATGGCCCGCTGTTGCGGGCCAAATTGCTGCGGGTGGCAGCAGACGAGCATGTGCTGGTCCTGACCCAGCACCACATCGTTTCCGATGGCTGGTCGATGGGGGTGATGGTCGACGAGTTGATCCAGCTCTATGCCGGCTACCGCCAGGGGCGCACGGTCAGCCTGCCGGACCTGCCGATTCAATACGCCGACTATGCCAACTGGCAGCGCCAGTGGATGGATGCCGGCGAGCGTGAGCGGCAACTGGGCTACTGGCTGGAGCAACTGGCCGGGGAGCAACCCTTGCTGATGCTGCCGCTGGACCACCCGCGCCCGGCGATCCAGAGCTATCGGGGGGCGCTGCTGGATATCCCGTTGCCGGAAGAGCTGCGCCTGGGCCTCAAGCAATTGGCCCAGCGTGAAGGGGCGACCCTGTTCATGCTGTTGCTGGCCTCGTTCCAGGTCTTGCTGCACCGCTACAGCGGCCAGGCGGACATCCGCGTCGGGGTGCCGACCGCCAACCGCAACCGGGTGGAAACCGAGCGCCTGATCGGCTTCTTCGTCAATACCCAGGTGTTCAAGGCCGAGGTCGACGGGCAACTGGGCTTCAATGATTTCCTGCAGCAGGTCAAGCAGACCGCGCTGATGGCCCAGTCCCACCAGGACTTGCCTTTCGAGCAGTTGGTGGAAGCCTTGCGCCCCGAGCGCAGCCTGAGCCACAGCCCGCTGTTCCAGGCAATGTTCAACCACCAGACCGCGGTCAAGAAGGGCGGGCAGAGCCAGCGCCTGGACGACCTCAGCATCGAGACCCTGAGTTGGCAGGGGCGCGCCGCGCAGTTCGACCTGACCCTGGATACCTTCGAATCCGAGGATGGCCTCTGGGCCTCCCTGACCTACGCCACCGACCTGTTCGAAGCCTCCACCATAGAGCGTCTGGCCCAGTCCTGGGTGCAGTTGCTGCAGGGCATTGTCCAGCAGCCACGCCAGCGCCTGGGGGACCTGCCGCTGCTGGGCGCTGCCGAGCAGCACCAGTTGCTGCACGAGTGGACCCCGGCCACCGGTGAGTTCCCCAGCGATGGTTGCGTGCAGCAGTTGGTGGAAGCACAAGCACTGAAAAGCCCGGAGTCCGAGGCCCTGTTGTTCGCTGGCCAGTGCCTGAGCTACCGGGAACTCAATGCCCGGGCCAATCGCCTGGCGCACAAGCTGATCGAGCTGGGCGTGGGGCCTGAAGTGCGGGTGGGCGTGGCCTTGCAGCGCACCCCGGAAATGGTCGTGGCGCTGCTGGCGGTGCTCAAGGCCGGTGGCGCCTATGTGCCCTTGGACCCGGATTATCCACAGGATCGTCTGGCCCACATGCTGCGCGACAGTCAGGCGCAGATCCTGTTGACCGAAAACGCCTTGCTGTCGCTGCTGCCGTCCGTGGAATCCTTGCAGACCCTGCAACTGGATGCCCAGCCGGGTTGGCTGGACGCGTATTCGCCGGAAAATCCGCCGCAGCGAGCTACTGCGGACAATCTGGCTTATGTGATCTACACCTCCGGCTCCACCGGCCTGCCCAAGGGCGTGGCGATTGCCCATCGCAACGTGCTGGCGCTGATCGACTGGTCGAACCGGGTGTACAGCACTGCAGACCTGCAAGGGGTGCTGGCTTCCACCTCGATCTGCTTCGACCTGTCGGTGTGGGAGCTGTTTGTCACCCTGTCCAGCGGCGGTTCCATCGTCCTGGCCCGCAATGCCCTGGAGCTTCCGGAGCTGGCGGATCGCGACCGGGTGCGCTTGATCAATACCGTGCCCTCGGCGATTGCCGCGCTACAACGCAGCGGGCAGATTCCGCCCAGCGTGCGAATCATCAACCTGGCGGGTGAGCCGCTGAAACAGGCGCTGGTGGATAGCCTCTACCAGCAGCCCGGGCTGGTGCATGTCTACGACCTGTACGGCCCTTCGGAAGACACCACCTACTCGACCTACACCCGGCGCGAGGCGGGAGGGCAGGCCAATATCGGTCGGGCCATCAGCAACACCCAGAGCTACATCCTCAGCCCGGACCTGCAACCGGTGCCGGTGGGCAGTGCCGGCGAGTTGTATCTGGCCGGCGCCGGGGTGACCCGAGGCTACCTGGCGCGCCCAGGGCTGACCGCCGAAAAGTTCGTACCCAACCCGTTCTCCAGCGACGGTGGCCGGTTGTACCGCACTGGCGACCTGACCCGTTACCGCGCCGATGGGGTGATCGAGTACATCGGCCGCATCGACCATCAGGTGAAGATCCGCGGTTTCCGTATCGAGCTGGGTGAAATCGAAGCGCGGCTGGTGCAGCAGGCGGCGGTGCGTGAAGCCTTCGTCCTGGCCCATGACAGCGAAAACGGCCAGCAACTGGTGGCCTATATCGTGCCGAGCGAGGCCACCCCGACCGTCGAGGCCCAGGCCGCCCTGCGCGACAGCCTCAAGACTGCACTCAAGGAACACGTGCCGGACTACATGGTGCCGGCCTACCTGCTGTTCCTGGAGGCGCTGCCCCTGACCCCCAACGGCAAGCTCGATCGCAAGGCCCTGCCCAAGGTCGACGCCCAGCAGATGCAGCAGGTCTACGTGGCGCCGCAGAGCGAACTGGAGCAGCAGATCGCGGCGATCTGGGCCGATGTGCTGAAGCTTGAGCAGGTCGGTGCCACCGACAACTTCTTCGAACTGGGCGGTGATTCGATCATCTCGATCCAGGTGGTCAGCCGCGCGCGGCAGGCCGGTATCCGCTTTACCCCGCGGGATCTGTTCCAGTACCAGACGGTACAGGGGCTGGCGGCAGTGGCCGAGCAGGGCGAGGGCGGGGTGCAGATCGACCAGGGCCCGGTGGGTGGCGCAACTGCGCTGCTGCCGGTGCAGCAGTGGTTCTTCGAGTCGCCCATGAGCGAACGCCATCACTGGAACCAGTCAGTGCTGCTCAAACCGGCCCAGCCGCTGCGCGCCGAGGTGGTAGAGAACGCCTTGCAGGCCCTGTGGGTGCAGCATGACGCCTTGCGCTTGCAGTTCAGCCAGGAGGCGGATGGCTGGTCGGCGCGTTTTGCCGATGCCGGCCAGCGGCCGGAGCTGCTCTGGCAGGTCGCAGTGGATGGCGCCCAGGCCATGGAACAGTCGGCGATCGAGGCGCAGCGCAGCCTGAACCTGCAGGACGGGCCGCTGCTGCGGGCCGTGCTGTTCAGCCTGGAGGACGGCAGCCAGCGCCTGTTGCTGGTGATTCACCACCTGGTGGTGGACGGGGTGTCCTGGCGGATCCTGCTGGAGGATCTGCAACGGGCCCACGCTCAACTCAGCGCCGGCCAGCCCCTGGCATTGCCGGCCAAGACCAGCTCGACCCAGGCCTGGGCCGAGCAGATGCAGGCCTATGCCCAAGGTGCGGCGCTGCAGGAAGAACTCAAGTACTGGCAGGCCCAGTTGCAGGGCGTCGAGTCGAACCTGCCGCTGGATCGCCCGGTGACCGAGTTGCAGAACCAGCACGCCAGCAGCCTGAGTTCACGCCTGGACAAGGCCCGTACCCAGCGCCTGCTGCAGGATGCCCCGGCGGCCTACCGCACCCAGATCAATGATTTGCTGCTCACCGCCCTGGCCCGGGTCATCACCCGCTGGACCGGCGAAGCCAGTGCCCTGGTGCAACTGGAAGGCCACGGCCGCGAAGACCTGTTCGACAGCATCGACCTGACCCGCACCGTGGGCTGGTTCACCAGCATGTTCCCGGTGAAGCTCACGCCCCAGGCGTCCCTGGCTGATTCGATCAAGTTCATCAAGGAACAACTGCGGGCGGTACCGAACAAGGGCATCGGCTTTGGCGCCCTGCGTTACCTGGGGGATGCTCAGGCGCAGCAGGCCCTGGCAGCCTTGGCCGTGCCGCGTATCACCTTCAACTACCTGGGCCAGTTCGACGGCAGTTTCGACGAGCAGGACTCCCTGTTCAAACCCAGCGGTGAAGCCAAGGGCGACGACCAGAGCCCACTGGCCCCGCTGAGCAACTGGCTGAGCCTGGATGGCCAGGTCTATGGCGGCGAGTTGAGCCTGAACTGGACCTTCAGCCAGCAGATGTTCGATACCGCCACCGTGCAGCGGCTGGCCGACGACTATACCGAGGAGCTCAAGGCGCTGGTGGCGCATTGCTGCACACCAGAGCTGGCGGGCGCGACCCCGTCGGACTTCCCACTGGCGGGCCTGAACCAGCAGCAACTGGATCGCCTGCCGGTGGCGATGGCCTCGGTCGAAGACCTCTACCCCCTGTCGCCGATGCAGCAGGGCATGCTGTTTCATACCCTCTACGAGCAGGCGGCGGGCGACTACATCAATCAACTGCGGGTAGACGTGGACGGCCTTGATCCGCTGCGCTTCCAGCAGGCCTGGCAGGCGGCCATCGATCGGCATGACATCCTGCGCACCGGCTTTATCTGGCAGGGCGAGGTGTCGACGCCGCTGCAAGTGGTGCACAAGCATATTGCCCTGGACTGCACCGAACATGACTGGCGCGGCCAGCCGCAGCAGCAGGAAGCCCTGGATACCCTGGCCACCGCCGAGCGCCAGCGTGGCTTCGAGCTGGATGCCGTGCCGTTGTTGCGCCTGACCCTGGTGCGTATCGACGAGCAGCGCTACCACCTGATCTACACCAACCATCACATCCTGATGGACGGCTGGAGCAACTCGCAGTTGCTCGGCGAAGTACTGCAACGTTATGCCGGTCAGTTGCCCAGCCACGCTGCGGGCCGCTACCGGGACTACATCGCCTGGCTGCAACGCCAGGATGCCCAGGCCTGTGAAAGCTTCTGGAAAGAACAACTGCAGACGCTGGATGAACCGACCCGCCTGACCCAGGCGCTGTCCCGGGTCGCGGACATTGCGGCCGGCACCGGCCACGGCAAGCATCATCGCGAGCTGGACCTGGCACAGACGGCACGGCTTGGCGAATTTGCCCGGCAGCAGAAGGTCACGGTCAATACCCTGGTGCAGGCGGCGTGGCTGCTGTTGCTGCAACGTTGCACCGGGCAGGACAGCGTGGTGTTCGGCGCCACGGTGGCGGGGCGCCCCGCGGAGCTCAAGGGCATAGAGCAGCAGGTGGGCTTGTTCATCAACACCTTGCCGGTGGTGGCCACGCCACGCCCGGACATGACCGTGAGCCAGTGGTTGCAGGCAGTGCAGAACCGCAACCTGGCGCTGCGCGACTATGAGTACACGCCGCTGTACGAAGTGCAGCGCTGGGCCGGGCTGGGCGGGGATGCGCTGTTCGACAACATCCTGGTGTTCGAGAACTACCCGGTGTCCGAAGCCCTGGAAAAAGGTGCTCCGGCGCAACTGCGCTTTGGCGCTGTGGGTAACCACGAACAGACCAACTACCCCCTGACGGTCGCGGTCAACCTGGGGGCGAGCCTGTCGTTCGAGTTCATCTATGCCCGTGAATCCTTCTCCGAGCCTTCGATGGTGCAGTTGGGCGGGCACTTGCAGGGCCTGTTGCTGAGCCTGATGGAGCATGCGCAAACCGGCCTGGGTGAGTTGCCATTACTGACGCAGGACGAGCAGCACCGTATCCGCCAGGATTGGGACCACACCGATGTGGTCTACCCGACCGAGCGTTTTGTTCACCAGCTGTTTGCCGATCAGGCGGCCAAGGCGCCGGATGCCCCGGCGGTGTTCTTCGCCGAGCAGCGCCTGAGCTATCGCGAGCTGGATACTCAAGCCAACCAGCTGGCGCACAAGTTGATCGAGCTGGGCGTTGGCCCGGAAGTGCGGGTGGCCATCGCCATGCCGCGTTGCGCGGAAATCATGGTGGCCTTCCTTGCCGTGCTCAAGGCCGGCGGGGTCTATGTGCCGCTGGATATCGAATACCCCCAGGACCGTCTGCGCTACATGATGCAGGACAGCGGCGCTTGGCTGCTGCTGACCCAGAACCATCTGCTGGATCGCTTGCCGATTCCTGAGGGGCTGCCGACCCTCAGCGTCGAAGGTGCGGCTGATTTTGCGGCTTACCCTGTGACCAGTCCGCAGGTGGATCTGGCCGAGGAAAACCTCGCCTATGTGATCTACACCTCTGGGTCCACCGGCTTGCCCAAGGGCGTGGCGGTGTCCCACGGCCCGCTGGCCATGCACAGCCTGGCCACCGGCGAGCGCTATGAAATGAGCCCGGCGGATTGCGAGTTGCACTTCATGTCCTTCGCCTTCGACGGCTCCCACGAAGGCTGGATGCACCCGCTGATCTACGGGGCCAGCGTGCTGATTCGCGACGATAGTTTGTGGTCGCCGGAATTCACCTACGAACAGATGCATCGCTATGGCGTCACCGTGGGTGTGTTCCCGCCGGTGTACCTGCAACAACTGGCGGTACACGCCGAGCGTGACGGCAATCCGCCGGCGGTGCGGGTGTACTGCTTCGGCGGCGATGCAGTGCCCCAGGCCAGTTACGATCTGGCGTGGCGAGTGCTGCGTCCGAAGTACATCTTCAACGGCTACGGCCCGACTGAAACCGTGGTTACGCCATTGATCTGGAAGGCCAAGGCGGGCGATCCGTGCGACGCGGCCTACGCGCCCATCGGCAATATCGTTGGCAACCGCAGCGCCTACGTGGCCGATGCCAACCTCAACCTATTGCCGGTTGGCGTGGCCGGCGAGCTGTACCTGGGCGGCCTGGGCGTGGCCCGGGGTTACCTGGATCGTCCGGGGCTGACGGCCGAGCGTTTTATCCCTGACCCCTACAGCACCGCCGGTGCCCGGTTGTACCGCAGCGGCGACCTGACCCGCTATCGCACAGATGGCTTGGTGGAGTACGTAGGCCGTGTCGACCATCAGGTGAAGGTGCGGGGCTTCCGTATCGAGCTGGGCGAGATCGAAGCGCGCCTGCTGGAGCAGGACCCGGTACTGGAAGTGGCGGTGATCGCCCAGCCAGGGCCGAGCGGCCAGCAGCTGGTGGGCTACATCGTGCCGGTGGACGCCGAGGTGGCGTCGAGCAACGAGCGCCAGGCGCAGTTGCGCGAGAGCATCAAGGCGCGCCTGCGCGAGAGCCTGCCGGACTACATGGTGCCGACCTACCTGCTGTTCCTCGAAGCACTGCCGCTGACACCGAACGGCAAGCTGGACCGCAAGTCGCTGCCGAAAGTCGATGCGCAGCTGATGCAGCAGACCTACGTCGCGCCGCAGAACCCGCTGGAACAACAGATCGCGGCGATCTGGGCCGATGTGCTGAAGCTTGAGCAGGTGGGCGTCACCGACAACTTCTTCGAACTGGGTGGCGACTCGATCATCTCGATCCAGGTGGTCAGCCGTGCCCGGCAGGCCGGTATCCGCTTCACCCCCAAGGACCTGTTCCAGCACCAGACGGTGCAGGGGCTGGCCACGGTGGCGGAGCAGGGCGAGGGCGGTTTGCAGATCGACCAGGGCCCGGTGCGTGGGCAGATGGCGCTGCTGCCGATCCAGCAGTGGTTCTTCGACACCCCGGTGCCGGAACGGCATCACTGGAACCAGTCGGTGCTGCTCAAGCCGCTACAGGCGCTGCAAGCCCAGCCCCTGGAAAGCGCATTGCAGGCCCTGACGGTGCAGCACGATGCCTTGCGCCTGCGCTTTACCGAACATCAGGGCACGTGGCGTGCAGCCTTTGCCGATGCCGAGGAGCCGGTGCAACTGCTGTGGCAGGCCAATGTCGCCGACGCCCAGGCGTTGCAGCAGTTTGCCGAGCAGGCCCAGAGCAGTCTCAACCTGCAGGAGGGCCCGTTGCTGCGGGCCGTGCTGTTCACCCTGGCCGACCAGAGCCAGCGCCTGTTGCTGATCGTTCATCACCTGGTGGTGGATGGGGTGTCCTGGCGGATTCTCCTGGAGGATCTGCAAGCCTTGCTGGGCGGCCAGGCACTGCCGGCCAAGTCCAGCTCGACCCAAGCCTGGGCCGGGCAGTTGCAGGCCTATGCCAGCAGCGCGGCGCTGCAGCAGGAGCTGGGTTACTGGCAGGCACAGTTGCAGGGTGTCGAATCGAACCTGCCTTGCGACCACGGCCACGACGGGTTGCAGAACCAGCACGCGAGCAGTGTCGAAACCCGGCTGAGCAAGGGTGATACCCAGCGCCTGTTGCAGGATGCGCCGGCAGCCTATCGCACCCAGATCAACGATCTGCTGCTTACCGCCCTGGCCCGGGTCATCACCCGCTGGACCGGCGACAGCAGCGCCCTGGTGCAGCTGGAAGGCCACGGCCGAGAAGAGCTGTTCGACAGCATCGACCTGAGTCGCACCGTGGGCTGGTTCACCAGCGTGTTCCCGGTGAAGCTGACGCCGCAGCCGGTCCTGGCCGACTCGATCAAGTTCATCAAGGAACAGCTGCGGGCGGTGCCGAACAAGGGCATCGGCTTCGGTGCCTTGCGCTACCTGGGGGATGCTCAAGCACAGGCAGCCCTTGCCGCACTGGCGGTGCCGCGCATCACCTTCAATTACCTGGGACAGTTCGACGGCAGTTTCGATGACCAGCAGGCATGGTTTGCCCCGGCCAATGAGGCCAAGGGCGACGACCAGAGCCTGCACGCCCCCCTGGGCAACTGGTTGACTCTCAATGGCCAGGTCTATGGCGGTGAGCTGAGCCTGGGCTGGAACTTCAGCCGGGCGATGTTCGATACCGCCACCATCGAGCACCTGGCGGATGACTACGCCCGGGAACTCAAGGCGCTGATCGAGCATTGCAGCCAGCCCGAGCACCGTGGCGCCACGCCATCGGACTTCCCGCTGGCCGGCCTGAGCCAGCAACAGCTGGACCGCTTGCCGCTGGCCCTGGCACAGGTAGAGGACCTTTATCCGCTGTCGCCGATGCAGCAAGGCATGCTGTTCCACACCCTGTATCAAGAGGAGGGTGGCGACTACATCAACCAGCTGCGGGTGGATGTGGACGGGCTCGATCCCGAGCGCTTCCGCCAGGCCTGGCAGGCAACCATCGAGCGTCATGACATCCTGCGCAGCGGTTTCCTCTGGCAGGGCGAACTGCCGGCGCCGATCCAGGTGGTGTACAAGCAGGTCAGCCTGGAGTGTGTCGAGCACGATTGGCGCTCGACGCAGCAGGCCCCGCAAGCCCTGGACACCCTGGCGGCGACCGAGCGTCAACGGGGCTTCGATCTGGCCGCTGCGCCCCTGCTGCGCCTGACCCTGGTGCGCACTGGCGAGCAGCGTTACCACCTGATCTACACCAACCACCACATCCTGATGGACGGCTGGAGCAACTCGCAGTTGCTCGGTGAAGTACTGCAACGTTATGCCGGTCAATTGCCGCAGCACCTGACCGGGCGCTACCGCGACTACATCGCCTGGCTGCAACGCCAGGACGCCACCCTCAGTGAGCATTTCTGGAAACAGCAACTGCAGGGGCTGGATGAGCCGACCCGTCTGGCCCAGGCCATTGCTGCCGGTGCACGAGCGCCGCTGGAGGAGGGCCATGGCAGCCATGGCTGCACCCTCGACGAGGCCCAGACCCGCAGCCTGGGCGAGTTTGCCCGCCAGCAGAAGGTCACGGTCAACACCCTGGTGCAGGCCGCCTGGCTGTTGCTGCTGCAACGCTGCACCGGGCAGGACACTGTGGTGTTCGGCGCCACGGTGTCCGGCCGGCCGGCGGAACTCAAGGGGGTGGAGCAGCAGATCGGGCTGTTCATCAACACCTTGCCGGTGGTGGCCGCGCCACTTCCGCAGTTGTCGGTCAGCGACTGGTTGCAGGCCGTGCAGGAGCGCAACCTGGCCCTGCGCGATTTCGAACACACGCCGCTGTATGACGTGCAACGCTGGGCGGGCCTTGGGGGCGAGGCACTGTTCGACAACATCCTCGTGTTCGAGAACTACCCGGTGTCCGAAGCCCTGGAGAAAGGCTCGCCGGCACAGTTGCAATTTGGCGCGGTAGGCAATCATGAGCAGACCAACTATCCGCTGACGTTGTCGGTGTTTGTCGCTGAACGCTTGTCATTCGACTACAGCTATTCGTACCAGCACTTCAGTGGCGCGGTGATCCGGCAACTGGCCGAGGGCCTGCAGCACCTGCTGCTGGCCATGATCGGCAACCCCGGGCAGTGCCTGGGGGATCTTTCGCTGCTCAGCGACGGGCAACGGACGGTCGTTGAACAGGAGTCCCGCCGGGCGGCCGGGCAAGTGGGCCGGGGCCTGAATATCCACCAGTTGATCGAAGCCCAGGCCGCGCGCACTCCGGATGCCGTGGCGCTGCTGTGCGCCGGTGAGCAACTGAGCTATGGCCAGTTCAACCAGCGGGCCAACCAGTTGGCCCATAAGCTGATCGAGCAGGGTGTAGGCCCGGATGTGCGGGTGGGCATTGCCGTGGAGCGCGGGCTGGACATGATTGTCGGCCTGCTGGCGGTGCTCAAGGCCGGTGGCGCCTACGTGCCGCTGGACCCCGAGTACCCCCAGGAGCGCCTGCACTACATGATGCAGGACAGCGGCATCCAGTTGCTGCTGACCCAGTCGCCGCTGCTGGAGCGTTTGCAGGATGGCCTCGCGGTGCCGTACCTGTGCCTGGACCAGGCTCCCGTCTGGCTGGCCGGTATGGCGCAGGGCAACCCGCCTGAGCGCAGCAGCGCGGAAAACCTGGCCTATGTGATGTACACCTCCGGCTCCACCGGCCGGCCCAAGGGCGTAGGTATTACCCACAACGCCCTGAGCCAGCACGCACGGGCCACCGCCAGCCATTTCAACATGACGGCTACGGACCGTGGCTTGCAGTTCTCCACCTTCAACTTCGATGCCTTTGTCGAACAGCTGTACCCGGCGCTGATCCGTGGTGCTTCGGTGGTGATCCGCGGCAAGGCGCTGTGGGACAGCGAAACCTTCTACCGCGAGCTGATCGAGCAAGGCATCAGTATCGTCGACTTGAGCACCGCCTACTGGTTCATGCTGGGCAAGGACTTCGCCGCCAAGGGGCCGCGGGACTTTGGCCGCCTGCGTCAGCTCAACCTGGGGGGCGAGGCCATGCCGGCGGAAGGCGTGGCCGCCTGGAAGCAGGCCGGCCTGAAACACGCCTGCCTGCTCAACACCTACGGGCCCACCGAGGCCACCGTGAGTGCCACGGCCCATGACTGCGGTGCCTACCTGAAGGGGACCGAGCCGCTGCCGGCGGTGATTCCACTGGGCAAGGCCCTGCCGGGCCGTTCCATCTACCTGCTGGACAGCAGCGGCAACCTGCCGCTCAACGGTGTGATGGGCGAGCTGATGATCGGTGGCGACCTGCTGGCCCGGGGTTACCACGACCGCCCAGGCCTGACTGCCGAGCGTTTCATTCCCGATCCGTTCAGCAGCGATGGTGGGCGCCTGTATCGCTCCGGCGATCTGGCCCGCTATGACGCCGAAGGCGTGATCGAATACGCCGGGCGCATCGACCACCAGGTGAAGATCCGCGGTTTCCGTATCGAAATGGGCGAGATCGAAGCGCGGCTGCTGGAGCTGACGCCAGTACGCGAGGCGCTTGTACTGGCCCAGGACGGCGCGAGCGGGCCACAACTGGTGGCTTATGTAGTGCCAGCCGCGCAGGTGGCGGCCGATACGCCGCAGGCCCAGGCGCAACTGCGCGAGCAATTGAAAGCGGCCCTCAAGGAGGTGCTGCCGGACTACATGCTGCCGGCGCACCTGCTGTTCCTCGAAGCGCTGCCGTTGAGCCCCAATGGCAAGCTGGACCGCAAGGCCCTGCCCAAGGCCGATGCCAGCCTGTTGCAGCAGGCCTACATCGCTCCACAGAGCGAGCTGGAACAGCAGATCGCCGCCCTCTGGAGCCAGGTGCTGGGCGTCGATCAGGTGGGCCTGGACGACAACTTCTTCGAGTTGGGTGGGCACTCCCTGGATGCCTTGCGCCTGATCGGCGCCATCAACCAGGCACTGGCTGTGCAACTGAGCATCAATGCGCTGTTCACGGCGCCGACCGTGGGGCAACTGGCTGGTGTGATCGCAGCCGGTCAGCCCGACAGTGCACAGAATGTCATCGCCCTGGGTGGCTCCGGCCAGCCGCTGTTCTGCTTCCACCCGGCGGGGGGCAGCGTGTATGGCTACCTGCCGTTGGCGGCGCAGTTGCGCGACCGTTGCGCGGTGTATGGCGTGCTGCACCAGGCCTACCTGCAAACCGACTGGAGCGAGGTTTCATGGCAGGCCATGATCGAGCGCTATGTCGCCAGCATCCGCCAGGTGCAGCCGAGCGGTCCCTACTATCTGGCGGGCTGGTCCCTGGGCGGGTCCATTGCCATGGACGTGGCCAGCGAACTGGAGGCGGCGGGAGAGACGGTGCGTTTCCTCGGCCTGCTCGACCCGACACCGCCTCAGGGCGCCGGGGACGATCAGATCCAGACGCAGGAGATGCCAGTCACTGTGACGGCCGAGTCCGAGTGGCAGGCGATCATCGACAAGCTCTGCCAGCAGTTCCCGGGCAGTGCAGAGATGATCGAGAGCCGCTTGAGGCGCGAAGCCGAGCTCGACTGGCAGAGCATCCATGGCTGGGTGGCTGGCAATATCCCCCTGGCTCCCGGCGAGCTGGATCGGGTGGTGGGGCTGTTCAAAGCCGAGTTCGACGCCTCGCTGGTCAGCGCGGTGTTCAATGACTTGAGCGCCTTGTCTGCGGCCTATGCCTATCGCCCCCTGCGGGTTGCGCCGCGGCTATGGTGGTCCAGCGATTATGCCCGGGAGCGGATCCAGATCATGGAGCAGGCCATGGGTCGTGAGGTGCAGGGTGGTGAGATAGCCGCTTCATATCATATCGAAGCCCGCCATGAAGCCATGGTGGACAGCCGAGCCTTGCTGGAGAGCTTCACAGAGCAGTTGCTGACCTGCTTGAACTGA	MQALIDSVGTLSSKERRALAILLKEKGINLFGIAPICSRGADEAPVLSYTQESQWFLWQLEPDSTAYHITTALRLTGELDLDALRHAFDTLIARHETLRTTFSEDDGTAVQVVHPPAPLDIEVIELHAGGLSYEAQVHALTDSKSQPPFDLRNGPLLRAKLLRVAADEHVLVLTQHHIVSDGWSMGVMVDELIQLYAGYRQGRTVSLPDLPIQYADYANWQRQWMDAGERERQLGYWLEQLAGEQPLLMLPLDHPRPAIQSYRGALLDIPLPEELRLGLKQLAQREGATLFMLLLASFQVLLHRYSGQADIRVGVPTANRNRVETERLIGFFVNTQVFKAEVDGQLGFNDFLQQVKQTALMAQSHQDLPFEQLVEALRPERSLSHSPLFQAMFNHQTAVKKGGQSQRLDDLSIETLSWQGRAAQFDLTLDTFESEDGLWASLTYATDLFEASTIERLAQSWVQLLQGIVQQPRQRLGDLPLLGAAEQHQLLHEWTPATGEFPSDGCVQQLVEAQALKSPESEALLFAGQCLSYRELNARANRLAHKLIELGVGPEVRVGVALQRTPEMVVALLAVLKAGGAYVPLDPDYPQDRLAHMLRDSQAQILLTENALLSLLPSVESLQTLQLDAQPGWLDAYSPENPPQRATADNLAYVIYTSGSTGLPKGVAIAHRNVLALIDWSNRVYSTADLQGVLASTSICFDLSVWELFVTLSSGGSIVLARNALELPELADRDRVRLINTVPSAIAALQRSGQIPPSVRIINLAGEPLKQALVDSLYQQPGLVHVYDLYGPSEDTTYSTYTRREAGGQANIGRAISNTQSYILSPDLQPVPVGSAGELYLAGAGVTRGYLARPGLTAEKFVPNPFSSDGGRLYRTGDLTRYRADGVIEYIGRIDHQVKIRGFRIELGEIEARLVQQAAVREAFVLAHDSENGQQLVAYIVPSEATPTVEAQAALRDSLKTALKEHVPDYMVPAYLLFLEALPLTPNGKLDRKALPKVDAQQMQQVYVAPQSELEQQIAAIWADVLKLEQVGATDNFFELGGDSIISIQVVSRARQAGIRFTPRDLFQYQTVQGLAAVAEQGEGGVQIDQGPVGGATALLPVQQWFFESPMSERHHWNQSVLLKPAQPLRAEVVENALQALWVQHDALRLQFSQEADGWSARFADAGQRPELLWQVAVDGAQAMEQSAIEAQRSLNLQDGPLLRAVLFSLEDGSQRLLLVIHHLVVDGVSWRILLEDLQRAHAQLSAGQPLALPAKTSSTQAWAEQMQAYAQGAALQEELKYWQAQLQGVESNLPLDRPVTELQNQHASSLSSRLDKARTQRLLQDAPAAYRTQINDLLLTALARVITRWTGEASALVQLEGHGREDLFDSIDLTRTVGWFTSMFPVKLTPQASLADSIKFIKEQLRAVPNKGIGFGALRYLGDAQAQQALAALAVPRITFNYLGQFDGSFDEQDSLFKPSGEAKGDDQSPLAPLSNWLSLDGQVYGGELSLNWTFSQQMFDTATVQRLADDYTEELKALVAHCCTPELAGATPSDFPLAGLNQQQLDRLPVAMASVEDLYPLSPMQQGMLFHTLYEQAAGDYINQLRVDVDGLDPLRFQQAWQAAIDRHDILRTGFIWQGEVSTPLQVVHKHIALDCTEHDWRGQPQQQEALDTLATAERQRGFELDAVPLLRLTLVRIDEQRYHLIYTNHHILMDGWSNSQLLGEVLQRYAGQLPSHAAGRYRDYIAWLQRQDAQACESFWKEQLQTLDEPTRLTQALSRVADIAAGTGHGKHHRELDLAQTARLGEFARQQKVTVNTLVQAAWLLLLQRCTGQDSVVFGATVAGRPAELKGIEQQVGLFINTLPVVATPRPDMTVSQWLQAVQNRNLALRDYEYTPLYEVQRWAGLGGDALFDNILVFENYPVSEALEKGAPAQLRFGAVGNHEQTNYPLTVAVNLGASLSFEFIYARESFSEPSMVQLGGHLQGLLLSLMEHAQTGLGELPLLTQDEQHRIRQDWDHTDVVYPTERFVHQLFADQAAKAPDAPAVFFAEQRLSYRELDTQANQLAHKLIELGVGPEVRVAIAMPRCAEIMVAFLAVLKAGGVYVPLDIEYPQDRLRYMMQDSGAWLLLTQNHLLDRLPIPEGLPTLSVEGAADFAAYPVTSPQVDLAEENLAYVIYTSGSTGLPKGVAVSHGPLAMHSLATGERYEMSPADCELHFMSFAFDGSHEGWMHPLIYGASVLIRDDSLWSPEFTYEQMHRYGVTVGVFPPVYLQQLAVHAERDGNPPAVRVYCFGGDAVPQASYDLAWRVLRPKYIFNGYGPTETVVTPLIWKAKAGDPCDAAYAPIGNIVGNRSAYVADANLNLLPVGVAGELYLGGLGVARGYLDRPGLTAERFIPDPYSTAGARLYRSGDLTRYRTDGLVEYVGRVDHQVKVRGFRIELGEIEARLLEQDPVLEVAVIAQPGPSGQQLVGYIVPVDAEVASSNERQAQLRESIKARLRESLPDYMVPTYLLFLEALPLTPNGKLDRKSLPKVDAQLMQQTYVAPQNPLEQQIAAIWADVLKLEQVGVTDNFFELGGDSIISIQVVSRARQAGIRFTPKDLFQHQTVQGLATVAEQGEGGLQIDQGPVRGQMALLPIQQWFFDTPVPERHHWNQSVLLKPLQALQAQPLESALQALTVQHDALRLRFTEHQGTWRAAFADAEEPVQLLWQANVADAQALQQFAEQAQSSLNLQEGPLLRAVLFTLADQSQRLLLIVHHLVVDGVSWRILLEDLQALLGGQALPAKSSSTQAWAGQLQAYASSAALQQELGYWQAQLQGVESNLPCDHGHDGLQNQHASSVETRLSKGDTQRLLQDAPAAYRTQINDLLLTALARVITRWTGDSSALVQLEGHGREELFDSIDLSRTVGWFTSVFPVKLTPQPVLADSIKFIKEQLRAVPNKGIGFGALRYLGDAQAQAALAALAVPRITFNYLGQFDGSFDDQQAWFAPANEAKGDDQSLHAPLGNWLTLNGQVYGGELSLGWNFSRAMFDTATIEHLADDYARELKALIEHCSQPEHRGATPSDFPLAGLSQQQLDRLPLALAQVEDLYPLSPMQQGMLFHTLYQEEGGDYINQLRVDVDGLDPERFRQAWQATIERHDILRSGFLWQGELPAPIQVVYKQVSLECVEHDWRSTQQAPQALDTLAATERQRGFDLAAAPLLRLTLVRTGEQRYHLIYTNHHILMDGWSNSQLLGEVLQRYAGQLPQHLTGRYRDYIAWLQRQDATLSEHFWKQQLQGLDEPTRLAQAIAAGARAPLEEGHGSHGCTLDEAQTRSLGEFARQQKVTVNTLVQAAWLLLLQRCTGQDTVVFGATVSGRPAELKGVEQQIGLFINTLPVVAAPLPQLSVSDWLQAVQERNLALRDFEHTPLYDVQRWAGLGGEALFDNILVFENYPVSEALEKGSPAQLQFGAVGNHEQTNYPLTLSVFVAERLSFDYSYSYQHFSGAVIRQLAEGLQHLLLAMIGNPGQCLGDLSLLSDGQRTVVEQESRRAAGQVGRGLNIHQLIEAQAARTPDAVALLCAGEQLSYGQFNQRANQLAHKLIEQGVGPDVRVGIAVERGLDMIVGLLAVLKAGGAYVPLDPEYPQERLHYMMQDSGIQLLLTQSPLLERLQDGLAVPYLCLDQAPVWLAGMAQGNPPERSSAENLAYVMYTSGSTGRPKGVGITHNALSQHARATASHFNMTATDRGLQFSTFNFDAFVEQLYPALIRGASVVIRGKALWDSETFYRELIEQGISIVDLSTAYWFMLGKDFAAKGPRDFGRLRQLNLGGEAMPAEGVAAWKQAGLKHACLLNTYGPTEATVSATAHDCGAYLKGTEPLPAVIPLGKALPGRSIYLLDSSGNLPLNGVMGELMIGGDLLARGYHDRPGLTAERFIPDPFSSDGGRLYRSGDLARYDAEGVIEYAGRIDHQVKIRGFRIEMGEIEARLLELTPVREALVLAQDGASGPQLVAYVVPAAQVAADTPQAQAQLREQLKAALKEVLPDYMLPAHLLFLEALPLSPNGKLDRKALPKADASLLQQAYIAPQSELEQQIAALWSQVLGVDQVGLDDNFFELGGHSLDALRLIGAINQALAVQLSINALFTAPTVGQLAGVIAAGQPDSAQNVIALGGSGQPLFCFHPAGGSVYGYLPLAAQLRDRCAVYGVLHQAYLQTDWSEVSWQAMIERYVASIRQVQPSGPYYLAGWSLGGSIAMDVASELEAAGETVRFLGLLDPTPPQGAGDDQIQTQEMPVTVTAESEWQAIIDKLCQQFPGSAEMIESRLRREAELDWQSIHGWVAGNIPLAPGELDRVVGLFKAEFDASLVSAVFNDLSALSAAYAYRPLRVAPRLWWSSDYARERIQIMEQAMGREVQGGEIAASYHIEARHEAMVDSRALLESFTEQLLTCLN	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	793.17	gnl|BL_ORD_ID|4935|hsp_num:0	5928			99	1647	colistin A; colistin B
BGC0000413.1|Pyoverdine_18 # 36396 # 42977 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.654	BGC0000413.1|Pyoverdine_18 	36396	42977	-	Loose	1000	135.961	almE	29.51	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGACAACACCACCGCGCTGAAGATTGTCAAAGGCTTCATCCTGCTGCCCCTGGAGAAGCGCAAGGTCTACCTGCAGAAGATGCTCGAACAGGGCATCTCCCCGGCCAACCTGCCGATTCCCGAGGTGCGCCTGAGCCAGGAGCGCCTGCCGCTGTCCTATGCCCAGCAACGCCAGTGGTTCCTCTGGCAACTGGCGCCCGAGAGCACGGCCTATCACATTCCCAAGGCCCTGCGTCTGCGCGGGAAACTGAATGTCGAGGCCTTGCAGCGCAGCTTCGACAGCCTGATCGCCCGGCATGAAAGCCTGCGCACGCATTTCGTCGAGGAGGCCGACACGGCGCTGCAGGTGGTCGCCCCCGAGGCGCGCCTGGAGCTGGTGCGCCAGGCACTGCCGGCCCAGGCGAGCCAGCAGCAGATCAATGCGGCCGTGCAGGACTTCGTCCAGGCCCAGACCCGGCGACTGTTCGATCTGCTGGCCGGGCCGTTGCTCAGGGTCGGCCTGTTGCAGGTGGCCGAGGATGACCATGTGCTGGTCCTGACCCAGCACCACATCGTCTCCGATGGCTGGTCGATGCAGGTCATGGTGGATGAACTGATCGCGTTCTACATCGGTTTCTGCCAAGGGCAGACGGCGTCGTTGCCGGCGCTGCCGATCCAGTATGCCGATTACGCCCTCTGGCAGCGCCACTGGATGGAGGCCGGTGAAAAGGACCGACAACTGGCCTACTGGACAGCGCAACTGGGCGGCGAGCAACCCTTGCTCGAACTGCCTCTGGATCGCCCGCGCCCCGTGGTGCAGAGCCATCGGGGCGGGCGCCTGGAGCTGACCCTGGAGCAGCCCTTGAGTGAAGCCCTGGGCAGCCTGGCCCAGCGGGAAGGGGTGACCCTGTTCATGCTGTTGCTGGCCTCTTTCCAGACCCTGCTGCACCGCTACAGCGGCCAGGCCGATATCCGCGTCGGTGTGCCCATTGCCAACCGCAACCGGGTCGAGACCGAGCGCCTGATCGGCTTCTTCGTCAACACCCAGGTGCTCAAGGCCGAGATCGACGGGCAGATGTCCTTCAGCCAGTTGCTGCAGCAGGTACGCCAGACCGCCCTGGCGGCGCAGGCGCACCAGGACCTGCCTTTCGAGCAACTGGTGGAGGCCTTGCAGCCGGAGCGCAGCCTGAGCCACAACCCGCTGTTCCAAGTGATGTTCAACCACCAGGTGGAAGCGGCGGGCGCAGGCAAACCCCTGAACCTGCCTGGCCTGAGCATCGAGGCCCTGGACTCCCAAGGGCAGTCGGCGCAGTTCGATCTGACCCTGGACACCGTGGAAACCCAGGGCCGGATCGCCGCGTCCCTGGTCTATGCCACCGATGTGTTTGACGCCGCCACCATCGAGCGCCTGGCCGCCCATTGGCGCCAGTTGCTGCAAGGCGTGGCCAGCCAGCCGCAGCAGCGCATCGGCCTGTTGCCATTGCTGGGGGCCGACGAGCAGGCGCAGATCCTCGACCAGTGGAACCGGCTGCAGCAGGCATTCCCTTCCCGGGCCTGCGTCCATCAGCTCATCGAGGCTCAGGCCGCCAGGGCGCCCCAGGCCATTGCCCTGACCTTCGCCGGGCAGAGCCTGGACTACCAGCAGCTCAACGAGCGGGCCAACCGCCTGGCGCACAAGCTCATCGAGCAGGGCGTGGGCCCCAATGTACTGGTGGGGCTGGCGGTGGAGCGCAGCCTGGAGATGGTCATCGGCCTGCTGGCGATTCTCAAGGCCGGCGGTGCCTATGTGCCGCTGGACCCGGCCTATCCCCAGGACCGCCTGCAGCACATGATGCAGGACAGCGCCATCGCGTTGCTGCTGACCCAGGAGCATCTGCTGCAGGGCTTGCCGGCGTTTGCCGGCAGTACCTGGTTGCTGGAGCAGCCCCTGGACGGCTACCGGGTAGACAACCCCGAGGTCGGGGTGACGCCCGAAGACCTGGCCTACGTGATCTACACCTCCGGTTCCACCGGCAAGCCCAAGGGCACCTTGCAGCCGCACCACAACGTCCTGCGCCTGTTCGCAGCCACCGAGCAGTGGTTCCAGTTCGGCGCCGAGGATGTCTGGAGCCTGTTCCACTCCTATGCGTTCGACTTCTCGGTGTGGGAGATTTTCGGGGCCCTGCTGTACGGCGGGCGGCTGCTGATCGTCCCCCAGGAGGTGGCGCGCTCGGCCCAGGACTTCTACCCGCTGCTCTGCAGCGAGGGCGTGACGGTGCTCAACCAGACTCCGTCGGCGTTCCGCCAGTTGATGCACGTGGCCTGCAGCGCCGAGCCTGCGCATCGGTTGCGCTACATCGTGTTCGGTGGCGAGGCCCTGGAGGTCAATACCCTGCAACCCTGGTTCCAGCGTTTCGGCGATCAGCGCCCGCAGCTGGTGAACATGTACGGCATCACCGAAACCACGGTGCACGTGACCTATCGTCCCTTGTCCGTGGCGGATCTGAGCCTGACGGGGGCCAGCCCGATTGGCGAGCTGATTCCCGACATGGCCTGGTACCTGCTGGACGGCAACCTGCAACCGGTGCCCAAGGGCTGCATCGGTGAGCTGTATGTCGGGCGTGCCGGGCTGGCCTGGGGCTACCTGAACCGTGGCGACTTGAGTGCGGCGCGGTTTGTCCCGGACCCGTTTGGCGAGGCTGGTGGGCGTCTCTACCGCACCGGCGATCTGGCGCGTTATCAGGCCGACGGTTCGATCGGCTACATCGGCCGTATCGACCACCAGGTGAAGATCCGCGGTTTCCGTATCGAGCTGGGGGAGATCGAAGCGCGGCTGCTGGAGTTGCCTGCGGTGCGTGAGGCGGTGGTGCTGGCCCCGGAAGGTCCCGACGGCCCGCAACTGGTGGCCTACGTGGTGCCCGCCGGCCTGGACTGGAACGGCCAGGATCCGCTTGCCGAGCAACTGCCACTGCGCGACGCCATCAAGGCCGGGCTGCGCGAGCACCTGCCGGGCTACATGGTTCCGGCCCATGTGCTGTTCCTCCAGGCGCTGCCCCTGACCGCCAATGGCAAGCTCAATCGCGCTGCCTTGCCGGCCATCGACGGCAGCCTGTTGCAGCAGGCCCACGTGGCCCCGCGCAGCGAGCGCGAACAGCAAGTGGCCGGGATCTGGGCCCAGGTGCTGAAACTGGAAAAGGTCGGCTTGACCGATAACTTCTTCGAGCTCGGCGGCCATTCGCTGCTGGCTACCCAGGTGATGTCGCGCATCCGCCAGGAGCTGGGCATCGAGGCGCCGCTCAAGCTGCTGTTCGAAGGCGAGTCGCTGGAAGATTTCGTCCGCCTGCTGGGCCCGGAAACTGCCCAGCCACTCCAGTCGATTCCCCTGGTGGACCGGCAGCAGCCGCTGGTGGTGTCCTATGCCCAGGAGCGCCAGTGGTTCCTCTGGCAGCTGGACCCCGACAGCAGCGCCTATCACATCCCCATGGCCCTGCGCCTGCGTGGCGCTCTGGATAGCCAGGCCCTGCAAAGCAGTTTCGATGCCTTGATCGCCCGCCATGAAAGCTTGCGCACGCACTTTGTCGAGAGCGCCGGGGGCCTGACCCAGGTGATCGCGGCCCAGGCCCGCTTGCCCATCAGCCAGCAAGACTTGTCCCTGCTGGTGGAGGCCGGCAACACCGATGACTTGATCAAGCAGGTTATCGACACCCAGGTACGTCAGCCGTTCGACCTGCGCCAGGGGCCGTTGCTGCGGGCCACCCTGGTGCGCCTGGCGGAGGACGAGCATGTGCTGGTGCTGGTCCAGCACCACATCGTTTCCGATGGCTGGTCGATGCAGTTGATGGTGGAGGAACTGATCCGGCTCTATGGCGCCCATAGCCAGGGGCAGCAGGCCGAGTTGCCGGCGCTGGCGGTGCAGTACGCGGACTACGCGGCCTGGCAACGCCAGTGGATGGAAGCCGGTGAGCGCGAGCGGCAACTGGATTACTGGTTGCAGCAACTGGAAGGCGGCGCTCAGGTTCTGGATTTGCCCCTGGACCATCCGCGGCCGTTGCAGCAAAGCCACGAGGGCGCGCGCCATGGCATCAGCCTGGATGGCGCCTTGCCGGGGGCCCTGAAACAGCTGGCCCAGCGCGAAGGGGTCACGCTGTTCATGCTGTTGCTGGCCTCGTTCCAGGTCCTGCTGCACCGCTACAGCGGCCAGGCGGACATCCGCGTCGGGGTGCCCACCGCCAACCGCAACCGGGTGGAGACCGAGCGCCTGATCGGCTTCTTCGTCAATACCCAGGTGCTCAAGGCTGAAGTCGACGGGCAACTGAGCTTCAGCGACTTTCTAAGTCAGGTCAAAAGAGCCGCGCTGGAGGCCCAGGAGCATCAGGACCTGCCCTTCGAACAACTGGTGGAAGCCCTCAAGCCGGAGCGCAGCCTGAGCTACAGCCCGCTGTTCCAGGTGATGTTCAACCACCAGGCGGCCGCCCGCCAGGACGCTGCAACCCTGGAGGTTCCAGAGTTGCAGGTGCAGATGCTCAGTGGCGAGGACAGCACGACCCAGTTCGATCTGAGCCTGGATACCTTCGAGTCCGGGGATCGCCTCTGGGCCTCCCTGACCTATGCCTGCGACCTGTTCGAGGCTTCCACCATCGAGCGTCTGGCCCAGTCCTGGGTGCAGTTGCTGCAGGGCATTGTCCAGCAGCCACGCCAGCGCCTGGGGGACCTGCCGCTGCTGGGCGCTGCCGAGCAGCACCAGTTGCTGCACGAGTGGACCCCGGCCACTGGTGAGTTCCCCAGCGATGGTTGCGTGCAGCAGTTGGTGGAAGCACAAGCACTGAAAAGCCCGGAGGCCGAGGCCCTGTTGTTCGCTGGCCAGAGCCTGAGCTACCGGGAACTCAATGCCCGGGCCAACCGCCTGGCTCACAAGCTGATCGAGCTGGGCGTGGGGCCTGAAGTGCGGGTGGGCGTGGCCTTGCAGCGCACCCCGGAAATGGTCGTGGCGCTGCTGGCGGTGCTCAAGGCCGGTGGCGCCTATGTGCCCTTGGACCCGGATTATCCACAGGATCGTCTGGCCCACATGCTGCGCGACAGTCAGGCGCAGATCCTGTTGACCGAAAACGCCTTGCTGTCGCTGCTGCCGTCCGTGGAATCCTTGCAGACCCTGCAACTGGATGCCCAGCCGGGTTGGCTGGACGCGTATTCGCCGGAAAATCCGCCGCAGCGAGCTACTGCGGACAATCTGGCTTATGTGATCTACACCTCCGGCTCCACCGGCCTGCCCAAGGGCGTGGCGATTGCCCATCGCAACGTGCTGGCGCTGATCGACTGGTCGAACCGGGTGTACAGCACTGCAGACCTGCAAGGGGTGCTGGCTTCCACCTCGATCTGCTTCGACCTGTCGGTGTGGGAGCTGTTTGTCACCCTGTCCAGCGGCGGTTCCATCGTCCTGGCCCGCAACGCCCTGGAACTGCCGGAGCTGGCGGACCGCGACCGGGTGCGCTTGATCAATACCGTGCCCTCGGCGATTGCCGCGCTACAACGCAGCGGGCAGATTCCGCCCAGCGTGCGAATCATCAACCTGGCGGGTGAGCCGCTGAAACAGGCGCTGGTGGATAGCCTCTACCAGCAGCCCGGGCTGGTGCATGTCTACGACCTGTACGGCCCTTCGGAAGACACCACCTACTCGACCTACACCCGGCGCGAGGCGGGAGGGCAGGCCAATATCGGTCGGGCCATCAGCAACACCCAGAGCTACATCCTCAGCCCGGACCTGCAACCGGTGCCGGTGGGCAGTGCCGGCGAGTTGTATCTGGCCGGCGCCGGGGTGACCCGAGGCTACCTGGCGCGCCCAGGGCTGACCGCCGAAAAGTTCGTACCCAACCCGTTCTCCAGCGACGGTGGCCGGTTGTACCGCACTGGCGACCTGACCCGTTACCGCGCCGATGGGGTGATCGAGTACATCGGCCGCATCGACCATCAGGTGAAGATCCGCGGTTTCCGTATCGAGCTGGGTGAAATCGAAGCGCGGCTGGTGCAGCAGGCGGCGGTGCGTGAAGCCTTCGTCCTGGCCCATGACAGCGAAAACGGCCAGCAACTGGTGGCCTATATCGTGCCGAGCGAGGCCACCCCGACCGTCGAGGCCCAGGCCGCCCTGCGCGACAGCCTCAAGACTGCACTCAAGGAACACGTGCCGGACTACATGGTGCCGGCCTACCTGCTGTTCCTGGAGGCGCTGCCCCTGACCCCGAATGGCAAGCTCGATCGCAAGGCCCTGCCCAAGGTCGACGCCCAGCAGATGCAGCAAGTCTACGTGGCGCCGCAGAGCGAGCTGGAGCAACAGGTCGCGGCGATCTGGGCCGATGTGCTGAAGCTGGATCGGGTGGGCATGAGCGACAACTTCTTCGAGCTGGGCGGCCACTCCCTGTTGGTGGCTCAGGTGGTGACTCGGGTCAAGCAGCAGTTTGGCGTGGATATGCCCATCAAGTCGCTGTTCGGCGCGGAGAGCCTCGCGGCCTTTGTCGAGAAGGTTCAGGCCCTGCGGCAGACAACTTCTTCACTGCAGGATGAATTGGCTAAATCTTTGGAGGCCCTCAAACGTTTATCTCCCGATGATCTTGAAAAAATAATTTCTTAG	MDNTTALKIVKGFILLPLEKRKVYLQKMLEQGISPANLPIPEVRLSQERLPLSYAQQRQWFLWQLAPESTAYHIPKALRLRGKLNVEALQRSFDSLIARHESLRTHFVEEADTALQVVAPEARLELVRQALPAQASQQQINAAVQDFVQAQTRRLFDLLAGPLLRVGLLQVAEDDHVLVLTQHHIVSDGWSMQVMVDELIAFYIGFCQGQTASLPALPIQYADYALWQRHWMEAGEKDRQLAYWTAQLGGEQPLLELPLDRPRPVVQSHRGGRLELTLEQPLSEALGSLAQREGVTLFMLLLASFQTLLHRYSGQADIRVGVPIANRNRVETERLIGFFVNTQVLKAEIDGQMSFSQLLQQVRQTALAAQAHQDLPFEQLVEALQPERSLSHNPLFQVMFNHQVEAAGAGKPLNLPGLSIEALDSQGQSAQFDLTLDTVETQGRIAASLVYATDVFDAATIERLAAHWRQLLQGVASQPQQRIGLLPLLGADEQAQILDQWNRLQQAFPSRACVHQLIEAQAARAPQAIALTFAGQSLDYQQLNERANRLAHKLIEQGVGPNVLVGLAVERSLEMVIGLLAILKAGGAYVPLDPAYPQDRLQHMMQDSAIALLLTQEHLLQGLPAFAGSTWLLEQPLDGYRVDNPEVGVTPEDLAYVIYTSGSTGKPKGTLQPHHNVLRLFAATEQWFQFGAEDVWSLFHSYAFDFSVWEIFGALLYGGRLLIVPQEVARSAQDFYPLLCSEGVTVLNQTPSAFRQLMHVACSAEPAHRLRYIVFGGEALEVNTLQPWFQRFGDQRPQLVNMYGITETTVHVTYRPLSVADLSLTGASPIGELIPDMAWYLLDGNLQPVPKGCIGELYVGRAGLAWGYLNRGDLSAARFVPDPFGEAGGRLYRTGDLARYQADGSIGYIGRIDHQVKIRGFRIELGEIEARLLELPAVREAVVLAPEGPDGPQLVAYVVPAGLDWNGQDPLAEQLPLRDAIKAGLREHLPGYMVPAHVLFLQALPLTANGKLNRAALPAIDGSLLQQAHVAPRSEREQQVAGIWAQVLKLEKVGLTDNFFELGGHSLLATQVMSRIRQELGIEAPLKLLFEGESLEDFVRLLGPETAQPLQSIPLVDRQQPLVVSYAQERQWFLWQLDPDSSAYHIPMALRLRGALDSQALQSSFDALIARHESLRTHFVESAGGLTQVIAAQARLPISQQDLSLLVEAGNTDDLIKQVIDTQVRQPFDLRQGPLLRATLVRLAEDEHVLVLVQHHIVSDGWSMQLMVEELIRLYGAHSQGQQAELPALAVQYADYAAWQRQWMEAGERERQLDYWLQQLEGGAQVLDLPLDHPRPLQQSHEGARHGISLDGALPGALKQLAQREGVTLFMLLLASFQVLLHRYSGQADIRVGVPTANRNRVETERLIGFFVNTQVLKAEVDGQLSFSDFLSQVKRAALEAQEHQDLPFEQLVEALKPERSLSYSPLFQVMFNHQAAARQDAATLEVPELQVQMLSGEDSTTQFDLSLDTFESGDRLWASLTYACDLFEASTIERLAQSWVQLLQGIVQQPRQRLGDLPLLGAAEQHQLLHEWTPATGEFPSDGCVQQLVEAQALKSPEAEALLFAGQSLSYRELNARANRLAHKLIELGVGPEVRVGVALQRTPEMVVALLAVLKAGGAYVPLDPDYPQDRLAHMLRDSQAQILLTENALLSLLPSVESLQTLQLDAQPGWLDAYSPENPPQRATADNLAYVIYTSGSTGLPKGVAIAHRNVLALIDWSNRVYSTADLQGVLASTSICFDLSVWELFVTLSSGGSIVLARNALELPELADRDRVRLINTVPSAIAALQRSGQIPPSVRIINLAGEPLKQALVDSLYQQPGLVHVYDLYGPSEDTTYSTYTRREAGGQANIGRAISNTQSYILSPDLQPVPVGSAGELYLAGAGVTRGYLARPGLTAEKFVPNPFSSDGGRLYRTGDLTRYRADGVIEYIGRIDHQVKIRGFRIELGEIEARLVQQAAVREAFVLAHDSENGQQLVAYIVPSEATPTVEAQAALRDSLKTALKEHVPDYMVPAYLLFLEALPLTPNGKLDRKALPKVDAQQMQQVYVAPQSELEQQVAAIWADVLKLDRVGMSDNFFELGGHSLLVAQVVTRVKQQFGVDMPIKSLFGAESLAAFVEKVQALRQTTSSLQDELAKSLEALKRLSPDDLEKIIS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	394.42	gnl|BL_ORD_ID|4935|hsp_num:0	5928			132	1650	colistin A; colistin B
BGC0000413.1|Pyoverdine_19 # 42977 # 54124 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.662	BGC0000413.1|Pyoverdine_19 	42977	54124	-	Loose	1000	135.191	almE	27.34	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAATGCAGAAGACTCCTTGAAGCTCGCCCGCAGATTCATTGAACTGCCGCTGGAAAAGCGCCGGCTGTTCTTGAAGGCTCTGGACAAGGAAGGCGTCGACTTCTCTCTGCTGCCGATTCCGGCGGGGGTTGCGGTGCCTGATCGCCAGGCCCTGTCCTATGCGCAGCAGCGCATGTGGTTTCTCTGGCAACTGGACCCGCAGAGCGCGGCCTACAACCTGCCCAACGCGGTCCGCCTGATCGGGCCGCTGGACCGGGCAGTGCTGGCGCAGGCCTTCGACTGGCTGCTGGAGCGGCATGAGAGCCTGCGCACGGTCTTTGCCCTGGAGGACGATGAGCCTCGGCAGGTGATCCAGGAGGCGCGGGTCGACATCGATTATCGGGAGCTTTGCGACCTCGACCCGGCGCAGCGCGAAACCAGGGTGCAACAGCTGGCCGACGCCGAAGCGCGCCGGCCCTTCGATCTGCAACAGGGGCCTTTGCTGCGGGTCTGCGTACTGGGCCTGGGCGAGCAGGAGCACGTGATGCTGCTGACCCTGCACCATATCGTCGCGGATGGCTGGTCGATGGGGGTCTTGATCGAAGAATTCCTGCACGCCTACGACAGCCTGCTCCAGGGTGAGGTGCCGAACGTCCCGGCGCTGCCGATCCAGTACCGCGACTACGCCCTGTGGCAGCGCAGCTGGCTGGAGGCAGGGGAGCAGGAGCGGCAACTGGACTACTGGCGCGCCAAGCTGGGTGACGAGCATCCGCCGCTGAAACTGCCCACCGACCATCCGCGGCCGGCCCATTCCAGCCGCCAGGGGCGCCGCCTGGATTTTGCCCTGGAACAACCCCTGGCCCAGCAACTGGGCGCCCTGGCGCGCCAGCAGGGGGTGACCCTGTTTGCCGTGCTGTTGGCCGGCTTCAAGCTGCTGCTATCGCGCTACAGCGGCCAGCAGGACATCCGGGTCGGCGTGCCCATCGCCAACCGCACGCGCCAGGAAGCCGAGGGGCTGATCGGTTTCTTCGTCAACACCCAGGTACTGCGTACCGAACTGAGCCCGCAATTGACAGTGCAGCAACTGCTGGCCGATATCCGCGAGACTACCCTGGGCGCCCAGGCCCATCAGGACCTGCCCTTCGAGCGCCTGGTGGAAGCCCTGCACCTGGAGCGCAGCCTGAGCCACAGCCCGCTGTTCCAGGTGCTGTACAACCACCAGCCCCAGGTCACCGAACTGACCACCTTGCACAGCCGCTCCGGGCTGCAAGTGCAGGCCTTGCCGCGCAACGAGCGCACGGTGCAGTTCGACTTGACCCTGGACACTTTCGAACGCGGTGGCCAGTTGCAGGCCGCCTTCACCTACGACTGCCAGTTGTTCGAAGCGCAGACCATCGAGCGCATGGCCGGCCACTGGCAGAACCTGTTGTGGGCGATGGTGCGCGAGCCGCAGTCGGCGCTTGCCGAACTGCCGCTGCTCAGTGCCCAGCAGCACCGGGGCTTCCTGGCCCAGGGGGCTGGCGCAGAAGAGGTGTTCAGCGCCGAATCGGTGCTCGAACTCTTTGCCCGCCAGGTCGCCGCGCAGCCCGAAGCACCGGCCCTGGTATTCGCCGGGCAGTGCCTGAGCTACCGCGAGCTGGACCTGCGTGCCAGCCGTCTGGCCGCAGCGCTGGTGGCGCGTGGCGTGGGGCCGGAAGTGCCGGTGGGTATCGCTGTGGAGCGTTCCCTGGAGATGGTGCTGGGCCTGTTGGCGGTGCTCAAGGCCGGCGGTGCCTATGTGCCCCTGGACCCGCAATACCCCGAACAGCGCTTGAGCTACATGCTTGAAGACAGCGGCGTACGCCTGCTGCTGAGCGAGACGGCGGTGCAGCCGCGGCTGCCGGTGGCGGCCCGGGTCGAGGTGCTGTTGCTGGATCAGGCACAGGCCTGGGCGCCGGACAGCGATCCGCTGGCAGCCTTGCCCGGGATGGCTGCCGGGAACCTGGCCTATTCGATCTACACCTCCGGCTCCACTGGTGCCGCCAAAGGCGTGAGCATCACCCACGGAGCCCTGGCCAACTATGTGCAGGCGATCATCCAGCGCCTGCCACTGGGGGCTGCGCGCACTATGGCCGTGGTCTCGACCATCGCCGCGGATCTTGGCCACACCACGCTGTTCGGCGCCCTGTGCTCCGGCAGTTGCCTGCACGTGATCGACCTGGATACCGGGTTGGACGCCGACGCCTTCGGCGCCTACCTGCACACCCACCAGATTGATGTATTGAAGATCGTCCCGTCGCATTTGCAGGCGCTGATGAGTGGCGAAGAACCGGCCCGTTCCCTGCCGCGCCAGTGCCTGGTGCTGGGCGGCGAGGCCTGCCCGGCGGCTCTGGTCCGCAGGATCGCGACCCTGGCACCGGAGTGCGCCGTGTTCAACCACTACGGCCCCACGGAAACCACGGTCGGCGCCCTGACCATGGCCGCCGCCACGCTGGCGGACGAGCGGGCGGTGGTGCCCCTGGGCCTGCCGCTGGCCAACGTCCGTGCGCGGGTGCTGGATGCATCCTTGCAACCGGTGGCGCCCGGCACTCCGGCCGAGCTGTACCTGGGTGGCGCCGGCCTGGCGCGGGGTTACCACCAGCGCGCGGCCTTGACCGCCGAGCGCTTTGTGCCGGACCCCTTCAGCGGCGACGGGCAGCGCCTGTACCGCACCGGTGACCTGGCGCGCTATCTGGACGGCGGGGTTATCGACTACCTGGGCCGCATCGACCATCAGGTGAAGATCCGCGGTTACCGTATCGAGCTGGGGGAAATCACCGCGGCCCTTAAGCAGTTGCCCCAGGTCGAAGACGCCGTGGCACAGGTGGTCAGTGTGGCGGGCGAGTCGCAAGTGGCGGCCTATGTGGTACTGGCCAAGGCTCAGGAACCGGAGGCGGCGTGGCAGGAGATCCGCCGGCAACTGGCGGTGGCCTTGCCCGACTACATGCTGCCCATGCATTTCCTGGCGTTGGCCGGCATGCCCTTGACCCCCAACGGCAAGCTCGACCTGCGGGCCCTGCCGCCATTGCAGCAGCAGGCGCCGGTGGAAGCCTTTGTGGCCCCGGTCAGCGAGCTGCAGCAGGGCATCGCGGCGATCTGGCAGGCGGTGCTCAAGGTCGAGCGGGTGGGCCTGGGCGACAACTTTTTCGCCCTGGGTGGCCATTCATTGCTGGCAACCCAGATCATGTCCCGGGTGCGTCGCCTGCTGGGGGCGGACGTGCCGCTGCGGGTGCTGTTCGAAACCTCGCGCCTGGACGAATTCGTCGAACAGGTACAGGCCTGCGCGGGCGCCGCGGCACTGCCGCAGATCGAGGTGCTGGAGCGTGACGGGCCCTTGCCGGCCTCCCATGCCCAGCAGCGGCAATGGCTGTTCTGGCAGATGCATCCGCAGAGCACTGCCTACCACACGCCGATCGTGGTCCGTTTGCAGGGGGAACTGGACCAGGCTGCCTTGCAGCAGACCTTCGATGCCCTGGCCCAGCGCCATGAAGCGTTCCGCACCACCTTCACCCAGCATCAGGAACGCCTGTGCCAGGTGGTGCATGCACAGGGCGCGATCAGCGTGGCCTGGGAGCGATTGACGCCGGGCCTGCCCCGCGAAGCCGTCCAGGCCCGCGCCCTGGAGGAGACCCAGCAACTGTTCGACTTGGAGCACGGCCCCCTGTGCCGGGCCCGGGTGCTGCAGATCGCCGAGCGCGATTACCTGCTGGTGGTGACCTTGCACCACATCATTTCCGATGGCGCCTCCATGAGTGTGCTGGCCCGGGAATTCGTCGCGCTGTACCGCGGCTTGATCCAGGGGCAGGCACCGCAGTTCGAGCCGTTGAGCGTGCAGTACGCCGACTACGCCAACTGGCATCGCAGCTGGCTGGAGCAGGGCGAGCAACAGCGCCAGCTGGATTACTGGCGCCAGCAACTGGGGCTGGAGCATCCGGTTCTGGAGCTGCCTCTGGATCATCCACGCCAGGCGTTGGTCTCCCACCGCCAGGAACGCCTGGGCCTGCGCCTGCCGGCGGACCTGGAGCAAGGGCTGCGGCGAGTGGCGCGGGAACATGACATGACCCTGTTCCAGCTGTTCCTGGGGTCGTTCGCGTTGCTGCTGCACCGTTACTCCGATCAGCCGGATATCCGCATCGGGGTGCCGGTGAGTAATCGCCGCCACCAGGAAATGGAAGGGGTGATGGGCTTCTTCGTCAACACCCTGGTGATGCGCGTCGAGCTGGCGCCGAGCCTGCCGGTGGGGCAGTTGCTGCGGCAGGTCAAGGCCACGGCCCTGGCCGCCCAGGCGCATCAGGACCTGCCGTTCGATCGTCTGGTGGATGCCCTCAAGCCCCAGCGTGCGCTGGACCAGAACCCGTTGTTCCAGGTGATGTACAACCACCTGAGCATTGCCGGGGAAAGCACCGACGGCACCAGCCTGCCGGGCCTGCAAGCCGAGGAAATGGTCCTGCAGGGCGGTACCGCGCAATTTGACCTGACCCTGGAAACCCTGGAGACCGACGCCGGGATCAACGCTTCGTTCATCTATGCCGGCGAATTGTTCGAGGTCTCCACTGTCCAGAGCCTTGCCGATCACTGGCGCAATCTGCTGCAAGGCATGCTTGAACCGCAGCAAGCCCTGGGCGAGCTGCCGATGCTGGGCCAGGACGAGCAGCGCCGCATTCGCCAGGAGTGGGACCACACCGATGCGGTCTACCCGACCCATCGTTTTGTCCACCAGCTGTTTGCCGATCAGGCGGCCAAGGCGCCGGACGCCCCGGCGGTGTTTTTCGCCGAGCAGCGCTTGAGCTATCGCGAGCTGGATACTCAAGCCAACCAGCTGGCGCACAAGTTGATCGAACTGGGCGTTGGCCCGGAAGTGCGGGTGGCCATCGCCATGCCGCGCTGCGCGGAAATCATGGTGGCCTTCCTGGCCGTGCTCAAGGCCGGTGGGGTTTATGTGCCGCTGGATATCGAGTACCCCCAGGACCGCCTGCGCTACATGATGCAAGACAGCGGCGCGTGGCTGCTGCTGACCCAGAGCCACCTGCTGGATCGCTTGCCGATCCCCGATGGCCTGCCGACCTTGTCGGTGGAACGGGCCGCAGATTTTGCCGGCTACCCCGCCAGTGCCCCGCAGGTGGATCTGGCCGAGGAAAACCTCGCCTATGTGATCTACACCTCTGGGTCCACCGGCTTGCCCAAGGGCGTGGCGGTGTCCCACGGCCCGCTGGCCATGCACAGCCTGGCCACCGGCGAGCGCTATGAAATGAGCCCGGCGGATTGCGAGTTGCACTTCATGTCCTTCGCCTTCGACGGCTCCCACGAAGGCTGGATGCACCCGCTGATCTACGGGGCCAGCGTGCTGATTCGCGACGATAGTTTGTGGTCGCCGGAATTCACCTACGAACAGATGCATCGCTATGGCGTCACCGTCGGTGTGTTCCCGCCGGTGTATCTGCAACAACTGGCGGTGCACGCGGAGCGCGATGGCAATCCGCCGGCGGTGCGGGTCTACTGCTTTGGTGGCGATGCAGTGCCGCAGGCCAGTTATGACTTGGCCTGGCGAGTGCTGCGTCCGAAGTACATCTTCAACGGTTACGGCCCGACTGAAACCGTGGTGACTCCTTTGATCTGGAAGGCCAAGGCGGGCGATCCGTGCGACGCGGCCTACGCGCCTATCGGCAATATCGTCGGCAATCGCAGCGCTTATGTGGCCGATGCCAACCTCAACCTGTTGCCGGTTGGCGTGGCCGGCGAGCTGTACCTGGGCGGCCTGGGCGTGGCCCGGGGTTACCTGGATCGACCTGGGCTGACAGCGGAACGCTTTATTCCTGACCCCTACAGCACCACCGGGGCCCGGCTGTACCGCAGCGGCGATCTGACCCGCTATCGCACCGATGGCTTGGTGGAATATGTGGGCCGTGTCGACCATCAGGTGAAGGTGCGGGGCTTCCGTATCGAGCTGGGCGAGATCGAAGCGCGCCTGCTGGAGCAGGACCCGGTATTGGAAGTGGCGGTGATCGCCCAGCCAGGGCCGAGCGGCCAGCAACTGGTGGGTTATATCGTGCCGGTGGACGCTGACGTGGCGTCGAGCAACGAGCGCCAGGCGCAGTTGCGCGAGAGCATCAAGGCTCGCCTGCGCGAGAGCCTGCCGGACTACATGGTGCCCACTTACCTGCTGTTCCTCGAAGCGCTGCCGCTGACGCCGAACGGCAAGCTGGACCGCAAGTCGCTGCCGAAAGTCGATGCGCAGCTGATGCAGCAGACCTACGTCGCGCCGCAAAACGACCTGGAACAACAGATCGCGGCGATCTGGGCCGATGTGCTGAAGCTTGAGCAGGTGGGCGTCACCGACAACTTCTTCGAACTGGGTGGCGACTCGATCATCTCGATCCAGGTGGTCAGCCGGGCGCGGCAGGCCGGTATCCGCTTCACCCCCAAGGACCTGTTCCAGCACCAGACGGTGCAGGGGCTGGCCACGGTGGCGGAGCAGGGCGAGGGCGGTTTGCAGATCGACCATGGCCCGGTGCGTGGGCAAATGCCGCTGCTGCCGATCCAGCAGTGGTTCTTCGACACCCCGGTGCCGGAACGGCATCACTGGAACCAGTCGGTGCTGCTCAAGCCGCTGAAGCCTCTGAGTGCCGAGGCACTGCAGCAGGGCTTGCAAGCCTTGCTCGAACACCACGACGGCCTGCGCCTGAAGTTTGTCGAAGAAGGCGCAGCCTGGGTCGCGACTTATGCCCCGCTGGGGCAGGTGACTGCGGCACCGTTGGCGGCGATGCAGGCCGATGCGCTGCTGTGGCTGGCGGACGACGCCACTGAAGATTCGTTGCAAGCCCTGTGCGATACCGCGCAACGCAGCCTCGATCTGCAACAGGGGCCTTTGTTGCGTGCCGTGCTCTTCACGTTGCGTGATGGCACCCAGCGCCTGCTGCTGGCCATCCATCACCTGGTGGTGGACGGGGTGTCCTGGCGGGTGCTGCTGGAGGACCTGCATCAGGCCCTGGTACAGCAGGCCGCCGGGCAAACCATCAAGCTGCCGGCCAAGACCAGCTCTTCCCAGGCCTGGGCCGGCCAGTTGCAAGCCTATGCCCGCAGCGCGGCGCTGCAGCAAGAGCTGGGTTACTGGCAGGCGCAGTTGCAGGACGTGGAGTCGGGCCTGCCCTGCGACCGGGCAACGGATCAGGTGGTGATCAAGGATGCCAGGAGTGTCAGCACCGAGCTGGACCCAAGCTATACCCAGCGCCTGTTGCAGGATGCGCCGGCGGCCTATCGCACCCAGATCAACGATCTGCTGCTCACCGCCCTGGCCCGGGTCATTACCCGCTGGACCGGCGACAGCAGCGCCCTGGTGCAACTGGAAGGCCACGGCCGCGAAGAGCTGTTCGACAGCATCGACCTGAGCCGCACCGTGGGCTGGTTCACCAGCGTGTTCCCGGTGAAGCTGACGCCGCAGCCGGCCCTGGCCGACTCGATCAAGCTCATCAAGGAACAGCTGCGGGCGGTGCCGAACAAGGGCATCGGCTTTGGTGCCCTGCGCTACCTGGGGGACGAAGCGGCGCAACAGACCCTCGCGGCACTGGCGGTGCCACGCATCACCTTCAACTACCTGGGCCAGTTCGATGGCAGCTTCGATGAGCCGGATGCCTGGTTTGCCCCCAGCGCCGAAGCCAAGGGTGCCGATCAAGGCGCCCAGGCTCCGCTGGGCAACTGGCTGAGCATCAATGGCCAGGTCTATGGCGGCCAATTGAAGCTGGGCTGGACCTTCAGCCAGGCGATGTTCGATACCGCCACCATTGAGCACCTGGCGGATGACTACGCCCGGGAGCTCAAGGCGCTGATCGAGCATTGCAGCCAGCCCGAGCACCGTGGGGTAACCCCGTCGGACTTCCCGCTGGCGGGCCTGAACCAACAGCAACTGGACCAGTTGCCACTGGCCCTGGCCGAGGTCGAGGACCTCTATCCGCTGTCGCCGATGCAGCAGGGCATGTTGTTCCATACCCTCTACGAGCAGGGCGCAGGCGACTACATCAACCAGCTGCGGGTGGACGTGGACGGGCTCGAACCCGAGCGCTTCCGCCAGGCCTGGCAGGCGGCCATCGACAGCCATGACATCCTGCGCAGCGGCTTCCTCTGGCAGGGCGAGCTGCCGGCGCCGATCCAGGTGGTGCACAAGCGTATCCGCCTGGACTTTGTCGAGCATGACTGGCGGGCGAACGAGGCCGTGCCGGCCGCCCTGGATGGCTTGGCCGAAGAAGAGCGCCTGCGTGGTTTCGACCTGCTGGCCGCGCCCCTGCTGCGCCTGACCCTGGTGCGCACTGGCGAGCAGCGTTACCACCTGATCTACACCAACCACCACATCCTGATGGACGGCTGGAGCAACTCACGGCTGCTCGGGGAAGTGCTGCAACGCTATGCGGGGCAGTTCGCGAGCCATGCGCCCGGGCGCTACCGCGACTACATCGCCTGGCTGCAACGCCAGGACGCCCAGCTCAGCGAGACCTTCTGGAAGCAGCAACTGGCGGTCCTGGATGAGCCAACCCGTCTGGCCCAGGCCATCAGCCGCGGTGGCCAGGCCCTGGCCGGCAAGGGCTACGCCGCCCATCAACAGCACCTGGACCTGCAACAGACGCAACGCTTGAGCGAGTTCGCCCGCCAGCAGAAGGTCACGGTCAACACCCTGGTGCAAGCCGCGTGGCTGTTGCTGCTGCAACGCTACACCGGGCAGGACAGCGTGGTGTTCGGTGCCACCGTGTCCGGGCGCCCGGCGGAGCTCAAGGGCGTGGAGCAACAGATCGGCCTGTTCATCAACACGCTGCCGGTCGTGGCTGCGCCGCGCCCGGACATGCCGGTCAGTGACTGGCTGCAACTGGTGCAGGAACGCAACCTGGCCCTGCGCGATTTCGAACACACGCCGCTGTACGACGTGCAGCGCTGGGCGGGCCTGGGGGGTGAGGCGCTGTTCGACAATATCCTGGTGTTCGAGAACTACCCGGTGTCCGAGGCCCTGGCCCAAGGTGCACCGGCGCAGTTGAGCTTCGGCATGGCGGCCAACCATGAGCAGACCAACTACCCGCTGACCCTGTCGGTGTACCTGGGGCAGACCCTGGCGTTCGACTACAGCTATGCCCTGGAGCATTGCGCCGAGGCGAACATCCGGCAACTGGCGGGCTACCTGGAGCAGGTGCTCATGGCGCTGGTGGAGCAGCCGCAGGCGAGCATCGGTGAGTTGGCGCTGACTGGCGCTACCGAGCGCCGCTTGATCGAGGAGCAACGCAGCCGTACTCCGGCGCGAGACCTGTCGCCGCTCTGCGTCCAGCAGTTGATCGAGGCCCAGGCCGCACGCACTGCGGATGCCGTGGCGCTGCTGTGCGCCGGCCAGCAACTGAGCTATGGCCAGTTCAACCAGCGGGCCAACCAGTTGGCCCATAAGCTGATCGAGCAGGGTGTAGGCCCGGATGTGCGGGTGGGCATTGCCGTGGAGCGCGGGCTGGACATGATTGTCGGCCTGCTGGCGGTGCTCAAGGCCGGTGGCGCCTACGTGCCGCTGGACCCCGAGTACCCCCAGGAGCGCCTGCACTACATGATGCAGGACAGCGGCATCCAGCTGCTGCTGACCCAGTCGCCGCTGCTGGAACGCCTGCGCGACGGGGTGGAGGTACCCCACCTGTGCCTGGATCAGCAGGGCCTGGACGGCTACTCCCTGAACAATCCAGCGCCGCGGGCCCAGGCCGACAACCTGGCCTATGTGATGTACACCTCCGGTTCCACCGGCCGGCCCAAGGGTGTGGATATCAGCCACCGCGCCTTGACCCAGCACGCCCAGGTTTCCCGGGACTACTTCAACATGAGCGCGGCAGACCGTGGCCTGCAGTTCTCCACCTTCAACTTCGACGCCTTTGTCGAACAGCTGTACCCGGCGCTGATCTGTGGCGCCTCGGTGGTGATTCGCGGCAAGGCACTGTGGGACAGCGAAACCTTCTACCGCGAGCTGATCGAGCAGGGCATCAGCATCGTCGATCTGAGCACCGCCTACTGGTTCATGCTGGGCAAGGACTTCGCCAGCCGCGAACCCCGCGACTTCGGCCGCCTGCGCCAGCTCAACCTGGGGGGCGAAGCCATGCCGGCAGAAGGCGTGGCGGCGTGGAAGAAGGCCGGCCTGAAACACGCCTGCCTGCTCAACACCTACGGGCCGACCGAGGCCACGGTGAGTGTTACCGCCCATGACTGCAGCCGTTACCTGCAGGACGGGCAAGCCTTGCCGAGCCAGATGCCGCTGGGCAAGGGCTTGCCGGGCCGCTCCATCTACTTGCTGGACAACAGCGGCAACCTGACCCTCAGCGGCGCCACCGGCGAGCTGATGATCGGGGGCGAGCTGCTGGCCCGGGGTTACCACGACCGCCCAGGCCTGACTGCCGAGCGTTTCATTCCCGATCCGTTCAGCAGCGATGGCGGTCGCCTGTACCGCTCCGGCGATCTGGCCCGCTATGACGCCGAGGGCGTGATCGAGTACGCCGGGCGCATCGACCACCAGGTGAAGATCCGCGGTTTCCGCATCGAAATGGGCGAGATCGAAGCGCGGCTGCTGGAGCTGCCACTGGTGCGCGAAGCCGTGGTGCTGGCCCAGGAGGCGGCCGGTGGTCCACAGCTGGTGGCCTACGTAGTGGCGGCCGCGGGCGTGGCGGTAGAGAGCCCGGAACAGCAGGCACAGGTGCGCGAGCAACTCAAAGCGGCCCTCAAGGAGGTGCTGCCGGACTACATGCTGCCGGCGCACCTGCTGTTCCTCGAGGCCCTGCCGCAGAGCCCCAACGGCAAGCTGGACCGCAAGGCCCTGCCCAAGGCCGACGCCAGCCTGTTGCAGCAGGCCTACATCGCCCCACAGAGCGAACTGGAACAGCAGGTCGCGGCGATCTGGGCCCAGGTGCTGGAGGTCGAGCAAGTGGGCATGAACGATAACTTCTTTGAACTAGGTGGGCATTCCTTGTTGGTAACCGCGATGGTCTCTCGAGTCCAGCTCAAGCTTGGGCGCCAGGTCAGTGTGCAGATGGCGTTTGAATTTCCCACCCTGGGGCTGTTCGTCAGCCAGTTGCAACAGGCGCCCGGCCAGGTGCAAGGCGCCGACCTGAGTGCGCTGGAACTGTTGCTCGACGAAATGGAGGCTGTGTAA	MNAEDSLKLARRFIELPLEKRRLFLKALDKEGVDFSLLPIPAGVAVPDRQALSYAQQRMWFLWQLDPQSAAYNLPNAVRLIGPLDRAVLAQAFDWLLERHESLRTVFALEDDEPRQVIQEARVDIDYRELCDLDPAQRETRVQQLADAEARRPFDLQQGPLLRVCVLGLGEQEHVMLLTLHHIVADGWSMGVLIEEFLHAYDSLLQGEVPNVPALPIQYRDYALWQRSWLEAGEQERQLDYWRAKLGDEHPPLKLPTDHPRPAHSSRQGRRLDFALEQPLAQQLGALARQQGVTLFAVLLAGFKLLLSRYSGQQDIRVGVPIANRTRQEAEGLIGFFVNTQVLRTELSPQLTVQQLLADIRETTLGAQAHQDLPFERLVEALHLERSLSHSPLFQVLYNHQPQVTELTTLHSRSGLQVQALPRNERTVQFDLTLDTFERGGQLQAAFTYDCQLFEAQTIERMAGHWQNLLWAMVREPQSALAELPLLSAQQHRGFLAQGAGAEEVFSAESVLELFARQVAAQPEAPALVFAGQCLSYRELDLRASRLAAALVARGVGPEVPVGIAVERSLEMVLGLLAVLKAGGAYVPLDPQYPEQRLSYMLEDSGVRLLLSETAVQPRLPVAARVEVLLLDQAQAWAPDSDPLAALPGMAAGNLAYSIYTSGSTGAAKGVSITHGALANYVQAIIQRLPLGAARTMAVVSTIAADLGHTTLFGALCSGSCLHVIDLDTGLDADAFGAYLHTHQIDVLKIVPSHLQALMSGEEPARSLPRQCLVLGGEACPAALVRRIATLAPECAVFNHYGPTETTVGALTMAAATLADERAVVPLGLPLANVRARVLDASLQPVAPGTPAELYLGGAGLARGYHQRAALTAERFVPDPFSGDGQRLYRTGDLARYLDGGVIDYLGRIDHQVKIRGYRIELGEITAALKQLPQVEDAVAQVVSVAGESQVAAYVVLAKAQEPEAAWQEIRRQLAVALPDYMLPMHFLALAGMPLTPNGKLDLRALPPLQQQAPVEAFVAPVSELQQGIAAIWQAVLKVERVGLGDNFFALGGHSLLATQIMSRVRRLLGADVPLRVLFETSRLDEFVEQVQACAGAAALPQIEVLERDGPLPASHAQQRQWLFWQMHPQSTAYHTPIVVRLQGELDQAALQQTFDALAQRHEAFRTTFTQHQERLCQVVHAQGAISVAWERLTPGLPREAVQARALEETQQLFDLEHGPLCRARVLQIAERDYLLVVTLHHIISDGASMSVLAREFVALYRGLIQGQAPQFEPLSVQYADYANWHRSWLEQGEQQRQLDYWRQQLGLEHPVLELPLDHPRQALVSHRQERLGLRLPADLEQGLRRVAREHDMTLFQLFLGSFALLLHRYSDQPDIRIGVPVSNRRHQEMEGVMGFFVNTLVMRVELAPSLPVGQLLRQVKATALAAQAHQDLPFDRLVDALKPQRALDQNPLFQVMYNHLSIAGESTDGTSLPGLQAEEMVLQGGTAQFDLTLETLETDAGINASFIYAGELFEVSTVQSLADHWRNLLQGMLEPQQALGELPMLGQDEQRRIRQEWDHTDAVYPTHRFVHQLFADQAAKAPDAPAVFFAEQRLSYRELDTQANQLAHKLIELGVGPEVRVAIAMPRCAEIMVAFLAVLKAGGVYVPLDIEYPQDRLRYMMQDSGAWLLLTQSHLLDRLPIPDGLPTLSVERAADFAGYPASAPQVDLAEENLAYVIYTSGSTGLPKGVAVSHGPLAMHSLATGERYEMSPADCELHFMSFAFDGSHEGWMHPLIYGASVLIRDDSLWSPEFTYEQMHRYGVTVGVFPPVYLQQLAVHAERDGNPPAVRVYCFGGDAVPQASYDLAWRVLRPKYIFNGYGPTETVVTPLIWKAKAGDPCDAAYAPIGNIVGNRSAYVADANLNLLPVGVAGELYLGGLGVARGYLDRPGLTAERFIPDPYSTTGARLYRSGDLTRYRTDGLVEYVGRVDHQVKVRGFRIELGEIEARLLEQDPVLEVAVIAQPGPSGQQLVGYIVPVDADVASSNERQAQLRESIKARLRESLPDYMVPTYLLFLEALPLTPNGKLDRKSLPKVDAQLMQQTYVAPQNDLEQQIAAIWADVLKLEQVGVTDNFFELGGDSIISIQVVSRARQAGIRFTPKDLFQHQTVQGLATVAEQGEGGLQIDHGPVRGQMPLLPIQQWFFDTPVPERHHWNQSVLLKPLKPLSAEALQQGLQALLEHHDGLRLKFVEEGAAWVATYAPLGQVTAAPLAAMQADALLWLADDATEDSLQALCDTAQRSLDLQQGPLLRAVLFTLRDGTQRLLLAIHHLVVDGVSWRVLLEDLHQALVQQAAGQTIKLPAKTSSSQAWAGQLQAYARSAALQQELGYWQAQLQDVESGLPCDRATDQVVIKDARSVSTELDPSYTQRLLQDAPAAYRTQINDLLLTALARVITRWTGDSSALVQLEGHGREELFDSIDLSRTVGWFTSVFPVKLTPQPALADSIKLIKEQLRAVPNKGIGFGALRYLGDEAAQQTLAALAVPRITFNYLGQFDGSFDEPDAWFAPSAEAKGADQGAQAPLGNWLSINGQVYGGQLKLGWTFSQAMFDTATIEHLADDYARELKALIEHCSQPEHRGVTPSDFPLAGLNQQQLDQLPLALAEVEDLYPLSPMQQGMLFHTLYEQGAGDYINQLRVDVDGLEPERFRQAWQAAIDSHDILRSGFLWQGELPAPIQVVHKRIRLDFVEHDWRANEAVPAALDGLAEEERLRGFDLLAAPLLRLTLVRTGEQRYHLIYTNHHILMDGWSNSRLLGEVLQRYAGQFASHAPGRYRDYIAWLQRQDAQLSETFWKQQLAVLDEPTRLAQAISRGGQALAGKGYAAHQQHLDLQQTQRLSEFARQQKVTVNTLVQAAWLLLLQRYTGQDSVVFGATVSGRPAELKGVEQQIGLFINTLPVVAAPRPDMPVSDWLQLVQERNLALRDFEHTPLYDVQRWAGLGGEALFDNILVFENYPVSEALAQGAPAQLSFGMAANHEQTNYPLTLSVYLGQTLAFDYSYALEHCAEANIRQLAGYLEQVLMALVEQPQASIGELALTGATERRLIEEQRSRTPARDLSPLCVQQLIEAQAARTADAVALLCAGQQLSYGQFNQRANQLAHKLIEQGVGPDVRVGIAVERGLDMIVGLLAVLKAGGAYVPLDPEYPQERLHYMMQDSGIQLLLTQSPLLERLRDGVEVPHLCLDQQGLDGYSLNNPAPRAQADNLAYVMYTSGSTGRPKGVDISHRALTQHAQVSRDYFNMSAADRGLQFSTFNFDAFVEQLYPALICGASVVIRGKALWDSETFYRELIEQGISIVDLSTAYWFMLGKDFASREPRDFGRLRQLNLGGEAMPAEGVAAWKKAGLKHACLLNTYGPTEATVSVTAHDCSRYLQDGQALPSQMPLGKGLPGRSIYLLDNSGNLTLSGATGELMIGGELLARGYHDRPGLTAERFIPDPFSSDGGRLYRSGDLARYDAEGVIEYAGRIDHQVKIRGFRIEMGEIEARLLELPLVREAVVLAQEAAGGPQLVAYVVAAAGVAVESPEQQAQVREQLKAALKEVLPDYMLPAHLLFLEALPQSPNGKLDRKALPKADASLLQQAYIAPQSELEQQVAAIWAQVLEVEQVGMNDNFFELGGHSLLVTAMVSRVQLKLGRQVSVQMAFEFPTLGLFVSQLQQAPGQVQGADLSALELLLDEMEAV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	668.17	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1647	colistin A; colistin B
BGC0000413.1|Pyoverdine_20 # 54337 # 55305 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.668	BGC0000413.1|Pyoverdine_20 	54337	55305	+	Loose	850	27.335	OprJ	50.0	3000802	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCTCCGCTCAATCGCTGACCGGCCTCCTCACCCAAGGCTTGCGCAAACTGACCGGCATCGACCGGTCCAGGCCAAAGGGCTACCGGGTAATCAACGTCGAGCTCAAGCAGCGCATCCACCTCAGCCCGTCCATGGCCCGCCTGGTGTTTACCGGCGAGGACATCGCCCAAGCGCGCACCCTGGCACCGGACCAGCGCATCAAGCTGCTGTTTCCCGGGGCCGATGGCACGCCCTCGCAACTGCCGGTGGAAGGCGACTGGCAGGCGGCCCGGCGCAAGCTGCCGGCCGAGCAGCAACCGCCGATGCGCACCTACACCATTCGCGCCCTGCGCCTGCACCCTGCGCAAATGGATGTGGATTTCGTCCTGCACGGGGTCAACGGCCCGGCCTCCGCCTGGGCCACCCATGCCCGGCCCGGCGACCGCCTGCAGATGGTGGTGCCGAACAAGGCCTACAGCGGCGACCCCGGTGGTTATGAATGGCTGCCGCCGGCAGGGATCCGCAAGGTGCTGTTGATGGGCGATGAAACCGCGCTGCCGGCGATTGCCGGCATTCTGGAAGAACTGCAGGGTTATCCGGACCATCCGGATGTGCAGGCGTTTATCGAAGTGCCCTATGAAAGCGATTGCATCGACCTGCGCTGCCACCCGCTGGCGCGGATCAACTGGCTGCCCCGGGACCTGCTGGGCGCACGCCATGGCGAAACCCTGATCCATGCCGCCCGGGAGCTGGCCGAACTGCCGCCGGCCAACAGCCAGCGCCGGCCGATCAAGGTTTCCGAACGCAACGACGAACAGCGCCTCTGGGAAACCGCCCAACCGGCGGACAACGATTTCTACGCCTGGGTGGCCGGCGAGTCGGCCACGGTGATGAACATTCGCCGCCACCTGATCAACGAGCGCGGCCAGGAGCGTCGCAACCTGACCCTGATGGGCTACTGGCGCCTGGGCAGCTCCCTGGGTTGA	MSSAQSLTGLLTQGLRKLTGIDRSRPKGYRVINVELKQRIHLSPSMARLVFTGEDIAQARTLAPDQRIKLLFPGADGTPSQLPVEGDWQAARRKLPAEQQPPMRTYTIRALRLHPAQMDVDFVLHGVNGPASAWATHARPGDRLQMVVPNKAYSGDPGGYEWLPPAGIRKVLLMGDETALPAIAGILEELQGYPDHPDVQAFIEVPYESDCIDLRCHPLARINWLPRDLLGARHGETLIHAARELAELPPANSQRRPIKVSERNDEQRLWETAQPADNDFYAWVAGESATVMNIRRHLINERGQERRNLTLMGYWRLGSSLG	MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVDAELRRLVDMALDNIRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSCSFLPTLTLPIFDGGRNRANLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS	67.22	gnl|BL_ORD_ID|745|hsp_num:0	704			747	849	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000413.1|Pyoverdine_21 # 55487 # 56227 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.669	BGC0000413.1|Pyoverdine_21 	55487	56227	-	Loose	900	26.1794	Corynebacterium striatum tetA	29.27	3004639	protein homolog model	n/a	n/a	penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACTCAGTTGAACCTGCTGTGCCTGCCGTATTCCGGCGCCAGCGCCATGGTCTACAGCCGCTGGCGCCGCAAGCTGCCGCAGTGGCTGCACCTGCAACCGCTGGAGCTGCCCGGGCGTGGCGCCCGTTATGCCGAGCCGCTGCACACCGACATGCGCGAGCTGGCGCGGCAGCTTGCCCTGGAAATCCGGGGCACGCTGCGCACCCCTTACGCCCTGTTCGGCCACAGCCTGGGCGCCTTGCTGGCCTGCGAACTGGCCCATGCCCTGCGCGCCCTGGGGTGCCCGGAGCCGGTGGCGCTGTTCGCCTCGGGCACTGCTGCGCCGACCCTGCGCACCGAATACGACCGGGGGTTTGCCGAGCCCAAGACCGATGAGCAACTGATCGAACAGTTGCGCACCCTCAACGGCACCAGTGAAGAAGTGCTGGCCAACCAGGAACTGATGAGCCTGACCTTGCCGATCCTGCGGGCCGACTTTCTCTTGTGCGGGCGCTTTCGCCCGGTGCAACGGCCACTGCTCAATTGCCCGGTGCATGTGCTGGGCGGCAAGACGGATCGCGCCACCACCGAGCAACTGATCGGCTGGAGCAAGGAAACCCACGGCAGTTTTTCGGTGGACATGCTGGCGGGCGGGCACTTCTTCATCCACGAGCACGAGGCCAAGGTGCTGAGCCTGCTCAAGGGCCATCTGGAGGTGCATCGCCGCCGCCACCTGCAACCGGTAGCCGCGGTTTCCTAG	MTQLNLLCLPYSGASAMVYSRWRRKLPQWLHLQPLELPGRGARYAEPLHTDMRELARQLALEIRGTLRTPYALFGHSLGALLACELAHALRALGCPEPVALFASGTAAPTLRTEYDRGFAEPKTDEQLIEQLRTLNGTSEEVLANQELMSLTLPILRADFLLCGRFRPVQRPLLNCPVHVLGGKTDRATTEQLIGWSKETHGSFSVDMLAGGHFFIHEHEAKVLSLLKGHLEVHRRRHLQPVAAVS	MKTYSWFVPPAPPADDPARLHPARWSSGNRVVRDMVGAYPGVLVLHILSYLIGSGISAFVPVVVGMIVDGLVGEEKFNAWWLFAVLVGIFIIQFIGEATGDGLATASVRRVTHNAQQHLSSGVLRRGAGAMSPGTVLNTIDADANTVGRYRELLSFPLMAIGYAVCAMVAMWSVSPWISLAIPASALIIALFAAWTAGPVTRVSLKRRAAEADVAGLATDASQGIRTVKGLGAGATVATRFHAETAKANGLMLTHLRVEVWLGFARFCVAWLCNLGIVGLSAWMTLRGEITPGQLTSVALLVQPALTMAGLAFGDLASGWGRAVASGQRIEQLHHAGDDAAGPEPTDTPVPGAGLWILEPAERSYATAAAWAQRADVLFPPHTVNVFEGTIADNVNPRGDVPEDVVKQALAAAHCQDILRRLGGINEAGELPDAPLGEAGLNLSGGQRQRVALARALAADPEVLILDDPTTGLDSVTQADVVAAVAALRADKTTVVITGNAAWQHAGTELEVA	47.95	gnl|BL_ORD_ID|2120|hsp_num:0	3337			450	690	tetracycline; oxacillin; oxytetracycline
BGC0000413.1|Pyoverdine_22 # 56298 # 57470 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.696	BGC0000413.1|Pyoverdine_22 	56298	57470	-	Loose	700	37.3502	tet(Z)	25.79	3000183	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCAAACCCCTACCGCGAACTGTTCAAGGCCCCCGGCAGCCGGGCCTTTGTGCTGGCCGGGATGATCGCGCGCATGCCGATCTCCATGACCGGCATCGGCCTGATCACCATGCTGGCTCAACTGCACGGCGGGTACGCCCTGGCCGGCTCGGTGGCGGCGACGTTCGCCCTGGCCACGGCGTTCTGCGCGCCCCAGGTATCGCGCCTGGTGGACCGTTACGGCCAGAGCCGGATATTGCCCCTGGCCGCCGGCCTGGGGGGCGGGGCGCTGCTGGCCCTGCTGCTGTGCACCCGCTTGCAGGCCCCGCACTGGACCCTGTTCCTCTGCGCCGCCCTGGCCGGCTGCATGCCCAGCATGTCGGCCATGGTCCGTGCCCGCTGGACCGAGCTGTACCGCGGCCAGCCGCAGCTGCAGACCGCCTATGCCCTGGAGTCGGTGCTCGATGAGGTCTGCTTCATTGTCGGCCCGCCCTTGTCGGTGGGCCTCAGCGTCGGCCTGTTTCCCGAAGCCGGGCCCCTGGCGGCGCTGCTGATGCTGGTGCTGGGGGTCAGTGTGTTCGTCATGCAGAAGAGCACCGAGCCGCCGGTCCATCCCCATGAGGAAGGGCACGCTGGCTCGATCATTCGTTCGGTGGAAATCCGCCTGCTGCTGTTGCTGATGACCGCCATGGGCACCATCGTCGGGGTGGTGGACGTGGTCAGCGTGGCTTTCGCCCAGCAACAGGGGCAGCCGGCGGCGGCGAGCATCGTGCTCTCGGTGTACGCGATCGGCTCATGCCTGGCGGGCATCGCCTTTGGCGCCCTGAAACTGGCCACGCCCTTGCCCCGGCTGTTCATGTACGGCGGTATCGCCACGGCGCTGACCACCTTGCCGCTGCTGCTGGCGAGCAACATCCTCGGCCTGTCCCTGGCGGTGTTCGTTGCCGGGCTGTTTTTCTCGCCGACCCTGATCGTCGCGATGGCCCTGGTGGAACGCAGCGTGCCGCCGGCCAAGCTCACCGAGGGCCTGACCTGGCTGGTCACCGGCCTGAGCATCGGCGTGGCCCTGGGGGCCGCGGGGTCCGGAGCGCTGGTGGACCAGTTCGGCGCCCGCAGCGGCTTCTGGTTGGCCCTGGCGGGCGGCGCGGTGGTACTGGGGGCGGCGTTGCAGAGCTATCGGCGCATGCGCTGA	MANPYRELFKAPGSRAFVLAGMIARMPISMTGIGLITMLAQLHGGYALAGSVAATFALATAFCAPQVSRLVDRYGQSRILPLAAGLGGGALLALLLCTRLQAPHWTLFLCAALAGCMPSMSAMVRARWTELYRGQPQLQTAYALESVLDEVCFIVGPPLSVGLSVGLFPEAGPLAALLMLVLGVSVFVMQKSTEPPVHPHEEGHAGSIIRSVEIRLLLLLMTAMGTIVGVVDVVSVAFAQQQGQPAAASIVLSVYAIGSCLAGIAFGALKLATPLPRLFMYGGIATALTTLPLLLASNILGLSLAVFVAGLFFSPTLIVAMALVERSVPPAKLTEGLTWLVTGLSIGVALGAAGSGALVDQFGARSGFWLALAGGAVVLGAALQSYRRMR	MLITATLDAAGLGLVMPILPTLLDQVGAPDDMIPLHVGLLTALYAIMQFLCAPILGRLSDRFGRRRVLVASLAGATIDYLVLALTDTLWVFYLARAVAGITGATNAVTATVIADITPPDQRAKRYGWLGACYGGGMIAGPAIGGLFGGVSPHLPFLVAAALAGITLVLSASLLRETRPPGSNGSHAQQPGTAKRTAVPGMLILLAVFGIVQFIGQAPGSTWVLFTQQRLDWNPVEVGVSLSIFGMVQVFVQAALTGRIVSRIGETRAILVGIAADAIGLIGLALIASTWAMLPILAALGLGSITLPALQTLLSRRAPEQQQGRLQGTLASLNSLTSIIGPVTFTGIFALTRTNADGTLWICAAALYVLCALLMIRETCASRRSR	101.56	gnl|BL_ORD_ID|1793|hsp_num:0	1885			111	735	tetracycline
BGC0000413.1|Pyoverdine_23 # 57606 # 58193 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.696	BGC0000413.1|Pyoverdine_23 	57606	58193	+	Loose	375	50.8322	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	30.39	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAGCCGCCCACGCGCCGCGATGATCGAGCAAACCCGCGCCAGGCTGATTGCCAGCGCGCGCCAGGCCTTTGCCCGCCTGGGCTACGCCAAGACCTCGATGGACGACCTGACCGCCGAAGCCGGGCTGACCCGGGGCGCGCTGTATCACCACTTCGGTGACAAGCAGGGGTTGCTGGCGGCGGTGGTGGAGCAGATCGACAGTGAAATGGATGAGCGCCTGGAGGCCATTTCCGCAGCGGCCAGTGATCCCTGGCAAGGCTTTGCCCAGCGCTGCCGGGCCTACCTGGAAATGGCCCAGGAAGCCGAGATCCGCCGCATCGTCCTGCAGGATGCCCGGGCCGTGCTGGGGCAACGGCAGCCAGCCGAGGAACACTGCATCGACTCCCTCAGCCGCCGCCTGCAAGCGCTGGTCGAAGCCGGGCTGATCACGCCCGCGCCGAGCCAGGCCCTGGCGCGCCTGATCAACGGCAGCCTGGTGGACGCGGCGCTGTGGATCGCCGCCGCCGAGCAGCCCGGGCAACGCCTGCAACAAGCCCTGCAGGCGCTTGAGCTGCTGCTGCGCGGGTTGCAACCACCGCGCTGA	MSSRPRAAMIEQTRARLIASARQAFARLGYAKTSMDDLTAEAGLTRGALYHHFGDKQGLLAAVVEQIDSEMDERLEAISAAASDPWQGFAQRCRAYLEMAQEAEIRRIVLQDARAVLGQRQPAEEHCIDSLSRRLQALVEAGLITPAPSQALARLINGSLVDAALWIAAAEQPGQRLQQALQALELLLRGLQPPR	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	90.70	gnl|BL_ORD_ID|2090|hsp_num:0	2306			27	333	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000413.1|Pyoverdine_24 # 58306 # 59106 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.668	BGC0000413.1|Pyoverdine_24 	58306	59106	+	Loose	400	28.1054	Erm(38)	28.17	3000601	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCAGATATCCCTCGACCAGCAGGTAGCCCTGGTCACTGGCGCCAGCTCCGGCATTGGCGCCGCCACCGCAATCGCCCTGGCGGCGGCCGGTGCCAGCGTGGTGCTCAACTACAACTCCCAGGCCGCGCCGGCCGAGCAGTTGGCCGCGCGGATCAATGCCGAAGGCGGCCGGGCCATTGCCATTGGCGCCGATGTGGCCGATGAGGCCCAGGTCGAGGCGCTGTTCGCCCAGGCCATCGAGGCCTTTGGTTTTCTCGACATCCTGGTGGCCAATTCCGGCCTGCAAAAGGATGGGCCGGCCGCCAGCCTGAGCCTGGACGACTGGAACCGGGTGATTGGCGTCAATCTCACCGGGCAGTTCCTCTGTGCTCGCGCGGCGCTGAACATCTTCCAGCGCCAGGGGGTACGCGCCGGGGTGTCCAAGGCGGCGGGCAAGATCATCCACATGAGTTCGGTGCACCAGTTGATTCCCTGGGCCGGGCACGTGAATTACGCGGCTTCCAAGGGCGGCGTGGACATGCTGATGCGCACCCTGGCCCAGGAAGTCAGCCAGCAGCGGATCCGCATCAATGGCATCGCCCCGGGGGCGATCCGCACCGCCATCAACCGCACCGCCACCGAGGGCGCGGCAGAGCAGGAACTGCTCAAGCTGATTCCCTACGGCCGGGTCGGCGACCCCGAGGATGTGGCCAATGCCGCGCTATGGCTGGCCTCGGACGCCTCCGACTATGTGGTCGGCAGCACCCTGTTCATCGACGGCGGCATGAGCCTCTATCCGGAGTTTCGCGGCAATGGCTGA	MQISLDQQVALVTGASSGIGAATAIALAAAGASVVLNYNSQAAPAEQLAARINAEGGRAIAIGADVADEAQVEALFAQAIEAFGFLDILVANSGLQKDGPAASLSLDDWNRVIGVNLTGQFLCARAALNIFQRQGVRAGVSKAAGKIIHMSSVHQLIPWAGHVNYAASKGGVDMLMRTLAQEVSQQRIRINGIAPGAIRTAINRTATEGAAEQELLKLIPYGRVGDPEDVANAALWLASDASDYVVGSTLFIDGGMSLYPEFRGNG	MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAVEVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRRLLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKARVNGPTPPGLGDT	68.91	gnl|BL_ORD_ID|1004|hsp_num:0	1097			615	822	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000413.1|Pyoverdine_26 # 60992 # 61369 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.696	BGC0000413.1|Pyoverdine_26 	60992	61369	+	Loose	450	23.8682	BlaB-27	35.71	3005540	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	BlaB beta-lactamase	ATGCCCGACTCGCCGATCATCGCCGTGATGATCCATGCCGCCGACTGGCGTGCCGCCACCCATTGGTACGCCCAGGCCTTTCCCCAGGCCCGCCGGGTGCTGCACGAGCCGGATGATTTCGGCCATTTGCAGCTTGCGGGCCTGTCCCTGGAAATCGTCCCCTGCGACGCCAAGGTCGGCCAGGGGCCGGCGGGCACGGTGGTGTACTGGCAGGTCGCCGATCTGCCCGGCCAGGTGCAGCGCCTGACCGGGCTGGGTGGGCGCCTGTATCGCGGGCCCATGGTCATTGAAGGCGGCGACTCGATCTGCCAGGTGCAGGACCCCTGGGGCAACTGCATCGGCCTGCGCCAGCCGGCCCGTTTGGGGCAGGCGTCATGA	MPDSPIIAVMIHAADWRAATHWYAQAFPQARRVLHEPDDFGHLQLAGLSLEIVPCDAKVGQGPAGTVVYWQVADLPGQVQRLTGLGGRLYRGPMVIEGGDSICQVQDPWGNCIGLRQPARLGQAS	MMKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDAQYVVAGHDDWKDQTSIQHTLDLISEYQQKQKASN	50.20	gnl|BL_ORD_ID|3319|hsp_num:0	4388			588	672	
BGC0000413.1|Pyoverdine_28 # 62165 # 63070 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.699	BGC0000413.1|Pyoverdine_28 	62165	63070	+	Loose	560	26.5646	AAC(3)-IIa	37.14	3002533	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCCCAGCCCAGCCTCCCTGCACCAGGTCAGCACCCCCAACCTGCATATCGCCTATGAGGAACATGGCCCGCGCAACGCCGAGCCGGTGATCCTGCTCCACGGGTTTCCCTACGACGTGCGGGCCTACGACGAGATCGCCCCGCCCCTGGCCGAGCGCGGCTATCGGGTCATCGTTCCCTACCTGCGGGGCTACGGCCCGACGCGCTTTGCCAGCGAACAGGTGATGCGCTCCGGGCAGCAGGCGGCCCTGGCCCGGGACCTGCTGGAGCTGATGGACGCCCTGCACCTGCCCCAGGCCACCCTCGCCGGCTACGACTGGGGTGGGCGCGCCGCGTGCATCGTCGCGGCGCTGTGGCCGCAGCGGGTCAAGGGCCTGATGAGCGCCGACGGCTACAACATCCAGGACATTCCCCGGGCCATCGAGCCCCGGGCGCCGGAGACCGAGCTGCGGCTGTGGTACCAGTACTACTTCAATACCCAGCGCGGGGTGGACGGCCTGACGGCCAACCGCCGGGAATTCTGCGAGCTGTTGTGGCGCCTGTGGTCGCCAACCTGGAAACAAGGGCCCGGGCTCTATGGCCTGAGCGCGCCCTCCTTCGACAACCCGGACTTCGTCGCGGTGGTGATCCATTCCTACCGCCATCGCTTCGGCTATGTGCCGGGCGACCCGGGCCTGGAAAGCATCGAGCGGGCGCTGGAGGCGCAACCGCCGATCCGGGTGCCGACCATCGCCCTGTGCGGCGCTGACGACGGCGTCGGCCCGGCCACCGAACCGGACCCCGATGTCGGCCTGTTCAGTGGGCCCTATCAGCGGCGGATCCTCCCGGGGATCGGCCACAACCTGCCCCAGGAAGCGCCGCAAGCCACCCTCGACGCGCTGCTGGAGTTGCTCGGCAAGCCCTGA	MPSPASLHQVSTPNLHIAYEEHGPRNAEPVILLHGFPYDVRAYDEIAPPLAERGYRVIVPYLRGYGPTRFASEQVMRSGQQAALARDLLELMDALHLPQATLAGYDWGGRAACIVAALWPQRVKGLMSADGYNIQDIPRAIEPRAPETELRLWYQYYFNTQRGVDGLTANRREFCELLWRLWSPTWKQGPGLYGLSAPSFDNPDFVAVVIHSYRHRFGYVPGDPGLESIERALEAQPPIRVPTIALCGADDGVGPATEPDPDVGLFSGPYQRRILPGIGHNLPQEAPQATLDALLELLGKP	MHTQKAITEALQKLGVQSGDLLMVHASLKSIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDNARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPNERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMPGRDGEVAWKTASDYDSNGILDCFAIEGKQDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPAHEAIERSCEPSG	105.24	gnl|BL_ORD_ID|430|hsp_num:0	478			744	849	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000413.1|Pyoverdine_30 # 63636 # 65078 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.686	BGC0000413.1|Pyoverdine_30 	63636	65078	+	Loose	700	28.4906	tet(X4)	42.22	3004720	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGGCTGATTTGCCAATCCTGCAGTGGGCTATCGCCCTGTTGCTCGCCCAGGGCGTGCTCGGCGCCCTGGATACTCTCTACCATCACGAACTCACCGTGGCCCTGCCGCAGCGTCACAGCGCCCGCAAGGAACTGAGCATCCATGCCCTGCGCTCGTGCTTCTACGGCGTGCTGTTCATGGGCATCGCCCACCTGGCGTTCCAGGGCATCTGGGCCCTGGTGATCGCCCTGCTGTTCGCACTGGAAATCGGCCTGACCCTGTGGGACTTCGTGGTCGAGGATCGCAGCCGCAAGCTGCCGGCCATCGAACGCATCATGCACACCGTGCTGGCGATCAACGCCGGGGCCTTCTTCGCCCTGTACGGCCTGCAACTGCTGGAATGGTCACGCCTGCCCAGTGCCTTGAATCCCATCGACCTGGGCTGGCAGGGCTGGGCCCTGAGCCTGTTCGCCGTGGGCGTCACCGCCTCGGGCATCCGCGACGGCCTGGCGGCGCTGCGCCTGCAACGCCAGGGCCAGGGCGCCAACCCCTTTGCCGGTGGCAGCGGCAAGCGGGTGCTGGTCACCGGTGGCACCGGTTTTATCGGCGAGACCCTGGTCAACCAACTGCTGGATGCCGGGCACACGGTCAGCGTGCTGGCCCGGGACCCGCTGCGCGCCGCCTACCTGTTCGACGGTCGCGCCCGTTGCCTGCGCTCGCTGAGCAAGCTGGGCCACGGCGAAGCCTTCGACGTGATCATCAACCTGGCCGGTGCCCCGGTGGCCGGGCCGCGCTGGTCGGCCAAGCGCCAGGCGCAACTGCTGGCCAGCCGGGTCGGCACCACCGAAGCCCTGCTCAACTGGCTGCAACACGCCCAGCACAAGCCGGAGCTGTGGATCCAGGCTTCGGCCATCGGCTTCTATGGCGTGCGCGACGCCAGCCAGAGCCTGGATGAAAACGCCGAGCGCGGCGAAGGCTTCATGGCCGACCTGTGCGCGCGCTGGGAATCCTCCGCCGAACCGGCCACCCGCTTCGGCGTGCGCCAGGTGGTGCTGCGCCTGGGGATCGTCTTCGGTCCCGGCGGCGCCCTGAAGCCATTGCTGATGCCCTTCCATTTCGGCTTTGGCGGACGCATGGGCGATGGCCGGCAGATCATGAGCTGGGTGCACCGCGACGACGTGTTGCAGGTGATGGCCCGGGCCATGAACGACCCGTCCCTGTCCGGCACCTACAACATGGTGGCGCCGGAAGCGGTGAGCCAGGGCACCTTCGCCACTACTGTCGGCAAGGTGCTCAAGCGCCCGGTGTGGCTGCACGTGCCGGCTGCGCCGGTACGGGCCCTGGCCGGGGAGATGGCCGAGCTGTTCTTCGACGGCCAGAAGGTAGTGCCGGCGCGCCTGCTGCAGGCCGGCTACCGCTTCCGTTACCCGACCCTGGACGCCGCCCTGCGCGACCTGACCTGA	MADLPILQWAIALLLAQGVLGALDTLYHHELTVALPQRHSARKELSIHALRSCFYGVLFMGIAHLAFQGIWALVIALLFALEIGLTLWDFVVEDRSRKLPAIERIMHTVLAINAGAFFALYGLQLLEWSRLPSALNPIDLGWQGWALSLFAVGVTASGIRDGLAALRLQRQGQGANPFAGGSGKRVLVTGGTGFIGETLVNQLLDAGHTVSVLARDPLRAAYLFDGRARCLRSLSKLGHGEAFDVIINLAGAPVAGPRWSAKRQAQLLASRVGTTEALLNWLQHAQHKPELWIQASAIGFYGVRDASQSLDENAERGEGFMADLCARWESSAEPATRFGVRQVVLRLGIVFGPGGALKPLLMPFHFGFGGRMGDGRQIMSWVHRDDVLQVMARAMNDPSLSGTYNMVAPEAVSQGTFATTVGKVLKRPVWLHVPAAPVRALAGEMAELFFDGQKVVPARLLQAGYRFRYPTLDAALRDLT	MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	124.68	gnl|BL_ORD_ID|2277|hsp_num:0	3402			33	165	tigecycline; tetracycline
BGC0000413.1|Pyoverdine_31 # 65093 # 67531 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.696	BGC0000413.1|Pyoverdine_31 	65093	67531	+	Loose	1500	32.7278	rphA	23.75	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAGCAAGCCCCTGTTGTACCTGCTGGCGGGCAATGGCAGCGCCGCCGACTGGTGGGACGATGCCCTGCCGCACTTCCAGCGCTATCAGGTGCAGCCCCTGGAGCTGCCGGGGTTTGGCGACAACCCGCTGCCGCCCTGCCAGGACCTGGGTGAATACGCCGAGGCCCTACTGGGCATGACCGAGCCGGGCCAGGGGATTGTCGCGGTGGGGGTCAGCGCGCTGATCGTGCTGCACGCCTTGCAGCGCCGCCCGGGGCACTTCTGCCGCAGTGTGCTGTTGTCGCCGGTGGGGGCCTTTCTCTGGCACCGGCGCTTGCCGGCGCTGATGTCGCCGCTGCCCGCGCGCTTGCTGATTCACGGTTTGCTCAGCCATAAACCGACGTGGTTTGCCGGCAAGTTCTCGCGCCAGCCGTGGAGCCAGGAGCAGTACCGGCGCATGGGCGCCGGCTATGGTCGGTGCCGGGCCTTCGTACCGCTGTGGGAGCAACTGCGGGCCGATACCGCGCTGCCGCTGCTGGAGTGGATCAAGGACCCGGTGCAACTGGTCTGGGGCGACCAGGACCGGCTGCTGGGGATTGCCCAGGCCGCAGCCTGGTCGGCCATCCTGGCCCGGGCCGACCTGCGGGTCAGCCTGCGGCCGGGCTGGGGCCATTACCCCTGGATCGACCACCCCGCCGAGTTCGTCGCCTGGCTGGAATCCGCCGACAACGGCTTCGTCGCCCACACCAAGGGCGGCCGCCTGCGCCTGGCGGAGCTGGCCGGCCAACCGGTGCCCAGCGCCCTGTCCCTGGACAGCGCCAGCGACCCGCAGCTGCCGGCCCTGCTCGCCAGCCAGCCTGCGGCGCTGTGGGCGGTGCGTTCCTCCAGCTACGGCGAGGATCAGGCCGACTCGGCCAATGCCGGCTTGAGCACCACTTACCTGCGGGTGCCCAGCGAGCAAGTGCCCGGGCGCATCAGCGAACTGCGCGATGCCGGGGTCGAGGAAGTGGTGGTGCAGCGCTTTATCCAGCCGACCCTGTCGGGGATCGCCTTCGTCCGTCACCTGGCGGTGGAACTGGAGTGGGTCGAGGGCCATCTGGAAAGCCTTGCCGACGGTCAGGTCAGCCCGCAGCGGGCGATCCTTTCACGCCTGGGCGCGGCCTGGGAAAGCGGCCATTTCGCCACCACCCGGGGCCTGAGCGCCAGCGCCCTGTGGGATTTCCTGCAAGGGGTGCTCAAGACCTTCCACTACGTGCCCGGTGATGTGGAATGGGCCTGGGACGGCCAGCAACTGTGGCTGCTGCAGTACCGCCCCATCAGCGACTACGGCTGGCGCCGGCACCTGACCGCGGCCAATATCGCCGAGATACTGCCACCGCAACCCAGCCGTTTCGTCGAGTACGGCCAGCGCCGGGCGGCGGCGAGCATTCCGGCGATCATGGCGCGCTGGGACGCCCGTGTACTGCAGGACAACGAGCCCTTCACCGCAGTGTTCGGCGGTGCTTCCTATATCAACAATGACCTGTTCCTGGCGCGGCTGGCCGACTGGGGCCTGCCCTCCTCCAGCTATGCCGGCGAGGTGGGCGGCGCCACCCCGCAGCTGCCCTTGCGGCCCCTGCGCCTGTTGCGCTCGCTGCCACGGTTCCTGCGCATGCAGCACATCGCCCGCGGCCACCTGCTGAGCCTGGAACCGGGCCTGCGGCGCTTCGACCGGGAACTGGCGCAGTTGCGCGCCGCCGGGGCCGACGGCCAGCAACTGGCAGACTGGTTCAGCCGCTTCTATGTGTTCGTGGTGCAGGGCAACCTGTGCATCGCCACCGCCCTGGCCAGCAGTGGTGGCGCGCTGCTGGGGCGTCCGCCCACCGCCTACGACAACCTGGACAACAGCCCCCATCGCCTGCCCTGGGAAACCGACCCAGGCACCCCGCGCCCGCAGTGCGCCGAGTTGCCGTTGCAAGCCTTCCCGCACTGGAGCCCAGCCATCACCCTGGCCCACCGCCTGGGCTTGCCGGGCATGCGCGGCTATTACCTGCAAGTGCGCGAGTGGTACCGGGACAACCTGATGCGGATCTTCTTCCGCCTGCACCACGCCGTGCCCGAGGCTGATCGCGGCTACTGGTTCGCCCCCCATGAGCAGGTGCGCAACCGTGGCGGCAGCTTCTGGCAGGACGGCCGCGAAGGCAGCGAGCAGGCGGCGGGGTTCATGATCTACCCGGGCCAGGTCCAGGGCGTGCTGGGGGTCGACATTCTGCTGGAGGACACCCTCGACCCCGGGCGCCATGCCCACTATCAGCAGGCCCGGGCAGTGATCGCACGCATGGGCGGGCGCCTGTCCCACGGTTCGACCCTGTTGCGCGAACTGCGCAAGCCCTCGGCGGTACTGCCCCAGGTAGACCCGGCCTGGATCGGCCGCGAAGTGCTGTATGCCGACGGCCAACTGAGCCTGGTAGAAGGCTGA	MSKPLLYLLAGNGSAADWWDDALPHFQRYQVQPLELPGFGDNPLPPCQDLGEYAEALLGMTEPGQGIVAVGVSALIVLHALQRRPGHFCRSVLLSPVGAFLWHRRLPALMSPLPARLLIHGLLSHKPTWFAGKFSRQPWSQEQYRRMGAGYGRCRAFVPLWEQLRADTALPLLEWIKDPVQLVWGDQDRLLGIAQAAAWSAILARADLRVSLRPGWGHYPWIDHPAEFVAWLESADNGFVAHTKGGRLRLAELAGQPVPSALSLDSASDPQLPALLASQPAALWAVRSSSYGEDQADSANAGLSTTYLRVPSEQVPGRISELRDAGVEEVVVQRFIQPTLSGIAFVRHLAVELEWVEGHLESLADGQVSPQRAILSRLGAAWESGHFATTRGLSASALWDFLQGVLKTFHYVPGDVEWAWDGQQLWLLQYRPISDYGWRRHLTAANIAEILPPQPSRFVEYGQRRAAASIPAIMARWDARVLQDNEPFTAVFGGASYINNDLFLARLADWGLPSSSYAGEVGGATPQLPLRPLRLLRSLPRFLRMQHIARGHLLSLEPGLRRFDRELAQLRAAGADGQQLADWFSRFYVFVVQGNLCIATALASSGGALLGRPPTAYDNLDNSPHRLPWETDPGTPRPQCAELPLQAFPHWSPAITLAHRLGLPGMRGYYLQVREWYRDNLMRIFFRLHHAVPEADRGYWFAPHEQVRNRGGSFWQDGREGSEQAAGFMIYPGQVQGVLGVDILLEDTLDPGRHAHYQQARAVIARMGGRLSHGSTLLRELRKPSAVLPQVDPAWIGREVLYADGQLSLVEG	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	93.87	gnl|BL_ORD_ID|890|hsp_num:0	910			180	942	rifampin; rifaximin; rifabutin; rifapentine
BGC0000413.1|Pyoverdine_32 # 67541 # 68524 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.705	BGC0000413.1|Pyoverdine_32 	67541	68524	-	Loose	200	55.8398	Escherichia coli soxS with mutation conferring antibiotic resistance	34.69	3003511	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGCCCACTGCGCCGAAAAACGTGTTTGTCCTGGCCTTCGCCAATGCCCAGTTGCTGGATGTCAGCGGGCCGCTGCAGGTGTTCGCCTCGGCCAATGACCGGGCCCGCGGCCTGGGCCTGCCTTTGCCCTACCTCCCGCGGGTGATTGCCAGCCCGGGCGGGGCGACCCTGAGCTCCTCGGGGCTGGCGCTGCTGGCCGAGCCGCTGCCGCTGCCGCAAGAGCCCTGCGACACCCTGATCGTTGCCGGTGGCTGGGGCGTCTACGAGGCGGCCCGTGATCCTGAACTGGTGGCCTGGGTGGCGGCCCGGGCTGCGGCGTCACGGCGGGTGGCGTCGGTCTGCACCGGGGCCTTTCTGCTGGCCGCCAGCGGCTGGCTGGACGGGCGCCGGGTGGTCACCCACTGGACCCGCTGCGAGCAGTTGGCCGAGCAATATCCGCGGCTGCAGGTGGAGGCCAATCCGATCTTCATCAACGATGGCCCGGTGTGGACCTCGGCCGGGGTCACCGCCGGCATCGACCTGGCCCTGGCCCTGGTGGAGGCCGACCTGGGGCGCGCAGTGGCACTGGAAGTGGCGCGGCAACTGGTGGTGTTTCTCAAGCGCCCGGGGGGCCAGTCGCAGTTCAGCGTAACCCTGTCGCTGCAGAACCAGGGTGGGCGTTTCGACCGGCTGCACGCCTGGATCGCCGAGCACCTGGACCGCGAACTGACGGTGCCGGTGCTGGCCGAGCAGGCGGGAATGAGCGAGCGCAGTTTCGTCCGTCACTACCGCGCCGACACCGGCCAGACCCCGGCCCGGGCCATTGAACTGATCCGTGTGGAAAGCGTCCGGCGCCTGCTGGCCGACAGCACCCTGCCGATCAAGCGCATCGCCGCCCAGTGCGGTTTCGGTAGCGAGGAAACCCTGCGTCGCAGCGTGCTGCGGGCCCTGGGCGTGACGCCCCAGGCCTACCGCGAACGCTTCGCCAGCATTGCGCAGCCTTGA	MPTAPKNVFVLAFANAQLLDVSGPLQVFASANDRARGLGLPLPYLPRVIASPGGATLSSSGLALLAEPLPLPQEPCDTLIVAGGWGVYEAARDPELVAWVAARAAASRRVASVCTGAFLLAASGWLDGRRVVTHWTRCEQLAEQYPRLQVEANPIFINDGPVWTSAGVTAGIDLALALVEADLGRAVALEVARQLVVFLKRPGGQSQFSVTLSLQNQGGRFDRLHAWIAEHLDRELTVPVLAEQAGMSERSFVRHYRADTGQTPARAIELIRVESVRRLLADSTLPIKRIAAQCGFGSEETLRRSVLRALGVTPQAYRERFASIAQP	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	305.61	gnl|BL_ORD_ID|1975|hsp_num:0	2066			27	321	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan; enrofloxacin
BGC0000413.1|Pyoverdine_33 # 68617 # 69303 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.710	BGC0000413.1|Pyoverdine_33 	68617	69303	+	Loose	400	31.5722	salE	27.16	3007029	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGGCAGTGCAGATAGGTTTTTTGTTGTTCCCCGAGGTCCAGCAACTGGATCTGACCGGTCCCCACGACGTACTGGCCTCGCTGCCGGATGTGCAGGTGCACCTGATCTGGAAGGAGCCGGGGCCGGTGGTGGCCAGCTCGGGGCTGGTGCTGCAGGCCACCACAAGCTTCGCCGACTGCCCGCCGCTGGATGTGATCTGCATCCCCGGCGGTACCGGGGTCGGGGCGCTGATGGAAGACCCGCAGGCCCTGGCGTTCATCCGCCAGCAGGCCGCCCGGGCGCGCTACGTGACCTCGGTGTGCACCGGCTCCCTGGTGCTCGGCGCCGCGGGCCTGCTCCAGGGCAAGCGCGCCACCACCCACTGGGCCTACCACGAACTGCTGGCGCCACTGGGGGCGATACCGGTGCATGAGCGGGTGGTGCGTGACGGCAACCTGCTGACCGGCGGCGGTATCACCGCCGGCATCGACTTCGCCCTGACCCTGGCCGCCGAACTGTTCGACGCCGCCACCGCGCAGCGGGTACAGCTGCAACTGGAGTACGCCCCGGCGCCGCCGTTCAATGCCGGCAGCCCGGACACGGCCCCCGCCAGCGTGGTGCAGCAGGCCCGCCAGCGCGCCGCGGATTCGCTGCACAAGCGCAGGGAAATCACCCTGCGCGCGGCCGCGCGGCTGGCAGCCGGCTGA	MAVQIGFLLFPEVQQLDLTGPHDVLASLPDVQVHLIWKEPGPVVASSGLVLQATTSFADCPPLDVICIPGGTGVGALMEDPQALAFIRQQAARARYVTSVCTGSLVLGAAGLLQGKRATTHWAYHELLAPLGAIPVHERVVRDGNLLTGGGITAGIDFALTLAAELFDAATAQRVQLQLEYAPAPPFNAGSPDTAPASVVQQARQRAADSLHKRREITLRAAARLAAG	MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN	41.99	gnl|BL_ORD_ID|4728|hsp_num:0	5740			129	357	tiamulin; retapamulin
BGC0000413.1|Pyoverdine_35 # 69677 # 70309 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.698	BGC0000413.1|Pyoverdine_35 	69677	70309	-	Loose	500	26.9498	mphA	52.63	3000316	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGCCGGACCTTTCCACCCTGTCGATCTTCCTCGGCGCCGTGCTGCTGTTGCTGCTGTCGCCGGGACCCAACATGGCCTTCGTCATCAGCCACGGCGCAGCCTATGGCTGGCGCGGTGGGGTGGCATCGGGGCTGGGGATCGGCGCCGCGGATATCGGCCTGACCCTGCTCACGGCCACGGGCGTCACCGCCGTGGTGGCCAGCTGGCCGCCGGCGTTCGACCTGATCCGCTATGCCGGGGTTGCCTACCTGTTGTGGCTGGCCTGGAAGGCCCTGGGCCAGCGGGGGGGCCTGGACCTTGCCGATACACCCCGGGTGCCGCTGGCCACGGTGTTTGTCCGGGCCCTGTGCAACAGCCTGCTGAACCCCAAGGCGCTGCTGTTCTTCATGGTGTTCCTGCCGCAGTTCGTGCGCCCCGAGCACGGCAGCATCGCTGTGCAACTGGTGGTCCTGGGCTTGCTGCTGACCCTGGTCAGCGGGGTCTTCCATACCAGCCTGGGGATCTTCGGCGCGGCCTTGCGCCGTGGCTTGCCCGGCAGCGATTCGCGGCTGGCCCGCTGGCAATCCTGGCTGCTGGCGGCGGTGCTGTTGGCCCTGGCCCTGCGCCTGGCGCTGCTGGCGCGTCCGCTCTGA	MPDLSTLSIFLGAVLLLLLSPGPNMAFVISHGAAYGWRGGVASGLGIGAADIGLTLLTATGVTAVVASWPPAFDLIRYAGVAYLLWLAWKALGQRGGLDLADTPRVPLATVFVRALCNSLLNPKALLFFMVFLPQFVRPEHGSIAVQLVVLGLLLTLVSGVFHTSLGIFGAALRRGLPGSDSRLARWQSWLLAAVLLALALRLALLARPL	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	69.77	gnl|BL_ORD_ID|1139|hsp_num:0	1243			495	552	erythromycin; roxithromycin; telithromycin; clarithromycin; azithromycin; dirithromycin; oleandomycin
BGC0000413.1|Pyoverdine_36 # 70397 # 71722 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.703	BGC0000413.1|Pyoverdine_36 	70397	71722	+	Loose	1900	33.113	MexW	30.51	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCCGTACCCGCTACAAAACCATCGTCGATCACTTCGCCCAGCGCATCCGCGCCGGCCAGCTGTGCCCAGGCACTCAGCTACCGACGGTGCGGGCGCTGATGGCCAGCGAGCAGGTGGCGCTGGCCACGGCGCTGCGGGTGTATCACGAGCTGGAAGCCATCGGCCTGGTGGTGGGCGAGCCCGGGCGCGGCACCTTTGTCCGCGACACCAGCCTGCCCCGGGGCATGGGCCTGGAACAGCACCCGGCCAGCGCCGCCTCGGTGGACCTGGCGTTCAACTACCCGTCCCTGCCCGGCCAGGCGGAAAGCCTGCGCGAGGGGCTGCGGGCGATAGCCGCCTCCGGCGACCTGGATGCCCTGCTGCATTCCGCGCCCCAGGGCGGCCGCCCCCATGAACGCCAGACCGCGGCGCGGCACCTGCGCAACCGCGAGATCCGCGTCGCCGCCGAGCAGGTGCTGATCGTCAATGGCGCCCAGCAGGGGCTGGCGGTGAGCCTGCTGGCGCTACTCCAGCCCGGAGACATCCTGGCAGTGGACGCCCTGACCTACCCCGGCCTCAAGACCCTGGCCCAGGTCCATCGCCTGGACCTCGAAGCGCTGCCCCAGCACAACGACCAGATGGACCTCGACGCCCTGCAGGCCCTGTGCCGCCGGCGCCCGGTGCGGGCGCTGTACTGCATGCCGACCCTGCACAACCCCCTGGGCACGGTGATGCCCCTGGCCGAACGCCGGCGCCTGGCGCAACTGGCCCGCGAGCATGACCTGCTGCTGATCGAGGACGGCGCCTACGCCTTCCTCGCCGAACCGGCCCCGCCGCCGCTGCAGACCCTGGCCCCGGAGCGCACGCTGTATATTTCCGGGCTGTCGAAAAGCGTCGCCTCGGGCTTGCGCCTGGGGTTTATCGTCGCGCCCCTGGAGATGATCCCGGCCCTGGAACGGGCGATCCGCGTGTCCACGTGGAGCACCCCGTCGCTGACCGTGACCCTGGGCTGCCGCTGGATCGAGTCGGGGCTGGTGGACAGCCTGGAAGAACAGAAGCGCAACGATGCCCGCAGCCGCCAGCAACTGGCCCGGAGGGTGCTCAAGGGCTGCGATTACCAGGCCTATGGCTCATCGTATTTTCTCTGGCTGAAACTGCCGGAAGGACGGCGGGCCGATGCCGTGGTGGCGGCCCTGGAACATCAGGGGGTAACGGTGACCTCGGCCGAGCCCTTCGCCACCACCGCCCATGTGCCCCAGGCCTTGCGCCTGGCCCTGGGCTCCATCGGCCTGCCGCTGCTGGAGCAGGCTCTGGAAAAGGTCCGCAACGAAATCACCCGCTAA	MRRTRYKTIVDHFAQRIRAGQLCPGTQLPTVRALMASEQVALATALRVYHELEAIGLVVGEPGRGTFVRDTSLPRGMGLEQHPASAASVDLAFNYPSLPGQAESLREGLRAIAASGDLDALLHSAPQGGRPHERQTAARHLRNREIRVAAEQVLIVNGAQQGLAVSLLALLQPGDILAVDALTYPGLKTLAQVHRLDLEALPQHNDQMDLDALQALCRRRPVRALYCMPTLHNPLGTVMPLAERRRLAQLAREHDLLLIEDGAYAFLAEPAPPPLQTLAPERTLYISGLSKSVASGLRLGFIVAPLEMIPALERAIRVSTWSTPSLTVTLGCRWIESGLVDSLEEQKRNDARSRQQLARRVLKGCDYQAYGSSYFLWLKLPEGRRADAVVAALEHQGVTVTSAEPFATTAHVPQALRLALGSIGLPLLEQALEKVRNEITR	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	43.32	gnl|BL_ORD_ID|2018|hsp_num:0	2208			1920	2253	erythromycin; acriflavine; tetracycline; chloramphenicol
BGC0000413.1|Pyoverdine_37 # 72057 # 72860 # -1 # ID=1_37;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.678	BGC0000413.1|Pyoverdine_37 	72057	72860	-	Loose	500	209.149	APH(6)-Ic	48.15	3002659	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	TTGTTCGAAACCTATATGAAACGCTGGCGCCTGACGCCCGATGGCGATCCCATCGTCACCCCGGGCAGCCGCCTGTTGCCGGTGCGTCTGCAAGACGGTGCGCCGGCCATGTTGAAGATTGCCCTGGATGAACACGAGCAGGCCGGCAACCGGCTGATGGCCTGGTGGGCCGGGGAGGGGGCGGCGCGGGTTCATGCCCAGCAAGGCGATGCCCTGCTGATGGAGCGTGCCATGGGCAAGGGTTCGCTGATGCGCATGGCCCTGGCGGGCCAGCACGATGAGGTCAGCCATATCGTCTGTGCCACCCTGCAACAGTTGCACCGGCCACGGGCACAACCGCGGCCGCCGCTGGTGTCGCTGGATCGCTGGTTTGCCGACCTGCGCGAGGCGGCGCCGCAGCAGGGCGGGTTGTTCCTGCGCTGCCTGGCCGAAGCCGAGCACCTGTTGGCCACGCCCCGGGAACCGGTGGTGCTGCATGGCGATATACACCACGACAATGTGCTGGACTTCGCCGAGCGCGGCTGGCGGGTGATCGACCCCAAGCGGGTCCATGGCGAGCGCACCTTCGATTTCGCCAACCTGATCTGCAACCCGGACCTGCCCAGCGCCACCGACCCTGTGCGCTTTGCCCGCCAGGTGCAGGTGATTGCCCGGGCGGCGCAGTTGGAGCCGCGCCGGCTGGTGCAGTGGGTGCTGGCCTTCAGTGGTTTGTCCGCTGCCTGGTTTCTCCAGGACGATCATCAGCCCGGGGCGCAGCACCAGCTCAAGCTCGCGGCTTTGGCCGCCCAGGCACTGGAGGGGTGA	MFETYMKRWRLTPDGDPIVTPGSRLLPVRLQDGAPAMLKIALDEHEQAGNRLMAWWAGEGAARVHAQQGDALLMERAMGKGSLMRMALAGQHDEVSHIVCATLQQLHRPRAQPRPPLVSLDRWFADLREAAPQQGGLFLRCLAEAEHLLATPREPVVLHGDIHHDNVLDFAERGWRVIDPKRVHGERTFDFANLICNPDLPSATDPVRFARQVQVIARAAQLEPRRLVQWVLAFSGLSAAWFLQDDHQPGAQHQLKLAALAAQALEG	MERWRLLRDGELLTTHSSWILPVRQGDMPAMLKVARIPDEEAGYRLLTWWDGQGAARVFASAAGALLMERASGAGDLAQIAWSGQDDEACRILCDTAARLHAPRSGPPPDLHPLQEWFQPLFRLAAEHAALAPAASVARQLLAAPREVCPLHGDLHHENVLDFGDRGWLAIDPHGLLGERTFDYANIFTNPDLSDPGRPLAILPGRLEARLSIVVATTGFEPERLLRWIIAWTGLSAAWFIGDGDGEGEGAAIDLAVNAMARRLLD	100.38	gnl|BL_ORD_ID|822|hsp_num:0	892			0	723	streptomycin
BGC0000413.1|Pyoverdine_38 # 72939 # 73397 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.647	BGC0000413.1|Pyoverdine_38 	72939	73397	-	Loose	300	24.6386	AAC(6')-Ib-cr8	23.73	3005118	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic inactivation	AAC(6'); AAC(6')-Ib-cr	ATGAATTCTTCAGATCGCATCGAACGCAAGATCCTGCTCAAGGCCGACCCGGCCCAGGTCTGGCAGGCGCTGAGCGAGGCCGAACGCTTCGGCCGCTGGTTTGGCGTGGCCCTGGCCGGCCAGCAGTTCATACCCGGCCAGCGGGCCCGGGGCGCGGTGACTTACCCAGGCTATGAGCACCTGACCTGGGATGTCCTGGTGGAGCAGATGCTGCCCCAGGAGCTGTTCTCCTTCCGCTGGCACCCCTACGCCATCGATCCCGCTCAGGACTATTCGGCAGAGCCCAGCACCCTGGTCCGGTTCGAACTTGAAGAGCACGCCGGTGGTACCTTGCTGCGGGTCACCGAGTCGGGCTTCGACGGCATTCCCGCCGAGCGCCGGCTCAAGGCCTTTCGCATGAACAGCCGGGGCTGGGACGAGCAGATGAGCAATATCGAGAACTACCTGCAGCAGGGTTGA	MNSSDRIERKILLKADPAQVWQALSEAERFGRWFGVALAGQQFIPGQRARGAVTYPGYEHLTWDVLVEQMLPQELFSFRWHPYAIDPAQDYSAEPSTLVRFELEEHAGGTLLRVTESGFDGIPAERRLKAFRMNSRGWDEQMSNIENYLQQG	MTNSNDSVTLRLMTEHDLAMLYECLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGRWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPYGPAVYMVQTREAFERTRSDA	82.61	gnl|BL_ORD_ID|2829|hsp_num:0	3845			6	183	amikacin; ciprofloxacin; kanamycin A; tobramycin
BGC0000413.1|Pyoverdine_40 # 74891 # 75292 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.614	BGC0000413.1|Pyoverdine_40 	74891	75292	+	Loose	300	25.7942	AAC(3)-IXa	38.24	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCGTCCGATCCTGTTGCTGGCCCTTGCGCCGCTGCTGCTGCTTGCTCCACTGGCCCAGGCCTATGAGTGCAACAACACCACCCAGACCGATATGAGCCTGTGCGCCAACTTCCAGCACAAGGCCGCGGACAAGGAGCTGAACGCCCTTTACCAACAGATCAACCAGCGCCTGAAAGACCAGCCACACAGCAAAAAGCTGCTGGTCAGCGCCCAGCGCGCCTGGGTGGCGTTCCGCGATGCCGAGTGCAGTTTTTCCACCTCGGGCGTGGAAGGTGGCAGCCTGTATCCGGTGGCCTACAGCAACTGCATCACGGCCTTGACCAAGACCCGCGTGGAGAGTTTCAAACAGTACCTGCAGTGCAAGGAAGGCGACTTGAGCTGCCCGGTCCCCGCACGGTAG	MRPILLLALAPLLLLAPLAQAYECNNTTQTDMSLCANFQHKAADKELNALYQQINQRLKDQPHSKKLLVSAQRAWVAFRDAECSFSTSGVEGGSLYPVAYSNCITALTKTRVESFKQYLQCKEGDLSCPVPAR	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	47.33	gnl|BL_ORD_ID|1870|hsp_num:0	2030			594	696	neomycin
BGC0000413.1|Pyoverdine_41 # 75395 # 76513 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.633	BGC0000413.1|Pyoverdine_41 	75395	76513	-	Loose	950	30.0314	adeK	31.34	3000782	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGAGCTATCACAGTGTGCGGCCTGGCCGCCGGCGCGGTTCTCAGCGCCTGTTCTTTCACCGCCCTGGCCGACGAGGGCCTGGCCCTCAACAGCGGTCACGAGTACATGGTGACCACCAATTACCCGAACAACCTGCACGTTCTCGATCTGGCCACCGACAGCCTGTACAAGACCTGCAAGATGCCCGACGCCTTCGGCCCCGGCACCGTGCAACTGTCGCCGGACCGCAAGATCGCCTACGTGCTGAACAACCACTATGCGGATGTCTACGGCGTCGAGCTCGACAGCTGCAAGCAGGTGTTCCACGCCAGCATCACCCAGCATCCGGGGGAGAAGGCGCGCTCGATGTTCGCCTTCACCGTCAGCCACGACGGCAAGGAGCTGTACACCGTGGCCAACCCGACCCTGTTGCTCAATGACCGCTATGAGGTCAAGGAGCCGCGGCTGGATGTCTACGCCACCGATGCCGGGCTCGACGCCAAGCCGCTGCGCAGTTTCCCCGCGCCGCGCCAGCTGACCATCATGCAGAGCGGCGACGACGGCACCCTGTATGTGGCCGGGCCGGACCTGTACAAGGTCGACGTCAAGACCGGCAAGTTCGAGGTGCTGATCCCCAGCCGCCACTGGAAACGCCCCAACTACAGCGCGCCGGACGTGCTCTACGTGTGGAACCAGCAGACCTTCCGCCATGACTTCTCGCTGCTCTACACCGCGGCGAAGTTCAAGGACAAGAAGCAGGACCCGGCTACCGCCGAGCCGCTGTACGGGCTGTTCAGCGTCGATCTTGCGACCGGCAAGACCGAGACCACCGACTTCGGCCCGCTGACCGAGATCTACTTCAGCGGCATGCGCTCGCCCACGGACCCCAACCTGATGTTCGGCGTGCTCAACCGCCTGGCCAAGTACGACATCAAGCAAAAGAAACTGCTCCAGGCCGCGACCCTGGAACACTCCTACTACTGCATCTCGTTCAATCGGGCCGGGACCAAGATCTACCTGGCGGGGACCTTCAACGACGTGGCGATCTTCGATGTCCAGAGCATGAAGCAGATCGGCAAGATCACCCTGCCGGGCGGCGACATGGCCATCACCACGGCGCAGATCTTCGTCCGCTGA	MRAITVCGLAAGAVLSACSFTALADEGLALNSGHEYMVTTNYPNNLHVLDLATDSLYKTCKMPDAFGPGTVQLSPDRKIAYVLNNHYADVYGVELDSCKQVFHASITQHPGEKARSMFAFTVSHDGKELYTVANPTLLLNDRYEVKEPRLDVYATDAGLDAKPLRSFPAPRQLTIMQSGDDGTLYVAGPDLYKVDVKTGKFEVLIPSRHWKRPNYSAPDVLYVWNQQTFRHDFSLLYTAAKFKDKKQDPATAEPLYGLFSVDLATGKTETTDFGPLTEIYFSGMRSPTDPNLMFGVLNRLAKYDIKQKKLLQAATLEHSYYCISFNRAGTKIYLAGTFNDVAIFDVQSMKQIGKITLPGGDMAITTAQIFVR	MQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQFFADPRLLEVIDLALANNRDLRTATLNIERAQQQYQITQNNQLPTIGASGSAIRQVSQSRDPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWLNYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQIAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAAGANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVKISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFRAGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSAELKKQ	76.86	gnl|BL_ORD_ID|1536|hsp_num:0	1664			810	996	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000413.1|Pyoverdine_42 # 76537 # 76860 # -1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.627	BGC0000413.1|Pyoverdine_42 	76537	76860	-	Loose	500	26.1794	OXA-198	25.0	3001805	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAACATCTCAAGCCGATCAACAACAAAGCTCAGAAACTGACCGAGGCCGCGGCCCAGGACCGTATCGAAGAAGTGCTGGCGATGAACTCCGTGGCCGGCTGCGCCTCGACCACCGACCCGGGCTGGGAAATCGATGCCTTTGGCGGCGTCTCGTCGCTGTGCCAGCCGATGGAGGCCGACCTCTACGGCTGCTCCGACCCTTGCTGGTGGCCGGCCCAGGTGCCGGACATGATGAGCACCTACCCCGACTGGAACAAGGACGCCCAGGCCTCCAACGACAACTGGCGCAACCTCGGCACCGTCTTCCCCAAAGACAAGTAA	MKHLKPINNKAQKLTEAAAQDRIEEVLAMNSVAGCASTTDPGWEIDAFGGVSSLCQPMEADLYGCSDPCWWPAQVPDMMSTYPDWNKDAQASNDNWRNLGTVFPKDK	MHKHMSKLFIAFLAFLLSVPAAAEDQTLAELFAQQGIDGTIVISSLHNGKTFIHNDPRAKQRFSTASTFKILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNRDQTLESAFKVSCVWCYQALARQVGAEKYRNYLRKSVYGELREPFEETTFWLDGSLQISAIEQVNFLKKVHLRTLPFSASSYETLRQIMLIEQTPAFTLRAKTGWATRVKPQVGWYVGHVETPTDVWFFATNIEVRDEKDLPLRQKLTRKALQAKGIIE	40.84	gnl|BL_ORD_ID|696|hsp_num:0	758			75	315	cloxacillin; oxacillin; cefalotin
BGC0000413.1|Pyoverdine_43 # 76862 # 78295 # -1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.631	BGC0000413.1|Pyoverdine_43 	76862	78295	-	Loose	700	27.7202	cfr(D)	29.73	3005021	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; glycopeptide antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGGGCGCAATTCTGAATCTGGTGGAGCGCAACCTGCATGAAGTGCAGGTGGACGCCAACCGCATGCTGTTCCATATCCCCAGCAGTTCGCTGTTTGCCAGCGATGCCTTGACCGGCAGCATCATCGATGCGCTGCGCGGCCCGGGCTGTACCCCGGAAGACTTGATCCAGCGTCTGGCCGGCGCCTATGACGGTGCCGACGTCAGCGACACCCTGCGTGAGCTGATGGCCCTGGAACTGGTCAGCGACGGCTCGCCCCTGACCCCGGAAATCGGCGTCAAACGGGTCGAACGCACGGCGATCAATACCGTGGTGCTCAACGTCAATACCGGCTGCAACCTGAGCTGCACCTACTGCTACAAGGAAGACCTGGACAAGCCCTCGGCGGGCAAGAAGATGGGCCTGGACACGGCCATTGCCTCGGTGGAAATGCTGCTCCAGGAGTCCCCGGACGAGGAGCGCTACACCGTGGTGTTCTTCGGCGGCGAACCCTTGAGCAACCGGCCGCTGATCGAGGCCATGGTGGACTACTGCGAACAGCGCTTTGCCGCGGCCGGCAAGTTCGTCGAGTTCGTCATGACCACCAACGCCACCCTGCTCACCGAAGAGGTGGTGGACTACCTCAACGCCCACCGCTTCGGGCTTTCGGTGAGCATCGACGGGCCCAAGACCGTGCACGACCGCAACCGCATCACCGTGGGCGGGCAAGGCACCTATGACGTGGTGCGGCGCAAGGCGAAGATGCTTCTGGAACGCTACGACAGCCGGCCGGTGGGGGCGCGGGTGACCCTGACCACCGGGGTCACCGACCTTGAGACCATCTGGGATCACCTGTTCAACGAGCTGGGGTTCGCCGAAGTGGGGTTCGCCCCGGTGACCTCGGGGGACATCAGCAGCTTCAACCTCAGCAGCGAGGAGTTGATCGAAGTCTTCGCCAGCATGAAGCGCCTGGGCCGGCGTTACCTGGCGGCGGCACTGGAGCACCGCAATATCGGCTTCTCCAACCTGCACCAGCTGATCACCGATATCCACGAGGGCCACAAGAAGGCGCTGCCCTGCGGCGCCGGACTGAAGATGCTGGCGGTGGACCACAAGGGCGAGCTGAACCTGTGCCACCGCTTCACCGGCTCATCCCTGCCGACCTTCGGCAATGTGCATGACGGTGGGGTCAAGCAGATGGAGCTCAATGACTTCCTGTCCCAGCGCCTGGACCGCACCAACACCGGCTGCGACAGCTGCCGCATCCGCAACCTGTGTTCCGGCGGCTGCTACCACGAGAGCTATGCCCGCTACGGCGACCCGGCGCATCCGACTTATCACTATTGCGAACTGATGCGTGACTGGGTGGATTTCGGCATCGAAGTCTACAGCCGGATCATGGCGCACAACCCTGCGTTCATCAGCAGCTACATCACTCCGCGCAAGGCTCACTGA	MGAILNLVERNLHEVQVDANRMLFHIPSSSLFASDALTGSIIDALRGPGCTPEDLIQRLAGAYDGADVSDTLRELMALELVSDGSPLTPEIGVKRVERTAINTVVLNVNTGCNLSCTYCYKEDLDKPSAGKKMGLDTAIASVEMLLQESPDEERYTVVFFGGEPLSNRPLIEAMVDYCEQRFAAAGKFVEFVMTTNATLLTEEVVDYLNAHRFGLSVSIDGPKTVHDRNRITVGGQGTYDVVRRKAKMLLERYDSRPVGARVTLTTGVTDLETIWDHLFNELGFAEVGFAPVTSGDISSFNLSSEELIEVFASMKRLGRRYLAAALEHRNIGFSNLHQLITDIHEGHKKALPCGAGLKMLAVDHKGELNLCHRFTGSSLPTFGNVHDGGVKQMELNDFLSQRLDRTNTGCDSCRIRNLCSGGCYHESYARYGDPAHPTYHYCELMRDWVDFGIEVYSRIMAHNPAFISSYITPRKAH	MLQKQLTKYQQIEKVLKECQQPNYRMKQILHCIFKEKKTDFNEMSVLPKNLRDTLTTEIGTSLLTVEPLIEQKSQQVRKVLFNLSGDNRIETVNMTYQAGWESFCISSQCGCNLGCQFCATGKIGLRKNLTAEEITDQVLYFLLKGHQIDSISFMGMGEPLANPHFFEALDIFMNPDMFQLSPRRLSVSTIGVIPKIKRLTAEYPQVHLTFSLHSPFDEERSQLMPINKSFPLLKVMDTLDEHIKVTSKKVYIAYILLPDVNDSLTHAVALADLLRSRYKKGKLYHVNLIRYNPTFDAPRTFKQVDEKQVKLFYQTLISKGINVTIRSQFGIEIDAACGQLYGNYEIKNKKTIQVND	133.61	gnl|BL_ORD_ID|2753|hsp_num:0	3763			330	510	vancomycin; teicoplanin; linezolid
BGC0000413.1|Pyoverdine_44 # 78375 # 79955 # -1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=10bp;gc_cont=0.676	BGC0000413.1|Pyoverdine_44 	78375	79955	-	Loose	700	26.5646	ACC-3	27.27	3001817	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGAAGAGAAGACTGCGCCTGAGGCTCAGTGCCAGCCTGCTGGCCATTGCCACCTGTACCGCCTTGCATGCCCCTTCGAGTTTTGCCGCTCGGGATGCGCAGAGCATCCTCAAGGAAACCTGCCAGGGTTGCCACACCCCCGAGGCCGGGGAAGCCCTGAGCCGCATCAGCCACCAGCGCAAGACCCCGGAAGGCTGGCTGATGAGCATTGCCCGCATGCAGACCATGCACGGGCTGCAAATCAGCGATGACGACCGCCGCACCCTGGTCAAGTACCTGGCCGATACCCAGGGCCTGGCGCCCAGCGAGACCGACGGCGTGCGCTACGCCCTGGAGCGACGGCTGAACACTGTCGAGCATTTCGACGAACAGACCACCCAGATGTGCGCCCGCTGCCACTCCGGCGCGCGGATCGCCCTGCAACGCCGGCCGGCCCAGGAATGGGAGCGGCTGGTGAATTTCCACCTTGGGCAATGGCCATCCCTGGAGTACCAGGCGCTGTCCCGGGACCGGGAATGGCTGCCCACCGCCCTCAAGGAAATGGTGCCGCTGCTGGCCAAGCGTTATCCCCTCGACAATCCCGCCTGGACAGCCTGGCAACAGGCCCGCCCGCAAGCGGCGGCGCTGGCGGGGGACTGGAGCTTCAGCGGCCACCTGCCGGGCAAGGGTGAACTGGCCGGGGTGATGAGCGTCAGCGCCGGGGAAGGCGATCAGTTCAAGCTCAGCGTCAAGGGCCAGTACGCCGATGGCAGCCCGTTCAATGGCGAGGGCAGCGCGATCCTCTACAACGGCTATGAATGGCGCGGCAATGTCACCGTGGATGGCGTGGTCATGCGCCAGGTGCTGGCGGCACAGGGCAATGCACTGCAAGGGCGGATGTTCGAGGCCGAGCACGACGAGCGCGGCCTGGACTTCATCGCCGCCCGGCAAGGCAGCCAGCGGTTGCTGGCGGTGCAGCCGGGTTACCTGAAGGCCGGTGAGGAGGCCGAGGTGACCCTGGTGGGCGCGGGCCTTGCGGGCACTCCGAGCTTCGGCAAAGGGGTGGAGGTCGTGCAGGTGCTGGAGCAGAGCCCCGAACGCATCCGCGTCAGGCTCAAGGCGGCGGCCAGCGCCCAGCCGGGGCTGCGGGAAGTCAGCGTCGGCAGCCTCAAGGGCGCGACGCTGGCGGTGTACCAGCGCATCGCCGAGGTCAAGGTGGTGCCGGCATTTGCCGTGGCGCGGATCGGTGACGGCGGCGGTTCGACGCCCAAGGTCCAGGGCCGCTTCGATGCCGAAGCCTGGGGCAAGGGGGCCGACGGCAAGGCCTACCGCATCGGCGTGATGCCGGCGCAGTGGAAGGTCGAGGCCTTCGACGCCCAGGCGGCCAAGGATGAAGACGTCAAGTACGCCGGCAGCATGCAGGCTGACAGTGGCGTGTTCACCCCAGGGGATGCCGGGCCCAACCCGCTGCGCAAGATGTCCACCAACAACGCCGGCAACCTCAAGGTGATCGCTGCGGTGGAGGAGGGGGGCAAGGCCCTGACCGGTGAAGGCCAGCTGATCGTCACCGTGCAACGCTGGAACAATCCACCCATTCCCTGA	MKRRLRLRLSASLLAIATCTALHAPSSFAARDAQSILKETCQGCHTPEAGEALSRISHQRKTPEGWLMSIARMQTMHGLQISDDDRRTLVKYLADTQGLAPSETDGVRYALERRLNTVEHFDEQTTQMCARCHSGARIALQRRPAQEWERLVNFHLGQWPSLEYQALSRDREWLPTALKEMVPLLAKRYPLDNPAWTAWQQARPQAAALAGDWSFSGHLPGKGELAGVMSVSAGEGDQFKLSVKGQYADGSPFNGEGSAILYNGYEWRGNVTVDGVVMRQVLAAQGNALQGRMFEAEHDERGLDFIAARQGSQRLLAVQPGYLKAGEEAEVTLVGAGLAGTPSFGKGVEVVQVLEQSPERIRVRLKAAASAQPGLREVSVGSLKGATLAVYQRIAEVKVVPAFAVARIGDGGGSTPKVQGRFDAEAWGKGADGKAYRIGVMPAQWKVEAFDAQAAKDEDVKYAGSMQADSGVFTPGDAGPNPLRKMSTNNAGNLKVIAAVEEGGKALTGEGQLIVTVQRWNNPPIP	MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVTLNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYVPELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIGTGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNMEVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWEQLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVT	139.52	gnl|BL_ORD_ID|1304|hsp_num:0	1422			3	135	
BGC0000413.1|Pyoverdine_45 # 80368 # 82023 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.649	BGC0000413.1|Pyoverdine_45 	80368	82023	+	Loose	550	28.4906	TER-1	32.88	3007001	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	TER beta-lactamase	ATGGATAGAAGCGCCTGTGCCCGTCTCGGCTCGCTGATCCTCTCGTTGTCTGCCCTGACCCTGGTCGGATGCAAGGAAGAAACCAGTCCCAAGACTGCAGCCGTCGCTGCGGCCCCCGCTCCGGCGGCCATGGTCATGCCGATCTGCGCCAATGGCGAATGCGCGGTGCTGGACCAGGACGGCAAGGTGCTGGTCAGCGCCGACAACGACTACGACGCCGTGGTTGCCCTGCCCCTGGACAAGACCTTCCTGTTCGCCAAGGACGGTACCTGGAACCTCAGCAGCGCCGATGGCAAGCAGACCCTCAAGGCCGCCTTCACCGATGACCTGCGGCTGCTGACCCCGGGCTACTTCGGCTTCGGCCAGGACGGCAAGCTGGGCATCATCGACCAGAGCGGCAAACAGATTCAGCCACCGCGCTTCGACGATCTGTACGTGGGCGGCAACGACGACTTCATCGTCTACGAGATCGGCGGCAAGCGCGGCATTCTCAGTGCCAAGGGCGAGGTGGTGACCGAAGCCCTGTATGACAGCAGCATGGTCCGCGATGACTTCGCCAAGCGCGGCTGGTGGATGATCGCCGAACGCGGCAACGACAAGTGGGCGCTGAACCTCAAGACCGGCGAGCAGAAGAAGATCGACTTCGACAGCATCGACTACTTTGCCAACCAGCATCTGGTGGTCAGCACCGAACAGGGCAAGGCCCTGGCCGATGCCCAGGCCCAGTTGATCAGCGCCGCCACCTACAACTGGATGGGCGAACCGGGTGACGGCCTGGTGGCCTTCCGGGAAAAATACGACAGCCCCTGCGGCTACATGGATTTCCAGGGCAAGACCGTGATCCAGGCCCAGTTCGGCACCTGCCAGGTATTCGGCAAGCAGGGCGCGCTGGTCACCGCCAAGAACGCCGACGGCAGCTCCGGCAAGGCCGGGCTGATCGACCGCCAGGGCCAATGGAAGGTGCAGCCGGTCTACGACTCGGCGGACCCGGCCGGCTTCAGCCCCCTGGGAATGTTCCGGCAGGTACCGGGGCTGAACCAGGTCGCGGTGCTGCAGAACGTGTTCAGCGCCACCTTCGGTATCTTCGATGTGGACAAGGGCGTCGAGCTGTTCAAGCCCACCTACGCCCAGATCGGCGCGATCAATGCCGACCTGTTCGTCTTCAGCACCGCCAACAGCCCGACCAAGCAGGCCACCCTGTTCGGCCAGGCCACCCAGGTGCGTACCGTGGGCCTGATGGACGCCAGCGGCAAGGTGCTGCTGGAGCCGGGCCAGTACGTCGACATCCACCTGGACAACAGCGGCCACTACCTGCTGGCCACCGACGACACCTCGGCCCTGGCCACCTCGGCGCTGTACGACCTCAAGGGCAAGCGGTTGATCCCCGGCAAGTGGCAGGAACTGGTGGTGGACGAAACCCGCGGCGCCATCTTCGGCTATGCCGTGGAAGGCATGGGCGATGACCAGTCCCGCAGCCTCAAGGCCCTGTATCGCCTGGACGGCACTCCGAGCTTCCAGGTCAGCCAGGTCGATTGCGGCGCCGAACAGGTGCACGACGGCCATGACCAGGTGCTGTGGCCGGCCAACCCCCAGGACTACTGCCCGCAGCCTGACGAAGTGGAAGACCAGGGCGAAGGCGACAACGCACAGGGCTGA	MDRSACARLGSLILSLSALTLVGCKEETSPKTAAVAAAPAPAAMVMPICANGECAVLDQDGKVLVSADNDYDAVVALPLDKTFLFAKDGTWNLSSADGKQTLKAAFTDDLRLLTPGYFGFGQDGKLGIIDQSGKQIQPPRFDDLYVGGNDDFIVYEIGGKRGILSAKGEVVTEALYDSSMVRDDFAKRGWWMIAERGNDKWALNLKTGEQKKIDFDSIDYFANQHLVVSTEQGKALADAQAQLISAATYNWMGEPGDGLVAFREKYDSPCGYMDFQGKTVIQAQFGTCQVFGKQGALVTAKNADGSSGKAGLIDRQGQWKVQPVYDSADPAGFSPLGMFRQVPGLNQVAVLQNVFSATFGIFDVDKGVELFKPTYAQIGAINADLFVFSTANSPTKQATLFGQATQVRTVGLMDASGKVLLEPGQYVDIHLDNSGHYLLATDDTSALATSALYDLKGKRLIPGKWQELVVDETRGAIFGYAVEGMGDDQSRSLKALYRLDGTPSFQVSQVDCGAEQVHDGHDQVLWPANPQDYCPQPDEVEDQGEGDNAQG	MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDERFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAELCAAAITLSDNTAANLLLASVGGTQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPQAMAKTLHNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSTLPHGWFIADKTGAGNRGSRGIIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW	194.01	gnl|BL_ORD_ID|4599|hsp_num:0	5670			570	789	
BGC0000413.1|Pyoverdine_46 # 82125 # 82790 # 1 # ID=1_46;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.664	BGC0000413.1|Pyoverdine_46 	82125	82790	+	Loose	1900	28.4906	MexI	29.31	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCAATGCTCTGCTCTTCGACCTTGATGGCACCCTGACCGACACCGACGCCCTGCACCTGCTGGCCCTGCAGCAACTGCTGCTGGAAGAGGATGGCCGGACCTTCACCCAGGAAGAATTCGAAGCCCATGTCAGCGGCCAGGCCAATGCCAACATGTGCCGCTACCTGTTCCCCGAGCGCAGCGTGGCGGAACATGAAGCCTTTGCCGAGCGCAAGGAAGTGCGCTTTCGCCAACTCTCCCCGCAACTGATGCCCATGCCCGGCCTGCTGCGCCTGCTGGATTTTGCCCAGGAGCACGGCATCGGCGTGTGCGTGGTCACCAACGCGCCCCGGGCCAATGCCGAGCACATGCTCGAGGTGCTGGGCCTGCGGCAGCGCTTCCAGACGGTGCTGGTGGCCGAGGAGTTGCCTGGGGCCAAGCCCGATCCCCTGCCCTACTTGAGCGGCCTGGAATGCCTGCAGGCCACCGCCGACCAGGCCCTGGCCTTCGAAGACTCGGTACCCGGGCTGACAGCCGCGGTAAAAGCCGGGATCTGCACGTTCGGCCTGGCCACCAGCCAGCGCCCGCAAACCCTGCTGGATGCCGGCGCCCACCGCGTGATCAACGACTTCGACGACCCGCAACTGTGGGCCGAGATCCGGCGCCGGCTCGATCTGCCCTGA	MLNALLFDLDGTLTDTDALHLLALQQLLLEEDGRTFTQEEFEAHVSGQANANMCRYLFPERSVAEHEAFAERKEVRFRQLSPQLMPMPGLLRLLDFAQEHGIGVCVVTNAPRANAEHMLEVLGLRQRFQTVLVAEELPGAKPDPLPYLSGLECLQATADQALAFEDSVPGLTAAVKAGICTFGLATSQRPQTLLDAGAHRVINDFDDPQLWAEIRRRLDLP	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	21.48	gnl|BL_ORD_ID|4683|hsp_num:0	1647			288	459	acriflavine; tetracycline; norfloxacin
BGC0000413.1|Pyoverdine_47 # 83178 # 84893 # -1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.662	BGC0000413.1|Pyoverdine_47 	83178	84893	-	Loose	1000	26.1794	vgaC	50.0	3002831	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGCTCGCCCATCCCCATACCAAATACCGCCCCTTTACCCCCGTGGACCTGGACTCGCGCCAGTGGCCGTCACGTACCATCACCCAGGCTCCGATCTGGCTGTCCACCGACCTGCGCGATGGCAACCAGGCGCTGTTCGAGCCGATGAACCGCGAGCGCAAGCTGCGCCTGTTCGAGGAACTGGTGCGCCTGGGCTTCAAGGAAATCGAAGTGGGATTCCCCGCCGCCTCGCGCACCGATTTCGAGGTGGTCCGCGAGCTTGTGGAACAGCAGCGGATTCCCGCCGACGTCACGCCCATGGTGATGACCCAACTGCGCGAGGACCTGATCCGCGAAACCGTACGCAGTGTGCAGGGTGCGCGCCGGGTCATCGTCCACCTGTACAACGCCATCGCCCCGGTCTGGCGGCGCGTGGTGTTCGGGCTTTCGGTGGATGAGGTCGAGGCCCTGGTAGAGCGCCATGTCAGGCTGTTGCGCGAGTTGACCGACCAGCACCCGGAAACCGAATGGGTGTTGCAGTATTCCCCCGAAACCTTCTGCATGGCGGAGCTCGAGGTGTCCCTGCGCATGTGTAACACCGCGATCCGTACCTGGGACGCCGGCCCGGGGCGCCCGATCATCATCAACCTGCCGACCACCGTCGAGGTGGCCACCGCCAACATCTTTGCCGACCAGATCGAATGGATGCACAAGCGCCTGGAGCGCCGCGACCAGGTCACGCTGTCAGTGCACCCGCACAACGACCGGGGCACCGGCGTGGCCTGTGCCGAACAGGCGTTGCTGGCGGGCGCCCAGCGGGTGGAGGGCTGCCTGTTCGGCAATGGCGAGCGCAGTGGCAACCTGGATCTGGTGACCCTGGCCCTGAATCTCTATACCCAGGGCATCAGCCCCGGGCTGGACTTCTCCGATATCGCGGCAGTGGCCCGGGTTGCCGAGGAATGCACGGCGCTACCGATCCATCCGCGCCATCCCTATGTCGGCGACCTGGTGTTCACCGCCTTTTCCGGCTCGCACCAGGACGCCATCGCCAAGGGCTTTGCCGCCCAGGCGGCTGACGGTTTCTGGGAGGTGCCCTACCTGCCCATCGATCCGCAGGACCTGGGGCGGACCTACGACAGCATCGTGCGGGTCAACAGCCAGTCCGGCAAAGGCGGGATCGCTTTCCTGCTGCAGCGTGACCACGGCATCGTCATGCCCCGGCGCATGCAGATCGAGTTCAGCGCCATTGTGCAGAAGCTGGCTGATGCCAGTGACGCCGAGTTGAGCAGCGATGCTTTATGGGAGGTGTTCCAGCGCACCTATCTGGCGTGTGCAGAGGGCACGGCCGGCCTGCGGTATCTCGCTCATCGGTTGTTCGATGCCCCCGAGGGGCAGGGGATCGAGCTGCGGGTCGCCACCCCCGGGAACCAGGAGGCGTGCTTGCATGGCGTGGGCAACGGACCTGTCGCGGCGGCCCTGGCCGCCCTGGGCTTGCCGCTGCGCATCGACAGTTTTGAAGAGCGCAACCTGGGGGCGGGGGCCGATGCGCAGGCGCTGGCAATTGTCGAAGCGGTGTGGCCGGGCGTTGCCGGGTCACGTTTTGGCGCCGGCTGTCACGCCAATATCGTCACCGCGTCGGTGCAGGCCGTGATCAATGCCGCGGCGCGGTTTTATCCCGAGCAGGCGCCGGCATTCGTCCCCACCCAGGCATCGCTTGCGGAGCGGGCGGCTCCCTGA	MLAHPHTKYRPFTPVDLDSRQWPSRTITQAPIWLSTDLRDGNQALFEPMNRERKLRLFEELVRLGFKEIEVGFPAASRTDFEVVRELVEQQRIPADVTPMVMTQLREDLIRETVRSVQGARRVIVHLYNAIAPVWRRVVFGLSVDEVEALVERHVRLLRELTDQHPETEWVLQYSPETFCMAELEVSLRMCNTAIRTWDAGPGRPIIINLPTTVEVATANIFADQIEWMHKRLERRDQVTLSVHPHNDRGTGVACAEQALLAGAQRVEGCLFGNGERSGNLDLVTLALNLYTQGISPGLDFSDIAAVARVAEECTALPIHPRHPYVGDLVFTAFSGSHQDAIAKGFAAQAADGFWEVPYLPIDPQDLGRTYDSIVRVNSQSGKGGIAFLLQRDHGIVMPRRMQIEFSAIVQKLADASDAELSSDALWEVFQRTYLACAEGTAGLRYLAHRLFDAPEGQGIELRVATPGNQEACLHGVGNGPVAAALAALGLPLRIDSFEERNLGAGADAQALAIVEAVWPGVAGSRFGAGCHANIVTASVQAVINAAARFYPEQAPAFVPTQASLAERAAP	MVLLEAKNIKHYIKDRLLLKIDELKIEHNDRIGLVGVNGSGKTTLLNILAEKFIPDEGTITPYAQSEILPQLKKTDAAKSGGEITQEYIQQTLNSAPALLLADEPTTNLDTDHIEWVEKKLKRWQGAFVLVSHDREFLDALCSVIWELEDGEITEYKGNYSDYLKQKEVEKQQQQSTYEKYEKEKKQLEKAIQLKEEKAQRATKKPKNLSASERRIKGSKPYFAKKQKKLHKTAGALETRVEKLEKVEKIKDQPPIKMDLPNERNLKNRVIIRVEDLEGLVPKQLLWKKATFQIYGGDKLAIIGPNGSGKTTLVKKIITQENGVTISPSVKIGYFSQNLMTLDVNKSILENVQNSSKQEESLIRTVLARMHFFDEDVYKPVHVLSGGERVKVALTKLLVSDINTLVLDEPTNYLDTEALKALENLLNEYTGSIIFVSHDRTFTENIATRILEIRNKKIEIFDGTYQQFKNRSTKKERDFQQEEQLLLDTKISEVLSRLSMEPSQALEKEFQNLLKEKSKLKE	109.39	gnl|BL_ORD_ID|1917|hsp_num:0	2123			315	369	lincomycin; clindamycin; virginiamycin M1; tiamulin; valnemulin
BGC0000413.1|Pyoverdine_48 # 85169 # 85999 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.665	BGC0000413.1|Pyoverdine_48 	85169	85999	+	Loose	200	44.2838	Escherichia coli soxS with mutation conferring antibiotic resistance	34.85	3003511	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGGACATTTTCACCTATGATAAGCGCCCCATGATCCCTTCCAGGACGGAGGCGCTGCGCTGCATGTCCGATCTGCTTGTTGTCTCGTCCATCGACTGCCTGTCCATGCCGGTTACCAGCATCGCCGTGGATTACCCCAACGGCCATGAAATACCTGCCCACAGCCATCCACGCTCGCAGCTGGCCTATGCCATCGAGGGCGTGCTGGTGATCGACACCGAGTCCGGCCGCTGGGTGGTGCCGCCCAGCCGCGGGGTGTGGTTGCAGGCCGGCGTCGAGCACCGGGTACGCATGCGCGGCGCGGTGCGCATGCGCAGCCTGTTCATCAATGTCGATGCCATTGCCGGCCTGCCCGAGCATGACTGCGTGATCGAGGTCTCGCCGTTGCTGCGCGAGCTGATCCTGGCCGCCGCCCAGGTCGGCACGCACTATTCGCCGGACAGCCGCGACGGCCGCCTGATGCGCCTGATCCTCGATGAGATGCGCTCGCTGCCGGTGCTGCCGTTCAGCCTGCCCTGGCCCCATGAGCCGCGCATGCTGCGGGTGTGCCAGGCGCTGGCGGACGATCCTTCGGACAACCGCACCGCCGAACAATGGGGCGACTGCCTGGCCATGAGCGCCAAGACCTTCCATCGCCAGTTCCAACGCCACACCGGCATCACCTTTGGCCGTTGGCGCCAGCAGGCGCGGTTGCTGATGTCCCTGGAGTGCCTGGCCGAGGGCATGCCGGTGGTGCAAGTGGCGCTGCAGCACGGCTACGACAGCCAGAGCGCCTTCGCCGCCGCCTTCAAGCGCCAGTTCGGCACGCCGCCTTCGGAGTTCTACCGCTGA	MDIFTYDKRPMIPSRTEALRCMSDLLVVSSIDCLSMPVTSIAVDYPNGHEIPAHSHPRSQLAYAIEGVLVIDTESGRWVVPPSRGVWLQAGVEHRVRMRGAVRMRSLFINVDAIAGLPEHDCVIEVSPLLRELILAAAQVGTHYSPDSRDGRLMRLILDEMRSLPVLPFSLPWPHEPRMLRVCQALADDPSDNRTAEQWGDCLAMSAKTFHRQFQRHTGITFGRWRQQARLLMSLECLAEGMPVVQVALQHGYDSQSAFAAAFKRQFGTPPSEFYR	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	257.94	gnl|BL_ORD_ID|1975|hsp_num:0	2066			111	309	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan; enrofloxacin
BGC0000413.1|Pyoverdine_49 # 86004 # 87593 # -1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.658	BGC0000413.1|Pyoverdine_49 	86004	87593	-	Loose	700	207.223	Klebsiella pneumoniae KpnH	27.27	3004597	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTAGTGCCCAGGCCGTATCGGAAGGCACCGGCGAGGCCGCCGCACAGGCAATCTCCCTGCGCACCTGGGTGGCGGTGCTGGGCAGCGTGGTGGGCTGCTTCATGGCCGGGATGAACGTGCACGTGACCAACGCTTCCCTGCCGGACGTGCGTGGCTCCCTGGGGGCGACTTTCGAGGAGGGGTCGTGGATCACCACCGCCTACCTGGTGGCGGAGATCATCATCATTCCCATGACCGGCTGGCTGGTTTCGGTGTTTTCCATGCGCAGGGTACTGATGGTCGGCACCGCCGGTTTCGTGCTGTTTTCGATCGCCTGTTCCCTGGCGCCGAACATCCACAGCCTGATCTTCGCCCGGGTGCTGCAAGGGGCCTTTGGCGGGGTGCTGATTCCCCTGTCGTTCCAGCTGATTGTCACCGAGCTGCCGGCGGCCCGGCATCCCATGGGCATGGCCCTGTTCGCCGTGGCCAACAATGTCGCCCAGGCCGCGGGACCGTCCCTGGGCGGCTGGCTCACCGATGCCTATTCGTGGCGCTGGATCTTCTACCTGCAAGTGCCGCCGGGGCTGTTGCTGCTGGCGGCCATCGGCTGGTCGGTGCGGCCCCAGCCTATGGTCCTGGCAAAGTTGCGCCAGGGTGACTGGGGCGGCATCGCCAGCATGGCCGTGGGCCTCTCGGCGTTGCAGATCATGCTGGAGGAGGGTGGCCGTTACGACTGGTTCGCCTCAAGCTTCATCAGCCATTGCGCGATCCTGGCCACGGTCGGCCTGCTGGCCTTCGTGGCCATCGAACTGCGTCGCGAGCAGCCGTTGATCAACCTGCGCCTCTTGGGGCGCTACAACTTCGGCATTGCCAGCCTGATGCAATTCACCTTCGGTGCGGTGGTGTTCGGCGTGGTGTTCCTGGTGCCCAACTACTTTGCCCAGATCCACGGCTACAACGCCCGGCAGATCGGCCTGATGATGATTCCCTACGGCCTGATCCAGTTCGTCATGTCGTTCGCCACCCCGCGGCTGATGCGCTGGACCAGCGCCCGCACCATCATCATTGCCGGGTTCGCCATCACTGGCATCGGCTGCCTGATGAACATCCACCTCAACCCCGATGCCTCGGTGAACGTCATCGTGCCCTCGCTGGTGGTGCGTGGTATCGGCCAGTCGCTGGTGGTGGTGGCGCTGGGGGTGATGGCGATCCAGGGGCTGGAAAAGGACCAGGTGGGCTCGGCCTCCGGACTGTTCTCCATGGTGCGTAACGTCGGCGGGGCCATCGGTATCGCGCTGTCCAGCCAGATCGTGGTGGAGCGCGAGAAACTCCACGCCCAGCGCATTGGCGAATCCGTCAGCCTGTTCGCCCAGGCCACCCAGGAGCGCCTGGTGGAACTGGTGCGCCTGCTGGCCCAGGCACCGGTAGAGTACGCAACGGCCCTGCATTCGGCGGCGCTGGCGCCCCTGCGCCAGCAAGCCCTGGGCATGGTGGACAAGGTGCTGCACCGCGACGCCCTCCTGCTGGCCTACAGCGATGCCTTCTTGCTGGCGGGGCTGGCCATGCTGTTGTGCGTGGTGGCCGGTGTGCTGCTGCGCCGGGCCTGA	MTSAQAVSEGTGEAAAQAISLRTWVAVLGSVVGCFMAGMNVHVTNASLPDVRGSLGATFEEGSWITTAYLVAEIIIIPMTGWLVSVFSMRRVLMVGTAGFVLFSIACSLAPNIHSLIFARVLQGAFGGVLIPLSFQLIVTELPAARHPMGMALFAVANNVAQAAGPSLGGWLTDAYSWRWIFYLQVPPGLLLLAAIGWSVRPQPMVLAKLRQGDWGGIASMAVGLSALQIMLEEGGRYDWFASSFISHCAILATVGLLAFVAIELRREQPLINLRLLGRYNFGIASLMQFTFGAVVFGVVFLVPNYFAQIHGYNARQIGLMMIPYGLIQFVMSFATPRLMRWTSARTIIIAGFAITGIGCLMNIHLNPDASVNVIVPSLVVRGIGQSLVVVALGVMAIQGLEKDQVGSASGLFSMVRNVGGAIGIALSSQIVVEREKLHAQRIGESVSLFAQATQERLVELVRLLAQAPVEYATALHSAALAPLRQQALGMVDKVLHRDALLLAYSDAFLLAGLAMLLCVVAGVLLRRA	MQQQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITSFGVANAISIPLTGWLAKRVGEVKLFLWSTIAFAIASWACGVSSSLNMLIFFRVIQGIVAGPLIPLSQSLLLNNYPPAKRSIALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGVAVVLMTLQTLRGRETRTERRRIDAVGLALLVIGIGSLQIMLDRGKELDWFSSQEIIILTVVAVVAICFLIVWELTDDNPIVDLSLFKSRNFTIGCLCISLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGIIPVILSPIIGRFAHKLDMRRLVTFSFIMYAVCFYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRTLAGSIGTSITTTMWTNRESMHHAQLTESVNPFNPNAQAMYSQLEGLGMTQQQASGWIAQQITNQGLIISANEIFWMSAGIFLILLGLVWFAKPPFGAGGGGGGAH	103.32	gnl|BL_ORD_ID|2732|hsp_num:0	3299			69	1473	erythromycin; gentamicin C; ciprofloxacin; spectinomycin; streptomycin; tobramycin; ceftazidime; ertapenem; piperacillin; azithromycin; imipenem; polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4; norfloxacin; ticarcillin; gentamicin
BGC0000413.1|Pyoverdine_50 # 87586 # 88695 # -1 # ID=1_50;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.711	BGC0000413.1|Pyoverdine_50 	87586	88695	-	Loose	600	150.984	emrK	34.05	3000206	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCCAGACCCCTGTTCCCGCTTTCCCGGTGCAAGCCGTCACCCGCCGTCGCTTACTCGGTTATGCCGGGCTGGCGCTGGTGTTGCTGCTGATTCTGGCCTGGGGCCTGCGCTGGTGGTTCAACGGGCGTTTCCTGGTGGAGACCGACGATGCCTACCTGCGCTCGGACATCGTCACCATCGCGCCCCGGGTCGCCGGCTACCTGGTGGCGGTCGAGGTCCGGGACAACCAGCCGCTCAAGGCTGGCGACCTGCTGGCGCGGATCGACGACAGCGACTACCGGGCCCGGGTCGAACAGGCGGAAGCGGCGCTGCGCGAGGCCCAGGCCGAACAGCGTGCCGGGCAGGCGCGGCTGGCCAATCTGGCCGCCCGCCAGCAACAGCAGCAGAGCCTGATCGCCGAAGCCCAGGCCCGGGTCGGCGCCGCCGAGGCCGAGGCACAACGGGCCGGCCAGGAAGGGCGGCGGCAGCAGCACCTGGCCAGCCAGCAAGTCAGCAGCGTGCAGCAACTGGAAAACGCCGCCGCCCTGGCCCGTCAGGCCGATGCCGCCCTGGGCGCGGCCCGCGCCAGCCTGGCCGCGCGGCGCCAGCAGGTACAGGTGCTCGATACCGAACAGCAAAGCGCCCGGGCGCAACTGGACAAGCTCGAAGCGGGCGTGGCCCGGGTCACGGCCCAGCGGCAACTGGCCCGCATCGATCTGGCTCGCACCTTGATCCGCAGCCCGGTGGACGGTATCGCCGGCCAGCGGCGCCTGCGCCTGGGGCAGTACGTCGAAGTCGGTGCGCCGCTGTTGGCGGTGGTGCCTGAGGACGCCTATGTGGTGGCCAACTACAAGGAAACCCAGGTCGACGGCATGCGGCCCGGGCAAGCGGCGCGGGTCGAGGTCGACGCCTTGGGCGGCCATGTACTGGAGGGACGGGTGGAGAGTTTCGCCCCGGCTTCCGGCGCCGAATTCGCCCTGCTGCCGGCGGACAACGCCACCGGCAACTTCACCAAGATCGTGCAGCGCATGCCGGTGCGCATCCGCCTCGATCCGGGGCAGCCGCGACAGGCGCAGCTGCGCCCCGGGATGTCGGTGGTGGTGACCGTGGACACCCGTCATGACTAG	MTQTPVPAFPVQAVTRRRLLGYAGLALVLLLILAWGLRWWFNGRFLVETDDAYLRSDIVTIAPRVAGYLVAVEVRDNQPLKAGDLLARIDDSDYRARVEQAEAALREAQAEQRAGQARLANLAARQQQQQSLIAEAQARVGAAEAEAQRAGQEGRRQQHLASQQVSSVQQLENAAALARQADAALGAARASLAARRQQVQVLDTEQQSARAQLDKLEAGVARVTAQRQLARIDLARTLIRSPVDGIAGQRRLRLGQYVEVGAPLLAVVPEDAYVVANYKETQVDGMRPGQAARVEVDALGGHVLEGRVESFAPASGAEFALLPADNATGNFTKIVQRMPVRIRLDPGQPRQAQLRPGMSVVVTVDTRHD	MELEDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPELASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL	105.13	gnl|BL_ORD_ID|556|hsp_num:0	609			15	921	tetracycline
BGC0000413.1|Pyoverdine_51 # 88692 # 90170 # -1 # ID=1_51;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.721	BGC0000413.1|Pyoverdine_51 	88692	90170	-	Loose	800	192.2	OprN	36.4	3000805	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCATTTACCCGAGGCCTGCATGGGCCCTGTGCGCCCTGTTGGCCGGTTGCACCCTGGGGCCGGAACGGCCGCCCGGCAGCACTGTGCCCCTGCCCGTGAGCCACCTGGACGCAACGGCCGAGCAGGGGCTCGACCAGTGGTGGCAGCTCTACCGTGACCCTGGGCTCAATGCCGCGGTACAGGAAGCCCTGAGCCAGAACCGCGACTTGCGGATGGCTGCGGCCAACCTGCTTCAGGCCCGGGCGCTGCTGCGCGAAACCGATACCCTGCGCCAGCCTTCCACCCAGGTGACGGCCCGCGCCGGCTACGGCAGTACCGCCGACGACCAGCTGGAAGCCGCCTTGCAGGACAGCCAGCACATCCGCACCGGCAGCCGCTATGGGGTCGGCCTGGATGTGCAGTGGGAGGCCGACCTGTTCGGCCGCCTGCACGGCCTGGCCGATGCCGCCCGGGCCGATGCCGAGGCGGCCCGGGCCGCCGAAGATGGCCTGCGGGTGGTGGTGGCTGCGGAAACCACCCGTGCCTGGTTGCAGGCCTGCAGCTATGGCCAGCGCCTGCAGGTGGCGGGCGAGTCCCTGGCGCTGGTGGAGCAGGGCCGGGCCCTGAGTGCCATGTTGTATCAGGCCGGCGCCGCAGTGACCCTGGATGTGGTGCGGGCCGAAGGCCTGGTGGGTCAAGTGCAGGCCAGCCTGCCGCCGTTGCAGGCCGGGCGGCAGCGGGCCCTGGCCGAACTGGCCGTCTTGCTGGGGCGCCCCCCGGGTGATGCACCGGCGGCGGCCAAGGCTTGTCACCAGGCCCCGCGCCTGGGTTCGCCCATGCCCCAGAGCGATGCCCTGGCCATGCTGCGTCGGCGTCCCGACGTGAGCCAGGCCGAGCGCCGGCTGGCGGCGGCCACGGCACGCATCGGCGTGGCTCGGGCCGATCTCTATCCAAGGGTCAGCCTGGGGGCCGGGGTCTTCACGTCGGCGCACCACCCCGCAGGTTTCGATGACCGCGACGCGTCGGTCTGGCAACTGGGGCCGCTGTTGTCCTGGAGCTTGCCCAACCTCAATGCCGCCCGCGCCCGCATCGCCCAGGCCAGCGCCGGAGAAAGCGCGGCGCTGGCGGATTTCGACCGCAGCATCCTGGCGGCCCTGAAGGAGCAGCAACAGGCCCTGAGCGACTACCAGGCCGCGTTGCAGCGCCAGCAAGCCCTGCACCTGGCAGCCGAACGTGACCACCAGGCCTTGCGCCTGGCCGGGCTAGCCAGGGCCGCCGGTGCCTCCACGGCCCTGGATTACCTCGATGCCCAGCGCACCGATGTACGTACCCGGGCCGCGGCAGCGCAGGCCGATGCCGCCGTCATCGATACCCAGGTGCTGGTGTTCAAGGCCCTGGGCGGCGGCTGGCGCAGCGCGCCGCCGATTGTCCTGCCGCAGCCGAGCCGGGCTGCGGCCAACCCTTTCCCGCGAACCCCCAACGAGCCTTTGCAATGA	MPIYPRPAWALCALLAGCTLGPERPPGSTVPLPVSHLDATAEQGLDQWWQLYRDPGLNAAVQEALSQNRDLRMAAANLLQARALLRETDTLRQPSTQVTARAGYGSTADDQLEAALQDSQHIRTGSRYGVGLDVQWEADLFGRLHGLADAARADAEAARAAEDGLRVVVAAETTRAWLQACSYGQRLQVAGESLALVEQGRALSAMLYQAGAAVTLDVVRAEGLVGQVQASLPPLQAGRQRALAELAVLLGRPPGDAPAAAKACHQAPRLGSPMPQSDALAMLRRRPDVSQAERRLAAATARIGVARADLYPRVSLGAGVFTSAHHPAGFDDRDASVWQLGPLLSWSLPNLNAARARIAQASAGESAALADFDRSILAALKEQQQALSDYQAALQRQQALHLAAERDHQALRLAGLARAAGASTALDYLDAQRTDVRTRAAAAQADAAVIDTQVLVFKALGGGWRSAPPIVLPQPSRAAANPFPRTPNEPLQ	MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA	104.24	gnl|BL_ORD_ID|293|hsp_num:0	172			66	1407	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000413.1|Pyoverdine_52 # 90407 # 90985 # 1 # ID=1_52;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.646	BGC0000413.1|Pyoverdine_52 	90407	90985	+	Loose	750	30.0314	SST-1	30.14	3006999	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SST beta-lactamase	ATGACCGAAGACTTCGATGTGCCCAGCCCCCACGAAAAGCACCTGGAACACGTGAGCGAACAAGCCCACGCGCGCAGTGACCGCTTCGCCAGCAAGATCGCGGTGATGACGGCGATCATGGCCACCCTGGGAGCGCTCCTGAGCTATCAGGCCGGCTCCTCGGAAAGCCTGGCGGCGATGGACAAGAACAATGCCGCGATGAAAAAGACCGAAGCCGCCAACCAGTGGAGCTACTACCAGGCCAAGTCCAGCCGGCAGAACCTGGCGGAGCTGGCGACCCACATTCCCGGAGTCGATGCCGCGCACTACGGCATCGAAGCCCAGCGCTACCAGAAGGAAAAGGAAGCGGTGCGCCTCAAGGCCGAGGCCCTGGAAGCCGAGGCCCGGGACTGGGACGAGCAATCGGAAGCCGCGCTGCACCAGCACCATCGCTGGGCCCAGGCGATGATGGCGATCCAGATCGCCATTTCGATGGCGGCCATCACCCTGCTGACCCGCAAGGAATGGCTGAAGAAGCTCGCCTACGGCGCGGCCGGCGGCAGCGTGCTACTGGGCACCCTGGCCTGGCTGCACATCTAG	MTEDFDVPSPHEKHLEHVSEQAHARSDRFASKIAVMTAIMATLGALLSYQAGSSESLAAMDKNNAAMKKTEAANQWSYYQAKSSRQNLAELATHIPGVDAAHYGIEAQRYQKEKEAVRLKAEALEAEARDWDEQSEAALHQHHRWAQAMMAIQIAISMAAITLLTRKEWLKKLAYGAAGGSVLLGTLAWLHI	MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFTQAMEQGMLPALGMRHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKVAHAWREALTATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYRIVQALDKR	50.79	gnl|BL_ORD_ID|4595|hsp_num:0	5665			609	819	
BGC0000413.1|Pyoverdine_53 # 91186 # 92676 # 1 # ID=1_53;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.664	BGC0000413.1|Pyoverdine_53 	91186	92676	+	Loose	500	26.5646	CRH-3	37.93	3006867	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CRH beta-lactamase	ATGGCTATTGCCCCACTGCTCGCCGCTACCACGGCCTTTATCCAGCGCGCCCCGCGCATGCTGATCGGTGCCCACTGGACCGAGGCCGGCGACGGCCAGACCATGCCCCTGCGCAACCCCGCCACCGGCGAACAGCTGTGCCTGGTGCCCCGGGCCACGGTGGACGATGTCGATCGCGCAGTGCTCGCCGCACGCCAGGCCTTCGACGATTCGCCCTGGACCCGCACCCGCCCCCGGGAGCGGCAGAACCTGCTGTGGAAACTCGCCGACCTGATGCAGCGCGACGCCGAACTGCTGGCCCAGCTGGAATGCCTGAACAACGGCAAGAGCGCCGCCGTGGCCCAGGCCATGGACGTGCAACTGTCCATCGATTTCTTGCGCTACATGGCCGGCTGGGCGACCAAGATCGAGGGTTCAAGCGTCGAGGTCTCGCTGCCCCTGATGCCTGACGATCAGTTCCACAGTTTTATCCGCCGCGAAGCCGTGGGCGTGGTCGGCGCCATCGTCGCCTGGAACTTCCCGCTGCTGCTGGCCTGCTGGAAACTCGGCCCGGCCCTGGCCACCGGTTGCACCCTGGTGCTCAAGCCCGCCGATGAAACCCCGCTCAGCGCCCTGAAACTCGCCGAACTGGTGCAGGAAGCCGGCTACCCCGACGGCGTGTTCAACGTGGTCACCGGCACCGGCATCACCGCCGGCAGTGCCCTGACCCGCAACCCCCTGGTGGACAAGCTGACCTTCACCGGCTCCACCGCCGTGGGCAAGGAAATCGGCAAGATCGCCATGGACTCCATGACCCGGGTAACCCTGGAACTGGGGGGCAAGTCACCAACCATCGTCATGGCCGACGCCGATCTGGCCAGCGCCGCCGCCGGAGCCGCCAGCGCGATCTTCTTCAACCAGGGCCAGGTGTGCTGCGCCGGCTCGCGGCTGTATGTGCAGCGCAAGCACTTCGACAACGTGGTGGCCGACATTGCCGGCATCGCCAACGCCATGAAGCTGGGCAACGGCCTGGACGCCAGCGTCGAGATGGGCCCGCTGATTTCCGCGCGCCAGCAGGAGCGGGTCTATCGCTACATCGAGATGGGCCGCGAAAGCGGCGCCACCATCGCCTGCGGCGGCGAACAGTTCGGCCCGGGGTATTTCGTCAAGCCGACGGTGATAGTGGATGTGGACCAGAAGCATTCGCTGGTGCAGGAAGAGATCTTCGGCCCGGTGCTGGTGGCCATTCCTTTCGACGATGAGGCCGACGCCCTGCGCATGGCCAACGACAGCCCCTACGGCCTGGGCGCGAGCATCTGGTCCAACGACCTGGCGGCGGTGCACCGGATGATTCCGCGGATCAAGTCCGGTTCGGTGTGGGTCAACTGCCACAGTGCCCTGGACCCGGCACTGCCGTTTGGCGGCTACAAGATGTCCGGGCTTGGCCGGGAAATGGGCCACGCGGCCATCGAGCACTACACCGAGTTGAAATCAGTGCTGATCAAGCTCTGA	MAIAPLLAATTAFIQRAPRMLIGAHWTEAGDGQTMPLRNPATGEQLCLVPRATVDDVDRAVLAARQAFDDSPWTRTRPRERQNLLWKLADLMQRDAELLAQLECLNNGKSAAVAQAMDVQLSIDFLRYMAGWATKIEGSSVEVSLPLMPDDQFHSFIRREAVGVVGAIVAWNFPLLLACWKLGPALATGCTLVLKPADETPLSALKLAELVQEAGYPDGVFNVVTGTGITAGSALTRNPLVDKLTFTGSTAVGKEIGKIAMDSMTRVTLELGGKSPTIVMADADLASAAAGAASAIFFNQGQVCCAGSRLYVQRKHFDNVVADIAGIANAMKLGNGLDASVEMGPLISARQQERVYRYIEMGRESGATIACGGEQFGPGYFVKPTVIVDVDQKHSLVQEEIFGPVLVAIPFDDEADALRMANDSPYGLGASIWSNDLAAVHRMIPRIKSGSVWVNCHSALDPALPFGGYKMSGLGREMGHAAIEHYTELKSVLIKL	MFKHLILLASITAPLTQAVAADPLSVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPNERFPLCSSFKGFLAAGVLAQSQDKPGLLDKRIRYSKTALPNWSPITTKHQASGMTVAELNAASVQYSDNGAANLLLKEINGPAALTAFMRSIGDARFRLDRLEPELNSAIPGDPRDTSTPKAVAESAQKLALGKALPEPQRQRLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGTANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK	171.03	gnl|BL_ORD_ID|3414|hsp_num:0	4483			60	228	
BGC0000413.1|Pyoverdine_54 # 92863 # 94782 # 1 # ID=1_54;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.626	BGC0000413.1|Pyoverdine_54 	92863	94782	+	Loose	500	27.335	FIM-1	33.33	3004786	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	FIM beta-lactamase	ATGGGATCAAATGGAAATGATCACGATTACATCCAGTGCGGCTGCCACAACCCCGTCTGGGAAGCCTTGAAAGACACCCTCGACCCCGCCAGCTATATCGCCAGCCACCCCAACGCAGCACAGGGCCCGGCCAGGGACGCGAACGGCGAGTCCCTGGTGTTTCATGACGGCATCATCTACCCCTTGCGCGACGGCAACATGGATGAGCGGGTCGAAGCCCTGGGCATCCATGCCGGCGACGTGGTCGCCGCGGGCACCCTGGCCGCCGTCGAAGCCCGCATGCAGGCCCTGGGCATCGACTACAAGAAGCAGTCGCTGCACGGCAAGACCCTGCTGCCCGGCCTGGTCGAGCCCCACGCCCACATCGTGCAGAGCTGCGCCATGGATGGCTGGCTGAACCTGGGCGCCATCGAGCCCGACGACGGCGATACCCAGCAGGCGCCAGAGAAAAACAGCCAGCGCCTGCGGCCGCTCTATACCTGGGGCTGGCTGAAGGAAACCATCCAGAACAACCTCCCCGAAGACAGCACGAGCTGGGTCCTCGGGCACCTGGTCGACCCGGCGCTGATGCCGTTCAAGGTGATGCCGGGCGGCCTGAACCGACTCATGACCCTGCAATGTGGCGACACGCCCGAAGAGGGCTACCTGGACACCATCGAGGCCAAGCGGCCGATGCTGCTGATCAGTGCCTCCATGCACACCGCCTACATGAACACGGCGGCCCGGGATCTGGTGCATGAAAGAACCGGGGTCATGGTCGAGAATGGCGTGCTGCAGGAAACCCAGATAGTGGCCGGGATCCTGTCGATTCCCGCCAGGCAGAAGCTTGCAATGCTGAAGATCTTCGAGCGCCTGGACACCTTCTTCGCCACCGCGGCCAGCCGCGGGATCACCCTACTGTACGACGCGATGATGGACCCCTTGTCGAAGCTGGTATTGAACGCCTACTTCCTGTCCCACCCCAGAACGCTGCGGATCGGCTACGCCGCCGCCTGCAACAACTCGCTCGAAGCCCTCAAGCTGCTGCCGGACTATCGGCCGGCCACGCGGGAAGAGGCCAGGCACATGTATCAGGGTTCGATCAAGGTGATCTCGGACGGGTCCAACCAGGGGTTGACCGGCTATCAGGTCGCGCCCTACTGCTGCGAGACAGACCGCCCGGTGGGCAACTTCAATCTGTGCGACAAGGGCGAGGACACCCCGAAAACACTCCCGGTCAAATACCAGGAATTTATCCACGCGGCGGTGAAAAAAGGCTGGCCGCTGATGATCCATGCCAACGGCGACCAGGCCATCGAATTCACTCTGCAGGCCTATGACCTGGCCCTGCAGGGCCAGAGCGGCCTGGACAAGCGCCATCGCATCGAACACTGCTCGCTGCTGAGCAAAAGCACCCTGGAAACCATGCAGCGCCTGGGCCTGTCACCGAGCTTTTTGATTGGCCATGTCGGCTACTGGGGCTACGCCTTCGATAAAGCCATTTTCGAAAAGAAGGCACACAACATGCTCGACCTCTGCAAGTCGGCCCTGGACCACGAGCTGCGGATTTCCCTGCACAGCGACTATTCCGTGACCCCACTGGGCCCCCTGCGTTCGATGGAGCAGGCGGTGACCCGCAAGATGGAAGGCATCCGCAATCATGACAACCAGTTCGTCCATGACCCGCGCCTGCAACCCATCCTCAATGAGGGCCAGTGCCTGACCCGCAAGCAGGCGCTGAAAGCCATCACCTACGACGCTGCCTGGCAGTGCCATGCCGAGGCCTGGACCGGCTCCCTGCAGGACCAGAACTTCGCCGACTTCGTGATCCTCGAGCAGGACCCACTGGACGAGAAGTTCCCGGCCACCCGGATTCGCGACATCAAGGTCTGCGAAACCTGGAAAGGCGGCCAGCGGGTGTACCTCAACCCCCGTAGCTGA	MGSNGNDHDYIQCGCHNPVWEALKDTLDPASYIASHPNAAQGPARDANGESLVFHDGIIYPLRDGNMDERVEALGIHAGDVVAAGTLAAVEARMQALGIDYKKQSLHGKTLLPGLVEPHAHIVQSCAMDGWLNLGAIEPDDGDTQQAPEKNSQRLRPLYTWGWLKETIQNNLPEDSTSWVLGHLVDPALMPFKVMPGGLNRLMTLQCGDTPEEGYLDTIEAKRPMLLISASMHTAYMNTAARDLVHERTGVMVENGVLQETQIVAGILSIPARQKLAMLKIFERLDTFFATAASRGITLLYDAMMDPLSKLVLNAYFLSHPRTLRIGYAAACNNSLEALKLLPDYRPATREEARHMYQGSIKVISDGSNQGLTGYQVAPYCCETDRPVGNFNLCDKGEDTPKTLPVKYQEFIHAAVKKGWPLMIHANGDQAIEFTLQAYDLALQGQSGLDKRHRIEHCSLLSKSTLETMQRLGLSPSFLIGHVGYWGYAFDKAIFEKKAHNMLDLCKSALDHELRISLHSDYSVTPLGPLRSMEQAVTRKMEGIRNHDNQFVHDPRLQPILNEGQCLTRKQALKAITYDAAWQCHAEAWTGSLQDQNFADFVILEQDPLDEKFPATRIRDIKVCETWKGGQRVYLNPRS	MRPLPHSYLKSLVICLLTAFAALTPVVNSGVQAAQPKDVPVTFTAITQGVWMHTSMKHMENWGHVPSNGLIVEKGDFSILVDTAWDDPQTAQIIEWSKDTLKKPIRWAVFTHAHDDKMGGVAALRQQGIVTYAAADSNRMAPQNGLTPAEHDLIFDSEHSTSVLHPLVIFDPGPGHTRDNIVVGLPEQGIVFGGCLIRPSGSTSLGNTADADLAHWKTAVLAVAQRFAEAQQIIPSHGPMAGRELFELTAQLAEKASIPSTP	243.89	gnl|BL_ORD_ID|2173|hsp_num:0	3584			585	741	
BGC0000413.1|Pyoverdine_55 # 94920 # 96239 # -1 # ID=1_55;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000413.1|Pyoverdine_55 	94920	96239	-	Loose	750	33.113	tet(54)	53.33	3004590	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCACACCATCCTGATCCTCGGCGCGGGGCCGGCCGGGGCCGCAGTGGCCCTGGGGCTGCGCCGCCTCGGCTACCCGGTGACCCTGGTCAGCGACTGGCGACGCTTTCCGGCCCTGGAAGGGGTCTCGCTGCGGGTGCTTGAAGCCTTGCGCGGTGCCGGCCTGGAACAGGCGCTGGCCCAGGCCCTGCAACCGTCCCAGCGGCGGGTGGCATGGAACGGTGCAGAACATGCGCAGAACATCGAATACCTGCTGGATCGCCCGGCCTTCGACCGCGGCCTGCGGGAGGCCTTGCGCGAAGCGCAGGTCAAGCTGATCGAGGGCCGGGTGCTGGGGGTGCAGTCCAGCGAGGCCGGGCATCGGGTCCAGGTGCAAGGGCAGGGCGAGGTGCGCGGCGAGTTCCTGGTGGAGGCCCGTGGCCGGCAGGCGCCGGTGCTGGACAAAGCCTTGCGCCAGGGGGGCGGCAAGGGCCTGCGCGGCCCGGAAACCGTCAGCCTGCTCAACCGCTGGCAGGGCCCTGGCGGCAGCGCCACCAGCGCGGTGCACAGCCTGGAGGACGGCTGGGCCTGGATGGCCCGGCGCGAGGACGGCCAGTGCTACTGGCAGCTGACCCTGGATGTGGAGAGCGCCGGGCTGCCGGGCAAGGCGCAGTTGCTGGAGTACTGTCGCCAGCGCCGCCTGGGCTCGGCCATGGCCCGGGAATTCTTTGCCGGTGGCCAGGAGCAGCAATTGCACCTGCATGCCCGCAGCAGCACGGCGATCCTCAACCCCCAGGCCTGTGGCGCGAACTGGCTGCGGGTCGGCGATGCGGCCATGGCCGTGGACCCTTTATCCGGCAACGGCATTTTCCAATCCCTGTCCTCGGCGTTGCAGGCCCCGGCGGTGATCAACACCTTGCTGCAGCAGCCGCAACGTGCAGCGCTGGCGCAGCGTTTTCACGGGCAGCGGGTGGAACAGTTGTTCCTGCGTTTTGCGCGCATCGGCCGGGACTTCTACGCCGACGAGCAACGCTGGCCCGAGCAGCCGTTCTGGCAGGCCCGCCGGCAGTGGCCGGATTGCCAGCCGGCGCACATTGCCGTGGACTTTTCGGCCTTGCGCATCGAGCGCGCCCCGGTGCTGCGCGACGGCCTGGTGGATGAAGCCGAAGTGGTGATCACCCCGGACCAGCCCCTGGGCATCTGGCATGTACAGGGCGTGGAACTGGCGCCGCTGTTGCGTCGTTTGCGCAGCCAGGGGGCGGCCCAGGCCCTGGCGCAGCTGAGCCCGGACCAGAATCGGCTGATACGCAGCTGGTTGCTGGCCCAAGGCTACCGCCCCTGA	MHTILILGAGPAGAAVALGLRRLGYPVTLVSDWRRFPALEGVSLRVLEALRGAGLEQALAQALQPSQRRVAWNGAEHAQNIEYLLDRPAFDRGLREALREAQVKLIEGRVLGVQSSEAGHRVQVQGQGEVRGEFLVEARGRQAPVLDKALRQGGGKGLRGPETVSLLNRWQGPGGSATSAVHSLEDGWAWMARREDGQCYWQLTLDVESAGLPGKAQLLEYCRQRRLGSAMAREFFAGGQEQQLHLHARSSTAILNPQACGANWLRVGDAAMAVDPLSGNGIFQSLSSALQAPAVINTLLQQPQRAALAQRFHGQRVEQLFLRFARIGRDFYADEQRWPEQPFWQARRQWPDCQPAHIAVDFSALRIERAPVLRDGLVDEAEVVITPDQPLGIWHVQGVELAPLLRRLRSQGAAQALAQLSPDQNRLIRSWLLAQGYRP	MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE	113.14	gnl|BL_ORD_ID|2726|hsp_num:0	3292			9	99	tetracycline; oxytetracycline
BGC0000413.1|Pyoverdine_56 # 96224 # 96907 # -1 # ID=1_56;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.711	BGC0000413.1|Pyoverdine_56 	96224	96907	-	Loose	1900	25.409	MuxC	36.07	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGCCTGAGCTGCGCATCGGCGTGATCGACAGCGGCCATGCCGCCCATCAGCGGGTGGCGGGCGGACGACGCTTCTTCCTGCAGCCCGAAGGGATAGGCCAGGGCCCCTTGCAGGAAGACGCCCTGGGCCATGGCAGCGCGATCATCGAGGCCATCGGCCAGCGCGCGCCGACGGCGCAGGTTTATGTGGCCCAGGTGTTCGACCGGCGCGCAGTCACCAGCGCCGCGCAAGTCAGCGCCGCGCTGTACTGGTTGCTTGCGCAGGACGTGCGCCTGATCAACCTGAGCCTGGGCCTGCGCCAGGATCGCGACCTGCTGCGCCAGGCCTGTGCCGCGGCCGAGGCCCGCGGGGTGCTGTTGTGCGCATCCAGCCCGGCCCAGGGCGAGGCGGTGTTTCCGGCCAGTTACCCCGGGGTGCTGCGCGTCACCGGCGATGCGCGATGCAGCGCGCAGCAGTGGTCATGGCTGAACACCGCCCAGGCTGATTTCGCCGCCTGCGTGCGCGGCAGCAGCCCGGGGCAATCCGGCGCCAGCCTGGGGTGCGCGGCCCTGAGCGGGCATATCGCGGCCTACCTGGGTGCCCAGCCGCAAGCCGACAAGGCCCAGGTCCGGCAGTGGCTGCAGGACAACGCCCACTACCAGGGGCCGGAACGCCGGCAACAGCCATGCACACCATCCTGA	MKPELRIGVIDSGHAAHQRVAGGRRFFLQPEGIGQGPLQEDALGHGSAIIEAIGQRAPTAQVYVAQVFDRRAVTSAAQVSAALYWLLAQDVRLINLSLGLRQDRDLLRQACAAAEARGVLLCASSPAQGEAVFPASYPGVLRVTGDARCSAQQWSWLNTAQADFAACVRGSSPGQSGASLGCAALSGHIAAYLGAQPQADKAQVRQWLQDNAHYQGPERRQQPCTPS	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	21.91	gnl|BL_ORD_ID|2367|hsp_num:0	2720			1803	1971	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000413.1|Pyoverdine_57 # 96897 # 98615 # -1 # ID=1_57;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.673	BGC0000413.1|Pyoverdine_57 	96897	98615	-	Loose	1190	276.174	novA	34.9	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGGCGCCTGATCACCCGGCTGGTGGACAGCCGCGACCCCCAGGCCCTGAGTGCCGCCCTGGGCTGGCTCTACAGTTTCGTGCGGCCCCACCGGCTGGCCATCGGCGGCCTGCTGGGGCTGTCGGTGTGCGCTTCCCTGCTGGTGCTGGTGCAGCCCTGGCTGACCAAGCTGCTGATCGACGACGGCCTGCTGGCCCGGGACTTCTCCAGACTGGTGCTGATCGCCGGCTTGATGATCCTCGCCGGTCTGCTGGGCACGCTGCTGTCCGGGGTCAATCGCTACCTGCATACGCGCCTGTCCGGACGCATCCTGTTTGCCCTGCGCGACGATCTCTATCGCCATCTGCAACGGCTGTCGCCGAGCTTTTACGGTCAGCGGCGGATCGGCGACCTGATGTCGCGCCTGGATGGCGATGTGGCAGAGATCCAGCGCTTTGCCGTGGACTCATTGTTCTCCGCCGTGTCCAGCGTGATCGGCCTGGTGGTGGCGCTGGCCATGCTCCTGACCCTGTCCTGGCAACTGTCGCTGCTGGCCCTGGTGCTGATTCCCCTGGATGTGCTCTGGCTGCGCTGGATGCGGCGCAAGGTGGAGCGCGATGTGCGCCAGTTGCGCGAGCGTTCGGCGGACATGTCCTCGTTCATGGTGGAAACCCTGCCGGTGATGAAGTTCATCCAGAGCGCCGGCCAGCAGCAGCGCGAGGCCCGGCGCCTGGATGGCCTTGGCCAGGGCTACCTGCAACAGCTGCTGAAACTGCAAGTCACCGAGTTCTTCACCCAGGCGGTGCCCGGTACCCTGACCTCGTTGTCCCGGGCCTGCGCCTTCCTGATCGGCGGCTACTGGGTGGTACAGGGCACCTGGCAACTGGGGGCGCTGATTGCCTTTTCCACCTACCTGGGCATGGCGGTGGGCCCGGTGCAGAGCCTGTTGGGCCTGTATGTGGCAATCCAGCGCATGACCGTGAGCCTCGGCCGGGTCATGGAGCTGCGTGGCGAGGAACCGGGCATCAGCAACCCCGAGGCGCCGCTGCCGGTGCCGGAGCAGGGCGAGCTGCATTTTCACGCAGTGCACTTTTGCCACCCGGGCCGCGGCTCGACCCTGCAGGGCATCGAGGCGCGTATTCCCTACGGTCGCAAAGTGGCCCTCAGCGGCACCTCGGGCGCAGGCAAAAGCACGCTCATCGACCTCTTGCAGCGCCACCACGACCCCCAGTCCGGGCAGGTGCTGCTGGGCGGCGTCGATCTGCGTCAGCTGGACCTGGCGCAGTTGCGCCGGCGGGTGGCGGTGGTCAGCCAGGATATCGTGCTGTTTCGCGGCAGCCTGGCGGACAACCTGGCCTACAGCGTGCCCGATGCCAGCCGCGAAGCCGTGGCCGAAGTGGCGCGGCTGGCGCAGTTGCAAGGGCTGATCGAGTCCCTGCCCGAAGGCCTGGACAGCCCCCTGGGGGAGCGCGGCCAGCAATTGTCCGGCGGCCAGAAACAACGCATCGCCATTGCCCGGGCGCTGCTCCAGGACCCGATGATCCTGGTGCTGGACGAAGCCACTTCGGCGGTGGACGAGGCCACCGAGCGCGAGGTGATCGAGGCCATCGACCACCTGTTCGCCGGGCGCACGCGGATCCTCATCAGCCACCGACCCTCGACCCTGGCCGATGCCGAACTGCGCTTCGAATTGCGCGATGGCGTACTGCATGCGCTGGAGGTGGCCCATGAAGCCTGA	MRRLITRLVDSRDPQALSAALGWLYSFVRPHRLAIGGLLGLSVCASLLVLVQPWLTKLLIDDGLLARDFSRLVLIAGLMILAGLLGTLLSGVNRYLHTRLSGRILFALRDDLYRHLQRLSPSFYGQRRIGDLMSRLDGDVAEIQRFAVDSLFSAVSSVIGLVVALAMLLTLSWQLSLLALVLIPLDVLWLRWMRRKVERDVRQLRERSADMSSFMVETLPVMKFIQSAGQQQREARRLDGLGQGYLQQLLKLQVTEFFTQAVPGTLTSLSRACAFLIGGYWVVQGTWQLGALIAFSTYLGMAVGPVQSLLGLYVAIQRMTVSLGRVMELRGEEPGISNPEAPLPVPEQGELHFHAVHFCHPGRGSTLQGIEARIPYGRKVALSGTSGAGKSTLIDLLQRHHDPQSGQVLLGGVDLRQLDLAQLRRRVAVVSQDIVLFRGSLADNLAYSVPDASREAVAEVARLAQLQGLIESLPEGLDSPLGERGQQLSGGQKQRIAIARALLQDPMILVLDEATSAVDEATEREVIEAIDHLFAGRTRILISHRPSTLADAELRFELRDGVLHALEVAHEA	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	93.01	gnl|BL_ORD_ID|1112|hsp_num:0	1210			69	1692	novobiocin
BGC0000413.1|Pyoverdine_58 # 98615 # 100519 # -1 # ID=1_58;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.678	BGC0000413.1|Pyoverdine_58 	98615	100519	-	Loose	400	221.861	TxR	43.96	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACTCTTATAAAAACAATAAAGGGTGAGCAGCAACACGAAGCCCGGCTGGCCCGGGAACGGCTGCACCTGGAAGGCCAGATCCCCGACGGGGTTCTGCGTGCGGAAATCGATGCCTCATGGCGGCGCAGCCTCAGCCATGGCGTGCACTTTGGCAGCCAGCACCAACTGACCCTGGAATCCAGCGCCAGCCTCGAAGTGCTGCTGGCCAGCAACCGCCTGTTGCTGGACGCGGCGATCCCGGCCATCGACTACCTGAGCCAGCATCAGGGCAAGGACGGGATGATCATCCTGGCCAATGCCGACGCCACCATCCTGGCGATCGAAGGCCGCGCCGACCGTCTCAAGGACAGCGGCGTGCAGGACATCACCCTTGGCGCCTGCTGGAGCGAAGCCACCCGCGGCACCAACGCCCTGGGCACGGCCCTGGTGGAGGCCCGGCCGACCCTGATCGACTGCGGCGAGCACTACCTGGACCGTCTCAGCCATTTCTCCTGCACCTCGGTGCCCATCCAGTGCCCCCAGGGCGAGATTCTGGGCGTGCTCGACCTGACCCGCGAAGGCCCCCTGGGCCGGGCCCAGGACAGCACCGCGCTGCTGGCCATGGCGGTCAGCCAGATCGAAGCCCGGGTGTTCCATGCCACCTACCCGGAGCAGATCGTCCTGGCCTTCCACAGCCGCCGGCAATACCTCGAATCACCGTGGCAGGGGCTGCTGGCCCTGAGCCTGGGCGGGCAGATCCTCGCGGTCAGCGGCCAGGCCTGCCAGTTGCTCAACACCCCGCGCGCAGCCCTGGTGGGCCGGCGCTGCGAAGAGTTCCTGGGGGGCGATGGCCTGCAACTGCTCGCACGCCTGCAACAGGGCGCCGTGGGCAGCCTGCAAACCGCCAAGGGCGAGCTGTTCTACAAGGCCCTGCGGGCGCCGCAGCCAGCGCTCAACCTGCATCGCGCGCCACGCAGCGCTCCGAAAGCCGCAGCCATGCCCCAGGACCTGGAAGCCCTGGCCGGGGGCAACAGCCGCTACGCCCGCACCTTGCGCATGGCCCGTCAGGGCCTGGCCAATGACCTGCCGGTGTTGCTACTGGGCGAAACGGGCACCGGCAAGGAAGTCCTGGCCCGGGCCCTGCACCGCGCCGGCAGCCGCGCCGAGAAACCCTTTGTCGCAGTCAACTGCGCGGCGATCCCCGAAGGCCTGATCGAGTCGGAACTGTTCGGCTATCGCGAAGGCGCCTTCACCGGCTCGCGTCGTGGCGGCATGATCGGGCGCCTGCAACAGGCCCACGGCGGCACCCTGTTCCTCGATGAGATCGGCGACATGCCCCTGGCCCTGCAAGCCCGCCTGCTGCGCGTGCTGCAGGACCGCAAGGTGGCGCCCCTGGGGGCCGGCGAAGAACAGGACATCGACATCGCCCTGATCTGCGCCACCCACCGCGACCTCAAGCAGCAGGTGCAGGACAAGGCTTTTCGCGAAGACCTGTTCTACCGGGTCAACGGCATCAGCGTGCTGTTGCCGGCCCTGCGCGAACGCGAAGACCTGCAGCCCCTGGTGGACAGCTTGCTGGCCAAGCTCGGTGGCGCACAGGTGAGCCTTAGCGATGAGCTGCGTCGGCTGCTGGCGGACTACCACTGGCCGGGCAATATCCGCCAGCTGGAGATGGTCCTGCGCACAGCCCTGGCCCTGCGCGAAGACGGTGAGTGCCACATCGGCCTGGAGCACCTGCCCGACAGCATGCTCGACGACCTCAATGCCAGTGCCCGACCGCAGACCGGGAGCATCCGCGAGAATGAGCTGGAGCTGATCCGCAGTGCCCTGGACAACCACCAGGGCAATGTCTCGGCGGCAGCGGACGCTCTGGGCATCAGCCGCGCGACCCTGTACCGCAAGCTCAAACAGTTGCGCGCCTGA	MTLIKTIKGEQQHEARLARERLHLEGQIPDGVLRAEIDASWRRSLSHGVHFGSQHQLTLESSASLEVLLASNRLLLDAAIPAIDYLSQHQGKDGMIILANADATILAIEGRADRLKDSGVQDITLGACWSEATRGTNALGTALVEARPTLIDCGEHYLDRLSHFSCTSVPIQCPQGEILGVLDLTREGPLGRAQDSTALLAMAVSQIEARVFHATYPEQIVLAFHSRRQYLESPWQGLLALSLGGQILAVSGQACQLLNTPRAALVGRRCEEFLGGDGLQLLARLQQGAVGSLQTAKGELFYKALRAPQPALNLHRAPRSAPKAAAMPQDLEALAGGNSRYARTLRMARQGLANDLPVLLLGETGTGKEVLARALHRAGSRAEKPFVAVNCAAIPEGLIESELFGYREGAFTGSRRGGMIGRLQQAHGGTLFLDEIGDMPLALQARLLRVLQDRKVAPLGAGEEQDIDIALICATHRDLKQQVQDKAFREDLFYRVNGISVLLPALREREDLQPLVDSLLAKLGGAQVSLSDELRRLLADYHWPGNIRQLEMVLRTALALREDGECHIGLEHLPDSMLDDLNASARPQTGSIRENELELIRSALDNHQGNVSAAADALGISRATLYRKLKQLRA	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	199.37	gnl|BL_ORD_ID|4724|hsp_num:0	3753			72	939	tetracycline
BGC0000413.1|Pyoverdine_59 # 100975 # 102000 # -1 # ID=1_59;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.673	BGC0000413.1|Pyoverdine_59 	100975	102000	-	Loose	700	26.1794	vanS gene in vanG cluster	40.0	3002937	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGCGCAGTTTTTTCCACCCCGAACAGTTGCTCCACCATCCACGCAGCTACTACTCGCGCGGCCAGATGCGCATACCCCAGGAGGTGCCGGAGCGCGCCCAGCGCCTGGTGCAGGCCGCACACTCCCTGGGTTTTGCCGTCGAGCAGCCACGGGATGCCGGGATGGCACCGTTGCTGGCGGTACACGGCGCACCGTACTTGGCGTTCCTGCAGGATGCGCACCAGGGCTGGAAGGACATCCCCGAAGACTGGGGCGATGAGGTGATGTCCAACATCTTCGTGCGTGAGCCCAATGCCCTGCGCGGGGTCCTGGCCCAGGCCGCGTGCTACCTGGCCGACGGCAGTTGCCCGGTGGGTGAGTCGACTTGGCGTGCAGCCTACTGGTCGGCGCAAAGTGCCGTCGCCGGGGCCCAGGCGTTGCTCGACGGTGAGCCGGCGGCCTACGCCTTGTGCCGCCCGCCGGGCCACCACGCCCGGTCCGAGGCGGCCGGGGGCTTCTGCTACCTGAACAATGCGGCGATCGCCGCCCAGGTCCTGCGGGACAAATACGCCCGGGTGGCGGTGCTGGACACCGACATGCACCACGGCCAGGGCATCCAGGAAATCTTCTACGAGCGCGCCGATGTGCTGTATGTCTCGGTGCACGGCGACCCGACCAACTTCTACCCGGGGGTGGCCGGGTTCGCCGAAGAGCGTGGCGCCGGGGCGGGGGAGGGCTACAACCTCAACCTGCCGATGGCCCATGGCGCCAGCGAAGGGGATTTCCTCGCCCGTCTGGAACAGGCCCTGGAGGCGGTGAAGGCGTTCGATGCCGAGGTGCTGGTGCTGTCTTTGGGGTTCGATATCTATGAACTCGACCCGCAGAGCAAGGTGGCAGTGACCCGGGACGGCTTCGCCATCCTTGGCCAGCGAATCCGCAGCCTGGGCCTGCCGTGCCTGATTGTCCAGGAAGGCGGCTATCACCTGGAAAGCCTGGAAGACAACGCCCGCGCCTTCTTCGCAGACTCTGGCGCCTGGGCCCTGTAG	MRSFFHPEQLLHHPRSYYSRGQMRIPQEVPERAQRLVQAAHSLGFAVEQPRDAGMAPLLAVHGAPYLAFLQDAHQGWKDIPEDWGDEVMSNIFVREPNALRGVLAQAACYLADGSCPVGESTWRAAYWSAQSAVAGAQALLDGEPAAYALCRPPGHHARSEAAGGFCYLNNAAIAAQVLRDKYARVAVLDTDMHHGQGIQEIFYERADVLYVSVHGDPTNFYPGVAGFAEERGAGAGEGYNLNLPMAHGASEGDFLARLEQALEAVKAFDAEVLVLSLGFDIYELDPQSKVAVTRDGFAILGQRIRSLGLPCLIVQEGGYHLESLEDNARAFFADSGAWAL	MDSDYTQLQTKILIRTAVVLFGAFALISASLSLLSGHFSRAVVGILEIFYKDYEKALVVYTYVFRDNKEWFVMIAAFVSFLIVLRLYLKGFTKYFNEINRGINALKEESSEDVVLSSELAATEKTINTIKHTLEQQKTAALVAEQRKNDLVVYLAHDLKTPLTSVIGYLTLLRDEKQISDELREKYICISLEKAERLENLINEFFEITRFNLSNIILEYSVVNLTRMLEQLVFEFNPMLAEKKLNCVLKTMPNKMIRCDANKMQRVFDNLLRNAVNYSFENTEISITVTQNENMVHIKFVNHGNTIPKEKLERIFEQFYRLDTSRSTGNGGAGLGLAIAREIVMLHGGTITARSEDEKIEFEVTILSS	92.66	gnl|BL_ORD_ID|4731|hsp_num:0	390			129	234	vancomycin
BGC0000413.1|Pyoverdine_60 # 102011 # 103240 # -1 # ID=1_60;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.667	BGC0000413.1|Pyoverdine_60 	102011	103240	-	Loose	770	25.7942	tet(J)	46.15	3000177	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTGAAAATCAATGGCCAGCGCCTCTGGGCGAGCCTGATGGCCATGGCCGAAATCGGTGCCACGGCCCGTGGCGGCAGCTGCCGCCTGGCCTTGAGCGATGAAGACCGGGCCGGTCGCGAACTGTTTGCCCACTGGTGCACCGAGGCCGGCATGAGCCTGAGCGTCGACCCCATTGGCAACCTGTTTGCCCGGCGCCCAGGTAGCGACCCGGACGCTGCCCCGGTAATGATGGGCAGCCATCTGGACACCCAGCCCGAAGGCGGGCGCTTTGATGGGGTCTACGGTGTGCTGGCCGGATTGGAAGTGGTACGCACGCTCAATGACCTCGGGATCCAGACCCGCAAGCCCCTGGAAGTGGCGGTCTGGACCAACGAGGAGGGCGCGCGTTTCACCCCGGCGATGTTCGGCTCGGCGGTGTTCACCGGGGTCATGGCCCTGGACGCCGCCCTGGCGGTGCGTGACGCCGATGGCATCAGCGTCGCCCAGGCCCTGCAGCGCACCGGTTATGCCGGCAGCCGGCCCCTGGGCGCAGCGGTGGATGCCTACTTCGAAGCCCATATCGAACAGGGCCCGATCCTTGAAGACAACGCCAAGAGCATCGGCGTGGTCAGCGGCGGCCAGGCCATCCGCTGGCTCGATGTGCAGGTCGAAGGCCTGGCGGCTCACGCCGGCACCACGCCGATGCCGCTACGCAAGGATGCGCTGTACGGCGCGGCGCAGATGATTCTTGCAGTGGAGCAGTTGGCAGCGGATTTTGCCCCCCAGGGCCTGACCACCGTGGGTGAGCTGAGCATCGCCAAGTCGTCGCGCAATACCATTCCCGGCCTGTTGAGCTTCACCGTCGACCTGCGCCACCACCAGGATCGGCAGATCGCCGCCATGGAGCAGCAGGTCGAGGAACGCCTGCAGGCCATCGCCGGCCAGCGCGGGCTCAAGGTCAGTATCAGCCGGCACTGGGTCAGCCCGGCCACGCCATTTGATGCCGAGTGCGTGGCGGCGGTGCAGCAGGCGGTGGATGGCCTGGGCTACGCTCAGCAGTCCATCGTCAGCGGCGCTGGCCACGACGCCATCTTGCTGGCCCGCTATTGCCCGACGGCCATGGTGTTCATTCCTTGTGTTGGTGGTCTGAGCCACAACGAAGCCGAAGACGTGTTGCCCGAGGACGTGCGCCAGGGCGCCGATGTATTGCTTAACGCCGTGCTGGCCCGTGCCGGCCAGGTTGAATAA	MLKINGQRLWASLMAMAEIGATARGGSCRLALSDEDRAGRELFAHWCTEAGMSLSVDPIGNLFARRPGSDPDAAPVMMGSHLDTQPEGGRFDGVYGVLAGLEVVRTLNDLGIQTRKPLEVAVWTNEEGARFTPAMFGSAVFTGVMALDAALAVRDADGISVAQALQRTGYAGSRPLGAAVDAYFEAHIEQGPILEDNAKSIGVVSGGQAIRWLDVQVEGLAAHAGTTPMPLRKDALYGAAQMILAVEQLAADFAPQGLTTVGELSIAKSSRNTIPGLLSFTVDLRHHQDRQIAAMEQQVEERLQAIAGQRGLKVSISRHWVSPATPFDAECVAAVQQAVDGLGYAQQSIVSGAGHDAILLARYCPTAMVFIPCVGGLSHNEAEDVLPEDVRQGADVLLNAVLARAGQVE	MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPILGKLSDKYGRKPILLISLLGAALDYLLMACPTSLWMLYIGRIIAGITGATGAVCASAMTDVTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQETQTTKISTEISALNQDTAPHSTTGFIKKSLFFWLIAYFIIQLIGQIPATIWVLFTQVRFAWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVWVMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSYSVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS	102.76	gnl|BL_ORD_ID|1040|hsp_num:0	988			117	195	tetracycline
BGC0000413.1|Pyoverdine_61 # 103260 # 104573 # -1 # ID=1_61;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.654	BGC0000413.1|Pyoverdine_61 	103260	104573	-	Loose	700	262.307	Acinetobacter baumannii AbaF	37.2	3004573	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGCCTTCCGCTTCGCCTCAGCCTCGCCGGGCTGCGGCCGCCGCCTTTATCGGCACCATGATCGAATGGTACGACTTCTACATCTACGCCACCGCCGCGGCGCTGGTGTTCGGTGCCTTGTTCTTCCCCTCCGACGACAAGCTGTTCAGCACCATGGCCGCCTTCGGCACCTTTGCCGTGGGCTTCTTCGCCCGACCTTTGGGGGGCATCATCTTTGGCCATATCGGCGACCGCATCGGCCGCAAGAAATCCCTGGTCATCACCCTGCTGATGATGGGCGTGGTCACGGTCTGCATCGGCCTGCTGCCAACTTATGCACAGATCGGTGCCCTGGCGCCGGTGCTGCTGATCCTGCTGCGCATCGTCCAGGGCATTGCCGTGGGCGGTGAGTGGGGCGGGGCGGTGTTGATGGCCGGCGAGCACGCGCCCAAGGGCCGGCGCAACTTCTTCGCGTCTTTCGCCCAGCTGGGCAGCCCGGCGGGGCTGATCCTTTCGCTGCTGGCCTTCAGCGCCGTGACCCGCCTGCCCGAGGACGCCCTGATGAGCTGGGGCTGGCGCCTGCCGTTCCTGGCCAGTGCGCTGTTGCTGCTGGTGGGCCTGGCGATTCGCCTGGGGGTCAACGAGTCGCCGGAGTTCCTCGCCAGTCGCGAGCTGGCGGCCAGGTCGCTACGCAAGGAGCAGGCTCCGGTAATGGAGGTGCTGCGCACCGCCTGGCGTCCCTTGCTGCTGTGCATCGGCGCCAACACCCTGGGGATTGCCGGGGTGTATTTCACCAACACCTTCATGATTGCCTACACCACCCAGCAGTTGGAGATACCCCGTTCGCTGATTCTCGAATGCCTGTTCGTGGTGGCGATCATCCAGTTCTGCATCCAGCCCCTGGCGGCCTGGACCGCCGAGAAAATCGGCGCCACGCGCTTTCTATGCCTGGTGTCAGTACTGGCCATGGCCTCGCCCTATCCGATGTTCGTGCTGGTGAGTTCCGGGCAGGCGCCGCTGATGATCCTCGGCATCGCCCTGGCGGTGGTGTGCATGGCTTCCTTCTATGCGGTGATCGCCGGTTACGTCAGCGGCATGTTCGAGACCCGGGTGCGCTACACCGCGATCTCCCTGGCCTATCAGGTCTGCGGTGCCCTGGCCGGCGGCCTGACCCCGCTGATCGGCACCTGGCTGGCCCATCGGTTCATTGGCCAATGGTGGCCGATGGCGGTGTTCTACAGCCTGATCGCTGCCGTTTCGCTGATCTGCGTGCTGGCCCTGGCACGCCGGCACGCTCACGCCCATCGCCTGGAAATGGCATCCCACGCCTGA	MKPSASPQPRRAAAAAFIGTMIEWYDFYIYATAAALVFGALFFPSDDKLFSTMAAFGTFAVGFFARPLGGIIFGHIGDRIGRKKSLVITLLMMGVVTVCIGLLPTYAQIGALAPVLLILLRIVQGIAVGGEWGGAVLMAGEHAPKGRRNFFASFAQLGSPAGLILSLLAFSAVTRLPEDALMSWGWRLPFLASALLLLVGLAIRLGVNESPEFLASRELAARSLRKEQAPVMEVLRTAWRPLLLCIGANTLGIAGVYFTNTFMIAYTTQQLEIPRSLILECLFVVAIIQFCIQPLAAWTAEKIGATRFLCLVSVLAMASPYPMFVLVSSGQAPLMILGIALAVVCMASFYAVIAGYVSGMFETRVRYTAISLAYQVCGALAGGLTPLIGTWLAHRFIGQWWPMAVFYSLIAAVSLICVLALARRHAHAHRLEMASHA	MTTTLKKVVAASMVGSVAEWYEFFLYGTASALVFGELFFQQTGNAIDGILAAFALYAVGFLARPLGGLVFGHYGDKIGRKKLLQISLIIVGITTFLMGCIPTFHQIGYWAPTLLVILRLIQGFAFGGEWGGAVILVSEHSPDDRRGYWASWPQTGVPLGNLVATLVLLLLSKNLSPEQFLDWGWRCAFWFSAVVVLIGLWIRKNVDDAEVFKEAQAKQQLLEKQQLGIIEVLKYHKKSVIAGIGARFAENILYYMVVTFSISYLKLVVHKDTSQILLLMFGAHLIHFFIIPFMGHLSDIFGRKPIYLIGAVLTAFWGFVGFPLMDTGNDWLIMLAIVLGLFIESMTYSPYSALMTELFPTHIRYTALSFCYQVAPIMAGSLAPLIALTLLKEFNSSIPISLYLVAASLISIVSILLVKETKGRSLAFKD	101.86	gnl|BL_ORD_ID|2716|hsp_num:0	3277			15	1269	fosfomycin
BGC0000413.1|Pyoverdine_62 # 104752 # 105717 # 1 # ID=1_62;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.643	BGC0000413.1|Pyoverdine_62 	104752	105717	+	Loose	500	45.8246	leuO	21.33	3003843	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCGACCGCGATGCCCGCCGCCTGCTCAATGACCGCCTCGACTGGAACCTGTTGCGCACCTTTCGGGTGATTGGCCAGGAGCTGAGCATCAGCCGTGCAGCGGCGCGCCTGCACTTGACCCAGCCGGCGGTCAGCCAGGCCCTCAAGCGCCTGGAAGAACAACTGGGCCGGCAGTTGATCGCCCGGCGCGGCCCACGCTTTGCCCTGACCGAAGTGGGTGAACAGATCTTCGCACTGGCCGGAGAGATCTACGGCCAGATGTCCCAGGTCAGCAGCATGCTGGAACAGCCCGCCGACGAAGTGATCGGCAAAGTGCGGCTGTTGATCATCAGCCGGATCTCCAGCGAACGCTTCGACGACTTCCTGGCCGACTTCCATCGTCAGCACCCGCGGGTCGATCTGGAGGTGGAAGTGATGCGCAGCTCGGACATCGTCAGCGCCCTGCAGGAAAAGACCGCGACCCTGGGCTTGAGCCTTAACCGCCGGCCACAGCCGCGCCTGGAACAGCGGCTGTTCCTGCGTCAGCGCTATGCGTTTTTCTGCGGCAAGCACCACCCGCTGTTCGGCCGCGGGGATGTGGCCGAGGGCGATCTGCAACGGGAGAACTTCGTCAGTTTCACCAGCGACCAGATCGGCGGCATGCTCTCGCCGCTGACCATCTTTCGCGATCAGCAGGGCTTCAGCGGGCGCATCGTCGCCTCATCCCCGAGCCTGGAAGAAGTACGACGCCTGGTGATCGCCGGCTTCGGCATCGGCTGCCTGCCGGAGCATGTGGTGGCGGCCGATACCGAAGCCGGGCTGCTGTGGCGCCTGCCGCCACACGAAGGCATTGCCGATGTCGACATTCACCTGCTGTGGAACCGCGAGCAGCGCATGAGCCGGGCCGAGGTACTGTTTTTGCAGAGCATCCAGCACATGCTCAGTCAGCATGAGCCGGCGCCGGGTAGCCTGATGTTGAAATGA	MSDRDARRLLNDRLDWNLLRTFRVIGQELSISRAAARLHLTQPAVSQALKRLEEQLGRQLIARRGPRFALTEVGEQIFALAGEIYGQMSQVSSMLEQPADEVIGKVRLLIISRISSERFDDFLADFHRQHPRVDLEVEVMRSSDIVSALQEKTATLGLSLNRRPQPRLEQRLFLRQRYAFFCGKHHPLFGRGDVAEGDLQRENFVSFTSDQIGGMLSPLTIFRDQQGFSGRIVASSPSLEEVRRLVIAGFGIGCLPEHVVAADTEAGLLWRLPPHEGIADVDIHLLWNREQRMSRAEVLFLQSIQHMLSQHEPAPGSLMLK	MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR	102.23	gnl|BL_ORD_ID|4926|hsp_num:0	5921			63	663	acriflavine; puromycin
BGC0000413.1|Pyoverdine_63 # 105719 # 107611 # -1 # ID=1_63;partial=00;start_type=ATG;rbs_motif=AGAAG;rbs_spacer=8bp;gc_cont=0.631	BGC0000413.1|Pyoverdine_63 	105719	107611	-	Loose	1000	160.999	mecD	28.12	3004185	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGCCCGAAGCGATTCCGATCAAGGACCACGAGAAAGAAAGCCGCCTGGTCAACAAACGGCTGCTGGCCTGTGCCGTATTGGTGGTGGCCATCACCTGCGCCCTGGTGGCGCGGATGTATTTTCTGCAAGTGGTGGAGTTCGACTACCACTCCACCGTTTCCGAGAACAACCGCGTCCATGTGCTGCCGATCACTCCCACCCGGGGGCTGATCTACGATCGCAACGGAGTGGTCCTGGCGGACAACCGCCCCAGCTTCAACCTGACGATCACTCGCGAACGCACCACCGACCTCAAGGGCGAGCTGGACACCGTGGTCGATCTGCTGCACTTGCCCCCGGAAGACCGCACGCTGTTCGACAAGGAGATGAAGCAGGCCCGTCATCCCTTCGTCCCCGTGACCCTGTTCTATGAGCTCACCGAAGAGCAGATCGCCGTGCTCGCGGTCAACGAATACCGGTTGCCCGGCCTGGACGTGGAAGCCCAGTTCGTCCGCCACTATCCCCTGGGCGCACACTTTGCCCACTCCATCGGTTACGTCGGGCGGATCAACGAGAAAGAAGCCAAGACCCTGGACTCGGTGGAGTACCGTGGCACCCAATCCATCGGCAAGACCGGCATCGAGAAATTCTACGAAGCCGAACTGCACGGCCATGTCGGTTATGAGGAAGTAGAAACCAACGCCCAGGGCCGGGTGATGAGAGTGCTCAAGCACACCGATCCGATCCCTGGGAAGAGCATCGTCCTGAGCCTGGACATCAAGCTCCAGGAAGCCGCTGAGGAGGCCCTGGGCGATCGCCGTGGTTCCGTGGTGGCTCTGGACCCGGCCACCGGCGAAGTCCTGGCCATGGTCAGCAAGCCAAGTTTCGACCCCAACCTGTTCGTCACCGGCATCAGCTTCAAGGAATACGCTGCGCTGCACGACTCCATCGACCGGCCCCTGTTCAACCGAGTGCTGCGAGGCCTCTACGCGCCGGGCTCCACCATCAAGCCGGAAGTGGCGATTGCCGGCCTCGATAGCGGCGTGGTTACCGCTTCGACCCGGGTCTTCGATCCGGGCTATTACCAACTGCCGGACTTCGACCACAAGTACCGCAACTGGAACCACAGCGGCGATGGCTGGGTGGACATGGACGCAGCGATCATGCGTTCCAACGACACCTACTTCTATGACCTGGCGCACAAGCTCGGCATCGACCGCCTGCACGACTACATGGCGATGTTCGGTCTGGGCGAGAAGGTCTCTCTGGACATGTTCGAAGAGTCTCCCGGCCTGATGCCCTCCCAGGCCTGGAAACGCGCCACCCGTCGCCAGCCATGGTTCCCGGGGGAAACCGTGATCCTCGGCATCGGCCAGGGCTATATGCAAGTCACGCCGCTGCAACTGGCCCAGGCCACCGCGCTGATTGCCAACAAGGGCGTGTGGAACCGTCCGCACCTGGCCAAGACCATCGATGGCGTGGCCCCGGTGGACGAGCATCCGATGCCCAACATCCTGCTGAAGAATCCCCGTGACTGGGATCAGGTCAACCACGGCATGCAGATGGTGATGCACGATCCCCGCGGTATCGCCCGCGCCGCGGCAGCCGGGGCGCAGTACCGCATCGCCGGCAAGAGTGGTACGGCCCAGGTGGTGGCGATCAAGCAGGGCGAGCGCTATGACCGTCTCAAGACCCGCGAGCGCAACCGTGACAACGCCCTGTTCGTGGGCTTCGCCCCGGCGGAGCATCCACAGATCGTGATTTCGGTGATGATCGAGAACGGCGAAGCCGGTGGTCGGGTGGCCGGCCCCGTGGTGCGGCAGATCATGGATGCCTGGCTACTGGACCAGAACGGCCACCTCAAGCCGCAGTACGCGGCCCCGGCCAAGGCCCCTGGCGATCCCCACGTCTGA	MPEAIPIKDHEKESRLVNKRLLACAVLVVAITCALVARMYFLQVVEFDYHSTVSENNRVHVLPITPTRGLIYDRNGVVLADNRPSFNLTITRERTTDLKGELDTVVDLLHLPPEDRTLFDKEMKQARHPFVPVTLFYELTEEQIAVLAVNEYRLPGLDVEAQFVRHYPLGAHFAHSIGYVGRINEKEAKTLDSVEYRGTQSIGKTGIEKFYEAELHGHVGYEEVETNAQGRVMRVLKHTDPIPGKSIVLSLDIKLQEAAEEALGDRRGSVVALDPATGEVLAMVSKPSFDPNLFVTGISFKEYAALHDSIDRPLFNRVLRGLYAPGSTIKPEVAIAGLDSGVVTASTRVFDPGYYQLPDFDHKYRNWNHSGDGWVDMDAAIMRSNDTYFYDLAHKLGIDRLHDYMAMFGLGEKVSLDMFEESPGLMPSQAWKRATRRQPWFPGETVILGIGQGYMQVTPLQLAQATALIANKGVWNRPHLAKTIDGVAPVDEHPMPNILLKNPRDWDQVNHGMQMVMHDPRGIARAAAAGAQYRIAGKSGTAQVVAIKQGERYDRLKTRERNRDNALFVGFAPAEHPQIVISVMIENGEAGGRVAGPVVRQIMDAWLLDQNGHLKPQYAAPAKAPGDPHV	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	92.92	gnl|BL_ORD_ID|2418|hsp_num:0	2828			423	1989	methicillin
BGC0000413.1|Pyoverdine_64 # 111475 # 111696 # 1 # ID=1_64;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=3bp;gc_cont=0.545	BGC0000413.1|Pyoverdine_64 	111475	111696	+	Loose	500	21.9422	OXA-243	22.22	3001610	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGCAGCTGATGTCGTCGATTAAGGAGGTGATCCAGCCGCAGGTTCCCCTACGGCTACCTTGTTACGACTTCACCCCAGTCATGAATCACACCGTGGTAACCGTCCTCCCGAAGGTTAGACTAGCTACTTCTGGTGCAACCCACTCCCATGGTGTGACGGGCGGTGTGTACAAGGCCCGGGAACGTATTCACCGCGACATTCTGATTCGCGATTACTAG	MKQLMSSIKEVIQPQVPLRLPCYDFTPVMNHTVVTVLPKVRLATSGATHSHGVTGGVYKARERIHRDILIRDY	MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPASTFKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKAAAYDLAENLFEVGEAGGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK	26.55	gnl|BL_ORD_ID|599|hsp_num:0	655			501	660	cloxacillin; oxacillin; cefalotin
BGC0000413.1|Pyoverdine_65 # 113733 # 114620 # 1 # ID=1_65;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.601	BGC0000413.1|Pyoverdine_65 	113733	114620	+	Loose	1900	26.9498	acrD	52.0	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATGACCAACCGCGCAGCCTTGCCTCGACCCTGTTTCCGGTGGGGCTGCTGCTTATTGCCATGGCCTCGATTCAGTCAGGAGCCTCACTGGCCAAGAGCATGTTCCCAATCGTTGGCGCACAAGGAACCACAACCCTGCGGCTGATTTTCGCCAGCATCATCATGCTGCTTCTATTAAGACCCTGGCGCGCCAAGTTCACCACCAACACCCTGCGCACCGTGATCATCTACGGCATGGCCCTGGGCGGCATGAACTTCCTCTTCTATATGTCCCTCAGGAGTGTCCCTCTGGGCATCGCCGTCGCCCTCGAGTTCACAGGCCCCCTCGCAGTAGCCATCTATGCGTCACGCAAGGCCATAGACTTCCTGTGGATCGCTCTGGCGATCGTCGGGCTGCTACTGCTTATTCCCACCGGAGCCACAGAAACAGCCATCGACCTGGTCGGTGCAGGTTATGCACTGGGGGCCGGGGTCTGCTGGGCGCTGTACATACTCTTCGGACAGAAGGCCGGAGCCGAGAACGGCATTCAGACCGCCGCCCTGGGCGTCATGATTGCTGCTCTCTTTGTTGCACCCATAGGCATAGTCCATGCCGGCGCCGCACTACTGACTCCCTCCCTGATCCCGGTTGCCCTGGGAGTCGCCATCTTGTCCACAGCCCTCCCCTATAGCCTGGAGATGGTTGCCCTGACTCGCATGCCAGCCCGGACCTTCGGCACCCTGATGAGTATCGAGCCCGCTTTCGGCGCGCTTTCGGGCCTGTTGTTCCTCCACGAGTACCTGTCCCTGTCCCAGTGGACGGCAATCGCTTGCATCATCCTGGCTTCCGTAGGCGCCACCATGACCATGCGCCGCGAGGCCAAACCAATAGTTGCAGTTGATTGA	MNDQPRSLASTLFPVGLLLIAMASIQSGASLAKSMFPIVGAQGTTTLRLIFASIIMLLLLRPWRAKFTTNTLRTVIIYGMALGGMNFLFYMSLRSVPLGIAVALEFTGPLAVAIYASRKAIDFLWIALAIVGLLLLIPTGATETAIDLVGAGYALGAGVCWALYILFGQKAGAENGIQTAALGVMIAALFVAPIGIVHAGAALLTPSLIPVALGVAILSTALPYSLEMVALTRMPARTFGTLMSIEPAFGALSGLLFLHEYLSLSQWTAIACIILASVGATMTMRREAKPIVAVD	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	28.45	gnl|BL_ORD_ID|1309|hsp_num:0	1427			1590	1665	
BGC0000413.1|Pyoverdine_66 # 114779 # 115060 # 1 # ID=1_66;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.553	BGC0000413.1|Pyoverdine_66 	114779	115060	+	Loose	400	23.0978	ACI-1	55.0	3004359	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	ACI beta-lactamase	ATGAAACGATTTTTGATACTGTTGGCCGTACTTGCAATTGCAGGCTGCGCGGCTACCGCGAAAACCGAAGTCAAACGGGGCAAGAAAGGACTCCACATCAACTGCTCGGGTTTATCTTCTTCCTGGGAAAAGTGCTACACCAAGGCGACTGAGTCCTGCGGCCCCAAAGGCTACAAGGTCATCGCCAAGTCCGGTGATGCCGTGGAAGACCCAGGCGACTACCCCTTCGGCCTGAACCCTGCCGGCTACACCAGCCGCAGCATGATCGTCATCTGCAAATAG	MKRFLILLAVLAIAGCAATAKTEVKRGKKGLHINCSGLSSSWEKCYTKATESCGPKGYKVIAKSGDAVEDPGDYPFGLNPAGYTSRSMIVICK	MKKFCFLFLIICGLMVFCLQDCQARQKLNLADLENKYNAVIGVYAVDMENGKKICYKPDTRFSYCSTHKVFTAAELLRQKNTSDLNEIRKFSAEDILSYAPITKDHVADGMTLAEICSASLRWSDNTAANLILQEIGGVENFKVALKNIGDKTTKPARNEPELNLFNPKDNRDTSTPRQMVKNLQVYIFGDILSDDKKKLLIDWMSDNSITDTLIKAETPQGWKVIDKSGSGDYGARNDIAVIYPPNRKPIVMAIMSRRTEKNAKSDDAMIAEAAKRIFDNLVF	32.75	gnl|BL_ORD_ID|2482|hsp_num:0	2874			657	702	penicillin; ceftazidime; amoxicillin; cefotaxime; ticarcillin
BGC0000413.1|Pyoverdine_67 # 115070 # 115639 # -1 # ID=1_67;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.625	BGC0000413.1|Pyoverdine_67 	115070	115639	-	Loose	375	42.743	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	36.76	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTTATTCAGCCAGTCACAAGCAGGAAACCCGCGAGCGTCTGCTGCAAAGCAGCGCGGCGCAGGCCAAGAACGAAGGTTTTTCCACTGTGGGGGTGGATGCCTTGATGAAAGCCATTGGCCTGAGTGGCGGGGCTTTCTATAGCCACTTCACCTCCAAGGACGAATTGTTCAGCTCGATTGTCGAGCGCGAGTTGAGCCAGAGTCTGGCGCGCCTGGGCGGGGAGGGGCAGCAGAATCAGGAGAAGTTGCGTCGCTGCCTGAAGCAGTACTTGAGCGTGGCGCATCTGCAACAGCCGGGTGCTGGCTGCGCACTGCCGGCATTGGGTGCGGAGATTGCCCGGGGGAGCCTAGAGGTGCGGCAGGAGGCGCAGGACTGGATCTGCCGCTTGCACCAGGCTTGGGCGCAGACTCTGGGCAGCGAGAGCCTGGCCTGGTCGATCCTGTCCCAGTGCGTTGGCGCGTTGGTGGTAGCGCGAATGCTGGTGAACCCAGCCATTCAGCATCAGGTGCTGGCGTCCAGCCATGAGCAGATCATCGGGCAGCTGGAGCGGCTGCCCGCAAGTTGA	MRYSASHKQETRERLLQSSAAQAKNEGFSTVGVDALMKAIGLSGGAFYSHFTSKDELFSSIVERELSQSLARLGGEGQQNQEKLRRCLKQYLSVAHLQQPGAGCALPALGAEIARGSLEVRQEAQDWICRLHQAWAQTLGSESLAWSILSQCVGALVVARMLVNPAIQHQVLASSHEQIIGQLERLPAS	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	87.91	gnl|BL_ORD_ID|2090|hsp_num:0	2306			6	204	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000413.1|Pyoverdine_68 # 115733 # 116473 # 1 # ID=1_68;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.605	BGC0000413.1|Pyoverdine_68 	115733	116473	+	Loose	190	28.1054	qacE	36.36	3005009	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTGCAACCTTGAACAAGAACAAAGTCGTACTGGTAGTGGGTGCCGGCGACGCGACCGGCGGTGCCATTGCCAAGCGTTTCGCCTCCGAAGGCTTTATTGCCTGCATGACCCGCCGCAGCGCGGACAAACTGCAACCCCTGGTGGACGCCATCCAGCAGTCCGGCGGCCAGGCCCATGGTTTTGGCTGTGATGCACGCAAAGAGGAAGACGTGATCGCGCTGATCGAGCAGATCGAAACCCAGATCGGCCCTATCGAGGCCTTTGTCTTCAATATTGGCGCCAATGTGCCCTGCAGCATTCTTGAAGAAACCGCACGCAAGTATTTCAAGATCTGGGAAATGGCCTGCTTTTCGGGCTTTCTCAATGCCCGGGAAGTGGCCAAGCGCATGGCCAAACGCCAACGCGGCACTATTCTGTTCACCGGCGCCACCGCAGGCGTACGCGGTGCCGCCGGCTTTGCCGCCTTCGCCGGGGCCAAGCACGGCATTCGCGCCCTGGCCCAGAGCATGGCTCGGGAACTGGGCCCCCTGAACATCCATGTCGGCCATGTCATCGTCGACGGTGCCATCGACACCGACTTCATCCGTACCAGCTTTCCCGAAAAATACGCCCTCAAGGACCAGGACGGCATCCTCAACCCCGAGCATATCGCCGAAAACTACTGGTACCTGCACAGCCAGCCTCGGGACGCCTGGACCTTCGAGCTGGACCTGCGCCCGTGGAACGAACGCTGGTAA	MTATLNKNKVVLVVGAGDATGGAIAKRFASEGFIACMTRRSADKLQPLVDAIQQSGGQAHGFGCDARKEEDVIALIEQIETQIGPIEAFVFNIGANVPCSILEETARKYFKIWEMACFSGFLNAREVAKRMAKRQRGTILFTGATAGVRGAAGFAAFAGAKHGIRALAQSMARELGPLNIHVGHVIVDGAIDTDFIRTSFPEKYALKDQDGILNPEHIAENYWYLHSQPRDAWTFELDLRPWNERW	MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVMKSIPVGVAYALWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLNLLSKASAH	223.64	gnl|BL_ORD_ID|2743|hsp_num:0	3754			141	264	
BGC0000413.1|Pyoverdine_69 # 116511 # 117107 # 1 # ID=1_69;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.600	BGC0000413.1|Pyoverdine_69 	116511	117107	+	Loose	2000	24.6386	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	30.88	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGAGCAAAAAGGTGGAGTTCTTCTTCGACCTGGGTAGCCCGACCTCATACCTGGCCTATACCCAACTGCCAAAAATCTGCGCCGAAACCGATAGCCAGCTGGTGTATCAGCCCATGCTGCTGGGCGGGGTCTTCAAGACCACCGGCAACGCTTCCCCCATCAGTGTTCCCGCCAAGGGCCGGTACATGCTGCACGACCTGGCGCGCTTTGCCCGGCGCTATGGGGTGGAGCTCAACTTCAATCCGCACTTTCCCATCAATACCCTGTTGCTGATGCGCGCCACCACCGGGGTTCAACTGCGCCTGCCGGAACGTTTCGGCGAATTCCTCGACTGCCTGTTCCGTGCGCTCTGGGTGGACAAACGCAACCTCAACGACCCGGCCACCATCACCCAGGTCCTGGAACAAGGTGGCTTCGACCCGCAGCAGATCCTCGACCTGAGCAATGACGAAGAGGTCAAGGCCGCCCTCAAGGACAAGACCGAACAGGCGTTGCAAAAAGGGGTGTTCGGCGCGCCCAGCATGTTCGTGGGAGACGAACTGTTCTTTGGCCAGGACCGCCTGGATTTCGTCCGCGAAGCCTTGAACGCGCCGTAA	MSKKVEFFFDLGSPTSYLAYTQLPKICAETDSQLVYQPMLLGGVFKTTGNASPISVPAKGRYMLHDLARFARRYGVELNFNPHFPINTLLLMRATTGVQLRLPERFGEFLDCLFRALWVDKRNLNDPATITQVLEQGGFDPQQILDLSNDEEVKAALKDKTEQALQKGVFGAPSMFVGDELFFGQDRLDFVREALNAP	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	16.69	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2727	2916	rifampin
BGC0000413.1|Pyoverdine_70 # 117192 # 119000 # -1 # ID=1_70;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.652	BGC0000413.1|Pyoverdine_70 	117192	119000	-	Loose	1000	30.4166	MCR-5.2	25.74	3004698	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAGTACCCAGCCTTCGACCAATGGAGTGGTCCCCCAGCGCTTGGCGCATGTCCGTCAGCTGATGAGCCGCGAAGGCATTCACGCCTTGCTGGTGCCCTCGGCCGACCCGCACCTGTCGGAATACCTGCCGGGCTACTGGCAAGGGCGCCAGTGGCTGTCGGGGTTTCATGGGTCGGTCGGGACCTTGATCGTGACCGCTGACTTTGCCGGCGTATGGGCCGACAGCCGTTACTGGGAGCAGGCCACCAAGGAACTCAAGGGCAGCGGCATCGAACTGGTGAAGTTGCAACCGGGCCAGCCCGGGCCCCTGGACTGGCTGGCCGAACAGACCCCGCAAGGTGCGGTGGTGGCGGTGGACGGCGCGGTCATGGCCTTGGCTTCGGCCCGTACCCTGGGCAGCAAGCTGCAGGAACGCGGGGCCAGCCTGCGTACCGATATCGACCTGCTACAGGAAGCCTGGAACGACCGTCCGTCATTGCCCGATCAACCGGTCTATCAGCATCTGCCGCCCCAGGCCACCCAGAGCCGGGTCGAGAAGCTTGCGGCGTTGCGCGCAACCCTCAAGGAGCGCGGCGCCGACTGGCATTTCATCGCTACCCTCGATGACATTGCCTGGCTGTTCAACCTGCGCGGCGCCGATGTGTCCTTCAACCCGGTGTTTGTCTCCTTTGCCCTGATCAGCCAGCAGCAGGCGACCTTGTTCGTGGCCTTGAGCAAGGTCGATGAGGCATTGCGCGCGCAACTGGAGGTGGATGGCGTCAGCCTGCGCGACTATTCAGAGGTGTCCGCGGCCTTGCAGGCAGTGCCGGAAGGCGTAGCGTTGCAGATCGACCCGGCGCGCGTCACCGCGGGCTTGCTGGAGCACCTGAACCCCGGGGTGAAGCTGCTGGAGGGGCTCAACCCCACCACCCTGGCCAAGTCGCGCAAGAGCCTGGCGGACGCCGAGCACATTCGCCAGGCCATGGAGCAGGATGGCGCGGCGCTCTGCGAATTCTTCGCCTGGCTGGACAGCGCCCTGGGGCGTGAACGCATTACCGAACTGACCATCGATGAGCGCCTGACGGCCGCCCGTGAACGGCGCCCGGGTTATGTCTCGCTAAGCTTCAATACCATTGCTGCGTTCAACGCCAACGGCGCCATGCCCCATTACCACGCCACGCCCGAAGAGCATGCGGTGATCGAGGGTGATGGCCTGTTGCTGATCGATTCCGGCGGCCAGTACCTGGGGGGCACCACCGATATCACGCGCATGGTGCCGGTGGGGACGCCGAGTGCCGAGCAGAAGCGCGATTGCACCCGGGTGCTCAAGGGCGTTATCGCGCTGTCCCGGGCGCAGTTTCCGCGGGGCATTCTGTCGCCGTTGCTGGATGCCATCGCCCGGGCGCCGATCTGGGCCGAGGGTGTGGACTACGGGCACGGCACCGGGCATGGCGTCGGTTATTTTCTCAACGTTCACGAAGGCCCGCAGGTGATTGCCTATCAGGCCGCAGCGACGCCGCAGACTGCGATGCAACCGGGGATGATCACTTCGATCGAACCCGGGACCTACCGCCCTGGCCGCTGGGGCGTACGAATCGAGAACCTGGCGCTCAACCGTGAGGCGGGCAAGACCGAGTTCGGTGAGTTTCTGAACTTCGAAACCCTCACCCTGTGCCCGATCGATACCCGTTGCCTGGAGCCATCGCTGCTCACCGAGGATGAGCGCGAATGGTTCAACGGCTATCACGCTGAAGTCCGCCGGCGCCTCAGCCCGCTGCTGGAGGGCCCGGCCCTGGAGTGGTTGCAGGTTCGTACTGCGGCTATCTGA	MSTQPSTNGVVPQRLAHVRQLMSREGIHALLVPSADPHLSEYLPGYWQGRQWLSGFHGSVGTLIVTADFAGVWADSRYWEQATKELKGSGIELVKLQPGQPGPLDWLAEQTPQGAVVAVDGAVMALASARTLGSKLQERGASLRTDIDLLQEAWNDRPSLPDQPVYQHLPPQATQSRVEKLAALRATLKERGADWHFIATLDDIAWLFNLRGADVSFNPVFVSFALISQQQATLFVALSKVDEALRAQLEVDGVSLRDYSEVSAALQAVPEGVALQIDPARVTAGLLEHLNPGVKLLEGLNPTTLAKSRKSLADAEHIRQAMEQDGAALCEFFAWLDSALGRERITELTIDERLTAARERRPGYVSLSFNTIAAFNANGAMPHYHATPEEHAVIEGDGLLLIDSGGQYLGGTTDITRMVPVGTPSAEQKRDCTRVLKGVIALSRAQFPRGILSPLLDAIARAPIWAEGVDYGHGTGHGVGYFLNVHEGPQVIAYQAAATPQTAMQPGMITSIEPGTYRPGRWGVRIENLALNREAGKTEFGEFLNFETLTLCPIDTRCLEPSLLTEDEREWFNGYHAEVRRRLSPLLEGPALEWLQVRTAAI	MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTGLLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVREASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMDVLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQQGRRPRALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRDYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLDEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEALVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDEQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATCRKGQPQ	110.26	gnl|BL_ORD_ID|2313|hsp_num:0	3396			654	939	colistin A; colistin B
BGC0000413.1|Pyoverdine_71 # 119056 # 120225 # -1 # ID=1_71;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.655	BGC0000413.1|Pyoverdine_71 	119056	120225	-	Loose	600	26.5646	ICR-Mo	37.5	3004569	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGAACAAGCGTCCTCTTTATTTCGACTACGCCGCCACCACGCCGGTGGATGAGCGAGTCATTCAGGTCATGCTGGAGTGCCTGGGTTTCAACGCCCATTTCGGCAATCCGGCGTCCAGTTCACACGCCTTTGGCCGGGAAGCGCGGGGTTACGTCGAGCGCGCCCGGCAACAAGTGGCACAACTGGTCGGCGCGCAGCCCGAGCAGATTGTCTGGACCTCCGGCGCTACCGAATCCAACAACCTGGCCCTCAAGGGGGTGATGCAGGCCCGGGGCGTGAGCGGCGGCCATGTCATCACCAGCCAGATCGAACACAAGGCGGTGCTCGACACCGCCCGGCAACTGCAGGAGGCCGGGGTCGCAGTGACCTACCTGGTGCCGGATGCCGATGGCCTGATCAGCGCGCAAGCGGTCAGCGAAGCCCTGCGCGACGACACCTTCCTGGTGTCGCTGATGCTGGTTAACAACGAACTGGGCACCCTCAACGACATTCCGGCCATTGGCGAGGTGGTGCGTGAGCGTGGCGCTCTGTTGCATGTGGATGCCGCCCAGGGTGCGGGCAAGGTGGCCATCGATCTGGCCCGGTGGCCGGTGGATCTGATGTCGTTCTCGGCCCATAAGCTATATGGCCCCAAGGGCATCGGCGCGCTGTATGTCGGGCCGCGGGCGCAGCAACACGTGCAGGCGCAGATTCATGGCGGCGGTCATGAGGGCGGCTTGCGCTCCGGAACCCTGGCCACCCACCAGATCGCGGCCATGGGCGCCGCCTTCGCCCTGGCCGGCGAACTGTTCGAGGAAGAAACCGCCGCCATCGTGCGTCTGCGCGGGCGCCTGCTGGAGCAACTGGCGGGTATCGCCGGCCTGCGCTTGAATGGCAGTGTTACCCAGCGCATTCCCCATACCCTGAGCCTGACCTTCACCGAGGGAGGTTTTGATGGGGCGGCGTTGGGCGCGGCCCTGGCCTTTTCCGCGACTTCGGCCTGCAACTCGGCAAGCAATGCGCCTTCCCATGTATTGCTGGCGCTGGGGCATGATGCCGGGCAGGCCGCGCGGACCATCCGCTTGAGCCTCGGGCGTTTCACCTGCGAACAGGATGTGGATCGCGCCGCTCAACTGATCCAGGCGGCGACCGCCTCAGCCCCTGCGTTCTGGGCCACAACACAACCTTGA	MNKRPLYFDYAATTPVDERVIQVMLECLGFNAHFGNPASSSHAFGREARGYVERARQQVAQLVGAQPEQIVWTSGATESNNLALKGVMQARGVSGGHVITSQIEHKAVLDTARQLQEAGVAVTYLVPDADGLISAQAVSEALRDDTFLVSLMLVNNELGTLNDIPAIGEVVRERGALLHVDAAQGAGKVAIDLARWPVDLMSFSAHKLYGPKGIGALYVGPRAQQHVQAQIHGGGHEGGLRSGTLATHQIAAMGAAFALAGELFEEETAAIVRLRGRLLEQLAGIAGLRLNGSVTQRIPHTLSLTFTEGGFDGAALGAALAFSATSACNSASNAPSHVLLALGHDAGQAARTIRLSLGRFTCEQDVDRAAQLIQAATASAPAFWATTQP	MVHLDKVSNRMSVNNSRWLAWRQQGINAYVMMGIVALFLTLTANITFFDKATEVYPFAQHIGFIGSLPLVLFGVMLLVIVLLSYRYTLKAVLIFLLLTAAVTAYFTDTYGTVYDVNMLQNALQTDKAESADLFNVNFILRILLLGVLPSVWVAWQKVTFPPIKRSILQRGLTYLVSLGLVVLPILAMSKNYASFFREHKQLRSYTNPATPVYALGKLASIQLKQAQAPKTQIMHATDAVQVSNPTTRKPKLVVFVVGETARGDHVQLNGYNRTTFPQMAATAGVTNFNQVIACGTSTAYSVPCMFSYVGMKDYDVDTANYQENVLDTLHRLKVNILWRDNNSSSKGVTNRLPAADFVDYKTARNNTMCNTNPYGECRDVGMLVGLDDYVKQQANQNTLNQDTLIVLHQMGNHGPAYFKRYDKQFEKFTPVCQSNELAKCDPQSVINAFDNALLATDDFLAKTVNWLDKYDSTHQVAMLYVSDHGESLGENGIYLHGMPYKIAPKAQKHVASMFWAGKHSGIQAVPSNTELTHDAITPTLLKLFDVRAQTVQGKPLFIK	69.71	gnl|BL_ORD_ID|2714|hsp_num:0	3271			1500	1596	colistin A; colistin B
BGC0000413.1|Pyoverdine_72 # 120436 # 121050 # -1 # ID=1_72;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.628	BGC0000413.1|Pyoverdine_72 	120436	121050	-	Loose	1000	25.7942	efpA	32.88	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCCTTTCCCCTGACCTGCTGTTGGCCTTCGCCCTGTTTGCCCTGGTCACTTCCATCACGCCCGGTCCCAACAACACTATGTTGCTGGCCTCGGGGGTGAACTTCGGCTTCAACCGTTCCATTCCCCACATCCTCGGCATCAGCTGCGGCTTCTTTGTCCTGGTGCTGGCGGTCGGCCTGGGCCTGGGGGCGGTGTTCGAGGCCTACCCGCTGCTGTACAGCGTGCTGCGCTACGTTGGCGCAGTGTACCTTCTGTACCTGGCGTGGAAGATTGCCCGTTCCGGGCCGCTGTCCGATGAACAGCAGCACCACGGCCGGCCGCTGGGCTATTGGGGCGCCGCGGCGTTCCAGTGGGTCAATCCCAAGGCCTGGGTCATGGCAGTGGGGGCCATCAGTACCTATACCCCGTTGCAGGGCTACTTCACCAATGTGCTGGTGATTGCCGCGGTGTTCGCGCTGATCAATGCGCCCACGGTGAGCCTCTGGGCTGCGTGCGGCAGCCTGCTGCGCAATGTGTTGCGCAACCCGCGCTGGTTGCGCCTGTTCAATCTGTTGATGGCCGCCTTGCTGGTGCTTTCCCTGGCACCGCTGTTGTTCGAAAAGATGAGTTGA	MSLSPDLLLAFALFALVTSITPGPNNTMLLASGVNFGFNRSIPHILGISCGFFVLVLAVGLGLGAVFEAYPLLYSVLRYVGAVYLLYLAWKIARSGPLSDEQQHHGRPLGYWGAAAFQWVNPKAWVMAVGAISTYTPLQGYFTNVLVIAAVFALINAPTVSLWAACGSLLRNVLRNPRWLRLFNLLMAALLVLSLAPLLFEKMS	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	38.49	gnl|BL_ORD_ID|2188|hsp_num:0	2427			930	1149	rifampin; isoniazid
BGC0000413.1|Pyoverdine_73 # 121153 # 121413 # -1 # ID=1_73;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.598	BGC0000413.1|Pyoverdine_73 	121153	121413	-	Loose	500	25.0238	rmtC	31.48	3000861	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAAGGCTTTCTCTGCTGTCTTGCTGTTGTTGGTTTCCAGTGTGCTGGCCGGTTGTGCCAGCCCCGGTGCACCGGAGTTGCGGCCCTATACCGCGCAGGAAACCCGGGAGCTGGCTATGGAGGCGTTGAACCGGCGCGGTTTGTCCTTCGATGAATACCAGCAGAAAAAGGCCGAGTTGCTGGGCCGCCCGGCGAGCTTCGACAGCCAGGGTGAAATGAGTGCACAGCGCAATATCAGTCGCCATCAACCTGCCAGTTGA	MKAFSAVLLLLVSSVLAGCASPGAPELRPYTAQETRELAMEALNRRGLSFDEYQQKKAELLGRPASFDSQGEMSAQRNISRHQPAS	MKTNDNYIEEVTAKVLTSGKYSTLYPPTVRRVTERLFDRYPPKQLEKEVRKKLHQAYGAYIGGIDGKRLEKKIEKIIHEIPNPTTDEATRTEWEKEICLKILNLHTSTNERTVAYDELYQKIFEVTGVPTSITDAGCALNPFSFPFFTEAGMLGQYIGFDLDKGMIEAIEHSLRTLNAPEGIVVKQGDILSDPSGESDLLLMFKLYTLLDRQEEASGLKILQEWKYKNAVISFPIKTISGRDVGMEENYTVKFENDLVGSDLRIMQKLKLGNEMYFIVSRL	30.60	gnl|BL_ORD_ID|1417|hsp_num:0	1540			246	408	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0000413.1|Pyoverdine_75 # 122387 # 123526 # 1 # ID=1_75;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.671	BGC0000413.1|Pyoverdine_75 	122387	123526	+	Loose	300	29.261	tet(W/N/W)	30.1	3004442	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGATGTGTTCTGGTTTCTTCCGACCCACGGCGACGGCCATTTCCTCGGCACTGCCCAGGGCGCGCGCCCGGTCACCCTCAACTACCTCAAGCAAGTGGCGCAGGCCGCGGACAGCCTGGGCTACCACGGTGTGCTGATTCCCACCGGGCGCTCCTGCGAAGACTCCTGGGTGATCGCCTCGGCCCTGGTGCCCCTGACCGAACGCCTGCGCTACCTGGTGGCGATCCGCCCGGGGATCATCTCCCCCACGGTTTCCGCGCGCATGGCCGCGACCCTGGACCGGCTGTCCAACGGCCGCCTGCTGATCAACGTGGTCACCGGCGGCGACCCGGACGAAAACCGCGGCGACGGCAGCTTCCTCAGCCACAGCGAACGCTATGAAGTCACTGACGAATTCCTGCAGATCTGGCGTCGGGTGCTGCAAGGCGAGGCCGTGGACTTCGAAGGCAAGCACCTGCATGTGCAGAACGCCAAGGCGCTCTACCCGCCCGTGCAGAAACCCTACCCACCGCTGTACTTCGGCGGTTCCTCCGAAGCCGCTCATGAACTGGCGGCGGACCAGGTGGATGTCTACCTGACCTGGGGCGAGCCACCGGCGGCGGTGGCGCAGAAACTGGCCGACGTACGCGAACGTGCAGCGCGCAAGGGCCGCACGGTGAAGTTCGGCATCCGCCTGCATGTGATCGTGCGTGAGACCGAGGACGAGGCCTGGAAAGCCGCGGACAAGCTGATCGAGCACATCAGCGACGACACCATCGCCGCCGCCCAGCAGTCCTTTTCCCGCTTCGACTCCGAAGGCCAGCGGCGCATGGCAGCGCTGCACGGCGGGCGCCGCGACCAGTTGCAGATCGCCCCCAACCTCTGGGCCGGGGTCGGCCTGGTGCGCGGTGGCGCCGGTACCGCCCTGGTGGGCAACCCGCAGCAAGTGGCCGAGCGCATCAAGGAGTACGCGGACCTGGGAATCGAGAGCTTCATTTTCTCCGGCTACCCGCACCTGGAAGAAGCCTATCGCTTCGCCGAGCTGGTGTTCCCGCTGCTGCCGGAGCCCTATGCCAGCCTGGCCGGCCGCGGTGTCACCAACCTCACCGGGCCGTTCGGCGAAATGATCGCCAACGACGTGTTGCCCAACAGCCGCTGA	MDVFWFLPTHGDGHFLGTAQGARPVTLNYLKQVAQAADSLGYHGVLIPTGRSCEDSWVIASALVPLTERLRYLVAIRPGIISPTVSARMAATLDRLSNGRLLINVVTGGDPDENRGDGSFLSHSERYEVTDEFLQIWRRVLQGEAVDFEGKHLHVQNAKALYPPVQKPYPPLYFGGSSEAAHELAADQVDVYLTWGEPPAAVAQKLADVRERAARKGRTVKFGIRLHVIVRETEDEAWKAADKLIEHISDDTIAAAQQSFSRFDSEGQRRMAALHGGRRDQLQIAPNLWAGVGLVRGGAGTALVGNPQQVAERIKEYADLGIESFIFSGYPHLEEAYRFAELVFPLLPEPYASLAGRGVTNLTGPFGEMIANDVLPNSR	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVYQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRLVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSDVPFPMLRTTITPKTAEQRDRLLDALTQIADTDPLLHYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQPRRPNSRLDKVRHMFSKIP	59.31	gnl|BL_ORD_ID|2492|hsp_num:0	2882			492	786	tetracycline; minocycline; chlortetracycline
BGC0000413.1|Pyoverdine_76 # 123661 # 124848 # 1 # ID=1_76;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.678	BGC0000413.1|Pyoverdine_76 	123661	124848	+	Loose	500	25.7942	Vibrio cholerae varG	24.44	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	GTGACTGCCAAACCGCAAAGCGCCCTGTTGTCCCCCCTGCAGACCGCCCGCCAACTGGCCGCCGAGTTTGCCCTGACCGCCGTCGAACGCGACGAGCGCGGCGGCACCCCCAAGGCCGAGCGTGACGCGCTGCGCCAAAGCGGCCTGCTGGCCCTGAGCATTCCCAGCCAGTTCGGCGGGCTCGGCGCGCCCTGGAGCGAGACGCTGAACATCGTCCGCGAATTCGCCCGGGTCGACAGCTCCATCGCCCATGTCTTCGGCTTCCACCACCTGATGCTGGCCACCGTGCGCCTGTTTGCCAAACCCGAACAGTGGCAACCCTGGTTCGAACAGACCGCACGCAAGAACTGGTTCTGGGGCAACGCCCTGAACCCACTGGACACCCGCACCGTGGTCCGGAACCTGGGGGGCTGGCGCGAGTTTTCCGGCAAGAAGAGCTTCTGCTCCGGTGCCAGCGACTCGGAAATGCTCATTGCCTCGGCAGTGGATGAAAGCAATGGCGGCAAGTTGCTGATCGCCGCGATCCCCAGCGGCCGCAGCGGCATCACCCTGCACCACGACTGGAACAACATCGGCCAGCGCCAGACCGATAGCGGCAGCGCCACCTTCGAACGGGTACGGGTGGAGGAGTCGGAACTGCTGCTGGACCCCGGCCCGCTGAGCACACCATTCGCCTGCCTGCGCCCGCTGATCGCCCAACTGACCTTCACCCACATGTTCCTCGGCATCGCCGAAGGCGCCTTCGAAGAAGCCCGGCAGTACACCCTCGGCGAAACCCGGGTCTGGCATAAGTCCAGCGCCCAGGACGTGCGCCAGGACCCCTACATACTCAGCCACTACGGCGAATTCTGGGTCGCCCTGGAAGGCATCCGCCTGCTGGTGGAGCGGGCCGCCGCGCTGCTGGACCAGGCCTGGGCCAAGGGCCCGGCCCTCAGCGCCGAAGAGCGCGGGCACCTGGCCACGGCCATCGCCACCGCCAAGGTCGCCGCCAGCCGCCAGGGCCTGGAGCTGTGCAGCCGCCTGTTCGAAGTCACCGGCGCGCGCTCGACCCACGCCTCCCTGGGCCTGGACCGGCACTGGCGCAACCTGCGCACCCAGACCCTGCACGACCCGCTGGACTACAAGCTTCATGAGCTGGGCGACTGGGCGCTGAACCAGTCCCTGCCAACCCCGACTTTCTACTCCTAG	MTAKPQSALLSPLQTARQLAAEFALTAVERDERGGTPKAERDALRQSGLLALSIPSQFGGLGAPWSETLNIVREFARVDSSIAHVFGFHHLMLATVRLFAKPEQWQPWFEQTARKNWFWGNALNPLDTRTVVRNLGGWREFSGKKSFCSGASDSEMLIASAVDESNGGKLLIAAIPSGRSGITLHHDWNNIGQRQTDSGSATFERVRVEESELLLDPGPLSTPFACLRPLIAQLTFTHMFLGIAEGAFEEARQYTLGETRVWHKSSAQDVRQDPYILSHYGEFWVALEGIRLLVERAAALLDQAWAKGPALSAEERGHLATAIATAKVAASRQGLELCSRLFEVTGARSTHASLGLDRHWRNLRTQTLHDPLDYKLHELGDWALNQSLPTPTFYS	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	101.28	gnl|BL_ORD_ID|2428|hsp_num:0	2842			195	465	meropenem
BGC0000413.1|Pyoverdine_77 # 124873 # 125973 # 1 # ID=1_77;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.654	BGC0000413.1|Pyoverdine_77 	124873	125973	+	Loose	400	223.016	TxR	46.78	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCAGCTTCTGACCCTACCCCCTTCGCCCGCCCTGGCGACCTCGATCCGCGCCACCGCCCAGGTGTTCGAGGACCCGAAATCCCAGGCCCTGCTGGCGCACCTGCAACAGGTGGCACCGAGCGAAGCCAGCGTGCTGATCATTGGCGAAACCGGGACCGGCAAGGAGCTGGTGGCGCGCCATATCCACAACCTCAGTGCCCGGCGCAACCGACCGTTCGTGGCGGTGAACTGCGGTGCCTTCTCCGAATCCCTGGTGGAGGCGGAACTGTTCGGCCATGAGAAAGGCGCCTTTACCGGCGCCCTCAGCGCCAAGGCCGGGTGGTTCGAAGAAGCCGACGGCGGCACCCTGTTCCTCGACGAGATCGGCGACCTGCCCATGGCCATCCAGGTCAAGCTGCTGCGGGTGCTGCAGGAGCGCGAAGTGGTGCGCCTGGGTTCGCGCAAGAGCATTCCCATCGATGTGCGCGTACTGGCCGCCACCAACGTGCAACTGGAAAAGGCCATCAACGCCGGGCATTTTCGCGAAGACCTGTATTACCGCCTGGACGTGGTCAGCCTGGAACTGAGCCCGCTGCGCGAGCGCCCCGGCGACATCCTGCCGCTGACCCGGCACTTCATCGAGGCCTACAGCCAGCGACTGGGCTACGGCAGCATCAGCATCAGCCCCGAGGCCGAGCACAAGCTCAAGAGCTACAGTTGGCCGGGCAACATCCGCGAGTTGGAAAACGTCATCCACCACACCCTGCTGATCTGCCGCAACGGGGTGATCCAGCGCGACGACCTGCGCCTGTCGAACATGCGCATCGAACGCGCCGACGACAGCCACCCGAGCCACGACGACTCCGCCGAGGCCCTGCTGGAACGGGCCTTTGAAAAACTCTTCGCCGAACAGGCCGGGGCCCTGCACGAAAAGGTCGAGGATGCCTTGCTGCGCGCGGCCTACCGCTTCAGCCACTACAACCAGGTGCACACCGCCAACCTGCTGGGCCTGAGCCGCAACGTCACCCGGACCCGGCTGATCAAGATCGGCGAACTGGCGGTGAACAAGCGGCGCCCGATCGATGCGCCCAACGAGCGCACCCTGCAACTGTCGATCTAG	MQLLTLPPSPALATSIRATAQVFEDPKSQALLAHLQQVAPSEASVLIIGETGTGKELVARHIHNLSARRNRPFVAVNCGAFSESLVEAELFGHEKGAFTGALSAKAGWFEEADGGTLFLDEIGDLPMAIQVKLLRVLQEREVVRLGSRKSIPIDVRVLAATNVQLEKAINAGHFREDLYYRLDVVSLELSPLRERPGDILPLTRHFIEAYSQRLGYGSISISPEAEHKLKSYSWPGNIRELENVIHHTLLICRNGVIQRDDLRLSNMRIERADDSHPSHDDSAEALLERAFEKLFAEQAGALHEKVEDALLRAAYRFSHYNQVHTANLLGLSRNVTRTRLIKIGELAVNKRRPIDAPNERTLQLSI	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	115.09	gnl|BL_ORD_ID|4724|hsp_num:0	3753			108	795	tetracycline
BGC0000413.1|Pyoverdine_78 # 125970 # 126335 # -1 # ID=1_78;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.626	BGC0000413.1|Pyoverdine_78 	125970	126335	-	Loose	1050	27.7202	carA	41.94	3002817	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGAGCGCCTTTGAAAAGACCCGCAGCTTTACCCAATTGATCGAGTTCGAGATCGAGCCCCATCAGCAACAGGCCCTGGTATCGGCCCTGGCCGAGCAGACCGAGCGCTTGGCCCAGGGCTATGGCGGTTTTCTGAGTGCCAGCGTGCAGGCCAGCGACGATGGCCGGCGGGTGCTCAATTACCTGCAATGGCAATCCCGGGAAGCCGGCGAAGCGGCGTTCCGGCGCTTCGAGAACGGCGAGCAGGATTTCTGGCAGTTGATCCTCGCCCACCAGGCCAAGACCGTGACCTTCGGTTCATTCCAGGTGCGCAGCAGCATCGCCCGTAGCCACGACAATGCCTTGCACTGCGACCTGCCGGGCTAG	MSAFEKTRSFTQLIEFEIEPHQQQALVSALAEQTERLAQGYGGFLSASVQASDDGRRVLNYLQWQSREAGEAAFRRFENGEQDFWQLILAHQAKTVTFGSFQVRSSIARSHDNALHCDLPG	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	21.96	gnl|BL_ORD_ID|853|hsp_num:0	928			735	822	carbomycin
BGC0000413.1|Pyoverdine_79 # 126444 # 126917 # 1 # ID=1_79;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.688	BGC0000413.1|Pyoverdine_79 	126444	126917	+	Loose	200	197.978	Pseudomonas aeruginosa soxR	67.13	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCGAACCCGACTCCCGTCATAAAGAGCTGAGCGTCGGCCAACTGTCGGCCCGCAGTGGCGTAGCCGTCACCGCGCTGCATTTCTACGAAACCAAGGGCCTGATCCACAGCCATCGCAACGCGGGCAACCAGCGCCGCTACCCACGTTCGGTGCTGCGCCGGGTGTCGCTGATCAAGGTGGCCCAGCGCCTGGGCATTCCCCTGGCAGAGATCGGCCAGGCCCTGGCGACCCTGCCCGCCGACCGCGCGCCCACTGCCGCGGACTGGCAGCGCCTGTCGGAACAGTGGAGCCGCGAACTGGACGAACGCATCCGCCAACTGAGCCTGCTGCGCGAGCGGCTGAACCAGTGCATTGGCTGTGGCTGCCTGTCCATGGAAGGGTGCCCGCTGCGCAACTATGGAGATGCCCTGGGAGACGCCGGCCCGGGCGCCCGCCTGCTGGAGCCCGACGCCGCCACCGACACCCCGTAG	MIEPDSRHKELSVGQLSARSGVAVTALHFYETKGLIHSHRNAGNQRRYPRSVLRRVSLIKVAQRLGIPLAEIGQALATLPADRAPTAADWQRLSEQWSRELDERIRQLSLLRERLNQCIGCGCLSMEGCPLRNYGDALGDAGPGARLLEPDAATDTP	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	100.64	gnl|BL_ORD_ID|2395|hsp_num:0	2775			21	450	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
BGC0000413.1|Pyoverdine_80 # 127111 # 128949 # 1 # ID=1_80;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.662	BGC0000413.1|Pyoverdine_80 	127111	128949	+	Loose	1000	30.8018	tva(A)	32.0	3004730	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGCCAAGGACTGCCACTTTCGAAAAGCCACGCTGGCTGCGCGATCTGCTGCGCTTTCTACCCCTGAAAAGCCAATTCGTACTGTCCGGTAACGTCCGTGACCTGCAGGCCAGTGAGGTCGCCCCCGGGGTCATCACCCCCCAGCCTTTCAACCTCAACCTGCGCAATGAACTGCTGGCGGCGGGCTATGCCCAGGTGCTGAGCTGGGATCCCCTAGGCGGCCTCAGGGTTTTGCTGGCCCCCGGCAGCGAGCCGGCCCAGGCCGATAACCTGCTGCGCGAGCTGGGCCTGACCCCGGTGGACGGGGCCGCGCCGGCCGGCCTCGACCTGTTGTCGGCGACCTTGCCGCGCCTGGTGGAGCGCCAGGGCGCGCCCCTGGCCCTGATTGTCGACTTTGCATCACGCCTGGTGATCCGCAATGACGCCCTGAGCGCCGCAGAACACCAGCTGTTCACCCAGGCCCTAGTGCTGTCCCACCAGGCCCGCAGCCGCCCGGCTGGGGAGCTGCGCACGCCGTTCTTCAACAGCATTCTCTGGGTGGTGGAAAAGGAAGGCGACCTGCCCGACTGGATGCTGATCGACAACCCACGCCTGCGGCCCATTCCCGTGTCCAAACCCGACCAGCAGGCCCGCCAGGCCCTGGCTCCGGCACTGTTGCGCGGCCTGCCCGGCGCCCAGGAGGCCAGCGAAGAAAGCCGCGACAGCGCGGTGCGGGCCTTCGTCGAAAACACCGAGGGCCTGCTGCTGCTCGACCTCAACGCGATCGTCCAGCTGGCCCGGGTCGAAGGCCTGGCCATGGAACGCATCGGCGATGCCGTACGCCGCTATAAAGTCGGGGTCACCGAAGACCCCTGGCTGAAGATCGACCGCCAGCGCATCCGCCAGGCCGACGGCTTCATTCGCCAGCGGGTCAAGGGCCAGGGCCACGCCGTGACCCACATGCTGGATATCGTCAAGCGCGCCATGACCGGGGTCGGCGCCAGCCGCAAGGGCAACCGGCCCCGGGGCGTGGCCTTTCTTGCCGGGCCCACCGGGGTCGGCAAGACCGAACTGGCCAAGACCATCACCAGCCTGCTGTTTGGCGATGAAAGCGCGTGCATCCGCTTCGATATGTCGGAATTCAGCGCCGAACACGCGGACCAGCGCCTGGTAGGCGCGCCACCCGGCTATGTCGGCTACGACGTGGGCGGCGAACTGACCAACGCGATCCGCGAAAAACCCTTCAGCGTGGTGCTGTTCGACGAGATCGAAAAGGCTCACCCGCGGATCCTCGACAAGTTCCTGCAGATCCTTGATGACGGTGTGCTTACCTCAGGCCGGGGCGACCGGGTGTACTTCTCCGAGGCGCTGATCGTCTTCACCTCCAACCTGGGCATCTACCGCCAGGGCGACAACGGCGAGCGAGTCGCCAACGTCCAGCCCGGCGAAGCCTTCGAAGCGGTGCAAGGCAAGGTCCAGGGCGAGATCGAGCGCTATTTCAAACTGGTGCTCAACCGCCCGGAAATCCTCAACCGGATCGGCGAGAACATCATCGTCTTCGACTTCATCCGCCCGGACATCGCCGAGCAGATCTTCCAGCAGATGGTCGGCAATATCCTCGCCGACCTGGCGGCCCAGGCCCTGCATGTGCAGCTCGATGACGACTCGCTGCACAACCTGCGCCAGCTGTGCCTGCAGGACCTGTCCAACGGTGGCCGGGGCATTCGCAACCAGTTGGAGGCGCACCTGCTCAACCCCCTGGCCCGGGCCCTGTTCGACCAGGATGCGCAGCCCGGCCAATCCTTCGAAATCCGCCAACTGCAGGCCGGCGGCCTGCAACTGCTTGCCCGCGCCTCGTGA	MPRTATFEKPRWLRDLLRFLPLKSQFVLSGNVRDLQASEVAPGVITPQPFNLNLRNELLAAGYAQVLSWDPLGGLRVLLAPGSEPAQADNLLRELGLTPVDGAAPAGLDLLSATLPRLVERQGAPLALIVDFASRLVIRNDALSAAEHQLFTQALVLSHQARSRPAGELRTPFFNSILWVVEKEGDLPDWMLIDNPRLRPIPVSKPDQQARQALAPALLRGLPGAQEASEESRDSAVRAFVENTEGLLLLDLNAIVQLARVEGLAMERIGDAVRRYKVGVTEDPWLKIDRQRIRQADGFIRQRVKGQGHAVTHMLDIVKRAMTGVGASRKGNRPRGVAFLAGPTGVGKTELAKTITSLLFGDESACIRFDMSEFSAEHADQRLVGAPPGYVGYDVGGELTNAIREKPFSVVLFDEIEKAHPRILDKFLQILDDGVLTSGRGDRVYFSEALIVFTSNLGIYRQGDNGERVANVQPGEAFEAVQGKVQGEIERYFKLVLNRPEILNRIGENIIVFDFIRPDIAEQIFQQMVGNILADLAAQALHVQLDDDSLHNLRQLCLQDLSNGGRGIRNQLEAHLLNPLARALFDQDAQPGQSFEIRQLQAGGLQLLARAS	MFIKFNKVSFSYDSSDNILNDVSFHIDNSCTAIVGENGCGKTTLAKLITGILKPNSGSIEYSNKNIITAYCDQECINLPDNAENLFYDDSSYSGYLTSIFKIDYNYLYRFDTLSFGERKRLQIASALYSNPDILVLDEPTNHIDIECKDILINVIKRLDCIVIIISHDIDFLDELVEKCIFIRNGNCKIRIGNYTQCRGYEKDEEDYNFSLYEESRKKAKILENRYKKLQNESDAKKSKCGSKRHIDKKDHDAKGKIDAARLAGKDSRLATKAKQAKSLYNNTVMEMESLYTKKREVMDMEFIGERYKGKFLFYLEAGETKINSIVLRHPELIVKKDSRIGIEGVNGAGKTSLLNYIIETMYDNSIDKEKIIYIPQDIDRESWNNTFNNIKALDHESLGFLMSFVNRLGSNAKSVINSLNHSPGEMRKIMLGMAVIKKPYIIMLDEPTNHLDIDSIERLEEALISFNCALIIVSHNRNFIKNAVNTLWSIKIEYNYSILDIKNTI	121.19	gnl|BL_ORD_ID|2257|hsp_num:0	3484			96	243	pleuromutilin
BGC0000413.1|Pyoverdine_81 # 128946 # 129590 # 1 # ID=1_81;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.671	BGC0000413.1|Pyoverdine_81 	128946	129590	+	Loose	400	25.7942	cmeR	29.85	3000526	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACATCAGCCTGTCGCGGGTGCACTTCCCGGTCACCACCCTGGGGCCGGGGCAGCGCCTGGGCCTGTGGTTCCAGGGGTGCAGCATCCGCTGTGCAGGCTGCATTTCCGCGGACACCTGGGGGCCGGGCAAGCACCCCTTGCCGTTGGCCCAGGTGCTGGACGACCTGCAACCCTGGTTGGCCCGGGCCGAAGGCATCACCCTGTCCGGCGGCGAGCCCTTCGACCAGCCCGAGGCGCTGCTGGCCCTGCTTCGAGGCCTGCGCGAGCGCACCGGGGTCGACATCCTGGTCTACAGCGGCCACTCCCTGGAAACCCTGCAACCGCTATTGCAACAAGCCGAAGGCCTGCTGGATGCATTGATCTGCGACCCCTTCGAGCAACAACAGGCGCAAACGCTGGTCCTACGGGGCAGCGACAACCAGCGCCTGATCTTCTTGACCGAGCTGGGCCGCCAGCGTCTGTCCACCTACCAGCGCCCGCTGCACCACGAAGACCGCGCGCTGGATGTGATGTTCGACGACGACGGCAGTGTCTGGATGGCTGGAATTCCCCGGCGTGACGACGTGCTGCGTCTGCGCGACCTGCTGCACGACCAGGGCCACCAACTCCAGATCAGCGCCCACACCTCACGCCGCCGTTAA	MNISLSRVHFPVTTLGPGQRLGLWFQGCSIRCAGCISADTWGPGKHPLPLAQVLDDLQPWLARAEGITLSGGEPFDQPEALLALLRGLRERTGVDILVYSGHSLETLQPLLQQAEGLLDALICDPFEQQQAQTLVLRGSDNQRLIFLTELGRQRLSTYQRPLHHEDRALDVMFDDDGSVWMAGIPRRDDVLRLRDLLHDQGHQLQISAHTSRRR	MNSNRTPSQKVLARQEKIKAVALELFLTKGYQETSLSDIIKLSGGSYSNIYDGFKSKEGLFFEILDDICKKHFHLIYSKTQEIENGTLKEILTSFGLAFIEIFNQPEAVAFGKIIYSQVYDKDRHLANWIENNQQNFSYNILMGFFKQQNNSYMKKNAEKLAVLFCTMLKEPYHHLNVLINAPLKNKKEQKEHVEFVVNVFLNGINSSKA	101.90	gnl|BL_ORD_ID|1131|hsp_num:0	1232			24	201	erythromycin; cefotaxime; fusidic acid
BGC0000413.1|Pyoverdine_82 # 129606 # 135923 # 1 # ID=1_82;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.685	BGC0000413.1|Pyoverdine_82 	129606	135923	+	Loose	550	28.8758	R39	32.67	3003565	protein homolog model	n/a	n/a	penam	antibiotic inactivation	R39 beta-lactamase	ATGATACGTTTTTGCCCCAATTGCCAGACTGAACGCCCACTGGCCGAAATTTTCTGTGAAGGCCAGGTAGACAACCGGGCCTGCGGCTGGGAACTTTCCGCCGAAGCGATTCATCCCGAAGGCTGGCGCCCACAACCGGTCATCACCCTCGAAGCGCTTGAGCCGCAGCCCCCGGTCGCGGCGGACAGCGGCTCCCCCCTGCTATGCGGCAACGGTCATGCCATGGCGGACGGCGACTTGATGTGCCTGGTCTGCGGCGCCGACCCGCTCGCCCCGGAGCAACAGCCACCCGCCGCGCCCCCAGCCGCCGACAGTGAAACCGTGATCGAAGGCTGGCGCCTCCTGCGCCAGATCAGCAGCGGCGGCGTGCGCGAGCGCTTTATCGCCGAGCACCGGGAAACCGCGCACCAGGCGGTGCTGACCCTGTACCAGGCCGGCGCCGAACCCGACCCATCGGTGTACGAAGCCCTCAAGCGCCTGCCCCGGGAACACGTGCCGGAAATCATCCTCACCGGCCGCTGGGACGAGCGCGCCTTCGAAGTGGCCGAGGAACTCACCGGCGGCACCCTGGCCGACCTGGGGATCGTGGTCAGCGACAGGGCCGCGGTGCAGCACATCGTCCGTGAACTGGGCCAGGCCCTGCATGCCTTCAGCGAAGCCGGCCTGCGCCACCGCGACCTGCGCCCGGCCACCTTGCTGGTGCGCAGCCGCGAGCCCCTGGACCTGGTGATCAGCGGCTTCGGTTCGGCGCGGCTGTCGGAGTTCGACCTGGACATCGTCTCGCCCCTGGAAACCAGCCGCTACATGGCCCCCGAAGCCATTGCCGGGGGCGTGGCCGCAGCCTCCGACTGGTGGAGCCTGGGGATGATCCTGCTGGAACAGCTGACCCAGGGAGAATGCTTCGCCGGCATCAATGCCAACGCCTACCTGATCCACATTCTGGCCAATGGCGTACTGCTGCCGGACGACCTCGACCCGCGCCTGGAGCTATTGCTGCGCGGCCTGCTGGCCCGGGACCGTCACCAGCGCTGGCAATGGCCCCAGGTTCAGGCCTGGCTCCAGGGCGAAAGCCCCAGCGTCCCGGCCTCGGTCGCCAGTGAAGAGGACGCCGAGGAAGGCGCCAGCGTCGCCCTGGGCAGCCGGCGCTTTCGCCGGCCAGGGCCGTTCGCCCTGGCTGCCGCCGAAGTCGAACACTGGCCCCAGGCCCTGGATCATCTGCTGCGCGGGGTGATCGTCACCTGGGCCGAACAGGCCGGTTTGCCCGCACGGCAGCTGGCGGGCCTGCGCCAGGTGGCCCAGCACGAAGGGCTGGACGATGACACCCGGCTGATGCTCGCCTTGAAACTGCTGAACCCGGAAATGCCCCTGATCCAACGCGGCGAGATCGTCACCCCCGGCTGGTTGCTGGAGCATCCCCTGGACGGTTACCGCTTGATCAGCGGCCCGGCCCCGGACCTGCTGGAACGCCTGGAGACCGAGCACTGGCTGTCGCGGCTCAAGCTGCGGACCGAACAGGTACGCCAGCGCGCCCAGCACCAGGCCATCGAACTGGACGAGGAGCAACTGCGCATCTACCTGCTCTCCAGCTCCCGCGCCCGTCTGGCCGCACAGTGGGAAGAACGCCAGCGCCTGCTGCCGGACAGCGAGCACAACGGCATCCTGTCCCTGGCGGACCGCCGCTCCATCAGCGAAGAAGACCTGATCGTGCTGCTCAGCGCCGCAATCGGGCAGTTCCGCTCGGTGGACGCAATCCTCGAAGAAGCCGCCACCCTGGCCCGCGAAGCCGTGGTCCTGAGCTTCGATGCGGCCAGTGCGCGTGCCCTGCTGGGGCTGCCGCGCCCGGCCTTGTACCGTGAAGTCGACGAGCGCATCAGCGGCTTTGCCCGTTGTGGCGTGCCGAGCGTCGATGAATGGGCCGAGCAGTTCCGCCTGGAACGCCGCATGCCCCTGGCCAGGGCCCTGGTGCTGCTGGCCATCGGCGCAGAGCAGTGGCTGGAGCCGCAAAAGCAGCACTACGTGTCGCAGATCCTCGACTTCTTCGAGAAGAAGGTCGCCAGCGTGGTGCTGCGCGGCCCGCTGGTGCGCATGAGCATCGGCAAGACCACCGCCCGGGTCGACCTCAACGAATTGCACAGTGAGCGCAGCCCGGCCCCGGCGCTGCTGGATCACCTGGTGGCGCGCAACGCCCAGCCCATCAGCCTCGACCCGGCGTGCTTCGCCGAAAACCCGCAGCTGGATGCACGGCTCAACAGCCTGTACCGCCAGAGTTCGCTGTACAAGCGCGACACCGGGATCGATGGCCTGTACCTGGGCTTCCCTTTCCTCCTGACCCGGGACGCGCGTGGCACCACTCGCACTCGCATCGCGCCGTTGCTGCTGTGGCCGGTCAAGCTGCTGCTGGAAGTCGGCAGCCGCGGCAAGGTGGCCCTGGTCTTCGACAGCGAGCGTGAAGAGGTGCGCCTCAATCCGGGGCTCGACACCTTGCTGGGCATCGATGCCGCCAAGCTCTGGCGCAAGGCCGCCGATGAACTGCTGGGGCGTTCGGCGCTCAAGGCCGCCGACGTGATGGACGCCTTCGGCATGCTGGCCACTGCCAGCTCCCGGGTGCTCGGCAGCCTGCCACCGCCGAGCACCGAAGTGCAGCCCTACCAGGATCAACTGGCCTGTGCCGCCGTGCTGTTCCATGTGGCCTTCATGGGCCAGGCCATCGGCGAGGACCTGCGCCAGCTCAAGGCCCTGCCCCCCGGCGGCACCGGCCTGGAAACCGCCCTGCGCCTGAACCCCGCGGAGCCCGACAGCGGCGACAGCGCTGCCACCGCGCTCGCGCCTGAACTGCAGCGCTTCTTTACCGTGGCCAGCGACCCCTCCCAGGAAGCCGCGGTGCTCCAGGCCCGACAGGCCCCCGGGCTGCTGGTGGAAGGCCCGCCCGGCACCGGCAAGAGCCAGACCATCGTCAACATGGTGGCCGACGCCATCGGCCGCCAGCGCAGCCTGCTGATCGTCTGCCAGAAGCACGCCGCCCTGGAAGTGGTGCACAAGCGCCTGGTGGCCGAAGGCCTGGGCAACCGGGTGGTGATGCTCAACGACATCAACCGTGACCGCGAACCGGTGATCCGCAGTGTCCGCGAACAGCTTGAGGCCCTGTTCAAGGACGATGCCGTCCAGCAACCCTGGCTGCACCAGCGTGAACGCCTGGCGGCACGCATCGAAGCCCTGGAGGGCGAACTGGATCGCTTCCACCAGAGCCTGCACCGCATCGATGAACACTGTGGCTTGAGCTACCGCCAGTTGATCGGCGAGCTGATCGGCCTGGAACAGGGGCCAGCGGCCCTGGATGTCCCGGTATTGCGCCAGCACCTGGCGGCCCTGGACATCGCCAGCCTGACCCGCCTGGAAGAGGCCTGCGCGCCGCTGATCCGCCTGTGGCTGCCGGCCCGCTATGAACACAGCGCCCTGGCCCAGCTCCAGCCCTTCCCCACCGACGCCGCCACGGTGCAAGCGTTCAACCAGGGCTTCGAGCGCCTGCTGAGCTGCGAGGAGCAGCGCCTGGAAACCCTGCAGGCACACCCGGCCGACTTCGAAGTCGACGACCCGGCGCCCTACCGCGCCTGGCTCGACCAGCACCTGCACAGCCTGCTGGGCCTGGACGATGAGCGTCGCCAACGGCTGGCACGCTGGCTCCCGCTGTTTCGTGGCAGCAACGGCCAGGCCGCAGAAGGCGACGGGCTGATCCAGGCCCTGCAGGCACTGGCTCAACAACTGGAACAGTGCGACGCCACCGCTTACCAGGCCGACCTGGCGCCGGGCCTCAGCGCCCTGCCCGCGGCCCAACTGCGCACCCTGCAGCAACGCGCCCGCGCCGTTATCCAGGGTCGCTCCTGGCTGGCGCGGCTCAACCCGCTGCGCCTGATCCGCCAGCGCCAGTTGCTGGCCTTCCTCGCCGAACAGGGCGCCGCGGCCCAGCCGCAGCGCCTGCCAGAACTGCTGGCGGCGGCCCTGCTGGAAAGCCAGTGGCGGCCCTTGCGCGCGCAGTTGCAACACCTGCATCAGCAACTGAGCCTTGCACAAATCGCCAGCGATTGCGGCCCGGGCCTGCTGCCGCAGGTACGCCAGGACCTCGGGCAACTGCAAGAAATGCGCGCCCTGGCCATGACCCTGGCGCAAGCCCCCCGGGTGGAGCAGTTGGATGCGGTGGTACTGACCGGCGAGCGGCGCTCTCTGGACAGCCTGCTGGCCGGCTACGACGCCGCGTTTATCCGCCACAGCGTGCGCCAGGACAGCCTGAATGCCCTGCAGCGCCTGGATCAGTGGCTGCAACCCGAGCTGCTGGGCCAACTGCGCCAGCGCGTGGAGCACAACCAGGGCAATCAGTCGGCCCTCAACCGCCTGCGCGACGCCTTGCCGACCCTGAGCGCCTACCAGGCTTTCCGGGCCCGGGCCGGCCAGCTGTCGCCGGCGGACCTGGAGTTGCTGGTAGTCCTGCGCGATTACCAGGACGCGCTCGACGCCATTCCCGCCGAGCAACTGGAAGCCGTGGTGCGGCACATGCTCAACCGCGAAGCACGGCTGGGCTGGAAGCGCCAGATCGAACAACGCCAACCCGAGCTGATGCTCGAGCACAGCGAAACCGCGGCGAAGATCGCCAGCCTGGGCGAAGCCGACACCCAGATGCGCAACCTCAACCGTCAGTTGCTCAGTGAAGGCATCGAGCTGTCGCGCCTGGGCACCCGCAAACAGTGGGAGGACGTCACCCGCCTCACCGGACGGCGTTCGCGACGCTTGCGCGAGTTCATGGAAATGGGCGCCGGCCTGGGGCTGATGAGCCTGCGACCGGTGTGGCTGATGAACCCGGACGTGGCCAGCCGGGTGCTGCCGCTCAAGCCCGGGCTGTTCGATACGGTGATCTACGACGAAGCCTCGCAGATGCCGGTGGAGTTCGCCCTGCCGACCCTGTACCGGGGCCGAGTCACAGTGGTCAGCGGCGACGAGAAGCAGATGCCGCCCACCGCCTTCTTCTCCAGCCGGGTGGAAAGCGACGAGGCCGAACTGTTCGATGGCGACCAGCCGGACGCCGATGCCGACGAGGAACAACGGGAGGCCTTCGAAGACACCTGGAACCGCCGCGAAATCAAGGACTGCCCGGACCTGCTGCAACTGGCTCGCAGCTCGCTACCCTCCACCACCCTGCAGATCCACTACCGCTCGGCCTACCGCGAGCTGATCGGTTTCTCCAACGCCTCGTTCTACGGCAACCGCCTGAGCATCCCGGTACGCCATCCCCAGGCCAATATCCTCGCCATCAAGCCGCTGGAGCTGATCCGCGTGGACGGCGTCTACCAGCAGCAGGTCAACCCCGACGAGGCCGAACGGGTGGTGGACTACCTGGCCGAGCTCTGGCAGGCGCCCTATGCCGAACGCCCCTCGGTGGGGGTGGTGACCTTCAACCGCAAGCAGGCCGACCTGATCGAAGAGCGCCTGGAGTTGCGCGCCGAGCAGGACCCGGCGTTTCGTGCGGCCTACAGCCAGGAGCGCGAACGCAGCGAGGACGGCGAGGACATGTCGGTGTTCGTCAAGAACGTCGAGAACGTCCAGGGCGATGAGCGCGACATCATCGTGTTCTCCTCGACCTTCGGGCGTAACAGCCAGGGCAGCTTCCGCCGCAACTTCGGGGTCCTGGGGCAGACCGGCGGCGAGCGCCGGCTCAATGTGGCGGTGACCCGGGCCCGGCGCAAAGTGGTGATGATCACCTCGATGCCGATTGCCGATATCTCCGACATGCTCACCACCCAGCGCCCGCCCGCCAGCCCGCGGGACTACCTGCAAGGCTACCTGGAGTACGCCCGCGCCCTGTCGGCCGGGGAGTTTGCCAGCGGCCACAGCCTGCTGGGGCGCCTGGTCACCGAGCGCCAGGATGCAAAGGTCCAGCACAACGCCCACAGCGACGGCTTCACCCAGGCGGTGGCGGCGTACATCCGCACCCTGGGCTGGAGCCCGGTCAGCGCCAACGAAGGGGATGCCTTCGGCCTGGACTTTGCCATCGAGCACCCCGATACCGGGCTCTACGCCCTGGGCATCGAATGCGATACCCCGCGCCACGGCCTCCTGGCCCGCGCTCGCTCCCGGGAAATCTGGCGCCCTTCGGTGCTGCGCCGGGCCATTCCCCACCTGCACCGGGTCTCGTCGCAGGCCTGGTACCACGACCCGCAAAGCGAGCGCGCTCGCCTGCAGGCCGCCATCGAGCAGGCCCTGCAGCCGCTGGCCGGTGCCGATTCGGTGACGCAGCCCCCAGCCCTGGCAGACACGGAGCAAACCCCATGA	MIRFCPNCQTERPLAEIFCEGQVDNRACGWELSAEAIHPEGWRPQPVITLEALEPQPPVAADSGSPLLCGNGHAMADGDLMCLVCGADPLAPEQQPPAAPPAADSETVIEGWRLLRQISSGGVRERFIAEHRETAHQAVLTLYQAGAEPDPSVYEALKRLPREHVPEIILTGRWDERAFEVAEELTGGTLADLGIVVSDRAAVQHIVRELGQALHAFSEAGLRHRDLRPATLLVRSREPLDLVISGFGSARLSEFDLDIVSPLETSRYMAPEAIAGGVAAASDWWSLGMILLEQLTQGECFAGINANAYLIHILANGVLLPDDLDPRLELLLRGLLARDRHQRWQWPQVQAWLQGESPSVPASVASEEDAEEGASVALGSRRFRRPGPFALAAAEVEHWPQALDHLLRGVIVTWAEQAGLPARQLAGLRQVAQHEGLDDDTRLMLALKLLNPEMPLIQRGEIVTPGWLLEHPLDGYRLISGPAPDLLERLETEHWLSRLKLRTEQVRQRAQHQAIELDEEQLRIYLLSSSRARLAAQWEERQRLLPDSEHNGILSLADRRSISEEDLIVLLSAAIGQFRSVDAILEEAATLAREAVVLSFDAASARALLGLPRPALYREVDERISGFARCGVPSVDEWAEQFRLERRMPLARALVLLAIGAEQWLEPQKQHYVSQILDFFEKKVASVVLRGPLVRMSIGKTTARVDLNELHSERSPAPALLDHLVARNAQPISLDPACFAENPQLDARLNSLYRQSSLYKRDTGIDGLYLGFPFLLTRDARGTTRTRIAPLLLWPVKLLLEVGSRGKVALVFDSEREEVRLNPGLDTLLGIDAAKLWRKAADELLGRSALKAADVMDAFGMLATASSRVLGSLPPPSTEVQPYQDQLACAAVLFHVAFMGQAIGEDLRQLKALPPGGTGLETALRLNPAEPDSGDSAATALAPELQRFFTVASDPSQEAAVLQARQAPGLLVEGPPGTGKSQTIVNMVADAIGRQRSLLIVCQKHAALEVVHKRLVAEGLGNRVVMLNDINRDREPVIRSVREQLEALFKDDAVQQPWLHQRERLAARIEALEGELDRFHQSLHRIDEHCGLSYRQLIGELIGLEQGPAALDVPVLRQHLAALDIASLTRLEEACAPLIRLWLPARYEHSALAQLQPFPTDAATVQAFNQGFERLLSCEEQRLETLQAHPADFEVDDPAPYRAWLDQHLHSLLGLDDERRQRLARWLPLFRGSNGQAAEGDGLIQALQALAQQLEQCDATAYQADLAPGLSALPAAQLRTLQQRARAVIQGRSWLARLNPLRLIRQRQLLAFLAEQGAAAQPQRLPELLAAALLESQWRPLRAQLQHLHQQLSLAQIASDCGPGLLPQVRQDLGQLQEMRALAMTLAQAPRVEQLDAVVLTGERRSLDSLLAGYDAAFIRHSVRQDSLNALQRLDQWLQPELLGQLRQRVEHNQGNQSALNRLRDALPTLSAYQAFRARAGQLSPADLELLVVLRDYQDALDAIPAEQLEAVVRHMLNREARLGWKRQIEQRQPELMLEHSETAAKIASLGEADTQMRNLNRQLLSEGIELSRLGTRKQWEDVTRLTGRRSRRLREFMEMGAGLGLMSLRPVWLMNPDVASRVLPLKPGLFDTVIYDEASQMPVEFALPTLYRGRVTVVSGDEKQMPPTAFFSSRVESDEAELFDGDQPDADADEEQREAFEDTWNRREIKDCPDLLQLARSSLPSTTLQIHYRSAYRELIGFSNASFYGNRLSIPVRHPQANILAIKPLELIRVDGVYQQQVNPDEAERVVDYLAELWQAPYAERPSVGVVTFNRKQADLIEERLELRAEQDPAFRAAYSQERERSEDGEDMSVFVKNVENVQGDERDIIVFSSTFGRNSQGSFRRNFGVLGQTGGERRLNVAVTRARRKVVMITSMPIADISDMLTTQRPPASPRDYLQGYLEYARALSAGEFASGHSLLGRLVTERQDAKVQHNAHSDGFTQAVAAYIRTLGWSPVSANEGDAFGLDFAIEHPDTGLYALGIECDTPRHGLLARARSREIWRPSVLRRAIPHLHRVSSQAWYHDPQSERARLQAAIEQALQPLAGADSVTQPPALADTEQTP	MLFPTARRTGFAALAALALVPAAACSGSAAPAEAEPASAEVTAEDLSGEFERLESEFDARLGVYAVDTGTGEEVFHRADERFGYASTHKAFTAALVLGQNTPEELEEVVTYTEEDLVDYSPITEQHVDTGMTLLEVADAAVRHSDNTAANLLFEELGGPEGFEEDMRELGDDVISADRIETELNEVPPGETRDTSTPRAMAGSLEAFVLGDVLEEGPRDVLTEMLLNNTTGDELIRAGVPEDWRVGDKTGGGSHGSRNDIAVVWPPEDDPIVIAVMSTREQEDAEFDNALVSGATEVVVEALAP	692.43	gnl|BL_ORD_ID|4671|hsp_num:0	332			372	645	
BGC0000413.1|Pyoverdine_83 # 135920 # 137254 # 1 # ID=1_83;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.649	BGC0000413.1|Pyoverdine_83 	135920	137254	+	Loose	1500	28.8758	rphB	34.38	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAGCGGCCCGAAAGTGGTGCGTATCGTCACCCGTGAAGAAATCCTGGAGATCTGCGCCGGTCACCTGCGGCGCCTGGAACAGGCGATTGCCCGCTGGGAAGAACAGGCCCAGCGCCTGGGGCAACTGACCGAACAGGAGCGGGCCGCCACCCACGAGCGGTTCAAACAATTGCGCCAATTGATCGAGGCCGATCGCCTGCTGGATCTGCAGAAACAGGTGCCGATCGAAATCCAGTACCTCAAGGACGATCTGCAACAGCGGGAAAACCGCGCGGTGCAGCAGGCCACGCAACAGCGCCAACTGGCCCGCCGCCAGCGGGAAAACGCCACCACTCTGCTGGGCGCGCTGCAAGGCAAAGCGCTGCCAACCGAACTGCTGCAACAGTTGCAGGCGCTTGCCGACGGACAGCCCGTGGCGGCTGTCGAGTCGATTCTCGCCCAGGGTTTCGCCAGCCTCGGTGCCACAGCCGAAGAACAGGACCTGAGCGAGGCACAGCAGCAACTGGCCCGACGCCTGCAAGGCGAGAACACCACCCAGACCCTGGCGCAATGGCGCGCCGCCCATGAACAAAAGGAACCCAGGCTGGAACGCATCGAGCAGCACATTGCCCAGTTGCTGACCCTCGACCATCAGGCCAGTGCCGAACCCTATCTGGCCAAGTTGCGCCAGATAGACGCCGAAACCCGCGAGCAACAGCGCAACCTGCTGCTGGACAGCCTGGTGCTGGAACTGGCCCAGGCCACCCGCGACAGCCATGAACGCCGCGCGCGCCTGGTTCTTCTCCAGGAGCTGGCCAATGAAGTCGCGATCCTATGTCCCGCGGCTGTCGAGCAAGAGCTGGTCCAGGCCGGACAATGCAGCCTGGCCAATATGGCGCCAGTGGATGAGCTGATTGCCCGGTTCAACACGCTGATCGAAGCCGAGCTGCAACAACGCGCCGCCCTGGCCCGTCGCCAGGCGGTACTCGAAGGCCTGGCCAGCCTGGGTTACGAAGTTCGCGAGGGGATGGCCACCGCCTGGGCCAAGGACGGTCGGGTGGTGCTGCGCAAGAGCGCCACTCCGGGGTATGGCGTGGAGGTTGGAGGCACGGCCGACAACGGCCGGCTGCAAGTACGTGCGGTCGCCCTCAGCGCCCAGCGCGACACCCAGCGCGACAAAGACATCGAGACCATCTGGTGCGGTGAGTTCCAGCGACTGCAAGCCCTGCTGGCCGCCCAGGGCGACGACCTGAGCATCGAGAAAGCCCTGGCCGTAGGGGCCGTACCGCTCAAGGAAGTGCAACTGGACAACACCCAGCAGGAATACCGGGAGCAGGCGCAACAGCGCACCTGA	MSGPKVVRIVTREEILEICAGHLRRLEQAIARWEEQAQRLGQLTEQERAATHERFKQLRQLIEADRLLDLQKQVPIEIQYLKDDLQQRENRAVQQATQQRQLARRQRENATTLLGALQGKALPTELLQQLQALADGQPVAAVESILAQGFASLGATAEEQDLSEAQQQLARRLQGENTTQTLAQWRAAHEQKEPRLERIEQHIAQLLTLDHQASAEPYLAKLRQIDAETREQQRNLLLDSLVLELAQATRDSHERRARLVLLQELANEVAILCPAAVEQELVQAGQCSLANMAPVDELIARFNTLIEAELQQRAALARRQAVLEGLASLGYEVREGMATAWAKDGRVVLRKSATPGYGVEVGGTADNGRLQVRAVALSAQRDTQRDKDIETIWCGEFQRLQALLAAQGDDLSIEKALAVGAVPLKEVQLDNTQQEYREQAQQRT	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	50.23	gnl|BL_ORD_ID|2235|hsp_num:0	2528			1755	1938	rifampin; rifaximin; rifabutin; rifapentine
BGC0000413.1|Pyoverdine_84 # 137352 # 138122 # -1 # ID=1_84;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.617	BGC0000413.1|Pyoverdine_84 	137352	138122	-	Loose	50	26.1794	vanY gene in vanF cluster	23.19	3002958	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGAAGAAGACCCTGGCCGTATTGGCCGCCGTACTGTCCCTGAGCGTCAACGCCAACGAAAAGCTGCTGGTGGGCGCGACCCCGGTGCCCCACGCCGAGATCCTCGAATTCGTCAAACCGCAACTGGCCAAGGAAGGCGTGGACCTGCAGATCAAGGTGTTCACCGACTTCATCCAGCCCAACCAGCAGCTGGCGCTGAAGAACCTCGACGCCAACTACTACCAGTACCGGCCGTTCCTCGATGACTTCAACAAGACCCGGCACACCGACCTGGTGCCCGTGGTGGGGGTGCACATCGAACCGTTCGGCGCCTATTCCACCAGGATCAAGAGCATCGCCGAGCTCAAGGACGGGGCCAGCGTTTCGATTCCCAACGACCCGGTGAACACCGGCCGGGCCCTGGTGCTGTTGGATGAAGCGGGGCTGATCAAGCTCAAGGACCCGAGCAACACCCTGGCCACCCAGCGCGATATTGTCGAGAACCCCAAGCACCTGAAGATCCGTGAACTGGAAGGCGCCTTGCTGGCCCGCTCGGTAAGCCAGGTGGACCTGGCGTTTGTCTTCGCCAACTACGCCCTGGAAGCCGGGATCGATACCAACAGCGCCTTGATCGTGGAGAAGGGCAAGGACCTGTACATCGAATTTCTGGTGGCGCGCCCGGACAACATCAACGACCCGCGGATCCAGAAACTGGCCAAGGCGCTGAACTCCGACGCCGTGCGCCAGTTCATCCTGACCCGCTACAAAGGCCAGATCGCCCCCGGCTTCTGA	MKKTLAVLAAVLSLSVNANEKLLVGATPVPHAEILEFVKPQLAKEGVDLQIKVFTDFIQPNQQLALKNLDANYYQYRPFLDDFNKTRHTDLVPVVGVHIEPFGAYSTRIKSIAELKDGASVSIPNDPVNTGRALVLLDEAGLIKLKDPSNTLATQRDIVENPKHLKIRELEGALLARSVSQVDLAFVFANYALEAGIDTNSALIVEKGKDLYIEFLVARPDNINDPRIQKLAKALNSDAVRQFILTRYKGQIAPGF	MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS	87.37	gnl|BL_ORD_ID|1808|hsp_num:0	1899			594	801	vancomycin
BGC0000413.1|Pyoverdine_85 # 138205 # 138870 # -1 # ID=1_85;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0000413.1|Pyoverdine_85 	138205	138870	-	Loose	700	25.409	EreB	36.36	3000363	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGGCCGAACTGTTCAAGAACATTTACTGGGCCGATATCGCCCAGGCCTGCGTCGATACCCTGAGCATGCTCGGCGCGGCCCTGGGTTTTACCGTGCTGCTGGGGCTGCCCCTGGGCGTGCTGCTGTTTCTCACCGGCAAGCGCCAGTTGCATGAAGCGGTGGGCCTGTATCGGGTGCTGTCGGTGCTGGTCAACATGCTGCGCTCCTTGCCCTTCATCATCTTGCTGATCGTGCTGATTCCCCTGACCACCTTGCTGGTGGGCACCTCGCTTGGCGTGCCGGGCACTATCCCGCCGCTGGTGGTGGGCTGCACGCCGTTCTTTGCCCGGCTGGTGGAAACCGCCCTGCGGGAAGTGGACCGCGGGGTGGTGGAAGCGACCCAGGCCATGGGCGGCAGCACCTGGCAGATCATTCGCCACACCTTGCTGCCCGAAGCCCGGGGCGGTCTGCTGGCGGCGGTCACGGTGACCGCCATCGTGCTGGTGGACTACACCGCCATGGCCGGGGTGATCGGTGGCGGCGGCCTGGGCGACCTGGCCATCCGCTACGGCTACCAGCGTTTCCAGACCGATGTGATGGTGGTCACCGTGGTCTTGCTGCTGGTGCTGGTGCAGGCCCTGCAGATGACCGGTGACCGCCTGGTGGCGCACTACAGCCGCCGTTGA	MAELFKNIYWADIAQACVDTLSMLGAALGFTVLLGLPLGVLLFLTGKRQLHEAVGLYRVLSVLVNMLRSLPFIILLIVLIPLTTLLVGTSLGVPGTIPPLVVGCTPFFARLVETALREVDRGVVEATQAMGGSTWQIIRHTLLPEARGGLLAAVTVTAIVLVDYTAMAGVIGGGGLGDLAIRYGYQRFQTDVMVVTVVLLLVLVQALQMTGDRLVAHYSRR	MRFEEWVKDKHIPFKLNHPDDNYDDFKPLRKIIGDTRVVALGENSHFIKEFFLLRHTLLRFFIEDLGFTTFAFEFGFAEGQIINNWIHGQGTDDEIGRFLKHFYYPEELKTTFLWLREYNKAAKEKITFLGIDIPRNGGSYLPNMEIVHDFFRTADKEALHIIDDAFNIAKKIDYFSTSQAALNLHELTDSEKCRLTSQLARVKVRLEAMAPIHIEKYGIDKYETILHYANGMIYLDYNIQAMSGFISGGGMQGDMGAKDKYMADSVLWHLKNPQSEQKVIVVAHNAHIQKTPILYDGFLSCLPMGQRLKNAIGDDYMSLGITSYSGHTAALYPEVDTKYGFRVDNFQLQEPNEGSVEKAISGCGVTNSFVFFRNIPEDLQSIPNMIRFDSIYMKAELEKAFDGIFQIEKSSVSEVVYE	52.74	gnl|BL_ORD_ID|1771|hsp_num:0	1921			687	786	erythromycin; roxithromycin; clarithromycin; azithromycin
BGC0000413.1|Pyoverdine_86 # 138874 # 140097 # -1 # ID=1_86;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.666	BGC0000413.1|Pyoverdine_86 	138874	140097	-	Loose	600	34.2686	LUS-1	35.0	3006942	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LUS beta-lactamase	ATGCCTGCATTGCCTGAATCTGCCGTTTATCCCCTGCACACTCCCGCTGCCCATGTGATCCGCGATGGCGCCGAAGCCCTGGCCGTGGCCCGGCAAGTGGCCGCGATCCTGCTGGAGCAGGACGCCGAGCGCGACCGTACCCGGGAAGTACCGGCGCAGGTGGTCGACCTGTACTCCAACAGTGGCTTGTGGGGCATCAGTGTGCCTCGCGAATTTGGCGGCGCCCAGGTGTCCTATGCGGTGCTGGCCGAGGTCATCGCGATCATTTCCGCTGCCGACCCGTCCTTGGGGCAGATCCCGCAGAACCACTACTGCCTGCTGGAAGACATCCGCCTGCAGGGCACGCCGGAGCAACAGGCGCACTTTTTCGCCCTGGCCCTGCAAGGCCATCGCTTTGCCAATGCGTTGTCGGAAACCGGCGGCAAGAACGTCCAGGACATCCAGGCCACTGTCCGCCGCTCGGGTGACGGTTATGTGATCAATGGCCGCAAGGGCTACTGCACCGGTTCGCTGTATGCCCATTGGCTGGCAGTGCTGGCCCTGGACGAGCAGGGCAGGGGCCAGCTGGCCTTCGTGCCCCGGGGCAGCGAGGGGCTGGCGGTGATCGACGACTGGGACAGCATCGGCCAGCGCACCACCTCCAGTGGCACCGTACTGGCCCAGGACCTCAAGGTGCCGGCCTTCAACCTGTTTCCCACCTACCGTTCCTACGAAAGCCCGACCCTGGCCGGGCCCTTCGCCCAGCTGACCACGGCCGCCATCGACGCCGGGATTGCCCGGGCGGCGCTGCGCGACACCATCGCCTTCGTGCGTGAGCATGCCCGGCCGTGGATCGATGCCGGGGTGGAGAAGGCCAGTGAAGACCCGCTGACCATCATCCAGGTGGGGGCCCTGGACATTCGCCTGGAAGCCGCCGAGGCCCTGCTGGAACGGGCCGGCCTGGCCCTGGACGCGGCCCGCCCGGCACCCGATGAAGACAATGTGGCCCGGGCCTCCCTGGCGGTGGCCAAGGCCAAGGTGCTGACCACCGAAATCGCCATCGAGGCCAGCAACAAACTGTTCGAACTGGGGGGCACCCGTTCCACCCTCAAGCGCCACAACTTCGACCGCCACTGGCGTAACGCCCGGGTGCATACCCTGCACGACCCGGTGCGCTGGAAATACCACGTGGTGGGCAACTGGCTGCTCAACGACATCAAGCCACCGCGCCATGACTGGTCCTGA	MPALPESAVYPLHTPAAHVIRDGAEALAVARQVAAILLEQDAERDRTREVPAQVVDLYSNSGLWGISVPREFGGAQVSYAVLAEVIAIISAADPSLGQIPQNHYCLLEDIRLQGTPEQQAHFFALALQGHRFANALSETGGKNVQDIQATVRRSGDGYVINGRKGYCTGSLYAHWLAVLALDEQGRGQLAFVPRGSEGLAVIDDWDSIGQRTTSSGTVLAQDLKVPAFNLFPTYRSYESPTLAGPFAQLTTAAIDAGIARAALRDTIAFVREHARPWIDAGVEKASEDPLTIIQVGALDIRLEAAEALLERAGLALDAARPAPDEDNVARASLAVAKAKVLTTEIAIEASNKLFELGGTRSTLKRHNFDRHWRNARVHTLHDPVRWKYHVVGNWLLNDIKPPRHDWS	MKGFFRIKSVVCGVFLLMISVNAFAQKSELREKLQRIVNAHSATIGFSLTDLRNGDTLTVNGTKHLPMQSVYKFHLALAVLDQVDQGKLKLDQKIMVKKSDLLPDTWSPLRDKYPNGEVEIPLSEILSFTVSQSDNNGCDILFRLIGGPAKVNRYIHHLGIKDVAITATEEQMHQNDQIQFTNWTTPQAATELLGLFYAKKILSPASHEFLCKVMTETSTGADKIKGLLPAGTLAAHKTGSSGANKSGLTAASNDIGIVTLPDGKHFAVAAFVSMTKEDEKATDLIIAELTKASWDYLTTGKP	134.32	gnl|BL_ORD_ID|3683|hsp_num:0	4753			102	267	
BGC0000413.1|Pyoverdine_87 # 140381 # 140848 # 1 # ID=1_87;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.654	BGC0000413.1|Pyoverdine_87 	140381	140848	+	Loose	780	29.6462	tet(H)	30.0	3000175	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCGTCAATCCCATTCCCGAAGGTTTCAGCGGCGTCACCCCCTACCTGGGCATCCAGCGCGCCGCCGAGGCCATCGAGTTCTACAAGAAGGCCTTCGACGCGGTGCAGATCATGCGCCTGGACATGCCCGACGGCAGGGTCGGCCATGCCGAACTGCGCATCGGCGGTTCTGCCATCATGCTCGGCAGCCCTTGCGAACAAACCCCGATGGGCAGCCCGGAAGCCCACAAGACGTCGGTCGGGCTGCACCTGTATGTGGAAGATGTCGACAGCCGCTTTGCCCAGGCGATCGCCGCGGGCGGCACCGAAGTGTCGGCGGTCAAGGACCAGTTCTACGGCGATCGCAGCGGCAGCCTGCGCGACCCTTTCGGGCATGTGTGGTTCCTCGCCAGCCGCAAGGAGGAACTGAGCGCCGAGGAAATCGGCCGACGGGCCCGGGAAATGTTCCAGCAACAGGCCGGCTGA	MSVNPIPEGFSGVTPYLGIQRAAEAIEFYKKAFDAVQIMRLDMPDGRVGHAELRIGGSAIMLGSPCEQTPMGSPEAHKTSVGLHLYVEDVDSRFAQAIAAGGTEVSAVKDQFYGDRSGSLRDPFGHVWFLASRKEELSAEEIGRRAREMFQQQAG	MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPILGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSDVTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFRETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRFDWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVWVILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSYSVAYWDGLLWLMGAILYAMLLITAYFHQRKTTPKAVISTP	38.75	gnl|BL_ORD_ID|1036|hsp_num:0	1027			720	960	tetracycline
BGC0000413.1|Pyoverdine_88 # 141145 # 142368 # 1 # ID=1_88;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.632	BGC0000413.1|Pyoverdine_88 	141145	142368	+	Loose	1900	33.113	acrD	28.16	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCGAAGAAGTCCCGTTCAAAAATCTGGTTTCTGGTGCACAGCTGGCTGGCCCTGCCCATCTGGTTCTTTGTGCTGATTGTCTGCGTCACCGGCACCCTGGCGGTGGTCAGCCAGGAGATCGTGTGGCTGGCCAACCCCGACGTGCGCGCCAGCAAGCCCAGCGATGACGCACAACCGCTGAATTACGACCAGATCGTCCAGGCCATCAAGCGCGCCGAACCCCAGACCCGGGTGGATACCATCGTCACCCCGGATGAAAGCCACTTCGCCCTGAGTGTCAGTGTCAGCTACCCGGACGGCCGCTCGCCGACGCTCTACGTCAACCCCTACACCGGGGTGATCCAGGGCACTAGCCCGCAGTTCGATTTCCAGGGCTTCACCCGCGCCCTGCACGGCTGGTGGCTGGTGCCCTTCACCAACGGCTACAGCTGGGGCTGGTACCTGGTGTCCTTGCTGGGCCTGCCCATGCTGGTGTCGCTGATCACCGGGCTGGTGGTCTACAAGAAGTTCTGGAAAGGCTTTCTCAAGCCGACCCTGCGCCTGCGCCACGGTGCACGGATCTTCTGGGGTGATTTCCATCGCCTGAGCGGCATCTGGTCGATCTGGTTCATCGCGGTGATCTCCATCACCGGCACCTGGTTCATGATCGAAGCGATTCTTTCGGACAACCACATTAGTATCTCCAGCGAACCCGTGGTCCCGGTGATCGCTCGCGAACAAGTGCCGACCACGGGCGATGGCAGCCCGGCGCCGATGATCGGCCTGGACCAGGCCATCGGCATTGCCACACAGAAAATCCCCGGCTTCGACATCAGCTTCGTCAGCCTGCCGAGCAACGCCTACAGCCACCTGTATGTCGGCGGCCGCGGCTGGTATCCGCTGATGTACCAGACGGCCAACATCAACCCCTATACCGGCTCCCTGGACACCTCGCACCTGCTGGCGGACCGCAACACCCTGGAGTTCGTCACCGAATCCATGCGCCCGTTGCACACCGGTGATTTCGGCGGCCTCTGGATCAAGCTGATCTGGTTCTTCTTCGGCCTGGTGCTGAGCATGATGGTCCTCAGCGGCCTGCTGATCTGGACCAAACGCACCGCCCTGGCCACCGCCAACGCCCTCAAGCGCGAAGAAAAGGCCGCCCGTGCGCGCCCCGCCAGCAAACCCGCCCAGGCACCCGCCCCGGCCATGCGCGCCGAAACCTCGGAGAGCACCCTGTGA	MSKKSRSKIWFLVHSWLALPIWFFVLIVCVTGTLAVVSQEIVWLANPDVRASKPSDDAQPLNYDQIVQAIKRAEPQTRVDTIVTPDESHFALSVSVSYPDGRSPTLYVNPYTGVIQGTSPQFDFQGFTRALHGWWLVPFTNGYSWGWYLVSLLGLPMLVSLITGLVVYKKFWKGFLKPTLRLRHGARIFWGDFHRLSGIWSIWFIAVISITGTWFMIEAILSDNHISISSEPVVPVIAREQVPTTGDGSPAPMIGLDQAIGIATQKIPGFDISFVSLPSNAYSHLYVGGRGWYPLMYQTANINPYTGSLDTSHLLADRNTLEFVTESMRPLHTGDFGGLWIKLIWFFFGLVLSMMVLSGLLIWTKRTALATANALKREEKAARARPASKPAQAPAPAMRAETSESTL	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	39.25	gnl|BL_ORD_ID|1309|hsp_num:0	1427			36	336	
BGC0000413.1|Pyoverdine_89 # 142365 # 142907 # 1 # ID=1_89;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.648	BGC0000413.1|Pyoverdine_89 	142365	142907	+	Loose	1150	24.2534	blaR1	31.37	3000217	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BlaZ beta-lactamase	GTGAGCCAGACCAGCACCGCCGCCGCGCCTTCGAACCTGAGCCGGCTCTGGCACAAGTGGCGCTTTCACCTGAACATCCTGCTGTTGCTGATTCCCCTGGGCTTCATGCCCAAATACTTCGCCGACGTTGCCCTGTTTCGCGGCGAAAGCGGCCTGGGTGAACGGGAGATCGGCGAAATCCAGGTCGGCCCCTGGAGCCTGCGCCTGGCGGAAATGCGCAACGAAGCGCCACGCAGCGATGGCCCCGCCGGTTACCTGAAAAGCTTCAACGCCGCCCTGTGCCAGGCCTGCATCGAGCCGGTCAAAGCCACCTACCTGCGCATCGGCAAGCCCCGCAGCCTGCGGGCCGCCGGGGTGATTTTCTTCGGCAGCCCGTACCGCATGGGCGCCAGCCTGCCCATCCCGGAAAAGACCAAGGCCGATTCCGAGCTGTGGATCACCATGGAAGGCTGGGACGGCAGCATGCACCAGGCATCCATTCCCCTGAGCCAGGCGTCACCCGCCACCGTGGCCTGGCTCGAAAAACAAGGAGGCAAACGATGA	MSQTSTAAAPSNLSRLWHKWRFHLNILLLLIPLGFMPKYFADVALFRGESGLGEREIGEIQVGPWSLRLAEMRNEAPRSDGPAGYLKSFNAALCQACIEPVKATYLRIGKPRSLRAAGVIFFGSPYRMGASLPIPEKTKADSELWITMEGWDGSMHQASIPLSQASPATVAWLEKQGGKR	MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGLSFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLLLTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKTYILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMRLDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIAFFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFAGNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGVEYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWLESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHAINGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID	30.61	gnl|BL_ORD_ID|1900|hsp_num:0	2063			87	216	
BGC0000413.1|Pyoverdine_90 # 142904 # 143242 # 1 # ID=1_90;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.649	BGC0000413.1|Pyoverdine_90 	142904	143242	+	Loose	500	23.8682	GOB-39	29.73	3005688	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGAGTTGCGCAGTATTCCCACGGCGCCTTGGCGCCCTGGCCCTGTTGTTGCTGGGCGGCGCCTTCAGCCACAGCGCCCTGGCCCACAACCCGATGTGCGAGTGCAAGGCCATAGACGCCGAGCAGATCCGCTGCACCGGTGGTTTTTCCGATGGCAGCGGCGCCCCGGGGGTGACCCTGGACGTGATCGGCTACGACGAAACCATCCTGGTGCCGGGCAAGCTGGGGGCCGACTCGACCCTGACCTTCAAGAAACCTTCCAGCGAGTTCTACGTACTCTTCGATGCGGGCCCCGGCCACGTGGTCGAGATCGACCAAGCGGATATCGAGGCCCCATGA	MSCAVFPRRLGALALLLLGGAFSHSALAHNPMCECKAIDAEQIRCTGGFSDGSGAPGVTLDVIGYDETILVPGKLGADSTLTFKKPSSEFYVLFDAGPGHVVEIDQADIEAP	MRNFATLFFMFVCLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGNSDYEMGKYGVTFKPVTLDKTLKDQDKIKLGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFKAMKNLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK	38.62	gnl|BL_ORD_ID|3583|hsp_num:0	4652			279	498	
BGC0000413.1|Pyoverdine_91 # 143239 # 143811 # 1 # ID=1_91;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.675	BGC0000413.1|Pyoverdine_91 	143239	143811	+	Loose	380	28.4906	AcrS	30.91	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTCCTGCCACCACCCAGGTCGTGCGCCCCGCCGGCGCCGGCCATGAAACCCTCTATGTGCTGTTGCTGTGTGCACTGATTCTGAGTGTGGCTGCCACCGTGGTGCTGTGGCGCGGCGAAGAAACCGCGACCGGCAGTGTCGCCAGCCACCAGTTGGACGCGCGCCGCGACCTCAGCGCCGGCGAGCAGGGCATCTATGCCGACCTGCGGGTGACCCTCGACGAAATCCACCTGCTGCGCGCCGAAAGCCAGGACCTGCCGACCCCCGAGGAACTGGCCGGCGAAGGCTTCGCACCCTTCGCCCAGGACGCCAGCTCGGTGAGCCGCGGTGGCCATATCTGGACAGTGCAGAACCAGGCCTACCTGGGCCTGAGCCAGAACCTGCAAGTGGCCGGCTCCTTTCTGATGCGCATCGACGCCGAAGATGACACCCAGGTGGATATCTGGCTCAACCGCGCCCCTTCCGCCGCCCTGCCCGCTGACCTGGGCGACGAACCACTGGCCGCCGCCGGCTGGCAACAGGTGGTGGCGCAATTCGATGCCGGAGTGACCCGCCAGCATCGCCACTGA	MTPATTQVVRPAGAGHETLYVLLLCALILSVAATVVLWRGEETATGSVASHQLDARRDLSAGEQGIYADLRVTLDEIHLLRAESQDLPTPEELAGEGFAPFAQDASSVSRGGHIWTVQNQAYLGLSQNLQVAGSFLMRIDAEDDTQVDIWLNRAPSAALPADLGDEPLAAAGWQQVVAQFDAGVTRQHRH	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	86.36	gnl|BL_ORD_ID|601|hsp_num:0	520			9	174	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000413.1|Pyoverdine_92 # 143847 # 144776 # 1 # ID=1_92;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.655	BGC0000413.1|Pyoverdine_92 	143847	144776	+	Loose	400	25.409	FusF	24.43	3004663	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	ATGCCTATTTCATCTCAACGCCGCCCCTTTCTGCAGGTGCTGCTGGTCAGTCTGCTGGCCCTGATGCTCAGCCCCCTGGCCAGCGCCGACCCGGCCAAGCGCCTGCGCATCGGCATCACCCTGCACCCCTACTACAGCTACGTGGCCAATATCGTCGGTGACAAGGCCGAGGTGGTGCCGCTGATTCCCGCCGGCTTCAACCCCCACGCCTACGAACCCCGGGCCGAGGACATCAAGCGCATCGGCACCCTGGACGTGATAGTGCTCAACGGCGTGGGCCACGATGACTTCGCCGACCGCATGATCGCCGCCAGCGAGCGCCCGGACATCCCGGTGATCGAAGCCAACGAAAACGTGCCGCTGCTGGCCGCCACCGGGGTGGCCGCGCGAGGCGCCGGCAAAGTGGTCAACCCGCACACCTTCCTCTCCATCAGCGCCTCCATCGCCCAGGTCAACAACATCGCCCGGGAGCTGGGCAAGATGGACCCGGCCAACGCCAAGACCTACACCCAGAACGCCCGCGCCTACGGCAAGCGCCTGCGGCAGATGCGCGCCGACGCCCTGGCCAAGCTGACCCAGGCGCCCAATGCCGACCTGCGGGTGGCCACGGTGCATGCAGCCTACGACTACCTGTTGCGCGAGTTCGGCCTGCAAGTCACCGCGGTGGTGGAGCCGGCCCACGGCATCGAACCCAGCCCCAGCCAGTTGAAGAAGACCATCGACCAACTGCGCGAGCTGGACGTCAAGGTGATCTTCTCGGAGATGGACTTCCCCTCCACCTACGTCGACACCATCCAGCGTGAATCCGGGGTCAAGCTCTACCCGCTGTCACACATTTCCTACGGCGACTACAGCGCCGACAAGTACGAGAAGGAAATGAAGGGCAACCTCGACACCGTGGTCCGGGCCATCCAGGAGGCCGGGGCATGA	MPISSQRRPFLQVLLVSLLALMLSPLASADPAKRLRIGITLHPYYSYVANIVGDKAEVVPLIPAGFNPHAYEPRAEDIKRIGTLDVIVLNGVGHDDFADRMIAASERPDIPVIEANENVPLLAATGVAARGAGKVVNPHTFLSISASIAQVNNIARELGKMDPANAKTYTQNARAYGKRLRQMRADALAKLTQAPNADLRVATVHAAYDYLLREFGLQVTAVVEPAHGIEPSPSQLKKTIDQLRELDVKVIFSEMDFPSTYVDTIQRESGVKLYPLSHISYGDYSADKYEKEMKGNLDTVVRAIQEAGA	MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIEKLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYIGWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQYTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS	144.39	gnl|BL_ORD_ID|2205|hsp_num:0	3364			6	360	fusidic acid
BGC0000413.1|Pyoverdine_93 # 144773 # 145516 # 1 # ID=1_93;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.695	BGC0000413.1|Pyoverdine_93 	144773	145516	+	Loose	570	92.4337	bcrA	31.58	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCGCCATCGAGACCCTGCTGCGGGGCCCGGCCATCGAGTTCGACCAGGTCAGCCTGACCCTGGGCCGCACCACCATCCTCGATCGCGTCGCCTTCCAGGTGCAGCCCGGCAGCGTGCACGCCCTGGTGGGCCCCAACGGCGGCGGCAAGAGTTCGCTGATCAAGACCCTGCTGGGGCAGATGCCGCACCAGGGCCAGTTGCGCCTGCAGTGGCCGGATGCCCCCGGCACCATCGGCTATGTGCCCCAGGCCCTGGAGTTCGACCGCGGCCTGCCCATGACCGTGGACGACTTCATGGCCGCCATGTGCCAGCGCCGCCCGGCCTTTCTCGGCCTCAGCCGGCACTACGCCCAGGCCATTGGCGAGGCCCTGGAACGAGTCGGCATGCAGGACAAGCGCAAGCGGCGCATGGGCGCCCTGTCTGGCGGTGAACGCCAGCGGGTGCTGCTGGCCCAGGGCCTGATCCCGGCCCCGCAACTGCTGGTATTGGACGAACCGATGTCGGCCCTGGACGAGGCCGGGATCCAGGTCTTCGAACGACTGCTCCACGACTGGCGCCAGAGTGGCATCACCCTGCTGTGGATCGAGCACGACCTGGAAGCAGTGGGTCGCCTGGCGGATCGGGTCACCGGTCTCAACCGCCGGGTGCTGTTCGACGGCCCGGCGCAGCAGACCCTGACCCCGGAGCGCCTGCTCTGTCTGTTCTCCACCCATCCACGAACCGCCGGGAGCGCTGCCTGA	MTAIETLLRGPAIEFDQVSLTLGRTTILDRVAFQVQPGSVHALVGPNGGGKSSLIKTLLGQMPHQGQLRLQWPDAPGTIGYVPQALEFDRGLPMTVDDFMAAMCQRRPAFLGLSRHYAQAIGEALERVGMQDKRKRRMGALSGGERQRVLLAQGLIPAPQLLVLDEPMSALDEAGIQVFERLLHDWRQSGITLLWIEHDLEAVGRLADRVTGLNRRVLFDGPAQQTLTPERLLCLFSTHPRTAGSAA	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	80.72	gnl|BL_ORD_ID|315|hsp_num:0	345			57	609	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000413.1|Pyoverdine_94 # 145516 # 146415 # 1 # ID=1_94;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.654	BGC0000413.1|Pyoverdine_94 	145516	146415	+	Loose	1900	28.1054	mexN	46.51	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCTATGAAGCTTTTCGCCTGATGGTCCAGGGCTGGGCTTCGGCCGGCTACCTGCCCGAAGCCCTGGCCTACGGGTTCGTGGTCAATGCGCTGCTGGCCGGCCTGCTGATCGGACCGGTGCTTGGCGGCCTGGGCACGCTGGTGGTGGTCAAGCGCTTCGCCTTCTTCTCCGAAGCGGTAGGCCACGCGGCCCTCACCGGAGTGGCCATCGGCATCCTCCTGGGCGAGCCCTACACCGGTCCCTACGGCAGCCTGTTCGGCTACTGCCTGCTGTTCGGCATCCTCCTCAACTACCTGCGCAACCGCACCGGGCTGGCTCCGGACACCCTGATTGGCGTCTTCCTCTCGGTGTCCCTGGCCCTGGGCGCCAGTCTGCTGCTGATCCTGGCCGGCAAGATCAATGTGCACATTCTTGAAAACGTGCTGTTCGGCTCGGTGCTCACGGTCAACGGCAACGACCTCTTGGTGCTGTTGATCGTCGGTGCCCTGGTGCTGGGCCTGAGCCTGCCGCTGTACAACCGCATCATGCTGGCCAGCTTCAACCCACAGCTGGCGGCCGTGCGCGGCGTCGCCGTCAAGACCCTGGACTACCTGTTCGTAATCCTGGTGACCCTGATCACCGTGGCCGCGGTCAAGGTCATCGGCGCCATCCTGGTGGGCGCGCTGCTGGTGATTCCGGCCGCTGCCGCCCGCTTGCTCAGCCAGTCCCTCAAGGGCTTCTTCTGGATCTCGGTGAGCATCGCCACCGTCAGCACCCTGTGCGGCATCCTGCTACCCATCGTCTTCGACCTGCCGGTGCCCTCCGGCGCCGCGATCATCCTGGTGGCCGGTGTCGCCTTCGCCCTGGCCGCCATCGCTCGCGGCACTGTCCCCAGCCTGAAAGGGAATATCGGATAA	MTYEAFRLMVQGWASAGYLPEALAYGFVVNALLAGLLIGPVLGGLGTLVVVKRFAFFSEAVGHAALTGVAIGILLGEPYTGPYGSLFGYCLLFGILLNYLRNRTGLAPDTLIGVFLSVSLALGASLLLILAGKINVHILENVLFGSVLTVNGNDLLVLLIVGALVLGLSLPLYNRIMLASFNPQLAAVRGVAVKTLDYLFVILVTLITVAAVKVIGAILVGALLVIPAAAARLLSQSLKGFFWISVSIATVSTLCGILLPIVFDLPVPSGAAIILVAGVAFALAAIARGTVPSLKGNIG	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	28.86	gnl|BL_ORD_ID|2021|hsp_num:0	2217			2508	2637	chloramphenicol; thiamphenicol
BGC0000413.1|Pyoverdine_95 # 146416 # 147399 # 1 # ID=1_95;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.679	BGC0000413.1|Pyoverdine_95 	146416	147399	+	Loose	500	26.5646	CTX-M-151	39.39	3002008	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGCACAGTTCATTGCCTCACCTGTCACTGCGTCGCCTGACCCTGGCCCTGGCCCTCGGCGGCCTGATCAGTACTCCGGCCCTGGCCGAGCGCGACCACTTCGAACCGATGCGCGTGGTCGCCAACCACGGCATGGGCAACACCGCGCTGCACAGCGCCACCTCAAGCAAATCACCGACGGTGCTGGCTTCCCTGCCGGTGACTTTCGGCCTGGGGCAGATCCTGCTGCAGGGTACCGACATCAAGCTGGAACGGGCCGCCCCGGCCAACCTGCCGGGCTCGCGGCAGACTGCCTATTTCACCGGGCGTGGCGCTCCGGCCCTGGCCAAGCTGGCACTCAATGCCGACGCAGTGATCGGCCTGCGCTCGATCTGGCCGGACGACCCGCTGTACCCCAACGCCCGGCGCAGCAACATCCGCATCGTCGAGATCGACGCTGCACGCCCGGTGGACGGCGCCCTGCCCGGGGTGGCCCTGCAACCGGGCAAGAGCGACGGGCTCAACGCCCAGCCCTGGCTGTCCAGCAACAACCTGGGGCGCATGGCCGACGTGCTGGCGGCGGACCTCGCGCGGCTGGCGCCCGAAGCCAAACCGCAGATCGAAAGCAACCTGGCGGGCCTCAAACAGCGCCTGCTGAAACTCAGCGCCGACAGCGAAGCGCGCCTGGCCGAGGCCGACAACCTCAGCGTGCTGAGCCTCTCCGAGCACTTCGGGTACCTGGTCAGTGGCCTGAACCTGGAACTGCTGGAAGTGGACGCCCGGGCCGACAACGAATGGACCCCCGAGGCCCTGAAAAAGCTGCAAGCCCGGCTCAAGGACAACGATGTGGCCCTGGTCCTGCACCACCGCCAGCCGTCCGATGCACTGAAAGCCGCCATCAGCGCCGGCGGCAGCCAGCTACTGGTGCTGGAAACCGACAGCGCCGACCCGCTCGCCGAACTGGAAGGCAACCTGCAGAAAGTCACCCAGGCCCTGAGCCTGTAG	MHSSLPHLSLRRLTLALALGGLISTPALAERDHFEPMRVVANHGMGNTALHSATSSKSPTVLASLPVTFGLGQILLQGTDIKLERAAPANLPGSRQTAYFTGRGAPALAKLALNADAVIGLRSIWPDDPLYPNARRSNIRIVEIDAARPVDGALPGVALQPGKSDGLNAQPWLSSNNLGRMADVLAADLARLAPEAKPQIESNLAGLKQRLLKLSADSEARLAEADNLSVLSLSEHFGYLVSGLNLELLEVDARADNEWTPEALKKLQARLKDNDVALVLHHRQPSDALKAAISAGGSQLLVLETDSADPLAELEGNLQKVTQALSL	MINKRLSIALALAAMIGTPVAMALESQKPGSDSANHIQHQMVQQLSALEKSANGRLGVAVIDTGSGAIAGWRMDEPFPMCSTSKVMAVAALLKQSEQTPELMSQPQPVASGDLVNYNPITERFVGKSMTFDELSAATLQYSDNAAMNLILAKLGGPQKVTAFARSIGDDKFRLDRNEPSLNTAIPGDLRDTSTPRAMALSLQKLALGDALGQVQREKLSHWLRGNTTGAASIRAGLPSGWSVGDKTGSGDYGTTNDIAVVWPTGRPPLVIVTYFTQPQQQAESQRPVLAKAAAIVASHYVLPKG	107.57	gnl|BL_ORD_ID|331|hsp_num:0	362			9	108	
BGC0000413.1|Pyoverdine_96 # 147611 # 148438 # 1 # ID=1_96;partial=00;start_type=ATG;rbs_motif=AGAAG;rbs_spacer=8bp;gc_cont=0.649	BGC0000413.1|Pyoverdine_96 	147611	148438	+	Loose	2000	26.1794	Staphylococcus aureus mupB conferring resistance to mupirocin	25.4	3000510	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGAGCGACTACGTAAAACTCAACAAGACCAACTGGGACGAACGCGCGCCCCTGCATGCCGCCTCGGCGGACTACGCAGTGCAGCGTTTTGTCGACGAAGCCGGCTATCTGTCCGACGTGGTGCAGTTCGACCGGCCCTTGCTGGGGGATATCCGAGGCCTGCGCGGGGTGCATCTGCAATGCCATATCGGCACCGACACCCTGTCCCTGGCCCGCCTCGGCGCGCAGATGAGCGGCGTGGATTTTTCCCCGGCGTCCCTGGCTGAAGCCCGGACCCTGGCCCGACGCTGCAATACGCCTATCGACTACCACGAGTCCGACGTGTTCCTGGCCGCCGAGGTACTGCCCCAAGGCAACTTCGATCTGGTCTACACCGGCATCGGCGCCCTGTGCTGGCTGCCGAGCATCGAGCGCTGGGCGCAGACCGTCGGCGCCCTGCTCAAGCCCGGTGGCCGGCTGTTCATCCGCGAAGGCCACCCGATGCTCTGGGCCATCAACGAAGATCACGACGACTCATTGCGGGTGGAACTGCCCTACTTCGAAACCCGCGAGCCTCTGGTCTGGGACGACGAAAACACCTACGTGGAAACCGACAGCCCCCTCAAGGCCACCATGACCCACGAATGGAACCACGGCCTGGGAGAGATCATCAGCGCCTTGCTGGCCCAGGGCCTGGACATCACGGGACTGGTGGAGCACCAGAGCATCCCCTGGGAAGCCCTGCCCGGGCAGATGGTGGTGGATGAACGCGGCGAATGGCGACTCAAGGAAGCGCCATGGCGCCTGCCACTGAGCTACACCTTGCAGGCCGTCAAGCGCGGGGGCTGA	MSDYVKLNKTNWDERAPLHAASADYAVQRFVDEAGYLSDVVQFDRPLLGDIRGLRGVHLQCHIGTDTLSLARLGAQMSGVDFSPASLAEARTLARRCNTPIDYHESDVFLAAEVLPQGNFDLVYTGIGALCWLPSIERWAQTVGALLKPGGRLFIREGHPMLWAINEDHDDSLRVELPYFETREPLVWDDENTYVETDSPLKATMTHEWNHGLGEIISALLAQGLDITGLVEHQSIPWEALPGQMVVDERGEWRLKEAPWRLPLSYTLQAVKRGG	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	26.62	gnl|BL_ORD_ID|4698|hsp_num:0	2271			90	279	mupirocin
BGC0000413.1|Pyoverdine_97 # 148728 # 148952 # -1 # ID=1_97;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.587	BGC0000413.1|Pyoverdine_97 	148728	148952	-	Loose	600	25.7942	DES-1	61.54	3004780	protein homolog model	n/a	n/a	penam	antibiotic inactivation	DES beta-lactamase	ATGACTTCAGTATTCGACCGTGAGGACATCCTGTTCCAGGTGGTGGTCAACCATGAAGAGCAATACTCGATCTGGCCCGACTACAAGGCCGTGCCCCAGGGCTGGCGCACTGTGGGCAAGAGCGGTTTCAAGAAGGACTGCCTGGCCTACATCGAAGAAGTCTGGACCGACATGCGTCCCCTGAGCCTGCGCCAGAAGATGGACCAGCAGGCCGTAGCCGGCTGA	MTSVFDREDILFQVVVNHEEQYSIWPDYKAVPQGWRTVGKSGFKKDCLAYIEEVWTDMRPLSLRQKMDQQAVAG	MHSRSSYSRRYVLAGLCALPFASLSAGLIFNSSADAASLAAINGKTLQKKLAELEAASGGRLGVAARSSNGGKSLSYRGDERFPMCSTFKVLAVAALLRDKPGILEQRIHFAQIDIQPWSPVTEKHLEDGMTVAELCAAMLQHSDNTAANLVLAKLGGPQGLTSLARSFGDTTFRLDRWEVELNTAIPGDARDTTTPLAMCNTLNGLLCGNLLKAPARERLTGWMLGCATGAGRIPAGIPQGWRSAHKSGSGENGTANDVGVLLPPSNPGKATKPGKNKGKPLTVALYLTGSRLTGPENDKILASATRLVCAAEGLAMPLDNMY	22.84	gnl|BL_ORD_ID|2660|hsp_num:0	3580			711	750	
BGC0000413.1|Pyoverdine_99 # 150683 # 152008 # -1 # ID=1_99;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.684	BGC0000413.1|Pyoverdine_99 	150683	152008	-	Loose	900	134.035	basS	32.36	3003583	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	GTGAGAAGCCTGCGCCTGCGCCTGAGCATGACCCTGGGCGCTGCCTTCATCCTGATCTGGGCCCTGGCCGCGGCCTGGATGCTCAGTGACCTGCGCAACCAGATGATGTTTTCCCTGGACCAGCGCCTGGTCGCTTCGGCGCGCATGGTCGCCGGGCTGCTGGAGCAGATGCCGGCGCTGCCGTCCCATGGCCCGAGCAACCAGATCAACAGCGCAGCCCTGACCATCCCCGGCGGCATGGCCTGCCAGGTCAGTTCCCTGCGCGGGCAGATCCTGGCCCGCAGCCACAGCACTCCGGAGCACCCGCTGGAAGCCGAGAAGCTGGGCTTTCACGACCAGATGATCGACGGCGCGCCCTGGCGCACCTTCACCCTGGTGCGCGGCGACATGCGCATCACCACCGCGGATCGCCAGGTCGAGCGCGAAGCCCTGAACATGTCGGTGCTGCTGGCGGCTTCGGTGCCGGTGGGCGTGGCCTTGCTCGGCTGCCTGTGGCTGCTGTGGCTGGGCATCGGCCAGAGCCTGGCCCCGCTGAACCGGATTCGTGACGCGCTGATGCGCCGCAGCGCCGACTCCCTGGAACCGTTGCAGATCCAGCCCATGCCCAGCGAGCTGCGGCCGCTGCTGGAAACCCAGAACCAGCTGTTCCAGCGCATTGCCAAGACCATCGAGCGCGAACGCCGCCTGACCGGTGACGCCGCCCACGAATTGCGCAGCCCGCTGACCGCGATCAAGACCCACCTGCAAGTGGCACGCATGACCGAAGGTGCGGCCCGGGATCAGTCCCTGGCCCGGGCCGAGGAGGGCGCCGACCGCATGCACCGCACCCTGGAGCAGCTGCTGTTGCTGGCCCGGGTCGAGGGCAGCCTGTCGTTCGACGACGGCGTGCACTGTACTGCCGAACAGGTGGCGCGCCTGGCGATCCAGGACGCCGCCGTGGGCGCTCGGGCCCGGGTCAAGCTGCATATGCACGGCAAGGCCGGCGAGGCTGCGGTGGAAATGCCCTCGACCCTGGCCATCGCTGCCTTGCGCAACTTGCTGGACAACGCACTGCGCCACACCCCTGAAGAATGCCCGGTGGAGCTGAACCTGGAGACAGTCGGCGCCCGGGTGCGTTTCCAGGTCCGCGACCATGGTTCGGGCATTCCCGCGCAAGACTTGCAGCACCTGACCCAGCGCTTCTGGCGCGACAGCCAGAGCAGTGGCTGTGGCCTGGGCCTGGCGATTGTCCAGGCCATCGTCCAGCGTTGCGGTTGCGAGCTGAATTTCGATAGCCGCCCCGATGGCCTGCGAGTCGAGCTGACCCTGCCTGCCCACCGCGCCTGA	MRSLRLRLSMTLGAAFILIWALAAAWMLSDLRNQMMFSLDQRLVASARMVAGLLEQMPALPSHGPSNQINSAALTIPGGMACQVSSLRGQILARSHSTPEHPLEAEKLGFHDQMIDGAPWRTFTLVRGDMRITTADRQVEREALNMSVLLAASVPVGVALLGCLWLLWLGIGQSLAPLNRIRDALMRRSADSLEPLQIQPMPSELRPLLETQNQLFQRIAKTIERERRLTGDAAHELRSPLTAIKTHLQVARMTEGAARDQSLARAEEGADRMHRTLEQLLLLARVEGSLSFDDGVHCTAEQVARLAIQDAAVGARARVKLHMHGKAGEAAVEMPSTLAIAALRNLLDNALRHTPEECPVELNLETVGARVRFQVRDHGSGIPAQDLQHLTQRFWRDSQSSGCGLGLAIVQAIVQRCGCELNFDSRPDGLRVELTLPAHRA	MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI	92.45	gnl|BL_ORD_ID|2350|hsp_num:0	249			309	1311	polymyxin B
BGC0000413.1|Pyoverdine_100 # 152009 # 152686 # -1 # ID=1_100;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.656	BGC0000413.1|Pyoverdine_100 	152009	152686	-	Loose	400	145.206	cprR	38.64	3005063	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	ATGCACGTACTTGTCTGTGAAGATGATGAGCTGATTGCCAGCGGGATAGTCGCCGGCCTCACGGCCCAGGGCCTGACGGTCGAGCATGTGGCCACCGCTTCGGCAGCGCGGGCCATGCTCGGCGTGGCCGATTTCGACGTGATGGTACTGGATCTTGGCCTTCCGGATGAAGACGGTTTGAAGCTGCTCAAGCAGCAGCGCCAGCAGGGCCTGGAGATTCCGGTGCTGATCCTCACCGCCCGCGACTCGGTGACCGACCGGGTCGATGGCTTGCAGGCCGGTGCCGACGATTACCTGCTCAAGCCCTTCGACCTGCGGGAACTGGCGGCGCGCCTGCACACCCTGTTGCGCCGGGTGGCGGGGCGCAGCGTCAACCTGATCGAGCACGGGCGCTTGACCTATGACCCGAGCACCCGGGAAACCCTGCTCGGCGGCCAACCGGTGGACCTCTCGCGGCGCGAGCAATCCCTGCTCCAGGCGCTGCTGCACAACCGTGGCCGGGTGCTGTCCAGCGAGCAACTCAAGGACAGCGTCTACGGTTTCAACGATGAGCTGGAGAGCAACGCGCTGAATGTGCACATCCACCACCTGCGGCGCAAACTCGGCAACGGCATCGTCGAAACCGTGCGCGGCCTCGGCTATCGCCTGGGCCCGGCCGACGGTGAGGAGAACCGCTAA	MHVLVCEDDELIASGIVAGLTAQGLTVEHVATASAARAMLGVADFDVMVLDLGLPDEDGLKLLKQQRQQGLEIPVLILTARDSVTDRVDGLQAGADDYLLKPFDLRELAARLHTLLRRVAGRSVNLIEHGRLTYDPSTRETLLGGQPVDLSRREQSLLQALLHNRGRVLSSEQLKDSVYGFNDELESNALNVHIHHLRRKLGNGIVETVRGLGYRLGPADGEENR	MHIHVLVVEDNFDLAGTVIDYLEAAGVVCDHARDGQAGLNLARANRYDVILLDIMLPRINGRQVCRQLREAGLQTPVLMLTALDTLQDKLDGFDAGADDYLLKPFELPELLVRLQALSRRRSGQAQRLQVDDLVMDLDSRQASRGGTPLALSPTAWKILECLMRASPALVTREQLGRSVWGDEPPESNTLNVHMHHLRSTVDKGFATPLIHTLHSVGFQLERK	100.90	gnl|BL_ORD_ID|2788|hsp_num:0	3803			6	660	polymyxin B; colistin A; colistin B
BGC0000413.1|Pyoverdine_101 # 152840 # 154591 # 1 # ID=1_101;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.678	BGC0000413.1|Pyoverdine_101 	152840	154591	+	Loose	400	28.8758	VIM-16	45.16	3002286	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGCGTCGATTGTTTCTCCTGTTGTTCATGCTCTTCACCACACTGGCGCACGCCGGCAACAACCCGTTCGAGGTCAAGCCCGACTTCCTGCCGGTGGGCAAGGCCTTCGTCTTCACCTCCGAGCGCCTGCCTTCAGGGGAAACCCAGCTGTTCTGGCAGATCGCCGACGGCTACTACCTGTATCAGAAGCGCCTGAAATTCGACGGCGTGGCGCCAGAGCTGCAACCCACCCTGCCGGCCGGTGAAGACCACAGCGACGAATTCTTCGGCCAGCAGACGGTGTATCGCCAGGGCCTGGAAGTGAAGCTGCCGGCCGCCGCCAGCGGCAAGGTCAAGCTGGGCTGGCAAGGCTGCGCCGACGCCGGCCTGTGCTACCCGCCACAAACCCTGGAAGTGGACCTGGGCGGTGCGCCCGCAGTGGCCGCCAGCAACGTCGCGACCACCAGCAATGGCTCGGCCCAGGACCAGTTGCTGGCCAATGACCTGCAACACAAATCCTGGGGCCTGGGCCTGCTGGCCTTCTTCGGTTTCGGCCTGCTGCTGGCCTTCGCCCCCTGCTCGCTGCCGATGCTGCCGATTCTGGCCGGCATGGTGGTGGGCAGCGGCGCCAGCCCGCGCCGGGGCCTGGCCCTGGCCTCTAGCTATGTGCTGTGCATGGCCCTGGTGTATGCCGGCATGGGGGTAATCGCCGCCCTTTTGGGCAGCAACCTGCAAGCCTGGCTGCAACAACCCTGGGTCCTGGGCAGCTTCGCCGCGCTGTTCGTGCTGCTGTCGCTGCCGATGTTCGGCTTCTTCGAGCTGCAGATGCCGGCCCTGCTGCGCGACCGCCTGGAAGGCGCCAGCCGCCAGCGCCAGGGCGGCAGCCTGATTGGCTGCGGCATTCTCGGCGCGCTGTCGGCCCTGTTGGTGGGCCCGTGCATGACCGCGCCACTGGCCGGCGGCCTGCTGTACATCGCCCAGACCGGTAACGCGCTGTTTGGCGGCCTGGCCCTGTTCGCCCTGGGCCTTGGCATCGGCCTGCCGCTGTTGCTGCTGGTGACCCTGGGCAACCGCTTCCTGCCCAAGCCCGGCCCGTGGATGAACCTGCTCAAGGGTGTATTCGGCATCCTGTTCCTGGGCACCGCCATCTACATGCTGCGCCCGGTACTGAACCCCGGCCTGTGGATGGGGCTGTGGGGCGCCCTGGCCCTGGTGGTGGCCTACTGCGCCTGGCAGCAACGGGCGATTGCCGGCCGCTTGCTGCACCTGTTCGGTGCCGGCGCGCTGCTGTTCGCGGCCTGGGGCGGCATGCTGCTGGTGGGTGCCGCCGGTGGCGGCGACGACCTGTGGCGGCCGCTTAAGGTCTACCGCGGTGGCCCTGTGGCCAATAGCGTCACGGCCCATGATGCCTTCACCACGGTAAAGTCCCCCGCCGAGCTGCAAGGCGCCCTGGACAGCGCCCGGGCCCAGGGCCAGTGGGTGCTGCTGGACTACTACGCCGACTGGTGCGTGTCCTGCAAGATCATGGAGAAAACCGTGTTCGGCCAGCCTCAGGTGCTGGAGGCCCTGAAGGATGTGCGCCTGCTGCGCCTGGACGTGACCCTGGACAACGCCGACGGCCGCGAACTCCTGAGCCGCTACAAGGTGCCGGGGCCACCGAGCATGCTGTGGATCGGCCCGGACGGCAGTGAACGCCGCAGCCAGCGCATCACCGGCGAAGTGGATGCCAACGCCTTCCTGCAACGCTGGACCCAGACCCGGGAAGCCCGTTGA	MRRLFLLLFMLFTTLAHAGNNPFEVKPDFLPVGKAFVFTSERLPSGETQLFWQIADGYYLYQKRLKFDGVAPELQPTLPAGEDHSDEFFGQQTVYRQGLEVKLPAAASGKVKLGWQGCADAGLCYPPQTLEVDLGGAPAVAASNVATTSNGSAQDQLLANDLQHKSWGLGLLAFFGFGLLLAFAPCSLPMLPILAGMVVGSGASPRRGLALASSYVLCMALVYAGMGVIAALLGSNLQAWLQQPWVLGSFAALFVLLSLPMFGFFELQMPALLRDRLEGASRQRQGGSLIGCGILGALSALLVGPCMTAPLAGGLLYIAQTGNALFGGLALFALGLGIGLPLLLLVTLGNRFLPKPGPWMNLLKGVFGILFLGTAIYMLRPVLNPGLWMGLWGALALVVAYCAWQQRAIAGRLLHLFGAGALLFAAWGGMLLVGAAGGGDDLWRPLKVYRGGPVANSVTAHDAFTTVKSPAELQGALDSARAQGQWVLLDYYADWCVSCKIMEKTVFGQPQVLEALKDVRLLRLDVTLDNADGRELLSRYKVPGPPSMLWIGPDGSERRSQRITGEVDANAFLQRWTQTREAR	MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWLHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE	219.17	gnl|BL_ORD_ID|549|hsp_num:0	602			102	192	
BGC0000413.1|Pyoverdine_102 # 154591 # 155454 # 1 # ID=1_102;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.671	BGC0000413.1|Pyoverdine_102 	154591	155454	+	Loose	500	30.4166	STA-1	27.97	3007000	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	STA beta-lactamase	ATGCTGACCTTTACCATCGGCACCTTTGCCATCGCCCTCAACCACCTGCTGTTGATCAGTGCCCTGGCCCTGGCCACCCTGGTGGGCTGGCGCGTGGCCAAGCGCGGCGGTGACAACCCTGAGTCGGTGCTGTTCAGCCTGTTCCTTTTGGGCATGCTCGCCGCCCGGGTCAGTTTCGTGCTCGCTTACTGGAAGCACTACCAGCACGACCTGTGGATGATCATCGACCTGCGCGACGGCGGCTTCCTGGCCTGGCCGGGGGTGATCGTCATGCTCCTGGCGGCCCTGGCCTGGGGCTGGAAACGCCCGGCGCTGCGCCGCCCATTGGGTGCCGGGGTGGCCAGCGGCCTGGCCTTCTGGCTGCTGGCGACCCTGGCCCTGACCCTCTACGACCAGGGCACGCGCCTGCCGGAAGTGGCCCTGCGCAACGCCGCCGGCGAAACCGTGCAACTCACCGACTACCAGGGTGGCCCGCTGGTGATCAACCTCTGGGCCACCTGGTGCCCACCGTGCCGGCGGGAGATGCCGGTGCTGGAAAGAGCCCAGCAGCAACGCCCGGACCTGACCTTCCTGTTCGTCAACCAGGCCGAAAGCATGCAAAGCGTCAGCACCTTCCTGGCCACCCAGGACCTGAACCTGAACAACGTGCTGTTCGACGGCAGTGGCCGCCTGGGCAAGGCCGTGGGCTCCATGGCCCTGCCGACTACGCTGTTCTATAGCGCCGATGGCCGCCTGCTGGGCAGCCACCTGGGGGAACTCTCGGAAGCCAGCCTGGCCCGGGCCCTGGAAAACTTCGACGGCGCCCACCCGACCTCGGTCGCCCCTTCAAGGAAACTGCCATGCCCTTCATCCGCCACTTGCTGA	MLTFTIGTFAIALNHLLLISALALATLVGWRVAKRGGDNPESVLFSLFLLGMLAARVSFVLAYWKHYQHDLWMIIDLRDGGFLAWPGVIVMLLAALAWGWKRPALRRPLGAGVASGLAFWLLATLALTLYDQGTRLPEVALRNAAGETVQLTDYQGGPLVINLWATWCPPCRREMPVLERAQQQRPDLTFLFVNQAESMQSVSTFLATQDLNLNNVLFDGSGRLGKAVGSMALPTTLFYSADGRLLGSHLGELSEASLARALENFDGAHPTSVAPSRKLPCPSSATC	MHPPLRPHPLWCSLRPATLALLLGVFGCRTSVPAPRPAAEPFTSITEDLRIQPLAPGVWRLVALSGEEWGHIPANGLVIAEGGGVLLVDPGWTEAQGERLLQWVEDTLKVPVHAGVATHFHADRTGGLRALQARGIPTHALALTAALTSQQDRPAPTHLFPGPAQQLGPVELFFPGPGHAPDNITVWHAASGILFGGCMVKDLKASSLGNLSDADLASWPRSVESLQARYPAARTVIPGHGEPGDTSLLAHTLELLRAGSR	109.96	gnl|BL_ORD_ID|4596|hsp_num:0	5666			444	741	
BGC0000413.1|Pyoverdine_103 # 155430 # 156197 # 1 # ID=1_103;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.634	BGC0000413.1|Pyoverdine_103 	155430	156197	+	Loose	400	26.9498	ErmQ	25.45	3000593	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCCTTCATCCGCCACTTGCTGAGCCTGTCTCTGGGCGCGGCGTTGCTCAACGCCCCACTGCTACAGGCCGAGGAACTGCCTGCGCCCATCCGCAAGATCGAAGAAAAAGGTGCCAAGATCATCGGCAGCTTCGACGCCCCGGACGGCCTCAAGGGCTACGCCGCGCAGTACCAGAACCGCGGCATGACCCTGTACCTCACCCCTGACGGCAAGCACGTGCTGCTGGGCAACCTCTACGATGCAGACGGCAAGGACCTGAGCGCCGAACCGTTGCAGAAACTGGTCTACGCGCCCATGGCCAAGGAAGTCTGGGGCAACCTGGAAAAGAGCAACTGGATCGCAGACGGCAAGGCCGATGCACCACGCATCGTCTACCTGTTCAGCGACCCCAACTGCCCCTACTGCAACATGTTCTGGGAACAGGCGCGGCCCTGGGTCAAGGCTGGCAAAGTGCAGTTGCGGCATATCATGGTGGGCATCATCCGCGAAGACAGCCCGGGCAAATCCGCCGCCCTGCTGGCCGCCAAGGACCCGCAGCAGGCCCTGCAGGATCACGAAAAGGCCGGCAAGGGCAGCGCCCTGAAACCCCTGGCCAGCATTCCCGCAGCGGTGCAGGCCAAGCTCGACGCCAACATGAAACTGATGGAAGAGCTGGAGCTGTCGGCGACCCCGGCGATCTTCTACCTCGACGACAAGGGCGAGTTGCAACAGCAGCAAGGCGCCCCGGCCCCGGGCAAGCTGACGCAGATCCTCGGCCCCAAATAA	MPFIRHLLSLSLGAALLNAPLLQAEELPAPIRKIEEKGAKIIGSFDAPDGLKGYAAQYQNRGMTLYLTPDGKHVLLGNLYDADGKDLSAEPLQKLVYAPMAKEVWGNLEKSNWIADGKADAPRIVYLFSDPNCPYCNMFWEQARPWVKAGKVQLRHIMVGIIREDSPGKSAALLAAKDPQQALQDHEKAGKGSALKPLASIPAAVQAKLDANMKLMEELELSATPAIFYLDDKGELQQQQGAPAPGKLTQILGPK	MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKSYWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIKKLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPSVDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISEVSYNDWIQLFRYKQKID	99.22	gnl|BL_ORD_ID|272|hsp_num:0	303			183	483	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000413.1|Pyoverdine_104 # 156411 # 157223 # -1 # ID=1_104;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.653	BGC0000413.1|Pyoverdine_104 	156411	157223	-	Loose	600	35.4242	EstT	25.22	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGCCTTTCGCAACCATCGATGGACAACCGTTGCACTACCTCGACCAGGGCCAGGGGCCGGTGGTGTTCCTGGCCGGCAGTTATTTGTGGGACACCGGCATGTGGGCGCCGCAGATCGAGGCGCTGTCGGCGCAGTATCGGGTGATCGCCGTGGACCTGTGGGGCCATGGCCAGTCCGGGGCGCTGCCTGAGGGCACCGCGTCGCTGGATGATGTGGCGCGGCAGATGCTGGCCTTGCTCGACCATTTGCAGATCGAGCGAGTAACCCTGGTGGGCTTGTCGGTGGGGGGCATGTGGGGCGCGCGCCTGGCCCTGGCGGCGCCGCAGCGCATCGACGGCCTGGTGCTGATGGACACTTACCTGGGCGCCGAGCCTGCGCCGACCCGGCAGTATTACTTTTCCCTGTTCCAGCAGATCGAGGACAGCGGCCTGATCGCCGAGCCGCTGCTGGATATCGTGGTGCCGATCTTCTTCCGTCCGGGGATCGATCGGCAGTCGGCGCTGTTCCAGGATTTTCGTGCCAGCCTCGCGGCGCTGCCGGCCGAGCGCCTGCGCCAGAGCGTGATTCCCATGGGGCGCATCACTTTCAGCCGGGCGGATGTGCTGGATCAGCTGCAGCACCTGGATGGGCCGAACACCTTGCTGCTGTGTGGTGATCAGGACAAGCCGCGACCACCTGCGGAAACCCTCGAGATGGCCGAACGCATTGGCTGCCCTTACCAGCTGGTTCCTGACGCGGGGCATATTTCCAGCCGGGAAAACCCGGAGTTCGTGACCCGGGCCTTGTTGGCGTTTTTACAGCGCAACGGCTGA	MPFATIDGQPLHYLDQGQGPVVFLAGSYLWDTGMWAPQIEALSAQYRVIAVDLWGHGQSGALPEGTASLDDVARQMLALLDHLQIERVTLVGLSVGGMWGARLALAAPQRIDGLVLMDTYLGAEPAPTRQYYFSLFQQIEDSGLIAEPLLDIVVPIFFRPGIDRQSALFQDFRASLAALPAERLRQSVIPMGRITFSRADVLDQLQHLDGPNTLLLCGDQDKPRPPAETLEMAERIGCPYQLVPDAGHISSRENPEFVTRALLAFLQRNG	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	88.24	gnl|BL_ORD_ID|4956|hsp_num:0	5948			147	480	tigecycline
BGC0000413.1|Pyoverdine_106 # 158247 # 159296 # -1 # ID=1_106;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.628	BGC0000413.1|Pyoverdine_106 	158247	159296	-	Loose	180	24.6386	ykkD	50.0	3003064	protein homolog model	n/a	n/a	aminoglycoside antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	small multidrug resistance (SMR) antibiotic efflux pump	GTGGAACAGATTTTCTGGCGTGATATCGAGGATTTGGCCGGCCACTGGAACGGCCTCGGCGTGGACGTCAAACGCCCGGCCAGCGGCAAGCCCAACCTGTGTCTGCTCAGTGGCAACAACAGCCGTATGCAGTTGGTGCTCGGCGACCAGACCCTGCTCTGGGGCACCATGTCCCGCTGCCTGTATGGCGTATGGCTGGTGCGCAATCACCTGCCGGAGCAACTGCCGCAAACCCTGGTGGGCCCCATCGACTCGCCTCAGGTGGAACAACAGGCGCGCCTCGACCCGGCGTTGCGCCTCAAGGCCTGGAGCCGCTTCTTCGTCGAGCAATTGATGCAGCACCAGCCGGACTTCTTTTACCCCGGCTACTGGCTGGTGCGGGCCCTGCGCCCGGCATCGCAGAAACCGATGCGGCCGCTGCTCAGCGGCACCGAAGCCTGGTACTTCAAGGGCGGTGAAGATGCCCTGAGCCATATGCCGCAGTGGGCGATCTATGGTCGCAACATCCTCGACAACCAACAGGCCGGTACGGCGCGCTGGGTCGGGTTGGGGGAGTACGGTGGCGCAGTAGTCGGCCTGCATGCCGTGGACCCGCATTCCGGGCGCTTGAAGTGGTGGCGCAAAAAAGCCCGCGAAGGCAGCTTGCCGCCGATCCTGCTGTGGTACGTCACCGGTCTGAGCTGCTATCTGATTCTCGATGGCCATTACCGCCTGCAGGCGGCCATCGATGAAAACCTGCCGCCGGAGTTTCTGGTGCTCAGCTCGCCGCGGCTCTACCGCTATCGCCCCAACCCGCAAGAGCAGCAGAAGGTGCTGGGGGCGCTGCAAGTGCAAATCCAGCGCAAAAAACTGGACACCGGGCGCTTCAACCAGTTGCTGATCAGCACCTTCGATGACCGGCCGTATCACGGCTTCGGCAGCCAGTCCTGGGCGGGGATTGCCTCGGAGCAAGTGTGGATCGACCAGGTCAGCGGCATTCTCAAAGAACGCGGTGACCTGAGCGATCTCGAAGAAATCCTCGAACGCGAAGCGCCGGAAGAATATCGGTGA	MEQIFWRDIEDLAGHWNGLGVDVKRPASGKPNLCLLSGNNSRMQLVLGDQTLLWGTMSRCLYGVWLVRNHLPEQLPQTLVGPIDSPQVEQQARLDPALRLKAWSRFFVEQLMQHQPDFFYPGYWLVRALRPASQKPMRPLLSGTEAWYFKGGEDALSHMPQWAIYGRNILDNQQAGTARWVGLGEYGGAVVGLHAVDPHSGRLKWWRKKAREGSLPPILLWYVTGLSCYLILDGHYRLQAAIDENLPPEFLVLSSPRLYRYRPNPQEQQKVLGALQVQIQRKKLDTGRFNQLLISTFDDRPYHGFGSQSWAGIASEQVWIDQVSGILKERGDLSDLEEILEREAPEEYR	MLHWISLLCAGCLEMAGVALMNQYAKEKSVKWVLLIIVGFAASFSLLSYAMETTPMGTAYAVWTGIGTAGGALIGILFYKEQKDAKRIFFIALILCSAVGLKILS	332.38	gnl|BL_ORD_ID|319|hsp_num:0	350			180	228	streptomycin; tetracycline; chloramphenicol
BGC0000413.1|Pyoverdine_108 # 160681 # 173709 # -1 # ID=1_108;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.670	BGC0000413.1|Pyoverdine_108 	160681	173709	-	Loose	1000	169.088	almE	29.22	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACGGACGCGTTCGAACTCCCCAGCACCCTGGCCCAAGCCCTTCAACGCCGGGCAGTCCTGGCACCTGATCAAGTGGCGTTGCGCTTTCTCGCCGAAGAGCAGGATCAGAGCGTGGTCCTCAGTTACCTGGACCTGGACCTTCGTGCGCGCACCATTGCTGCGGCTCTGCAAGCCAACGCCGAATTCGGCGATCGCGCGGTATTGCTGTTTCCCAGCGGCCCGGACTACGTCGCGGCGTTCTTCGGTTGCCTGTACGCCGGGGTGATCGCGGTGCCGGCCTATCCGCCGGAATCCACCCGTCGTCATCACCAGGAGCGCCTGATTTCCATCATGGCCGACGCCGAGCCACGGTTGCTGCTGACCAGCGCCGGGCTGCGGGATTCACTGTTGCAGATGGACGAACTCAAGGCCCCAGGCGCGCCGCAACTGCTGTGTGTGGACACCCTGCAAGCCGGGCTGGCCGAAGACTGGCAGGCCGTGGCGCTGCAGGGCGACGACATCGCCTTCCTGCAATACACCTCGGGCTCCACCGCGCTGCCCAAAGGCGTGCAGGTCAGCCATGGCAACCTGGTGGCCAACGAACTGCTGATCCGTCGCGGCTTCGGTATCGACCTCAACCCGGACGACGTGATCGTCAGCTGGCTGCCGCTGTACCACGACATGGGCTTGATTGGCGGCCTGCTGCAACCGATTTTCAGCGGCGTGCCCTGTGTGCTGATGTCACCGGCCTACTTCCTGGCGCGGCCCGTACGCTGGCTGGAAGCGATCAGCGAATACGGCGGCACCATCAGCGGCGGCCCGGATTTCGCCTACCGCCTGTGCAGCGAACGGGTCAGCGAGTCGGCCCTGGAGCGCCTCGACCTCAGCGGCTGGCGCGTGGCCTATTCGGGGTCCGAGCCGATCCGCCTGGACACCCTGGAGCGTTTCGCCGAGAAGTTCAGCGCCTGCGGTTTCAGCCATGAAAACTTCCTCGCCTCCTACGGCCTGGCCGAAGCCACCCTGTTCGTGGCCGGTGGCGTGCGCGGCCAGGGCATCCCGGCCCTGCACCTGGACGACCAGGCCCTGGCGCAGAACCGCGCCGAGCCGGGGCAGGGCAGCGCGATGATGAGCTGCGGCTTCAGCCAGCCGGAACACGCCGTGCTGGTGATGGATCCGCAGCAACTGGGCGAATTGCCTGACAACCGTATTGGCGAAGTCTGGGCCGCCGGGCCGAGCATTGCCCATGGCTACTGGCGCAATCCTGAAGCCACCGCCAAGACCTTCGTCCAGCATGCCGGTCGTACCTGGTTGCGCACCGGTGACCTGGGCTTTATCCGCGATGGCGAGCTGTTCATCACCGGGCGCCTGAAGGACCTGCTGATCGTGCGCGGGCACAACCTCTACCCCCAGGACATCGAAAAGACCATCGAGCGCGAGGTGGAAGTGGTGCGCAAGGGCCGGGTGGCGGCGTTTGCGGTCACCGAGCAGGGTCAGGAAGGCATCGGCATCGCCGCGGAAATCAGCCGCAGCGTGCAGAAGATCCTGCCCCCCGAGGCGCTGATCAAGGCCATCCGCCAGGCGGTGGCCGAAGCCTGCCAGGAAGCGCCGAGCGTGGTGGTGCTGCTCAACCCCGGGGCCCTGCCGAAAACCTCCAGCGGCAAGTTGCAGCGTTCCGCCTGCCGCACGCGGCTGGCCGATGGCAGCCTGGATTACTACGCGCTGTTCCCGCAGGCCGGCAGCGAACCCGCCCGCGTCGGCGAAGGTTCTGGCGATGAGCTGCAAAACCTGATCGGGCGGATCTGGCAGGAACAGCTGCAATGCGCTTCAGTGGCGGCCGACGATCACTTCTTCCTCCTGGGGGGCAACTCGATTGCCGCTACCCAGGTGATCGCCCGCCTGCGTGAAGAGCTGGGGCTGGAACTGGGCTTGCGCCTGCTGTTCGAGGCTCCGACCCTGGGTGCCTTCAGCGCTGCCGTGGCGCGCCAGCAGCAGGACGGCGGCGTGGCCCAGGGCAGTATCAATGCCCTGTCGCGCCAGCAGCCGCTGCCCCAATCCCTGGCGCAGAACCGCCTGTGGATCACCTGGCAACTGGACCCGCAGAGCAGCGCCTACAACATTCCCGGCGGCCTGCGCTTGCGTGGCGAGCTGGATGAAGAGGCCCTGCGCGCCAGCTTCCAGCAACTGATCCAGCGCCACGAAGCGCTGCGCACGCGCTTCTTCGAGCGTGACGGCCAGGCCCTGCAACAGGTGGATGCCGCCGGCGAATTCAACCTGCAGGTGATCGATATCAGCGACCTGCCACCGGCCGAGCGTGAAGCCCGGGCGCGGCAGATCCGCGAAGACGAGGCCCGGACCCAGTTCGATCTGGAGAAGGGGCCGCTGTACTGGGCGACCCTGGTGCGCCTGGATGACGAAGAACACCAACTGCTGCTGACCCTGCACCACATCATCGCCGACGGCTGGTCGCTGAATGTGCTGATCGACGAGTTCTCGCGGCTCTATGCCGCCGCGGCCCAGGGCCAGAGCCTGGAGCTGGCGCCCCTGGCCCTGCAATACGCCGACTACGGCAGCTGGCAGCGCCAGTGGCTGGCCCAGGGCGAAGGCCAGCGCCAGCTGGACTACTGGAAACAGCAGTTGGCGGACGAAGCCCCGGTGTTGAACCTCGCCACCGACCACCCGCGTTCGGCCCAGGTCCGCCACAGCGCCGCGCGCCATGACCTGCGCCTGAGCGCGAGCCTCAGTGAAGCCGTGCGCCAGACCGCCCAGGCTCGGCAGGCCACGCCGTTCATGCTGTTGCTGGCGGCGTTCCAGACCCTGCTGCACCGCTACAGCGGGCAGGGCGATATCCGCATCGGTGTGCCCAACGCCAACCGCCCGCGCCTGGAGACCCAGGGCCTTCTGGGCTTTTTCATCAACACCCAGGTATTGCGCGGGCAGTTGGATTCGCGCCAGTCCTTCGCCGACCTGCTGCAGCAGACCCGCCGCACCGCCCTGGAGGCCCAGGCCCACCAGGACCTGCCTTTCGAACAATTGCTCGAAGCCTTCCCCGAAGCCCGTGAGCAGGGCCTGTTCCAGGTCATGTTCAACCACCAGCAGCGCGACCTCAGTGCCTTGCGCCGCCTGCCGGGGCTGCTGGCCGAAGAGCTGCCGTGGCACAGCCGCGAGGCCAAGTTCGACCTGCAACTGCACAGCGAAGAGGACCGCAACGGCCGCCTGAGCCTGGCCTTCGACTACGCCGACGAGCTGTTCGACGCGGCCAGCATCGAGCGTCTGGCCGGGCATTTCATCAGCCTGCTGGAGCATGCCTGCCTGCAACCGGACTGCGCCCTGGGCGACTTGCCGTTGCTCGGCAACGCCGAAGCGGCGCAACTGCAGCAATGGAGCGTGGCCCCCTGCGCGCCGGCCGAGCAGTGGCTGCCGGAGCGCCTGCACGAACAACTGCGCCAGAGCCCGGAACGCACCGCGCTGGTCTGGGACGGCGGCCAGCTGGGCTTTGCCGAACTGCACGCCCAGGCCAACCGCCTGGCCCATTACCTGCGGGACAAGGGGGTCGGCCCGGACGTGTGCGTGGCCATCGCCGCCGAACGTTCGCCGCAACTGCTGATCGGCCTTCTGGCAATCATCAAGGCCGGTGGCGCCTACGTGCCCCTGGACCCGGACTACCCCGCCGAACGCCTGGCCTACATGCTCGGCGACAGCGGCGTGCAACTGCTGCTGACCCAGACCCATCTGCTGGGCCGGATGCCCGAAGCCCCGGGTGTCAGCGCCATCGCCATGGACAGCCTCAAGCTCGACAGCTGGCCGAGCCACGCGCCGGGCCTGCACCTGCACGGCGAACACCTGGCCTACGTGATCTACACCTCCGGTTCCACCGGCCAGCCCAAGGGCGTCGGCAACACCCATCGCGCGCTGATGGAGCGCCTGCAATGGATGCAGGACAGCTACCAGCTGCAAGCCGACGATGTGCTGATGCAAAAAGCCCCCATCAGCTTCGACGTGTCGGTGTGGGAGTGCTTCTGGCCGTTGATCACCGGCTGCCGCCTGCTGATCGCCGCCCCCGGCGAGCACCGCGATCCCCATCGCATCGCCCAGCTGGTGCAGGAGTACGGCGTCACCACGCTGCACTTCGTGCCGCCGCTGTTGCAGTTGTTCGTCGATGAGCCGCTGAGCGCCGAATGCCACAGCCTGCGCCGGGTGTTCTCCGGTGGCGAAGCCCTGCCGGCCGAGCTGCGCAATCGCCTATTGCAGCAGTTGCCCAACGCGCAACTGCACAACCGCTACGGCCCCACCGAAACCGCGATCAACGTCACCCATTGGCAGTGTTCGGTGGATGACGGCGAGCGCTCGCCCATTGGCCGGCCGCTGGGCAATGTGCTGTGCCGGGTGCTGGATGCCGAGCTCAATCTGATGCCCGCCGGGGTGCCCGGCGAGCTGTGCATCAGCGGCCAGGGCCTGGCCCGGGGTTACCTGGGACGCCCGGCGCTGACCGCCGAACGCTTTGTGGTCGACCCCCTGAGTGAGGAGGGCGCGCGCCTGTACCGCACCGGTGACCGCGTACGCTGGTGCGCCGACGGCGTGCTGGAATACCTCGGTCGCCTCGACCAGCAGGTCAAGCTGCGGGGCTTTCGGGTCGAGCCGCAGGAAATCGAAGCGCGGCTACTGGCCCAGGACGGCGTGGCCCAGGCCGCGGTGCTGGTGCGCGATACCGTCGCCGGCCCGCAGTTGATCGGCTACTACACCGCCCAGGCCAGCGACGAAGATGAAACCGAGCAAAGCGCCCGGCTGAAAACTGCCCTGGCCGCCGAGCTGCCGGAATACATGGTGCCGGCGCAACTGCTGCGGCTGGACGCCATGCCCCTGAGCCCCAGTGGCAAGCTCGACCGCCGGGCCCTGCCGGAGCCGCAATGGCTGGTGCGCGAGCACGTCGAACCGAGCACCGAACTGGAACAACAGATCGCGGCTATATGGCGCGAAGTGCTGGGCCAGCCACGCATCGGCCTCAAGGACGACTTCTTCGCCCTGGGCGGGCATTCGCTGCTGGCGACCCAGATCATTTCCCGCACCCGCCAGGCCTGCGACGTCGAACTGCCGCTGCGGGCGCTGTTCGAAGCCAGCGAACTGGGGGCCTTTGCCGAGCAGGTGCTGCTGATCCAGCAGTCCGGCGCGCGCAACCAGCAACCGCCGATTGCCCGGGTCGACCGCAGCCAGCCGGTGCCGCTGTCCTATTCCCAGCAGCGCATGTGGTTCCTCTGGCAGATGGAGCCCGACAGCCCAGCCTATAACGTCGGTGGCATGGCGCGGCTGTCTGGCGTGCTCGACGTGGGCCGCTTCGAGGCCGCGCTGCAAGCGCTGATCCTGCGTCACGAAACCCTGCGCACCACCTTCCCTAGCGTCAATGGCGTGGCCCATCAGCAGGTGCATGCCGACACCGGCCTGCGCATGGCCTGGAAGGACTTCTCGGCCCTGGCCCCGGATGCCCGGCAACAACGCCTGCAACAACTGGCGGACAGCGAAGCGCACCAGCCCTTCGACCTGGAGACCGGCCCCTTGCTGCGCGCCTGCCTGGTCAAGGCCGGCGAGCAGGAGCATTACTTCGTCCTGACCCTGCACCATATCGTCACCGAAGGCTGGGCCATGGACATCTTCGCCCGCGAGCTGGGCGCGCTGTACGAAGCCTTCCTCGACGACCGCGAATCGCCCCTGGAACCGCTGCCGGTGCAGTACCTGGACTACAGCGTGTGGCAGCGCCAGTGGCTGGAATCCGGCGAGCGCCAGCGTCAGCTGGACTACTGGACCGGGCAACTGGGCCGCGAACACCCGCTGCTGGAGCTGCCCAGCGACCGGCCACGCCCGGCGGTGCAAAGCCACCAGGGCGAGCTGTACCGCTTCGATTTGAGCGACGAACTGGCGGCCCGGGTGCGCGCCTTCAATGCCGAGCACGGCCTGACCCTGTTCATGACCATGACCGCCGCGTTGTCGCTGCTGCTCTATCGCTACAGCGGCCAGAGCGACCTGCGCATCGGCGCGCCGGTGGCCAACCGCATCCGTCCGGAAAGCGAAGGGCTGATCGGCGCCTTCCTCAACACCCAGGTGCTGCGTTGCCAGCTCGACGGGCAGATGAGCGTCAGCCAGTTACTGGAGCAGGTGCGCCACACCGTGATCGAGGGCCAGTCCCACCAGGACCTGCCGTTCGACCATCTGGTGGAAGCCTTGCAACCACCGCGCAGCACCGCCTACAACCCGCTGTTCCAGGTGATGTGCAACGTCCAGCGCTGGGAATTCCAGCAAAGCCGGCAGTTGGCGGGCATGACCGTGGAATACCTGGTCAACGATGCCCGGGCCACCAAGTTTGACCTCAACCTGGAAGTCACCGACCTGGATCAGCGCCTGGGCTGTTGCCTGACCTACAGCACCGACCTGTTCGACGAGCCGCGCATTGCGCGCATGGCGGCCCATTGGCGCAATCTGCTGGAGGCCTTGCTCAGCGATCCGCAACAGCGTCTGTGCGAATTGCCGCTGCTGCACGCCGAGGAACAGCAGCAACTGCTGGACAGCTTGAGTGTCGAGCCTGGCGAGCAACGTCTGGACCAGTGCATCCACCACCTGTTCAGCGAACAGGCCCTGGCCCGCAAGGACGCACCGGCCCTGACCTTCGCCGGACAGACCCTGAGCTACAGCGAACTGGACAGCCGCGCCAACCGCCTGGCCTGGATGCTTCGCGAGCGTGGCGTGGGCCCGCAAGTGCGGGTCGGCCTGGCCCTGGAGCGCTCCCTGGAAATGGTCGTCGGCCTGCTGGCGATCCTCAAGGCCGGTGGCGCCTACGTGCCCCTGGACCCGGAATACCCCCTGGATCGCCTGCACTACATGATCGAGGACAGCGGCATCGGCCTGCTCCTCAGCGATGCGCGGATGTTCGCCGCCCTGGGTGAGTTGCCCATCAGTGTAGGCCGCTGGTGCCTGGAGGAAGACGGCGCGCTGCTGGCCGACTACCCGGCCGGCGAATTGCCCTTCATCAGCCTGCCCCAGCATCAGGCGTACCTGATCTACACCTCCGGCTCCACCGGCCAGCCCAAGGGCGTGGTGGTGTCCCACGGGGAAATTGCCATGCACTGCCAGGCGGTGATCCGTCGTTTCGGCATGCGCGCGGACGATTGCGAGCTGCACTTCTATTCCATCAACTTCGACGCCGCCACCGAGCGCTTGCTGGTGCCGCTGCTCAGCGGTGCCCAGGTGGTGCTGCGGGCCCAGGGCCAGTGGGACGCCGAGGAAATCTGCCAGCTGATTCGTCAGCATCGCATCAGCATCCTCGGTTTCACCCCGAGCTACGGCAGCCAGTTGGCCCAGCATCTGGCGACCCAGCAGCAGACCCTGCCGGTGCGCATGTGCATCACAGGCGGCGAGGCCCTGACCGGCGAACACCTGCAGCGCATCCGTGCGGCCTTCCAGCCGAGCCTGTTCTTCAACGCCTACGGCCCCACCGAAACCGTGGTCATGCCCTTGGCCAGCCTGGCGCCGGAGCAATTGGCGGACGGCGTGGCCAGCGTGCCGATCGGCCGCATCGTCGGGGCCCGGGTGGCTTACATTCTCGATGCCGATCTGGCGCTGGTGCCCCAAGGGGCGACCGGTGAGCTGTATGTCGGCGGCGCCGGTCTGGCCCAGGGTTATCACCGTCGTCCGGGGATGAGTGCCGAGCGTTTTGTCGCCGATCCGTTCGCCACAGATGGCGGGCGCCTGTACCGCACCGGGGACCTGGTGCGCCAGTGCGCCGACGGCCAGGTGGAATACATCGGCCGGGTGGACCATCAGGTGAAGATCCGCGGTTTCCGCATCGAGCTGGGGGAAATCGAAACCCGCCTGCTGGATCATCCGGCCGTGCGTGAAGCGGTGGTGCTGGCCTTGGATACCCCGGCCGGCAAGCAGCTGGCTGGTTACCTGGTGACCGAGGTGGCCGAGCACAACGATGTGCAGCAGGCCAACCTGCGTGAAGCCCTCAAGCAGCAGCTGAAAACCCAGCTGCCGGACTACATGGTGCCGACCCACCTGATCCTCCTGGCCAGCATGCCGTTGACCGCCAACGGCAAGCTCGACCGCCGGGCCCTGCCATTGCCGGACCCGGAGCTCAACCGCCAGCAGTACGTGGCGCCGAGCAATGAGCTGGAACAGACCCTGGCCGGGGTCTGGGGCGAAGTGCTGAACGTGCAGCAAGTGGGCCTCAACGACAATTTCTTCGAACTGGGGGGCGACTCGATCCTGTCGATCCAGGTGGTCAGCCGTGCCCGCCAGTTGGGGATTCACTTCACCCCGCGGGACCTGTTCCAGCACCAGACCGTGCAGACCCTGGCGCGGGTCGCCAGCCACACTCAGCGCGTCAGCGCCGAGCAGGGCCAGCTCAGTGGCGAAGCGTCGCTGACGCCGATCCAGCACTGGTTCTTCGACAGCCGCATTCCCCAGCCGCAGCACTGGAACCAGGCCTTGTTGCTGGAACCGCTGGGCACCCTGGATGGGTCGTTGCTGGAGCAAGCGCTGCTGGCGGTGCTGGAGCAGCACGACGCCTTGCGCCTGCGTTTCTCTCAGGCAGGTGGGCAGGCAGGCGGGCAATGGCGCGCCGAGTACCTGCCGTTGTCCGATGCTCCCTTGCTCTGGCAGGTGCGGGTGCCGTCCATGGCCACCTGCGAGGCACTGTTCGCCGATGCCCAGCGCAGCCTCGACCTGGAACACGGGCCGCTGCTGCGGGCGGTGCTGGTGGACGGCCCTGAAGGCGAGCAACGCCTGTTGCTGACCATCCACCACCTGGTGGTGGACGGTGTGTCCTGGCGCGTGCTGCTGGAAGATCTGCAAAACGCCTATCGTCAGTTGCAAGCCGGGCAGGCCCTGAAGCTGCCGGCCAAGACCAGTGCCCTGCGGGACTGGTCGAGCCGCCTGCAAGCCTATGCCGGCAGCGAGTCCCTGCGTGAAGAGCTCGGCTGGTGGCAGCAGCAATTGGCCGGCCCGGCCGCGCAACTGCCGGGGCTCAAGGCCACTGGCAGCCAGCAGCATCAACAGGCTCAAAGCCACAGCGTGACCCTGGATGCCGAGCGCACCCGTCAGTTGCTGCAACAGGCTCCAGCGGCCTACCGCACCCAGGTCAACGACCTGCTGCTGACCGCCCTGGCCCGGGTGCTGTGTCGCTGGAGCGGGCAGCCTTCGGCCCTGGTGCAACTGGAAGGCCACGGCCGCGAGGCGCTGTTCGACGAGATCGACCTGACTCGCACCGTGGGTTGGTTCACCAGCGCCTATCCGCTGCGCCTGACGCCGTTGCAGGTGGAAGAAGCGGCCGGGCAGGGCGCCTCGATCAAGGCCATCAAGGAACAACTGCGGGCCGTGCCGCACAAGGGCCTGGGTTACGGCGTGCTGCGCTACCTGGCGGATGAAAGCTGCCGCGAGGCCCTGGCAGCGCTGCCGCTGGCGCCGGTGACCTTCAACTACCTGGGGCAGTTCGACCAGAGTTTCGGTACCGATGCACTGTTGCGCCCGTTGGATGAATCCGTCGGCCCGGCCCATGCACCGGAAGCACCGTTGCCCAACGAACTGAGCATCGACAGCCAGGTGTATGGCGGCGAGCTGGTGCTGCGCTGGACCTACAGCAGCGAACGTTTCGACGCCGAGCTGATCAGCGAGCTGGCGAGCGCCTACCTGGGCGAGCTGCAGAGCCTGATCGGCCATTGCCTGAAGGACGATGCCGGTGGCCTGACGCCGTCCGACTTCCCCCTGGCGCGCCTGACCCAGGCCCAGCTCGATGGCCTGCCGGTACCGGCGGCGCAGATCGAAGACGTCTACCCGCTGACCCCGATGCAGGAGGGCATGCTGTTGCACACCCTGCTGGAGCCGGGCACCGGCCTGTATTACATGCAGGACCGCTACCGCATCAACAGCGAACTGGACCCGGAGCGTTTCGCCCAGGCCTGGCAGGCGGTGGTGGCGCGCCACGAAGCCTTGCGCGCGTCTTTTTGCTGGAACGTCGGCGAAGACATGCTGCAAGTTATCCACAAGCCGGGCCGCACCCCGATCGAGTTTCTCGACTGGAGCGCGGTGCCCGAGGCCGAGCAGGAAGCCAAGCTGCAAGCCCTGCACAAACAGGAGCGTGAGGCCGGCTTCGATCTGCTCAACCAGGCGCCGTTCCACCTGCGGCTGATCCGCGTTGGTGCGGCCCGTTACTGGTTCATGATGAGCAACCACCACATCCTCATCGATGCCTGGTGCCGCTCGCTGCTGATGAACGACTTCTTCGAGATCTACACCGCCCTCGGTGAAGGTCGCGAGGCGCAACTGGCGGTGCCACCGCGTTACCGCGACTACATCGGCTGGCTGCAACACCAGAGCCTGTCCGAGGCGCGGCAGTGGTGGCGGCAGAACCTTGAGGGCTTTGAACGCACCACGCCGATCCCCAGCGACCGGCCGTTCCTGCGCGAACACGCCGGTGACAGCGGCGGCATGATCGTCGGCGACTGCTACACCCGCCTGGATGCCCGGGATGGTGCGCAACTGCGGGAACTGGCGCAGCAGCACCAGCTCACCGTCAACACCTTCGCCCAGGCGGCCTGGGCCCTGGTGCTGCGGCGCATGAGCGGCGATCGCGACGTATTGTTCGGGGTCACCGTGGCCGGGCGCCCGGTGGAAATGCCGGAGATGCAACGCACCGTCGGCCTGTTCATCAACAGCATCGCCCTGCGGGTCAAGCTGCCCCAGGACGGTGAGCGCTGCAGCGTGCGCCAGTGGCTCAGCGGCTTGCTCGACAGCAACATGCAGCTGCGCGAATACGAGTACCTGCCGCTGGTGGCGATCCAGGAAACCAGCGAACTGCCCAAGGGCCAGCCGCTGTTCGACAGCCTGTTCGTGTTCGAGAACGCGCCGGTGGAAGTCTCGGTGCTGGACCGTGCCCAGAGCCTGAACGCCAGTTCGGATTCCGGCCGTACCCACACCAACTTCCCGATCACCGCGGTGTGCTACCCGGGGGATGACCTGGGCCTGCACCTGTCCTACGACCAGCGCTACTTCGAGCAGGCGACCATCGAGCGCATGCTCGGCGAGTTCAAGCGCCTGCTGCTGGCCCTGATGCAGGGCTTTCATGGCGACATGGCCGAACTGCCGCTGCTGGGCGAAGAAGAGCAGGACTTCCTGCTGGCCGGCTGCAACCAGAGCGAGCATGAGTACCCGCTGGAGCGCAGCTACGTGGAACTGTTCGAGGCCCAGGTGGCGGCTCATCCGCAACGCATCGCCGCCAGTTGCCTGGACCAGCGTTACAGCTATGCCGAGTTGAACCGCTGCAGCAACCGCCTGGGCCACGCCCTGGTTGCCAACGGCGTGGGCTTTGATCAGCCGGTGGCCCTGCTGGCCGAGCGCGGCCTGGAACTCTTGGGCATGATCATCGGCAGCTTCAAGGCCGGGGCCGGCTACCTGCCCCTGGACCCGGGCCTGCCGGGCCAGCGCCTGGGCCGCATCATCGAGCTCAGCCGCACGCCGATCCTGGTCTGCACCGCGGCCTGCCGCGAACAGGCCCAGGCCCTGCTGGACGAGTTCGGCTGTGCCGGGCGTCCGCGGCTGCTGGTCTGGGAAGAGCTGCAAGCCGCCGGGCATGCCGAGCACAACCCGGGCCGCTACAGCGCGCCGGACAACCTGGCCTATGTGATCTACACCTCCGGTTCCACCGGCCTGCCCAAGGGCGTGATGGTGGAGCAGCGCGGCATGCTCAACAACCAGCTGAGCAAGGTGCCGTACCTGCACTTAAGTGAGGCCGACGTGATCGCCCAGACCGCGTCCCAGAGCTTCGACATTTCGGTCTGGCAGTTCCTTGCCGCACCGCTGTTCGGCGCTCGGGTGGACATCGTGCCCAACACCATCGCCCACGATCCCCAGGGGCTGTTGGCCCACGTCGAGGAGCAGGGCATCACGGTGCTGGAGAGCGTGCCGTCGCTGATCCAGGGCATGCTCGCCCAGGACGCCATCGCCCTGGATGGCCTGCGCTGGATGCTGCCCACCGGCGAGGCCATGCCGCCCGAGCTGGCGCACCAGTGGCTGCTGCGTTATCCACAGGTCGGCCTGGTCAACGCCTACGGCCCGGCGGAGTGCTCCGATGACGTGGCCTTCTTCCGTGTCGATATGGCCTCGACCCGTGGCGCCTACCTGCCCATCGGCACGCCCACCGACAACAACCAGTTGTACCTGATGGACGAAGCCCTGGAGCTGGTGCCCCTGGGAGCGGTGGGTGAATTGTGCGTGGCTGGCACCGGTGTTGGCCGTGGCTACGTCAGCGACCCGTTGCGTACCGCGCTGGCCTTCGTGCCCCATCCGTTCGGTGCAGCGGGCGAACGCCTGTACCGCACCGGCGACCTGGCACGCCGGCGCAGCGACGGCGTACTGGAATACGTTGGCCGCATTGACCATCAGGTGAAGATCCGCGGCTACCGCATCGAGCTGGGGGAAATCGAAGCGCGCCTGCATGAACAGCCGGAATTGCGCGATGCCGCCGTGGGCGTGCAGGAGGGCGTCAACGGCAAGCACCTGGTTGGGTACCTGGTGGCCAGTGACACGAACCTGAGCCCGAGCGAATGCCTGGAGCGGATCAAGCCGCGGCTGCGCGCCGAACTGCCGGAATACATGGTGCCGCTGCACTGGTTGTGGCTTGCGCACCTGCCGCTCAACGCCAACGGCAAGCTCGATCGCAAGGCCCTGCCGGCCCTGGAGATCGGCCAGCTGCAGAGCCAGGACTACCTGGCCCCGGGCAATGAGCTGGAGCAAACCCTGGCGGACATCTGGGCCGAGGTGCTCAAGGTCGAACGGGTGGGCGTGCGCGACAACTTCTTCGAGTTGGGCGGGCATTCCCTGCTGGCGACCCAGATCGCTTCACGGGTACAGAAGACCCTGCAACGCAACGTGCCGCTGCGGGCCATGTTCGAATGCAGCACGGTGCAGGAGCTGGCCGCGTACATCGACGGCCTGGGGGCCAATGAAATCAGCGAGGAGAAAGTGGATCGGCTGAGCGACCTGATGGCCGAACTGGAGGGGCTGTGA	MTDAFELPSTLAQALQRRAVLAPDQVALRFLAEEQDQSVVLSYLDLDLRARTIAAALQANAEFGDRAVLLFPSGPDYVAAFFGCLYAGVIAVPAYPPESTRRHHQERLISIMADAEPRLLLTSAGLRDSLLQMDELKAPGAPQLLCVDTLQAGLAEDWQAVALQGDDIAFLQYTSGSTALPKGVQVSHGNLVANELLIRRGFGIDLNPDDVIVSWLPLYHDMGLIGGLLQPIFSGVPCVLMSPAYFLARPVRWLEAISEYGGTISGGPDFAYRLCSERVSESALERLDLSGWRVAYSGSEPIRLDTLERFAEKFSACGFSHENFLASYGLAEATLFVAGGVRGQGIPALHLDDQALAQNRAEPGQGSAMMSCGFSQPEHAVLVMDPQQLGELPDNRIGEVWAAGPSIAHGYWRNPEATAKTFVQHAGRTWLRTGDLGFIRDGELFITGRLKDLLIVRGHNLYPQDIEKTIEREVEVVRKGRVAAFAVTEQGQEGIGIAAEISRSVQKILPPEALIKAIRQAVAEACQEAPSVVVLLNPGALPKTSSGKLQRSACRTRLADGSLDYYALFPQAGSEPARVGEGSGDELQNLIGRIWQEQLQCASVAADDHFFLLGGNSIAATQVIARLREELGLELGLRLLFEAPTLGAFSAAVARQQQDGGVAQGSINALSRQQPLPQSLAQNRLWITWQLDPQSSAYNIPGGLRLRGELDEEALRASFQQLIQRHEALRTRFFERDGQALQQVDAAGEFNLQVIDISDLPPAEREARARQIREDEARTQFDLEKGPLYWATLVRLDDEEHQLLLTLHHIIADGWSLNVLIDEFSRLYAAAAQGQSLELAPLALQYADYGSWQRQWLAQGEGQRQLDYWKQQLADEAPVLNLATDHPRSAQVRHSAARHDLRLSASLSEAVRQTAQARQATPFMLLLAAFQTLLHRYSGQGDIRIGVPNANRPRLETQGLLGFFINTQVLRGQLDSRQSFADLLQQTRRTALEAQAHQDLPFEQLLEAFPEAREQGLFQVMFNHQQRDLSALRRLPGLLAEELPWHSREAKFDLQLHSEEDRNGRLSLAFDYADELFDAASIERLAGHFISLLEHACLQPDCALGDLPLLGNAEAAQLQQWSVAPCAPAEQWLPERLHEQLRQSPERTALVWDGGQLGFAELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLIGLLAIIKAGGAYVPLDPDYPAERLAYMLGDSGVQLLLTQTHLLGRMPEAPGVSAIAMDSLKLDSWPSHAPGLHLHGEHLAYVIYTSGSTGQPKGVGNTHRALMERLQWMQDSYQLQADDVLMQKAPISFDVSVWECFWPLITGCRLLIAAPGEHRDPHRIAQLVQEYGVTTLHFVPPLLQLFVDEPLSAECHSLRRVFSGGEALPAELRNRLLQQLPNAQLHNRYGPTETAINVTHWQCSVDDGERSPIGRPLGNVLCRVLDAELNLMPAGVPGELCISGQGLARGYLGRPALTAERFVVDPLSEEGARLYRTGDRVRWCADGVLEYLGRLDQQVKLRGFRVEPQEIEARLLAQDGVAQAAVLVRDTVAGPQLIGYYTAQASDEDETEQSARLKTALAAELPEYMVPAQLLRLDAMPLSPSGKLDRRALPEPQWLVREHVEPSTELEQQIAAIWREVLGQPRIGLKDDFFALGGHSLLATQIISRTRQACDVELPLRALFEASELGAFAEQVLLIQQSGARNQQPPIARVDRSQPVPLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVGRFEAALQALILRHETLRTTFPSVNGVAHQQVHADTGLRMAWKDFSALAPDARQQRLQQLADSEAHQPFDLETGPLLRACLVKAGEQEHYFVLTLHHIVTEGWAMDIFARELGALYEAFLDDRESPLEPLPVQYLDYSVWQRQWLESGERQRQLDYWTGQLGREHPLLELPSDRPRPAVQSHQGELYRFDLSDELAARVRAFNAEHGLTLFMTMTAALSLLLYRYSGQSDLRIGAPVANRIRPESEGLIGAFLNTQVLRCQLDGQMSVSQLLEQVRHTVIEGQSHQDLPFDHLVEALQPPRSTAYNPLFQVMCNVQRWEFQQSRQLAGMTVEYLVNDARATKFDLNLEVTDLDQRLGCCLTYSTDLFDEPRIARMAAHWRNLLEALLSDPQQRLCELPLLHAEEQQQLLDSLSVEPGEQRLDQCIHHLFSEQALARKDAPALTFAGQTLSYSELDSRANRLAWMLRERGVGPQVRVGLALERSLEMVVGLLAILKAGGAYVPLDPEYPLDRLHYMIEDSGIGLLLSDARMFAALGELPISVGRWCLEEDGALLADYPAGELPFISLPQHQAYLIYTSGSTGQPKGVVVSHGEIAMHCQAVIRRFGMRADDCELHFYSINFDAATERLLVPLLSGAQVVLRAQGQWDAEEICQLIRQHRISILGFTPSYGSQLAQHLATQQQTLPVRMCITGGEALTGEHLQRIRAAFQPSLFFNAYGPTETVVMPLASLAPEQLADGVASVPIGRIVGARVAYILDADLALVPQGATGELYVGGAGLAQGYHRRPGMSAERFVADPFATDGGRLYRTGDLVRQCADGQVEYIGRVDHQVKIRGFRIELGEIETRLLDHPAVREAVVLALDTPAGKQLAGYLVTEVAEHNDVQQANLREALKQQLKTQLPDYMVPTHLILLASMPLTANGKLDRRALPLPDPELNRQQYVAPSNELEQTLAGVWGEVLNVQQVGLNDNFFELGGDSILSIQVVSRARQLGIHFTPRDLFQHQTVQTLARVASHTQRVSAEQGQLSGEASLTPIQHWFFDSRIPQPQHWNQALLLEPLGTLDGSLLEQALLAVLEQHDALRLRFSQAGGQAGGQWRAEYLPLSDAPLLWQVRVPSMATCEALFADAQRSLDLEHGPLLRAVLVDGPEGEQRLLLTIHHLVVDGVSWRVLLEDLQNAYRQLQAGQALKLPAKTSALRDWSSRLQAYAGSESLREELGWWQQQLAGPAAQLPGLKATGSQQHQQAQSHSVTLDAERTRQLLQQAPAAYRTQVNDLLLTALARVLCRWSGQPSALVQLEGHGREALFDEIDLTRTVGWFTSAYPLRLTPLQVEEAAGQGASIKAIKEQLRAVPHKGLGYGVLRYLADESCREALAALPLAPVTFNYLGQFDQSFGTDALLRPLDESVGPAHAPEAPLPNELSIDSQVYGGELVLRWTYSSERFDAELISELASAYLGELQSLIGHCLKDDAGGLTPSDFPLARLTQAQLDGLPVPAAQIEDVYPLTPMQEGMLLHTLLEPGTGLYYMQDRYRINSELDPERFAQAWQAVVARHEALRASFCWNVGEDMLQVIHKPGRTPIEFLDWSAVPEAEQEAKLQALHKQEREAGFDLLNQAPFHLRLIRVGAARYWFMMSNHHILIDAWCRSLLMNDFFEIYTALGEGREAQLAVPPRYRDYIGWLQHQSLSEARQWWRQNLEGFERTTPIPSDRPFLREHAGDSGGMIVGDCYTRLDARDGAQLRELAQQHQLTVNTFAQAAWALVLRRMSGDRDVLFGVTVAGRPVEMPEMQRTVGLFINSIALRVKLPQDGERCSVRQWLSGLLDSNMQLREYEYLPLVAIQETSELPKGQPLFDSLFVFENAPVEVSVLDRAQSLNASSDSGRTHTNFPITAVCYPGDDLGLHLSYDQRYFEQATIERMLGEFKRLLLALMQGFHGDMAELPLLGEEEQDFLLAGCNQSEHEYPLERSYVELFEAQVAAHPQRIAASCLDQRYSYAELNRCSNRLGHALVANGVGFDQPVALLAERGLELLGMIIGSFKAGAGYLPLDPGLPGQRLGRIIELSRTPILVCTAACREQAQALLDEFGCAGRPRLLVWEELQAAGHAEHNPGRYSAPDNLAYVIYTSGSTGLPKGVMVEQRGMLNNQLSKVPYLHLSEADVIAQTASQSFDISVWQFLAAPLFGARVDIVPNTIAHDPQGLLAHVEEQGITVLESVPSLIQGMLAQDAIALDGLRWMLPTGEAMPPELAHQWLLRYPQVGLVNAYGPAECSDDVAFFRVDMASTRGAYLPIGTPTDNNQLYLMDEALELVPLGAVGELCVAGTGVGRGYVSDPLRTALAFVPHPFGAAGERLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQPELRDAAVGVQEGVNGKHLVGYLVASDTNLSPSECLERIKPRLRAELPEYMVPLHWLWLAHLPLNANGKLDRKALPALEIGQLQSQDYLAPGNELEQTLADIWAEVLKVERVGVRDNFFELGGHSLLATQIASRVQKTLQRNVPLRAMFECSTVQELAAYIDGLGANEISEEKVDRLSDLMAELEGL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	780.94	gnl|BL_ORD_ID|4935|hsp_num:0	5928			159	1656	colistin A; colistin B
BGC0000413.1|Pyoverdine_27 # 61366 # 61827 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.662	BGC0000413.1|Pyoverdine_27 	61366	61827	+	Loose	300	30.8018	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide	30.77	3003394	protein variant model	A102T	n/a	pyrazine antibiotic	antibiotic target alteration	Pyrazinamide resistant pncA	ATGAACCAGGTGCTGCTGATCATCGACGTGCAACCCTGCTTCAACCCTCCGCAGTGGCTGGTGGACGGCATCAACCGCCTGCTCGGGCGCATGCCCTCGGTGGCCACGGTGGAGCGCCATGATGAAAGCCGCACGCCCTTCGCCCGGCAACTGGGCTGGCAGCCGGCGGTGGATGACCAGAGCCTGGTGGCCGCCGACAAGGTCTTCATCAAGCACGGCTACGGGCCGACGACGGAGATTCTCGAGCACCTCAAAAGCCTCGCCCCCGAGCGTGTGCTGGTGTGCGGTATCCAGACCGACACCTGCGTGCTGGCCGCAGGTTTTGCCCTGTTCGATGCCGGCTTGCAGCCGACCCTGCTCACCGACCTGACCGTGGGTTCGTCCCTGGACCGCAGCGGCGGCCTGGGCATCGACCTGTGGCGGCATCACTTCAAGCACCTGGCCCGCAGCGACGAACTCTAG	MNQVLLIIDVQPCFNPPQWLVDGINRLLGRMPSVATVERHDESRTPFARQLGWQPAVDDQSLVAADKVFIKHGYGPTTEILEHLKSLAPERVLVCGIQTDTCVLAAGFALFDAGLQPTLLTDLTVGSSLDRSGGLGIDLWRHHFKHLARSDEL	MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSGTPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWLRQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASVELVCSS	82.26	gnl|BL_ORD_ID|1945|hsp_num:0	851			210	504	pyrazinamide
